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1. Introduction   
 
________________________________________________________________________ 
 
 
 
 
 
Nowadays environmental contamination is a recognized worldwide problem. Significant 
part of the environmental pollution is caused by the application of pesticides in 
agriculture, horticulture and forestry, by emissions of hazardous chemical substances 
formed during industrial processes and combustion reactions. A large number of these 
compounds and/or their degradation products are highly toxic and they have negative 
effects not only on the ecosystem, but also on human health. In this context it is necessary 
to control the presence of xenobiotics in the environment and at the same time to assess 
the risk to human health due to the presence of these chemicals at workplace or in the 
environment in order to prevent adverse effects.  
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1.1. Environmental and human biological 
monitoring 
 
Environmental monitoring provides information about the use, the fate and the 
degradation of contaminants, and more important, about their concentration in air, water, 
soil, plants, and foods to which the population is exposed. These data can be used only as 
an estimation of the external human exposure to xenobiotics. Because of various 
environmental factors (e.g. temperature, humidity, and wind), biological factors (e.g. 
work habits, smoking, compliance with safety protocols, etc.), the adsorbed or internal 
dose estimates generated by environmental monitoring are frequently under suspect. 
Actual internal exposure can be evaluated only by biological monitoring (BM) (see 
Figure 1.1). Biological monitoring, defined as an evaluation of exposure through the 
measurement of parent compounds, metabolites, or DNA and protein adducts in 
biological samples, can confirm the absorbance of a chemical from the environment 
regardless of the route [2,3]. BM is a complement to environmental monitoring. It is an 
approach for early detection of exposure, and indirectly of risk, and prevention of future 
adverse health effects. Although BM was promoted as a valuable method for exposure 
assessment as early as 1954 [4], in recent years it is gaining increasing popularity in 
occupational and environmental health in order to assess individual chemical exposure [5-
7]. 
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Figure 1.1. Environmental and biological monitoring 
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Biomonitoring usually involves the determination of an exposure marker (biomarker) 
such as parent chemical and/or its metabolite(s) in body fluids (blood, urine), tissues or 
exhaled breath [6]. The definition of biomarker varies slightly acrross scientific fields, but 
the most widely used by toxicologists, occupational hygienists and epidemiologists is an 
indicator of some change in a biological system that can be related to the exposure to, or 
the effect from, a specific chemical [8-10]. Biomarkers are classified into biomarkers of 
exposure to xenobiotics (include intact parent chemicals, metabolites, and 
macromolecular adducts), biomarkers of effect (may be an endogenous compound, a 
measure of functional capacity, or any indicator of actual or potential health impairment), 
and biomarkers of susceptibility (may be a genetic characteristic or a preexisting disease) 
[8].  
 
Some of the desired characteristics of an ideal biomarker of exposure are: specificity in 
relation to the xenobitic, stability in vivo and in vitro, availability by non-invasive 
sampling, relevance to the dose of exposure, presence in concentrations detectable by 
current analytical methods at a reasonable cost in a reasonable time [9,11]. Recently Aitio 
outlined three types of biomarker specificity: analytical specificity (well known to 
analytical chemists and pertaining to the ability of the method to respond specifically to 
the analyte in a complex matrix), metabolic specificity (the extent to which the marker is 
the product of the chemical of interest), and source specificity (the extent to which the 
source of exposure can be attributed to the workplace, lifestyle factors, diet, ecological 
exposures, etc.) [12]. 
 
In the selection of a biological medium for monitoring are important the excretion 
patterns of the selected analyte, the complexity for obtaining the sample, the sampling 
time, and the availability of data relating excretion to exposure [13]. Urine is the most 
widely used biological medium, because is the route of excretion for many xenobiotics, it 
is easy to collect, and the measured concentration of the parent chemical or metabolite is 
proportional to the adsorbed dose for the majority of xenobiotics. To standardize results, 
analyte concentrations in urine usually are adjusted with respect to specific gravity, 
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osmolality, or creatinine concentration. Blood is also an excellent medium for 
biomonitoring, but practical considerations often limit its use for routine control. Thus, 
obtaining samples requires an invasive procedure and blood is frequently a troublesome 
matrix for many analytical methods. Expired breath is used to monitor volatile chemicals. 
Nails, hair, sweat, saliva, milk, feces, teeth, and fat have potential utility for biological 
monitoring, but each is accompanied by disadvantages, such as collection difficulties or 
problems related to contamination, storage, or analysis of samples. 
 
1.1.1. Governmental regulations 
 
In order to control environmental contamination and to protect the population from it, 
governmental agencies have established several directives. In 1976 the European Union 
(EU) set the “black list” of 132 dangerous substances (based on their toxicity, stability 
and bioaccumulation) that should be monitored in waters (Directive 76/464/CE). In the 
list are included organohalogen compounds, substances that can be converted to them and 
other carcinogenic compounds (pesticides, polycyclic aromatic hydrocarbons, etc.) (see 
Table 1.1.). 
 
Table 1.1. Chlorophenols included in the lists of priority contaminants set by EU and by US-EPA 
EU 
Directive 76/464/CEE 
US-EPA  
List of priority contaminants (EPA 8041) 
2-Amino-4-chlorophenol Phenol 
2-Chlorophenol 2-Chlorophenol 
3-Chlorophenol 2,4-Dichlorophenol 
4-Chlorophenol 4-Chloro-3-methylphenol 
4-Chlorophenol-3-methylphenol 2,4,6-Trichlorophenol 
3,4,5-Trichlorophenol Pentachlorophenol 
3,5,6-Trichlorophenol  
2,4,6-Trichlorophenol  
2,4,5-Trichlorophenol  
2,3,4-Trichlorophenol  
Pentachlorophenol  
 
Later the Directive 96/61/CE advised the establishment of monitoring programs to control 
the emission of industrial discharges from textile, pulp, and paper factories, refineries, 
etc. to air, water and soil. More recently, the Directive 2000/60/CE sets the general 
Introduction 
 5 
strategies for water protection and the priority dangerous substances to be controlled 
during the following years. Among them are hexachlorobenzene (HCB), 
hexachlorocyclohexane (HCH, lindane), polycyclic aromatic hydrocarbons (PAHs), 
pentachlorobenzene, pentachlorhenol (PCP), etc. With the aim to protect the health of the 
general population the European Union has established the value of 0.1 µg/L as 
maximum individual concentration and 0.5 µg/L for total concentration of pesticides and 
related products in drinking water (Directive 80/778/CEE). In the US the Environmental 
Protection Agency (EPA) has established the maximum level for each pesticide or its 
transformation products according to their toxicity [14]. For the protection of the public 
against toxic effects of pesticides, regulatory agencies in many countries have established 
standards specifying the residue levels of each pesticide in various foodstuffs. Thus, 
WHO has evaluated and reviewed the acceptable daily intakes (ADI) of pesticides [15].  
 
In occupational hygiene, biological monitoring is used as part of an array of techniques 
for evaluating the workers risk of health damage due to exposure to chemical agents. It is 
especially valuable when conducted to indicate exposure to potentially harmful chemicals 
at a time when preventive measures can be effective in reducing or eliminating the health 
risk. Many organizations worldwide have developed reference values for biological 
monitoring. The Biological Exposure Indexes (BEI) published by the American 
Conference of Governmental Industrial Hygienists (ACGIH) are reference values 
intended as guidelines for the evaluation of potential health hazards in the practice of 
industrial hygiene [16]. The ACGIH also establishes reference values for airborne 
chemical concentrations in the workplace, called Threshold Limit Values (TLV) and 
represent conditions under which nearly all workers may be exposed repeatedly over a 
working lifetime without adverse health effects. Each year ACGIH publishes a list of 
those chemicals for which there are BEIs. The list consists of reference values for 
chemicals and their metabolites in urine, exhaled air, and blood. The chemical 
contaminants included are inorganic compounds, organic solvents, gases, pesticides, and 
specific metabolites. Occupational exposure limits (OELs) issued in the US by the 
Occupational Safety and Health Administration (OSHA) require measurements of toxic 
substances in air rather than in biological samples [17]. Most of OSHA's limits were 
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adopted from the 1968 list of TLVs set by the ACGIH. Although there are no formal 
requirements to monitor exposures to these substances, it is implicit in the standards that 
air sampling will be performed. TLVs and in lesser extent the BEIs have been used by 
governmental agencies around the world as the basis for workplace environmental 
regulations. At this time, biological monitoring plays at most a supporting or 
complementary role in industrial hygiene practice in the US since BEIs have been 
established only for ~50 compounds, while about 700 have TLVs set [18]. 
 
BM has been used more widely in Europe than in the US as one of the several 
complementary tools for assessing worker exposure to chemicals. The most extensively 
used reference values for biological monitoring in Europe are the Biological Tolerance 
Values (BAT) of the German Research Society [19]. Reference and human biological 
monitoring (HBM) values for environmental toxins have also been recommended by the 
Commission on Human Biological Monitoring of the German Federal Environmental 
Agency [20]. Reference values are intended to indicate the upper margin of the current 
background exposure of the general population and used to identify subjects with an 
increased level of exposure. HBM values are derived from human toxicology and 
epidemiology studies and are intended to be used as a basis for a health-related evaluation 
of HBM data. Usually the commission recommends two different HBM values: HBM I, 
the concentration of an environmental toxin in a human biological material (usually 
blood, serum, plasma, or urine) bellow which there is no risk for adverse health effects in 
individuals of the general population; and HBM II, above which there is an increased risk 
for adverse health effects. Reference values and methods have been developed also in UK 
[21]. United Kingdom Control of Substances Hazardous to Health (COSH) uses two 
types of OEL – the occupational exposure standard (OES) and the maximum exposure 
limit (MEL). In many cases the reference values used worldwide are similar, but there are 
significant differences in both the approach to setting biological reference values and in 
their interpretation [19]. For example, the BAT are established as maximum tolerable 
levels, whereas in the US the BEI values established by ACGIH are generally linked to 
air concentrations and apply nearly all workers. A part from different approaches, 
geographic variation in background levels may also influence the reference values. 
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During the past decade the European Union has established its own procedure for setting 
OELs [22]. The Directive 98/24/EC on the protection of the health and safety of workers 
from the risks related to chemical agents at work lays down the minimum requirements 
regarding protection of workers. It defines the terms OELV, biological limit value (BLV), 
health surveillance (HS) and set employers` obligations to determine, assess and prevent 
risks arising from hazardous chemical agents. A key feature of the directive is the setting 
of exposure limits, on the one hand, in the form of indicative and binding OELVs (the 
concentration, in the air breathed in by a worker, of a chemical agent, over a certain 
period) and, on the other hand, in the form of binding BLV (the concentration, in the 
human body, of the relevant agent). The Directive 2000/39/EC establishes the first list of 
indicative OELVs containing limits for 63 substances and also places an obligation on 
member states to establish national OELVs taking into account the Community OELVs, 
determining its nature in accordance with national legislation and practice. The last 
directive must have been implemented by December 2001. 
 
1.1.2. Biological monitoring methods 
 
The classical procedure used to identify and quantify the biomarkers includes its 
extraction and separation from other potentially interfering substances of the biological 
sample and further quantification by instrumental analysis (GC, LC, MS), genetic toxic 
assays, enzymatic and bacterial assays, and immunoassays. The current techniques and 
methods applied for BM are reviewed in [7,23,24]. Although conventional analytical 
methods offer detection limits in the sub-ppb level, they are labor intensive, require 
specialized expensive equipment and sometimes suffer recovery losses. Techniques that 
are not laboratory-based (test kits, dipsticks, indicators, portable devices, and real-time 
monitors) are needed to reduce the cost, and to provide information in time to avoid 
hazardous chemical exposures. BM as part of the occupational medicine is seeking for 
techniques “that cost next to nothing per analysis” [12]. Immunochemical techniques are 
gaining application in the area of human exposure assessment [25,26]. Immunoassays 
have been developed for the detection of key urinary biomarkers of exposure to pesticides 
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and other environmental pollutants, such as triazines, organophosphorous insecticides, 
carbaryl, naphtalene, and PAHs [27-30]. 
 
1.2. Organochlorinated compounds 
 
1.2.1. Production, use and application of chlorophenols 
 
Chlorophenols have been used as anti-stain agents for wood products since the early 
1930s. They have been widely used as anti-fungal agents (preservatives for adhesive, 
synthetic textiles, rubber, wood, paints) in the textile and leather industry and as anti-
microbial agents in pulp and paper mill systems. Although the use of chlorophenols as 
preservatives has dropped down in many developed countries and bleaching procedures 
use alternative procedures other than chlorination processes, chlorophenols are also 
important synthetic intermediates in the manufacture of many industrial and agricultural 
chemicals, such as chlorophenoxy herbicides (2,4,5-T), dyes, fungicides (i.e. prochloraz) 
or bleaching agents (i.e. chloranile). The importance of this industry is evidenced by the 
great amount of phenoxy herbicides and chlorophenols produced (e.g. only one phenoxy 
herbicide manufacturing plant in Germany produced more than 9820 tones/year for the 
period 1965-1989) [31]. Chlorophenols, also appear in the environment when industrial 
wastewater or drinking water resources containing organic materials such as phenolic 
derivatives (i.e derived from lignin), or certain aromatic acids are disinfected. 
Wastewaters from pulp and paper mills have important levels of chlorinated organic 
compounds due to the bleaching processes used. Thus, between 0.6 to 1.6 mg/L 
adsorptive halogenated organic compounds (AOX) were estimated to be emitted daily, by 
the Finish industries in the late 80's [32]. In fact is worth noting that the amount of AOX 
found in several American and European pulp and paper samples was significantly high 
(6 to 1265 mg/L), even if in some occasions these were marketed as total chlorine free 
(TCF) or elemental chlorine free (ECF) products [33,34]. Chlorophenols are also formed 
during the combustion of organic matter in the presence of chlorine or chlorine containing 
compounds [35,36].  
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1.2.2. Physicochemical properties of 2,4,6- and 2,4,5-
trichlorophenols 
 
2,4,6-Trichlophenol (2,4,6-TCP) is yellow to pinkish-orange solid and 2,4,5-trichlophenol 
(2,4,5-TCP) is a colorless solid, both in the form of needles. The technical grade product 
of 2,4,6-TCP is 97% pure and of 2,4,5-TCP is 95% pure. All technical and formulated 
2,4,6- and 2,4,5-TCP products are contaminated in varying degrees by 1,3,6,8-
tetrachlorodibenzo-p-dioxin, 2,3,7,8-trichlorodibenzo-p-dioxin, and tetra-, penta, hexa-, 
and hepta-chlorodibenzofurans. Some of their physicochemical properties are presented 
in Table 1.2.  
 
Table 1.2. Physicochemical properties of 2,4,6-TCP and 2,4,5-TCP 
Chemical/Physical Property 2,4,6-TCP 2,4,5-TCP 
Molecular formula C6H3Cl3O C6H3Cl3O 
Molecular weight 197.45 197.45 
Boiling point (760 mmHg) 246°C 247°C 
Melting point 69°C 69°C 
pKa 6.23 7.4 
Log Kow (octanol/water) 3.69 3.72 
Water solubility (25°C) 800 mg/L 1200 mg/L 
 
The commercial production of 2,4,5- and 2,4,6-TCP in the US was first reported in 1950. 
In the 80s their production in US ceased. The present major use of 2,4,5-TCP is as an 
intermediate in the manufacture of the herbicide 245-T (2,4,5-trichlorophenoxyacetic 
acid), and the pesticides Silvex (2-(2,4,5-trichlophenoxy)propionic acid, 2,4,5-TP), 
Ronnel (o,o-dimethyl-o-2,4,5-trichlorophenyl phosphorothionate), and sodium 2,4,5-
trichlorophenate [37]. 2,4,6-TCP is still used in the synthesis of the fungicide prochloraz 
and in the synthesis of chloranile. 
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1.2.3. Distribution and degradation of trichlorophenols in 
the environment 
 
Even though the discharge of chlorophenols to the environment has decreased during the 
last decade in developed countries, their persistence has determined their widespread 
distribution in the environment still today. Chlorophenols have been identified as usual 
contaminants of surface waters. Particularly, 2,4,5-TCP and 2,4,6-TCP were detected in 
several rivers and lakes in Europe, Canada and South Africa, e.g. in the Isipingo river, 
South Africa, the concentrations were ranging from 0.41 to 6.51 µg/L for 2,4,5-TCP and 
from 1.6 to 26.6 µg/L for 2,4,6-TCP [38]; in the Peace and in the St. Maurice Rivers in 
Canada 2,4,6-TCP has been detected at concentrations up to 30 µg/L [39,40]; in a lake in 
Finland 2,4,5-TCP was found at concentrations 0.001-0.651 µg/L [41]. Similarly, 
trichlorophenols have been found to contaminate soils and sediments. They have been 
measured in sediments of Swedish riverine at low µg/g levels, 40-50 Km downstream 
from cellulose plant discharges [42]. Concentrations of 25-10000 µg/Kg have been also 
measured in the sediments of streams in British Columbia in Canada [43]. In the 
suspended particles and the sediment of Lake Saimaa in Finland, 2,4,6-TCP was detected 
at concentrations between 0.14 and 0.99 µg/g [44]. In New Zealand the sediments of the 
Tarawara and Waikato Rivers contained up to 7.5 and 9.4 ng/g of 2,4,6-TCP, respectively 
[45]. As a consequence significant levels of TCP accumulate in fish and seafood [40,46]. 
A bioconcentration factor of 250-310 has been measured in fish. Contamination of the 
groundwater near sawmills or waste sites has also been reported [47,48]. Drinking water 
may also contain TCPs among other chlorinated phenolic compounds at low levels. Thus, 
concentrations of 2,4,6-TCP varying from 0.03 to 0.7 µg/L have been detected in the 
drinking water of Janakka (Finland), Ville Mercier (Quebec, Canada), and in Utah (USA) 
[49-51]. 2,4,5-TCP has been detected at concentrations 35-59 µg/L in Finland [52] and at 
28 ng/L in Taiwan [53]. 
 
The complete degradation of TCPs (to HCl, CO, CO2) in the environment is slow. 
Various studies on aerobic and anaerobic degradation of TCPs were carried out [54-56]. 
Their abiotic degradation (photocatalytic and ozonation) was also described [57-59]. 
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1.2.4. Absorption, Distribution, Metabolism, Excretion and 
Toxicity (ADMET) of 2,4,6- and 2,4,5-trichlorophenols 
 
Human exposure to chlorophenols takes place by skin absorption, inhalation or oral 
ingestion. As no rigorous toxicokinetic studies in humans are available, the information 
on their ADMET is based mainly on animal studies. ADMET studies on rats fed with 
2,4,6-TCP revealed that the highest concentration of 2,4,6-TCP was found in kidney with 
biological half-times between 1.4 and 1.8 h in the blood, brain, fat, kidney, liver and 
muscle [60]. 82% of the dose is excreted in the urine and 22% in the feces. Binding 
capacity of chlorophenols to serum proteins is enhanced according to their molecular 
weight and level of chlorination [61,62] 
 
Chlorophenols are excreted to the urine as such or in the form of glucuronide and sulfate 
conjugates, the amount of conjugation depending on the particular chlorophenol and its 
concentration in urine [63,64]. At low concentrations sulfate conjugation is dominant, but 
when chlorophenol concentration increases, acid conjugation becomes more important 
[64]. Tubular reabsorption has been observed. A study carried out with sawmill factory 
workers demonstrated that tri- and tetrachlorophenols were excreted totally conjugated 
(97-92.9% for 24h urine, 80.5-79.1% for morning urine and 86.4-81.6% for afternoon 
urine) and the extent of conjugation of PCP was lower (76.2% - 24h urine, 69% -
afternoon urine) [64]. The urinary half-times for tri-, tetra-, and pentachlorophenol were 
18h, 4.3 days and 16 days, respectively. 
 
2,4,6-TCP and 2,4,5-TCP are within the five chlorophenols out from 19 considered to 
have significant toxicological effects and potential carcinogenicity. Although human 
studies have lead to inconclusive results, those carried out in animals have provided 
sufficient evidence of the 2,4,6-TCP carcinogenic effects and inadequate evidence of 
2,4,5-TCP carcinogenicity [65]. CPs affect porphyry metabolism and have been 
confirmed to have mutagenic and immunosuppressive properties [66]. Their toxicity 
seems to be related to the dechlorination mechanism in tissues, which causes enzyme 
inactivation and liver dystrophy [67]. It was also demonstrated that 2,4,6-TCP induces 
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chromosome breakage and aneuploidy in vitro [68]. Long-term exposure of experimental 
animals fed with 2,4,6-TCP contaminated food results in changes in liver and spleen 
cells, in a decrease of the body weight and a decrease of the survival [69]. Test involving 
acute exposure of animals, such as the LD50 test in rats, have shown 2,4,6- and 2,4,5-
TCPs to have moderate acute toxicity [70]. Chronic (long-term) ihnalation by humans is 
associated with respiratory effects such as cough, chronic bronchitis, chest wheezing, 
altered pulmonary function, and pulmonary lesions [69]. Acute intoxication produces 
irritation of the skin, eyes, nose, mucous membranes and upper respiratory tract [71]. 
Additional exposure symptoms may include skin rashes (chloracne), fever, convulsions, 
nausea, vomiting, etc. 
 
An oral Minimal Risk Level (MRL) of 0.003 mg/Kg/day would be applicable to TCPs for 
intermediate exposure duration according to the updated toxicological profiles of 
chlorophenols of the Agency for Toxic Substances and Disease Registry (ATSDR) of the 
U.S. Department of Health and Human Services [70]. Similarly, in Finland an ADI of 50 
µg/day has been established [48]. A recent study among U.S. men aged 30-60 
demonstrated that the occupational exposure to chlorophenols is a risk factor for nasal 
and nasopharyngeal cancers closely associated with the duration of exposure [72]. On the 
other hand, long-term use of chlorophenol polluted household drinking water and 
consumption of contaminated fish have been correlated with certain symptoms, related to 
those occurred after chlorophenol occupational exposure, such as gastrointestinal and skin 
symptoms [73]. 
 
1.2.5. Trichlorophenols as potential biomarkers of 
exposure to orgarnochlorine compounds 
 
2,4,5-TCP and 2,4,6-TCP are considered urinary pesticide residues. They are metabolic 
products of some organochlorine fungicides (hexachlorobenzene), organochlorine 
insecticides (lindane) [74], certain organophosphorous insecticides [75,76], and 
chlorophenoxyacid herbicides, [77]. Animal experiments demonstrated that 
chlorophenols (including 2,4,5-TCP and 2,4,6-TCP) are the main metabolites of HCH 
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[78,79]. In addition, 2,4,5-TCP was found to be the urinary metabolite of HCB [80]. 
Figure 1.2. gives an overview of the chlorinated substances which can be metabolised to 
2,4,5- and 2,4,6-TCPs in the human body. The resulting TCPs are excreted with the urine 
as glucuronic conjugates or sulfates. A study on the excretion and conjugation of 
chlorophenols in saw mill workers demonstrated that the average apparent half-time for 
2,4,6-TCP was 18h [64]. This has an important implication for biological monitoring of 
chlorophenol exposure: Specimen collection for analysis must take place rather soon after 
exposure; otherwise, the TCP that is rapidly excreted may go undetected [64]. Thus, the 
detection of 2,4,5-TCP and 2,4,6-TCP in urine may be an indicator of exposure to 
chlorophenols and to the above-mentioned organochlorine substances, frequently used in 
industry, commerce, agriculture and private households for a variety of reasons [66].  
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Figure 1.2 Trichlorophenols as potential biomarkers of exposure 
Introduction 
 14 
1.2.5.1. Chlorophenols as indicators of exposure to dioxins 
 
Chlorophenols have been named predioxins and can be contemplated as indicators of the 
formation of dioxins [81]. In all combustion processes where chlorine or chlorine 
compounds are present, chlorobenzenes, PCBs, and CPs are formed, the last two groups 
recognized as the actual precursors for dioxin (PCDDs and PCDFs) formation [82]. 
Dioxins, including the most toxic congener 2,4,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 
are formed as unwanted impurities during the manufacturing of chlorophenols and their 
derivatives. Thus, in a German plant the estimated median concentration of TCDD in 
1955-1970 was 5 ppm in 2,4,5-T products, but could reach values between 10 to 50 ppm 
in some processes. Measurements made in the 1970s, revealed that the median 
concentration of TCDD was about 1 ppm and lower than 0.1 ppm after the introduction of 
a new dioxin extraction procedure in 1981 [83]. Dioxins also form in the manufacture of 
pulp and paper following chlorination processes and are emitted from the metallurgical 
industry. They are ubiquitous environmental contaminants and have been found 
throughout the world in soil [84,85], sediment [86], food (fish, meat, cow's milk) [87-90], 
human adipose tissue [91,92] and mothers' milk [93,94]. The main source of exposure of 
the general population is through ingestion of contaminated food. It is important to note 
that animals´ exposure to PCP (cows fed PCP-treated wood and steers accidentally 
exposed to PCP-treated wood) results in high levels of dioxins in milk and beef products 
[87,88]. 
 
PCDDs/PCDFs have been recognized as hazardous highly toxic organochlorine 
compounds [95], since the Seveso accident in 1976 [96] and other accidents at different 
chlorophenol and phenoxy herbicide manufacturing plants [97-101],. Exposure to dioxins 
has been associated to an increased risk for all cancer combined and numerous acute and 
chronic health effects among humans (severe chloracne, porphyria cutanea tarda, 
endocrine disruption etc.) (For recent review on sources of exposure and toxicological 
effects see [102]. Thus, an increased risk for circulatory disease, especially ischemic heart 
disease and possibly diabetes was present among phenoxy herbicide and chlorophenol 
production workers and sprayers according to an IARC international cohort study [103]. 
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The exposure to the TCDD-contaminated herbicide 2,4,5-trichloropheno1 (2,4,5-T) in an 
Austrian plant resulted in symptoms of chloracne and neurogical diseases in the 
production workers [104]. A morbidity study of former pentachlorophenol-production 
workers demonstrated that 17.8% of them had evidenced current or past chloracne [105].  
 
In general, their excretion in urine can be regarded as an indirect indicator of current 
exposure to dioxins [81]. A recent study [106] demonstrates that 2,4,5-TCP and other 
chlorophenols are transformed in vitro to PCDDs/PCDFs by a biochemical-catalyzed 
oxidation. The experiments confirmed that a biochemical formation of dioxins from 
precursors such as chlorophenols can take place in the human body and that this 
metabolic pathway may lead to a higher inner exposure with PCDDs/PCDFs than is now 
assumed. Figure 1.3 presents an overview of the possible relationship between CPs and 
dioxin exposure and their excretion in biological fluids.  
 
There is such type of controversy in the literature dedicated to the discussion on the 
correlation between CPs and dioxin exposure and excretion and the resulting health 
Excretion of:
• Chlorophenols in urine
• Dioxins in blood
catalized oxidation
Exposure to:
• Chlorophenols
• Chlorophenol derivatives
• Dioxins (impurities)
dioxins
O
H
Cln O
H
Cln
O
O ClnCln
PCDDs
PCDFs
O
ClnCln
Chlorophenols
 
 
Figure 1.3. Relationship between chlorophenol and dioxins exposure and excretion 
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effects. However, no doubt exists on the fact that occupational exposure to CPs, 
chlorophenoxy herbicides, and other chlorophenol derivatives produces increased dioxin 
levels in serum. This observation has been extensively described for a variety of 
industrial sectors (waste incinerators, saw mills, chemical plants, etc.). A study performed 
on workers from three different incineration plants in Germany demonstrated that both 
levels of chlorophenols in urine and PCBs in serum were related to the exposure and they 
were higher for the plant with greater amounts of waste burned [35]. An association 
between PCDD/PCDF blood plasma concentration and past exposure to chlorophenols 
has been found for sawmill workers exposed to chlorophenol-containing anti-stain agents 
[107,108]. A study conducted with a group of 20 active employees from BASF exposed 
to phenoxy acid herbicides or/and chlorophenols revealed that although median 
PCDDs/PCDFs concentrations in blood were comparable to the background 
concentrations in the general population, median levels of 2,3,7,8-TCDD, the sum of 
hexachlorodibenzo-p-dioxin, pentachlorodibenzofurnas, and two dioxin toxicity 
equivalents values were higher in 7 employees assigned to synthesis operations than for 
12 employees assigned to other operations [109]. Time of employment in certain 
production areas in chlorinated phenoxyacetic acid herbicides (2,4-D, 2,4,5-T) and 
chlorophenol-manufacturing plants was shown to be a good predictor of 2,3,7,8-TCDD 
levels in blood serum or adipose tissue [83]. Similarly, serum levels of 2,3,7,8-TCDD 
were positively correlated with overall duration of spraying for phenoxy herbicides 
sprayers [83]. They were considerably lower among workers employed after the 
implementation of government regulations to reduce dioxin content in phenoxy 
herbicides. Finally, it has been reported that chimney sweeps had higher levels of 
PCDDs/PCDFs and PCBs in blood, and chlorophenols in urine than those of the control 
group without occupational exposure [110]. However, this study does not present a clear 
evidence on the relationship between urinary CP levels and serum dioxin levels: low 
correlations between blood-fat PCB concentrations as well as urinary chlorophenol 
concentrations and the corresponding PCDDs/PCDs blood concentrations were found 
[110]. In this connection the authors pointed out that chlorophenols indicate actual 
exposure to chlorine compounds, whereas PCDDs/PCDFs and PCBs indicate chronic 
exposure. There are also some uncertainties, in the literature, on the correlation between 
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the presence of dioxin in serum and the resulting toxicological effects. Thus, no clear 
association to some non-cancer mortalities such as cerebrovascular disease was observed 
among phenoxyacid herbicide and chlorophenol production workers and sprayers [103]. 
It was also reported little evidence to support a relationship between the risk of childhood 
cancer and paternal occupational exposure to chlorophenate fungicides and their dioxin 
contaminants in British Columbian sawmills [111].  
 
In conclusion, it is evident that further well-defined studies on the correlation between 
dioxin exposure and urinary chlorophenol excretion would be needed to establish if CPs, 
which are analytical easier to determine, are suitable as predicting parameters for the 
levels of internal PCDD/PCDDF concentration. 
 
1.2.5.2. Occupational exposure to chlorophenols 
 
Occupational exposure may occur through inhalation and dermal contact with this 
compound at workplaces where 2,4,6-TCP, 2,4,5-TCP or the above-mentioned substances 
are used or produced. The National Institute for Occupational Safety and Health (NIOSH) 
had statistically estimated that 851 workers were potentially exposed to 2,4,6- and 2,4,5-
TCP during a three years period National Occupational Exposure Survey (NOES) [112]. 
Worker exposure has been reported in plants producing such kind of chlorinated 
pesticides or fungicides [83,105,109], in pesticide spray operators [83], in Finnish saw 
mills [108], industrial incinerator waste plants [36,113] and electrical utility linemen in 
contact with chlorophenols treated poles used in the electric line construction [114]. Some 
examples for urinary and serum chlorophenol levels for occupationally exposed persons 
are presented in Table 1.3. It can be observed that the levels are quite different depending 
on the industry sector. According to the literature found TCPs are mainly determined in 
urine, although they can be also detected in blood serum. As biological fluid, urine is 
more convenient for samples collection, treatment and analysis. On the other hand, the 
levels of TCPs in urine are higher than in serum [64]. 
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Table 1.3. Cholorophenols levels in biological fluids from occupationally exposed persons (µg/L) 
Industry Clorophenol Min-Max conc. 
Mean 
conc. Reference 
Lindane plant 2,4,6-TCP 2,4,5- and 2,3,6-TCP 
280-3900 
300-6900 
850 
2300 [74] 
Chemical plant 
2,4,6-TCP 
2,4,5-TCP 
2,3,6-TCP 
2,3,5,6-TtCP 
2,3,4,5-TtCP 
PCP 
nd-168 
nd-1168 
nd-284 
nd-528 
nd-800 
nd-1266 
27 
132 
52 
69 
111 
154 
[115] 
TtCP plant: 
synthesis 
packers 
Total CPs 
 
nr 
nr 
 
2300 
1900 
[83] 
2,4,6-TCP 
2,3,4,6-TtCP 
PCP 
nd-0.24 
nd-0.13 
nd-0.08 
nr [116] 
2,4,6-TCP 
2,3,4,6-TCP 
PCP 
nr 
nr 
nr 
5.04 d 
7.59 d 
0.34 d 
2,4,6-TCP 
2,3,4,6-TCP 
PCP 
nd-0.53 c 
1.05-6.01 c 
0.26-1.49 c 
0.22 c 
2.78 c 
0.85 c 
[64] Saw-mills 
2,4,6-TCP 
2,3,4,6-TCP 
PCP 
nd-3.81 
1.35-16.36 
nd-19.56 
nr 
nr 
nr 
[117] 
2,4,6-TCP 
2,4,5-TCP 
PCP 
nr 
nr 
nr 
3.5 a 
0.6 a 
1.9 a 
[118] Waste 
incinerator 2,4,6-TCP 
2,4,5-TCP 
0.16-28.3 
0.02-1.18 
2.91 
0.46 [36] 
Harbour mud 
2,4,6-TCP 
2,4,5- and 2,3,5-TCP 
2,3,4,6- and 2,3,5,6-TtCP 
PCP 
1.9 b 
0.7 b 
2.1 b 
11.5 b 
0.5 
0.7 
<0.5 
1.6 
[119] 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6-TtCP 
2,3,4,5-TtCP 
2-5 
2-34 
1-9 
1-5 
3 
4 
2 
1 
[120] 
Electrical 
utility PCP 
<15 years experience 
>15 years experience 
 
nr 
nr 
 
45.8 a 
18.9 a 
[114] 
a The data is expressed in µg/g creatinine urine. 
b The reported value is the 95% percentile. 
c The data correspond to serum levels. The remaining data in the table correspond to urinary levels. 
d The data is expressed in µmol/L. 
nr – not reported; nd-not detected (below LOD); 
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Finally, it is important to note that in most of the studies reported the health risk 
assessment due to occupational exposure is evaluated on the basis of a comparison of the 
chlorophenol levels with those corresponding to control groups, such as administration 
workers, general population living close to the industry plant or reference values set for 
the country. 
 
1.2.5.3. General population exposure to chlorophenols 
 
Exposure of the general population has been noted via contaminated environment, 
textiles, leather goods, domestic preservatives, and edible products [121,122]. Several 
studies performed in Germany and the US demonstrate that 2,4,5-TCP and 2,4,6-TCP can 
be found in the urine of a high percentage of the population [121-124]. Some examples of 
the cholorophenols levels in urine and serum from non-occupationally exposed persons 
are presented in Table 1.4. Urinary 2,4,5-TCP and 2,4,6-TCP were found in 54% and 
37%, respectively, of the population of Germany [121]. Besides, the levels of 2,4,5-TCP 
and 2,4,6-TCP in urine of refugees from the former USSR, Africa and Asia were 
significantly higher than those found in Germans (the medians differed by a factor of 
three) [124]. The analysis of the urine of adults in the US having not known occupational 
contact to chlorophenols or related substances revealed that 2,4,5-TCP and 2,4,6-TCP 
were present in 20 and 9.5% of the population [122]. In another study on the levels of 
Arkansas children 2,4,5-TCP was observed in 54% of the samples and 2,4,6-TCP in 11% 
of the samples [125]. 
 
Although exposure limit values (BEI/BAT) for some CPs (p-chlorophenol, 
pentachlorophenol) in biological fluids are established, there is still lack of information 
about TCPs (see Table 1.5).  
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Table 1.4. Cholorophenols levels in biological fluids from non-occupationally exposed persons 
(µg/L) 
Country Clorophenol Min - Max Median 95% Reference 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6- / 2,3,5,6-TtCP 
1.2-15 
0.8-75 
2.5-191 
2 
1 
2 
4.7 
4.5 
22.2 
[121] 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6-TtCP 
dl a-3.97 
dl-3.35 
dl-4.86 
0.61 
0.25 
0.36 
1.74 
1.1 
1.86 
[123] 
PCP 0.5-189 2.8 nr [126] 
PCP nr-59.3 b 1.7 b 6.1 b [127] 
Germany 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6- / 2,3,5,6TtCP 
<dl-3.80 
<dl-3.00 
<dl-15.49 
0.60 
0.85 
<dl 
2.37 
2.73 
6.94 
Asia 2,4,6-TCP 
2,4,5-TCP 
2,3,4,6- / 2,3,5,6TtCP 
nd-35.78 
0.34-8.89 
<dl-4.73 
1.90 
2.00 
<dl 
33.05
8.48 
4.49 
Africa 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6- / 2,3,5,6TtCP 
0.40-11.70 
0.70-42.50 
<dl-16.30 
1.70 
1.85 
0.60 
9.63 
34.77 
12.69 
former 
USSR 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6- / 2,3,5,6TtCP 
0.50-19.32 
0.50-14.4 
<dl-5.40 
1.71 
1.80 
0.60 
16.32 
12.05 
5.25 
Yugoslavia 
2,4,6-TCP 
2,4,5-TCP 
2,3,4,6- / 2,3,5,6TtCP 
nd-4.00 
0.51-3.00 
<dl-1.70 
1.1 
1.1 
<dl 
1.70 d 
1.90 d 
0.80 d 
[124] 
TCPs 
2,3,4,6- / 2,3,5,6TtCP 
PCP 
not detected 
nr 
4-136 
- 
6.2 
25 
- 
nr 
nr Spain 
PCP 2.5-116.5  21.9 b nr 
[128] 
Spain 2,4,5-TCP 
2,4,6-TCP 
PCP 
nr 
nr 
nr 
0.4 c 
0.6 c 
1.7 c 
nr 
nr 
nr 
[118] 
Canada PCP 0.1-3.6 0.5 nr [129] 
Slovakia 
2,4,6-TCP 
2,4,5-TCP 
2,3,6-TCP 
2,3,5,6-TtCP 
2,3,4,5-TtCP 
PCP 
nd-106 
nd-380 
nd-116 
nd-161 
nd-268 
nd-300 
nd 
nd 
17 
nd 
nd 
19 
nr 
nr 
nr 
nr 
nr 
nr 
[115] 
2,4,6-TCP 
2,4,5-TCP 
nd-41 
nd-32 
<1 
1 
4 
7 [125] USA 
2,4,6-TCP 
2,4,5-TCP 
0.8-63 
1.2-25 
<1 
<2 
3 
3.3 [75] 
a The detection limit (dl) is 0.02 µg/L for urine samples. 
b The data correspond to serum levels. The remaining data in the table correspond to urinary levels. 
c The data is expressed in µg/g creatinine urine. d The data correspond to the 75th percentile. 
nr – not reported; nd-not detected (below limit of determination) 
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Table 1.5. Reference values for biological monitoring 
Parent  
chemical Biomarker 
Biological 
fluid BEI
a / BATb Reference values 
urine 2 mg/g creat.a 8 µg/L 
c 
(6 µg/g creat.) PCP PCP 
serum/plasma 5 mg/L a 12 µg/L c 
blood 20 µg/L b 0.3 µg/L c Lindane serum/plasma 25 µg/L b - Lindane 
trichlorophenols urine nd 4.5 µg/L 
d 
(5 µg/g creat.) 
HCB serum/plasma 150 µg/L b 0.4 µg/L c 
HCB 
trichlorophenols urine nd 4.5 µg/L 
d 
(5 µg/g creat.) 
p-dichlorobenzene 2,5-dichlorophenol urine nd 5 µg/g creat. d 
chlorobenzene p-chlorophenol urine 25 mg/g creat.a - 
a Biological Exposure Index (OSHA); b Biological Tolerance Value (GCIHHCCWA) 
c Reference values of the Commission on Human Biological Monitoring of the German Federal 
Environmental Agency. The value reported for HCB corresponds to the age group 26-36 years 
[20]; d Background levels in the general population of Germany [36,81]; nd – not defined 
 
At present, reference values based on the background level of the general population are 
used to evaluate whether occupational exposure to CPs or related organochlorine 
compounds has taken place or not. The reference values means that 95% of the non-
occupationally exposed general population has concentrations lower than this level. In 
Germany the reference value of 4.5 µg/L (5 µg/g creatinine) for 2,4,6-TCP and 2,4,5-TCP 
is set [81]. In Finland, a biological reference limit of 0.5 µmol/L has been established for 
total urinary chlorophenols (as the sum of TCPs, TtCPS and PCP) for non-exposed 
persons [130]. 
 
1.2.6. Analytical methods for trichlorophenol determination 
in environmental and biological samples 
 
The methods used for chlorophenol analysis are quite diverse and depend on the type of 
the matrix sample used (water, solid, air, urine, serum, etc.). Analytical techniques mainly 
used in the determination of chlorophenols in environmental and biological samples are 
gas chromatography with electron-capture (GC-ECD) [78,123,131], flame ionization 
Introduction 
 22 
(GC-FID) [132,133] or mass spectrometer detectors (GC-MS) [117,121,134-136]. Liquid 
chromatography (LC or HPLC) in combination with ultraviolet (UV) [137], 
electrochemical detection [77,138-140] or capillary electrophoresis [141-143] has also 
been used. The standard and official methods for determination of TCPs in water are the 
EPA methods 604, 625 and 8041 [144-146]. They are based on chlorophenol liquid-liquid 
or solid phase extraction followed by derivatization with diazomethane, methylene 
chloride or pentafluorobenzyl bromide and GC-FID, GC-ECD or GC-MS detection. 
However, the LOD of these methods (for example, 0.64 µg/L for method 604-GC-FID, 
0.58 µg/L for method 604-GC-ECD and 2.7 µg/L for method 625-GC-MS) cannot satisfy 
the requirements of the EU regarding pesticide levels in drinking water (Directive 
80/778/CCE). 
 
The most frequently employed analytical procedures for chlorophenols involve the use of 
solvent extraction [117,120,147], solid-phase extraction [36,120,123,131,136,148], solid-
phase microextraction [116,149,150] or supercritical fluid extraction [151,152]. Different 
derivatization reactions are often required to increase the volatility of the analytes 
[117,121,135,153,154]. Although many of the methods mentioned above offer very low 
detection limits (at the low ppb range), they lack the necessary speed for rapid screening 
of large number of samples, such as those needed for biomonitoring. This is due to the 
extensive sample clean-up required prior to the analysis as well as the time needed for 
chromatographic measurements. Furthermore, the lipids present in the serum and in urine 
samples often cause interferences in the GC/LC analysis of these compounds, especially 
at levels close to the detection limit. Therefore, rapid, cost-effective, and reliable 
screening techniques with simple or no sample pre-treatment are essential for routine 
assessment of human and environmental exposure to hazardous chemicals. 
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Figure 1.3. Antibody structure. Constant domains: CL; CH1, CH2 and CH3; variable domains: 
VL and VH. Antigen binding site: CDR (hypervariable regions): L1, L2, L3; H1, H2, H3; 
constant framework: black line. 
 
1.3. Immunochemical techniques 
 
1.3.1. Antibody - structure, properties and production  
 
The key component in any immunochemical technique is the antibody. Antibodies are 
globular proteins produced by the immune system of the mammals as a defense against 
foreign agents (antigen, Ag). The structure of the antibody molecules varies depending on 
their isotype, but all possess common characteristics, typified by the immunoglobulin G 
(IgG) subclass, which is the one most used in immunochemical applications. The IgGs 
(Mw 150 kDa) are composed of four polypeptide chains: two identical heavy (H) and two 
identical light (L) chains (50 kDa and 23-25 kDa, respectively) interlinked by disulphide 
bridges (see Figure 1.3) [155].  
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The region that carry the antigen binding sites is known as Fab fragment, and the constant 
(crystallized) region that is involved in immune regulation is termed Fc. Both H and L 
chains are divided into constant (C) and variable (V) domains based on their amino acid 
sequence variability. The most important regions of the antibody with regard to the Ab-
Ag binding interaction are the variable regions, consisting of the association of the VH 
and VL domains. Within each of these domains there are three distinct areas of even 
higher sequence variability, known as complementary determing regions (CDRs), 
bounded by four framework (FR) regions. The CDRs of the VH and VL domains formed 
the antigen-binding site. Their amino acid sequence and spatial conformation determine 
the binding specificity and binding strength (affinity) of the Ab molecule. The interaction 
between Ab and Ag is reversible and it is stabilized by electrostatic forces, hydrogen 
bonds, hydrophobic and Van der Waals interactions [156]. At equilibrium when the 
AbAg complex is formed, the affinity constant Ka is defined as : 
 
[ ]
[ ] [ ]AgAb
AbAgKa ⋅=  
 
Antibody fragments can be generated by enzymatic or chemical degradation and by 
genetic engineering [157]. These include the F(ab)2, Fab, Fd fragments; Fv, the smallest 
fragment required for complete Ag binding; single-chain scFv fragments, in which Fv is 
stabilized by a flexible amino acid linker; etc. (see Figure 1.3). 
 
Currently, antibodies can be produced by three different techniques, yielding polyclonal 
Abs (pAb, if purified from animal's antiserum), monoclonal Abs (mAb, if produced via 
hybridoma techniques), and recombinant Abs (if based on genetic engineering). 
Polyclonal antiserum contains several different populations of IgGs exhibiting binding 
properties to different epitopes (antigenic determinants) on the antigen. The activity of a 
polyclonal antiserum is a combination of the responses from different Abs having as well 
as different tolerance to solvent and matrix interferences, which is important for assay 
performance [155]. Many environmental immunoassays are based on pAbs, because they 
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can have a high affinity for a given analyte (average detection limit 0.01-0.1 ppb), robust 
nature for analysis in sample matrixes and their production is far simpler than monoclonal 
and recombinant Abs [158]. Polyclonal Abs can be difficult to obtain in large and 
reproducible quantities; however, large-scale production can be achieved using goats and 
sheeps.  
 
Monoclonal Abs are produced by fusing antibody-producing spleen cells from an 
immunized animal (mouse) with mutant tumor cells derived from myelomas (cancerous 
murine plasma cells) [159]. Thus, mAbs contain a unique defined IgG molecule produced 
by a single cell clone. The advantages of the hybridoma technology are that, theoretically, 
it provides an unlimited amount of Abs with identical affinity for an Ag and the 
possibility to screen for those clones of Abs with the desired pattern of specificity. 
However, generally mAbs have lower affinities to small molecules than pAbs and are 
more expensive to produce [26]. 
 
Recombinant Ab phage display technology, developed during the last decade, has 
allowed the generation of a variety of Ab fragments mimicking the immune response in 
vitro. In general the whole process include (1) the preparation of Ab encoding libraries 
(V-genes repertoires) derived by a range of methods (by isolation of mRNA from 
hybridoma, spleen cells or lymphocyte of immunized or no immunized donors, assembly 
of gene fragments to create synthetic V-gene repertoires, etc.); (2) cloning of the genes in 
a bacterial plasmid vector; (3) expression in bacteria (E.coli) and then co-infection with 
helper bacteriophage virus, displaying Ab fragments on its surface as a fusion with 
normally occurring coat protein; (4) screening for antigen specificity and antigen-driven 
selection (for reviews see [160,161]). Although the development of these methods has 
been conducted mainly by therapeutic application, recombinant Ab fragments were used 
also in environmental analysis [162-165]. Genetic engineering provides an elegant way 
not only for providing unlimited amounts of biorecognition molecules but also for the 
alteration of existing properties and the supplementation with additional functions for 
their application in immunosensors [166,167]. Another very important advantage of these 
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techniques over the conventional methods for obtaining pAbs and mAbs, is their cost-
effective production. 
 
1.3.2. Antibody-based analytical methods  
 
Immunochemical methods are based on the specific (selective) binding of an Ab to an Ag 
(or analyte). They are bioaffinity methods that can be used in bioanalytical determination 
(immunoassays) and bioseparation (e.g. immunoaffinity extraction) of a target analyte in 
a variety of sample matrixes [26,157]. Nowadays, immunoassay methods provide cost-
effective, sensitive, and selective analyses for many compounds of environmental and 
human health concern. Development on immunosensor systems is a great promise for 
future automation of these immunodetection strategies. Immunoaffinity chromatography 
methods are also used as efficient sample preparations prior to immunochemical or 
instrumental detection. 
 
Immunochemical methods are simple, fast, and sensitive, with high throughput, easily 
learned by nonscientist users and can be very cost-effective, compared to conventional 
analytical methods which are often time-consuming, labor intensive, expensive, and 
laboratory oriented. Immunoassays are versatile and can be tailored in various formats to 
particular purposes, ranging from quantitative laboratory tests to simple “yes/no” 
screening tests that are field-portable. These advantages can be exploited in monitoring 
programs where great number of samples needs to be analyzed. The major disadvantage 
in immunoassays is the tendency toward a positive bias due to matrix effects in real 
sample measurements (false positives). Thus, as effective screening techniques 
immunochemical methods are complementary in effect to the standard analytical 
techniques. 
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1.3.2.1. Bioanalytical detection methods 
 
1.3.2.1.1. Immunoassays 
 
Immunoassays (IAs) were first applied in clinical settings where their sensitivity and 
selectivity were used for diagnostic purposes [168]. In the 1970s chemists realized the 
potential of immunoassays for the environmental monitoring of pollutants [169,170]. 
Antibody-based analytical detection methods have gained favor in environmental 
analytical processes beginning in the 1980s, when they were recognized as useful 
screening techniques for the detection of compounds of environmental regulatory concern 
[171]. Over the following years a great number of IAs for detection of trace amounts of 
contaminants, such as pesticides, industrial residues and their degradation products in the 
environment (water, soil, sediments, etc.) have been developed ([158,172-174]). 
Nowadays, an important number of IAs for pesticides are commercially available and the 
US-EPA has validated some of these assays and included 13 of them in the SW-846 
methods list [175]. The IA technology have found also wide application in 
pharmaceutical, food, veterinary and forensic analysis. A more recent application is in the 
area of human exposure assessment to a variety of industrial chemicals, trace 
contaminants (such as PAHs, PCBs, PCDDs) and pesticides reviewed in [7,25,26,28,29]. 
Several IAs have been developed recently for urinary detection of metabolites, such as 
mercapturates [176-178], phenyl glucuronides [179,180], 3,5,6-trichloro-2-pyridinol 
[181-184], PAHs [30], etc. Human biomonitoring studies usually require the analysis of 
large number of samples (e.g., routine urinary screening of workers in a chemical 
manufacturing plant, or monitoring large populations to determine background levels of 
xenobiotic metabolites). High sample throughput is a feature of immunoassays that makes 
them particularly suited to field studies or large-scale monitoring efforts. In addition, Ab 
cross-reactivity may allow both parent molecule and its metabolite to be registered 
simultaneously. In this context, EPA encourages the development of immunochemical 
techniques and devices for human exposure monitoring [26]. 
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Immunoassays are very versatile and they can readily be formatted to suit particular 
requirements of the intended application [156,185]. They are homogeneous (if the 
immunoreaction takes place in solution) and heterogeneous (if one of the 
immunoreagents is immobilized on a solid support (micro plates, tubes, micro spheres, 
magnetic particles). Heterogeneous assays does not require a separation between the free 
and bound phases, whereas homogeneous assays require no separation before detection 
since the Ag-Ab binding modulates the activity of the reporter enzyme or label. Although 
simpler to perform (quick, no washing steps), homogeneous immunoassays are more 
hampered by matrix interferences. Heterogeneous formats have found a broader 
application to many fields and also to different kind of analytes. 
 
In IA procedures the quantification of small molecules is performed under competitive 
conditions. The general strategy of competitive assays is based on the competition 
between the free Ag (analyte) and a fixed amount of labeled Ag for a limited amount (low 
concentration) of Ab. At the end of the reaction the amount of labeled Ag and 
subsequently the free Ag is determined. The labels used to quantify the immunoreaction 
can be of different nature. The initially developed IAs (RIA, radioimunoassays) used 
radioactive reporters [186,187], but due to the generation of radioactive residues and the 
adverse health and environmental impacts produced, they have been replaced by other 
types of labelling substances. Nowadays enzymes are the most common used labels in 
IAs for environmental analysis [188]. The most frequently used enzymes are horseradish 
peroxidase (HRP), alkaline phosphatase (AP), and glucose oxidase (GO). Enzyme 
immunoassays (EIA) use the enzyme substrate reaction to produce a chromogen often 
absorbing in the visible region. The amplifying effect of the enzyme label allows for the 
development of many sensitive assays using absorbance measurement at the end point. 
The more common EIA techniques are the competitive homogeneous IA named EMIT 
(Enzyme Multiplyed Immunoassay Technique) and the heterogeneous EIA, ELISA 
(Enzyme Linked Immunosorbent Assay). ELISAs are the most popular EIAs used in 
environmental monitoring. The most usual configurations for the analysis of small 
molecules (direct and indirect ELISA) are shown in Figure 1.4. In the direct competitive 
Ab coating format the equilibrium is established between the Ab bound to the solid phase 
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Figure 1.4. Scheme of the most commonly employed heterogeneous IA configurations (ELISA) 
for the detection of low molecular weight analytes. 
(either directly or through orienting agents, such as antibodies generated against 
immunoglobulins (anti-IgG) or protein A), the analyte and the analyte-enzyme tracer 
(ET) that are in the solution (see Figure 1.4.A). After the main incubation step, the 
unbound reagents are washed away and the amount of label bound to the solid phase by 
the Ab is measured. A decrease in the signal is directly proportional to the amount of 
analyte present in the sample.  
 
Another possibility to perform the direct IA is the Ag coated format, which is based on 
the competition between the immobilized Ag (or surface derivatized analyte) and the 
analyte for a fixed small amount of labeled Ab. The indirect competitive ELISA works 
under the same principle as the coating Ag (CA) format, but the concentration of the 
analyte is measured in this case indirectly by the quantification of bound Ab with a 
second labeled Ab (labeled anti-IgG) (see Figure 1.4.B). 
 
Introduction 
 30 
Fluorescence immunoassays (fluroimmunoassays, FIA) use fluorescent labels, such as 
fluorescein, rhodamine, cyanines or rare earth quelates (Eu(III), Tb(III)) [189]. 
Fluorimetry (fluorescence) was introduced in immunological assays mainly because of its 
superior sensitivity (10-1000-fold higher) compared to that of spectrophotometric 
methods. The search for single molecule detection [190] has stimulated the development 
of a variety of FIAs that are gaining popularity. The main limitation of these techniques 
when applied to biological fluids is the limited sensitivity due to background noise. This 
has provoked the search for novel labels with longer excitation and emission 
wavelengths. 
 
The current trends in IAs include an emphasis on non-radioactive labels, more specific 
reagents, and improved formats for automating or performing IAs [185]. In this context, 
flow injection methods coupled to immunoassays (FIIA) allows continuous operation and 
high sample throughput providing rapid results and sensitivity detection [191,192]. 
Furthermore, IA automation and system integration continue to be some of the most 
dynamic and innovative areas for research and development in the clinical diagnostic 
industry [193].  
 
1.3.2.1.2. Immunosensors 
 
Immunosensors are part of the biosensor technology field, which is broad, diverse and 
multidisciplinary in nature. The term biosensor is defined as an analytical device that 
consists of a biological component (Ab, enzyme, receptor, DNA, cell, etc.) in intimate 
contact with a physical transducer that converts the biorecognition process into a 
measurable signal (electrical or optical) (see Figure 1.5). In this sense, immunosensors 
are affinity-based sensors designed to detect the direct binding of an Ab or an Ag to form 
an immunocomplex at the transducer surface. Depending on the transducer technology 
employed, immunosensors can be divided into three principal classes: optical, 
electrochemical and piezoelectrical (see Table 1.6).  
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Figure 1.5 Essential components of a biosensor (biorecgnition element, transducer and 
electronic part involved in data processing and display). 
 
Table 1.6. Transducers and principle of detection in biosensors 
Transducer Method Principle Detection a 
Surface Plasmon 
Resonance (SPR) 
Changes in refractive index D 
Total Internal Reflection Evanescent wave I Optical 
Photon Correlation 
Spectroscopy (PCS) 
Changes in scattered light D 
Amperometric Changes in the oxidation state of the 
electrochemical substances 
I  
Potentiometric Changes in the surface potential D, I Electro chemical 
Conductimetric 
Impedimetric 
Changes in the conductivity of the 
solution 
D, I 
Bulk acoustic Piezo 
electric Surface Acoustic Wave 
(SAW) 
Changes in the frequency of a 
piezoelectric crystal 
D 
Thermal Thermistor devices Changes in temperature produced as the result of an enzymatic reaction 
I 
a D –direct detection; I – indirect detection. 
 
Furthermore, as they are based on the principles of the solid-phase immunoassays, they 
can be either direct (where the immunochemical reaction is directly determined by 
measuring the physical changes induced by the formation of the immune complex) or 
indirect (where a sensitive detectable label is combined with the Ab or Ag of interest). As 
environmental contaminants are often small-sized molecules, most of the devices reported 
perform indirect measurements by using competitive immunoassay configurations and/or 
labels such as enzymes, fluorescent chemicals, or electrochemically active substances. 
The sensitivity and specificity of an immunosensor are determined by the same 
characteristics as in other solid-phase immunoassays, namely, the affinity and specificity 
of the binding agent, and the background noise of the detection system (transducer). 
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Challenges still encountered with biosensor development are fabrication, immobilization 
onto a transducer, effective signal generation, miniaturization and integration.  
 
The majority of biosensor research is currently directed towards clinical applications, but 
a variety of immunosensors for environmental applications have also been developed in 
the last years [194-197]. Both types of optical and electrochemical transducers have 
demonstrated to provide detection limits in the low parts-per-billion to the high parts-per-
trillion range. Research on the Ab field is still growing and future perspectives also count 
on the use of recombinant fragments with desired characteristics, better defined regarding 
their chemical structure, stability, etc.. As the orientation of the binding molecule 
(recognition element) after being immobilized onto a transducer would likely to affect the 
sensitivity it is desirable to equip the recombinant Ab fragments with suitable tags to 
facilitate their orientation at the sensor surface [166]. However, implementation and 
commercialization of immunosensor technology is being slow. With further improvement 
in the fabrication of miniaturized biosensors that are simple, rapid, portable, cost-
effective, and with ability to regenerate, it is anticipated that they will provide a powerful 
tool for environmental and biological monitoring. 
 
1.3.2.2. Bioseparation techniques 
 
Immunochemical techniques are recognized not only as bioanalytical detection methods, 
but they have found also application for extraction and sample preparation prior to a 
second analytical method [26,198-200]. Immunoaffinity extraction (IAE) (or 
immunoaffinity chromatography (IAC)) for trace-analysis of low-molecular weight 
analytes in complex matrices have several advantages over conventional SPE formats: it 
provides a highly selective extraction based on specific molecular recognition; antibody 
cross-reactivity allows multiresidue analysis targeting a parent compound and its 
metabolites or a class of structurally related analytes; IAC allows pre-concentration of 
analytes from large sample volumes resulting in low detection limits; it minimizes 
reliance on organic solvents to achieve efficient separation [201-203] and it have great 
potential for the selective purification especially of polar compounds which are difficult 
Introduction 
 33 
to isolate by other commonly used supports. A wide range of applications of solid-phase 
immunoaffinity extraction has been developed, both on-line and off-line, being coupled 
mostly to HPLC, GC and capillary electrophoresis [200], and to a lesser extent to 
immunoassays [204-206]. The most common applications are focused on organic 
pollutants such as pesticides and toxins in environmental samples (water, soil, crops, 
food) and drugs in biological matrices (plasma, urine, tissue) reviewed in [201,202,207-
210]. However, besides its demonstrated versatility and specificity, IAC is still seldom 
used for human exposure monitoring studies. Isolation of PCDD and PCDF from serum 
samples using IAC prior to GC-MS has been reported [211-213]. Evaluation of the 
occupational exposure to PAH has been performed by measuring the urinary excretion of 
PAH metabolites using IAC-HPLC [214,215]. 
 
Although proven to be suitable for sample preparation and cleanup, IAC is still seldom 
used in routine environmental analysis. This is partly because very effective and 
relatively cheap solid-phase extraction methods for some contaminants, such as pesticides 
are already available commercially. In addition, the method requires relatively high 
amount of Ab and hence it is regarded as uneconomical if Ab is limited. This limitation 
can be easily overcome by the use of pAbs from large animals (goat, sheep, cattle) or 
monoclonal Abs. The actual high price of these immunoreagents increases the cost of the 
IAC technique. In this context recombinant DNA technologies will hopefully decrease 
the price, facilitating the widespread commercial application of immunoaffinity 
purification methods. 
 
1.4. Immunochemical techniques for 
organochlorinated substances 
 
A variety of immunochemical methods have been developed for many organochlorinated 
substances, such as pesticides (organochlorines, chlorophenoxy acids) and trace 
contaminants. Some examples for the immunodetection of the most important 
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organochlorinated contaminants in environmental and biological matrices are presented in 
Table 1.7.A and B.  
 
Table 1.7.A. Immunochemical techniques for organochlorinated substances 
Compound Immunochemical technique c Matrix Reference 
Pesticides    
Organochlorines a    
buffer [216] ELISA water, soil, food [217] DDT 
CFIA buffer [218] 
PCP IA drinking, ground, surface water [219] 
water [182,220] 
water, soil [221] ELISA 
urine [183,184] 
PFIA tap water [222] 
Triclopyr 
Immunosensor water [223] 
Chlorophenoxy acids b    
RIA buffer [224] 
buffer [225,226] ELISA river water, urine [227] 
EIA soil [228] 
IAC water [229] 
dipstick IA water, fruit, urine [230] 
buffer [231-233] FIA fruit juice [234] 
water [235-241] Immunosensor soil extract [242] 
Immunosensor water [243] 
2,4-D 
Immunosensor buffer [244] 
ELISA apple juice [245] 
PFIA buffer [233] 2,4,5-T 
Immunosensor water [238,240] 
Dichlorprop PFIA apple [246] 
MCPA Immunosensor water [239] 
a DDT (1,1,1-(trichloro)-2,2-bis(p-chlorophenyl)ethane); PCP (pentachlorophenol); Triclopyr 
(3,5,6-trichloro-2-pyridinol); b 2,4-D (2,4-dichlorophenoxyacetic acid); 2,4,5-T (2,4,5-
trichlorophenoxyacetic acid); dichlorprop (2-(2,4-dichlorophenoxy)propanoic acid); MCPA (2-
methyl-4-chlorophenoxyacetic acid); c ELISA (enzyme linked immunosorbent assay); RIA 
(radioimmunoasay); EIA (enzyme immunoassay); IAC (immunoaffinity chromatography); FIA 
(fluoroimmunoassay); PFIA (polarization fluoroimmunoassay); CFIA (chemiluminiscent flow 
immunoassay). 
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Table 1.7.B. Immunochemical techniques for organochlorinated substances 
Compound Immunochemical technique b Matrix Reference 
Trace contaminants a    
buffer [247]  
fish tissue [248] ELISA 
soil [249] 
IAC water [210] 
PFIA buffer [250] 
LIA buffer [251] 
river water, soil [252] 
PCBs 
Immunosensor buffer [253] 
ELISA buffer [165,254] PCDDs 
 IAC milk [255] 
milk, serum [256] PCDDs/PCDFs IAC serum [212,213,257] 
2,4-Chlorophenol ELISA  [258] 
a PCB (polychlorinated biphenyls); PCDD (polychlorinated dibenzo-p-dioxins); PCDF 
(polychlorinated dibenzofurans). b ELISA (enzyme linked immunosorbent assay); LIA (liposome 
immunoagregation assay); IAC (immunoaffinity chromatography); PFIA (polarization 
fluoroimmunoassay). 
 
In addition, there are many commercially available immunoassays for environmental 
analysis of DDT, lindane, 2,4-D, chlorpyrifos and 3,5,6-trichloro-2-pyridinol, PCBs 
[174]. It is important to note that the US-EPA recognized some of these commercial 
immunoassays as official methods of detection and they were included in the list of SW-
846 methods (see Table 1.8). 
 
Table 1.8. Immunoassays methods for organochlorinated compounds accepted by US-EPA 
Method Substance Matrix 
4010 PCP water, soil 
4015 2,4-D water, soil 
4016 2,4,5-T soil 
4020 PCBs soil, oil 
4041 Chlordane soil 
4042 DDT soil 
 
Based on this overview it can be observed that the only work reported on chlorophenol 
immunoassays is the development of an ELISA for the detection of 2,4-dichlorophenol 
[258]. Recently in our group have been developed direct and indirect ELISAs for 2,4,6-
TCP [1,259,260]. It was demonstrated that these immunoassays could be applied for the 
2,4,6-TCP analysis in drinking water samples. As it was shown in the previous chapters, 
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2,4,5-TCP could be considered as biomarker of exposure to many organochlorine 
substances. According to our knowledge there is no existing immunoassay or antibody 
against this analyte produced. Finally, the immunochemical determination of 
chlorophenols in biological samples is still not accomplished. 
 
1.5. Objectives 
 
With all these precedents the general goal of this thesis has been to investigate the 
potential of the immunochemical techniques to assess exposure to organochlorinated 
compounds. With this aim we have addressed the following objectives: 
 
1. Development of an ELISA for detection and quantification of 2,4,5-TCP. 
 
2. Evaluation and validation of the performance of the immunoassays (ELISAs) for 2,4,5-
TCP and 2,4,6-TCP in environmental (water) and biological (milk, human serum and 
urine) samples. 
 
As a result of these studies it became evident the necessity to develop compatible and 
efficient sample treatment procedures. For this reason we have set the following 
additional objective: 
 
3. Development of HTS-SPE-ELISA for urinary detection of 2,4,6-TCP. Validation and 
application to human biological monitoring for exposure assessment. 
 
As a preliminary study for an automated immunosensor device to analyze 2,4,6-TCP in 
urine, the following objective was also proposed: 
 
4. Development of QFIA for 2,4,6-TCP based on laser-induced fluorescence detection in 
microdroplets and its application to urine samples. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________________________ 
 
2. Development of an ELISA  
 for 2,4,5-trichlorophenol  
 
________________________________________________________________________ 
 
 
 
 
 
The most crucial step in the development of an immunochemical technique for low 
molecular weight environmental pollutants is the hapten design. Immunoassay specificity, 
selectivity and detectability are mainly determined by the antibody and the chemical 
structure of the competitor used as CA or ET [158,174,261,262]. Many examples in the 
literature prove that an appropriate design of the immunizing hapten determines the 
features of the resulting antibodies. As small organic molecules (Mw < 2000 Da) are not 
able to elicit an immune response in an animal, it is necessary to transform the analyte to 
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an immunogenic molecule, which consists of a hapten covalently coupled to a protein. A 
hapten is a molecule analogous to the target analyte and properly functionalized to allow 
covalent attachment to a carrier compound. An ideal hapten is one that preserves most of 
the steric and electronic characteristics of the analyte and mimics the target analyte in 
chemical structure as closely as possible. It is advisable to avoid modification of the 
immunogenic groups in the target molecule and/or introducing new ones, as this supposes 
an alteration of its structural, geometrical and electronic properties, and consequently a 
reduction of the sites for potential molecular recognition. 
 
The attachment point to the carrier should be placed far from the important sites of the 
target analyte and separated by a spacer arm to avoid hindrance by the carrier. A 3-6 atom 
spacer length has often been considered as optimum size [263,264], although not many 
exhaustive studies have addressed this point. Moreover, IAs have been described when 
Abs had been raised using haptens with shorter spacer arms [176,265]. Some authors 
have found a correlation between the length of the spacer arm in the immunogen and the 
Ab selectivity. Thus, Got et al. have demonstrated that a spacer with an average length of 
4-6 carbon atoms results in the production of more specific polyclonal Abs [266]. On the 
other hand, too long spacer arm could result in Ab against the spacer. In addition, the very 
long chain could fold placing the hapten inside the protein structure. The spacer arm 
should preferably replace a carbon hydrogen bond instead of a functional group. Ideally, a 
spacer ram should be a chain of methylenes terminated by a functional group (-COOH, -
OH, -SH, -NH2) through which the carrier protein will be attached. The presence of bulky 
or other functional groups or heteroatoms may lead to the generation of Abs versus the 
spacer arm and consequently to a poor recognition of the free analyte in the competitive 
ELISA [267,268]. 
 
The introduction of the spacer arm in the molecule may cause deformations of the 
molecular geometry as well as changes in its electronic distribution. On the other hand, 
the chemical synthesis of the hapten often is one of the most time-consuming steps of the 
antibody production process. Therefore, the synthetic effort needed to produce antibodies 
against an organic molecule should be carefully evaluated in relation to the chances to 
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obtain a good antibody. Nowadays, it is possible to make computer assisted theoretical 
and molecular modeling studies in order to predict the suitability of a particular chemical 
structure as a hapten to raise antibodies against the target analyte [158,259,269-272]. This 
facilitates the logical comparison of the 3-dimensional structure (3D) and the electrostatic 
properties of the designed hapten with those of the target analyte. Such an approach has 
been valuable in the choice of an ideal hapten for synthesis and sensitive immunoassays 
have been developed using this modeling approach.  
 
 
2.1. Design of an immunizing hapten to raise 
antibodies against 2,4,5-TCP. Molecular modeling 
studies. 
 
Initially, we considered three possible positions in the chemical structure of 2,4,5-TCP 
where a spacer arm can be introduced leading to three different immunizing haptens 
presented in Figure 2.1. In hapten A the spacer arm substitutes the hydrogen atom of the 
ortho position. Although the linker is too close to the phenolic group, it remains free and 
the three chlorine atoms in this hapten are placed at the same positions as in the target 
analyte. In hapten B the spacer arm is placed through the oxygen atom and the aromatic 
ring does not suffer any apparent geometric modifications. This maximizes the 
recognition of the aromatic group and the particular distribution of the chlorine atoms. 
Finally, hapten C respects the phenolic group free with the spacer arm introduced at the 
meta position of the aromatic ring. 
 
As was mentioned, the introduction of a spacer arm into a molecule can cause important 
geometric deformations. Thus, based on semiempirical models MNDO [273] we 
optimized the geometries of the three haptens in order to compare them to the geometry 
of the analyte (2,4,5-TCP). Figure 2.2 shows these chemical structures at their minimum 
energetic levels. 
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Figure 2.1. Structures of the possible immunizing haptens for the production of
antibodies against 2,4,5-TCP 
 
 
Figure 2.2 Optimized geometries of 2,4,5-TCP and haptens A, B and C according to MNDO 
models. Calculations have been made using the corresponding amide derivatives to mimic the 
conjugated haptens. The elements are presented in the following manner: C - gray; H – 
yellow; O – blue; Cl- green. 
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As it can be observed the considered haptens' structures do not differ significantly from 
the geometry of 2,4,5-TCP. The introduction of the spacer arm does not produce 
significant conformational changes in these molecules. Their planar geometries were 
preserved as in the target analyte. 
 
Another important factor to be considered in hapten design is the electronic distribution 
(punctual charge density and total sum of the punctual charges in the molecules). This 
factor is very important, if we consider that the Ab-Ag recognition is also defined by 
electrostatic forces, hydrogen bonds or Van der Waals interactions. In the design of 
immunizing haptens for 2,4,6-TCP [259] the real differences between the electronic 
distribution of the haptens and those of the target analyte were observed when the acid-
base equilibria of the phenolic compounds in aqueous media (ArOH → ArO- + H+) were 
considered. Both the neutral compounds and the corresponding conjugated bases coexist 
in an aqueous media in a ratio depending on the pH and their pKa. For example, with a 
pKa of 7.1, one can assume that both the acid and the conjugated base of 2,4,5-TCP will 
coexist in a physiological media or in the assay buffer. 
 
Consequently, punctual charges in the aromatic ring for both species (acid and conjugated 
base) of the haptens A - C and the target analyte were calculated at their minimum 
energetic conformations. Figure 2.3 shows the results obtained for each atom of the ring 
and the sum of those charges. It can be observed that the punctual charges of the analyte 
and haptens A, B and C are quite similar, if they considered as organic acids (see Figure 
2.3 A). Only the balance of the total charge is slightly more positive for hapten B. In 
contrast, the punctual charges vary significantly if the haptens are considered as 
conjugated bases (see Figure 2.3 B). As phenoxides the charges of the target analyte and 
haptens A and C follow the same pattern and the total charge of each of them is negative. 
Since in hapten B the hydroxyl group is blocked and it cannot participate in the acid-base 
equilibrium, the punctual charge distribution in this hapten is independent on the pH of 
the media and its total charge remains positive. Therefore, haptens A and C mimic better 
the analyte considering their geometry and punctual charges. 
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Figure 2.3. Total charge and punctual charges of 2,4,5-TCP and haptens A, B and C as phenols 
(A) and phenoxydes (B). The relative amounts of these two forms depend on the corresponding 
pKa values (see Table 2.1). The bars show the total charge. Haptens A and C mimic better the 
behaviour of the target analyte in both situations. On top it is shown the acid-base equilibrium for 
2,4,5-TCP molecule. 
 
It should be noted that the comparisons based on punctual charges are only valid if the 
phenolic acids have the same tendency to give protons to the media, that means all these 
compounds have similar pKa values. According to the Gibbs equation on proton transfer 
reactions, the deprotonation enthalpy (DPE) is directly related to the pKa. Dewar et al 
proved that semiempirical models provide reliable data regarding PA (proton affinities) 
and DPE values [274]. Using MNDO semiempirical models we could determine the 
formation enthalpies of 2,4,5-TCP, hapten A and hapten C as organic acids [Hf (ArO-)] 
and as conjugated bases [Hfr (ArOH)]. The DPE values of the proton transfer equilibria 
could be calculated according to the following equations: 
 
∆H0= ∆Hfp-∆Hfr 
∆H0= [∆Hfp (H+) + ∆Hfp (ArO-)]-∆Hfr (ArOH) = DPE, 
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where ∆Hfr is the formation enthalpy of the reagents and ∆Hfp is the formation enthalpy 
of the products. According to the literature the formation enthalpy of the H+ is 367.2 
Kcal/mol, [274,275]. Table 2.1 shows the DPE values for 2,4,5-TCP and haptens A and 
C deprotonation equilibrium reactions calculated by MNDO semiempirical models.  
 
Table 2.1. Calculated values for DPE and pKaa 
Compound DPE, kcal/mol pKa 
2,4,5-TCP 354.96 7.10 ± 0.23 
Hapten A 359.89 7.38 ± 0.50 
Hapten C 355.60 7.14 ± 0.28 
a The formation enthalpy for H+ is considred to be 367.2 kcal/mol. 
 
The DPE values clearly indicate the acidic character of these compounds but there are no 
significant differences between them. This fact was additionally supported by theoretical 
calculations of the pKa values using suitable software (see Table 2.1). Therefore, we can 
conclude that both haptens A and C mimic reasonably well the properties of the target 
analyte. In summary, considering the theoretical studies on geometry, charge distribution 
and pKa both haptens A and C could be excellent immunizing haptens for the production 
of 2,4,5-TCP antibodies. 
 
Finally, the synthetic feasibility is another aspect to be considered. The introduction of an 
alkylamino group in ortho of 2,4,5-TCP, as it appears in hapten A, had already been 
reported by Stokker et al for the preparation of a new class of saluretic agents [276]. 
Hapten A (3-(2-hydroxy-3,5,6-trichlorophenyl)propanoic acid) was prepared by R.Galve 
from our group following a similar procedure [277]. In contrast, the introduction of the 
spacer arm at meta position of the target analyte needed for the preparation of hapten C 
seemed to be more difficult from synthetic point of view. Regioselective nucleophilic 
substitution at meta positions of phenolic substances has been reported by preparing first 
arene-tricarbonyl-chromium (0) complexes [278] of the corresponding aromatic 
compound. Another strategy could go beyond using 3(3-hydroxyphenyl)-propenoic acid 
as starting material (possessing already the spacer arm in meta) and introducing the 
chlorine atoms in the last step [259]. However, the introduction of a chlorine atom on the 
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less active meta position of the aromatic ring could also be tricky. Therefore, we decided 
to use only hapten A as immunizing hapten. 
 
 
2.2. Antibody production 
 
Hapten A was coupled to KLH (keyhole limpet hemocyanine) and BSA (bovine serum 
albumin) following the mixed anhydride method (MA) and the KLH conjugate was used 
to raise antibodies in white New-Zealand rabbits (see Experimental Section). The 
obtained antisera were named As53, As54 and As55. Antibodies against hapten B were 
produced in our group within the context of a project aimed to raise antibodies against 
chlorophenoxy acid herbicides. These antisera were named As56, As57 and As58. With 
the aim to prove the results of the theoretical studies we decided to evaluate both groups 
of antiserum for their ability to bind 2,4,5-TCP on a competitive ELISA. 
 
 
 
2.3. Competitor haptens 
 
The immunoassays for the analysis of small organic molecules are usually performed 
under competition. The general strategy for competitive assays is based on the 
competition between the free analyte (Ag) and the labeled antigen for a limited number of 
Ab binding sites. The labeled antigen in the direct competitive format is an enzyme tracer 
(ET) and in the indirect format is a coating antigen (CA) (see Figure 1.4.). ETs and CAs 
are obtained by conjugation of a hapten, called competitor, to an enzyme or proteins.  
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Contrary to the immunizing haptens, requirements regarding similarities between the 
competitor and the target molecule are not so strict. In general the chemical structure of 
the immunizing hapten is the main factor influencing IA specificity, while the chemical 
structure of the competitor mainly defines IA detectability. It has been often reported an 
increase in the detectability by introducing a certain degree of heterology in the chemical 
structure of the competitor (so called competitior heterology effect) [181,260,272,279-
281].  
 
In this way, the equilibrium constant defining the formation of the immunocomplex 
competitor-Ab would be lower than the one directing the reaction between the analyte 
and the Ab (see Figure 2.4). Despite the heterology concept, its application is not always 
general [216,259]. It is suggested that high-affinity Abs may be able to render excellent 
assays even under homologous conditions while the detectability of IAs based on Abs 
with low affinity for the analyte may be increased by using heterologous competitors 
[174]. 
 
It is difficult to predict which chemical structure would give the best competitor. Optimal 
heterologous system is usually accomplished by the screening of several haptens coupled 
to enzymes or proteins. These haptens may have different degree of heterology depending 
on the variation of the chemical structure and the length and/or the position of the spacer 
arm. Thus, it is important to dispose of several competitors with different chemical 
analyte
immunogen
competitor
Keq
K´eq
K´eq < Keq for 
heterology combinations
 
Figure 2.4. Heterology principle 
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structure and to find out experimentally the one who provides the best immunoassay. The 
chemical structures of the haptens used as competitors in this work are presented in 
Figure 2.5.  
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Figure 2.5. Chemical structure of the competitors 
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Haptens 3, 4 and 5 keep the phenol group and the three Cl atoms, whereas haptens 1, 2, 
11 and 12 have the hydroxyl group blocked by the linker. Haptens 7, 8, 9 and 10 keep the 
phenolic group, but posses only two Cl atoms and the spacer arm is introduced in 
different positions of the aromatic ring. The competitors were prepared by R.Galve from 
our group [259,260,277]. 
 
 
2.4. Development of a competitive direct ELISA 
 
Initially we decided to develop a direct competitive ELISA format with the Abs 
immobilized to the plate. As enzyme label we selected horseradish peroxidase (HRP). 
This enzyme has one or two free lysine groups accessible for bioconjugation [282]. It is 
advisable to use different conjugation methods for the immunizing hapten and the 
competitor in order to avoid possible interferences (background noise or Ab recognition) 
in the assay due to secondary products (sub-products) that may be formed during the 
immunogen preparation [283,284]. Since the immunizing haptens were prepared by the 
mixed anhydride (MA) method, we used the active ester (AE) method to attach haptens 
A, 1-5 and 7-12 covalently through their carboxylic groups to the lysine residues of the 
HRP (see Experimental Section for general procedure description). 
 
2.4.1. Screening of the antiserum avidity for the ETs (1D 
and 2D) 
 
On a first set of experiments we selected the ETs recognized by the As using a non-
competitive direct ELISA format-1D (one dimension) (see Figure 2.6). In this format the 
plate is coated with the As at a fixed concentration and its interaction with the serially 
diluted ET is tested (see Experimental Section).  
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The Amax values obtained for all As/ET combinations are presented in a color scale in 
Table 2.2. Recognition was observed only for the homologous or quasi-homologous ETs. 
Thus, As53-55 (immunogen A-KLH) did only recognize A-HRP with an acceptable titer, 
while 5-HRP was only recognized by As55. As56-58 (B-KLH) did only recognize 2-HRP 
that only differs from hapten B in the length of the spacer arm. 
 
IgG
Enzyme tracer
Substrate
Product
 
 
Figure 2.6. Noncompetitive direct ELISA 
Table 2.2. Absorbances obtained in noncompetitive direct ELISA 1D experiments for 
all As/ET combinations.  
Immunogen A-KLH B-KLH 
As 
ET 
53 54 55 56 57 58 
1       
2       
3       
4       
5       
A       
7       
8       
9       
10       
11       
12       
The plates were coated with As (1/1000 dilution). The absorbance shown corresponds to 
1 µg/L ET.  3,3¨,5,5¨-Tetramethylbenzidine was the substrate used for the enzymatic 
reaction. The absorbance was measured at a wavelength of 450 nm. 
 
    
    
Absorbance   0 0.1 0.3 1.0 1.5 
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Next, the relative avidity of these As versus the recognized ETs was evaluated in a two-
dimensional checkerboard titration experiment (2D) (see Experimental Section) (see 
Figure 2.6). The binding curves were obtained for seven ET concentrations (see Figure 
2.7).  
 
From these experiments we selected the appropriate concentrations to perform the 
competitive assays. A trade-off should be done between concentration high enough to 
achieve good signal and as lower as possible in order to achieve least LOD. We chose an 
As concentration giving a 70% of the saturated signal and an ET concentration producing 
signal between 0.7 and 1 units of absorbance at 450 nm. Table 2.3 summarizes the 
selected concentrations of the immunoreagents for all the As/ET combinations and the 
corresponding Amax values.  
 
Table 2.3. Concentration of the immunoreagents selected in non-competitive direct ELISA - 2D. 
As / ET As dilution ET conc., µg/L Amax 
53 / A-HRP 1/16000 2 0.86 
54 / A-HRP 1/16000 2 0.58 
55 / A-HRP 1/16000 5 0.81 
55 / 5-HRP 1/6000 2 0.80 
 
The As(56-58)/2-HRP combinations produced a maximum absorbance of only 0.3 units 
when the As was diluted 1/500 times and the ET was used at a concentration of 2 µg/mL. 
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Figure 2.7. 2D experiment for As55/5-HRP. The red circle shows the combination of 
immunoreagents´ concentration chosen for the competitive assay. 
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Thus, we focused on the antisera raised against hapten A to test their ability to bind 2,4,5-
TCP in a competitive assay. 
 
2.4.2. Direct Competitive ELISA 
 
In the direct competitive ELISA (Ab coating format) the analyte and the enzyme tracer in 
solution compete for the immobilized Abs (see Figure 1.4.A). After the main incubation 
step the unbound reagents are washed and the amount of enzyme-label bound to the solid 
phase by the Ab is photometrically determined. A decrease in the signal is directly 
proportional to the amount of the analyte present. Using standard analyte concentrations a 
dose-response curve can be obtained. It has a sigmoidal shape with linear portion and can 
be fitted to the four-parameter logistic equation (see Experimental Section). 
 
We performed direct competitive immunoassays with the above selected combinations of 
As/ET using the concentrations presented in Table 2.3 according to the procedure 
described in the Experimental Section. All tested combinations gave competitive assays, 
although their detectability was too poor for our purposes. Table 2.4 shows the 
parameters of the standard curves for these immunoassays.  
 
Table 2.4. Features of the competitive direct ELISAs 
As ET Amax Amin Slope IC50a r2 
53 A-HRP 0.81 0 -0.43 18.87 0.989 
54 A-HRP 0.63 0.06 -0.89 165.48 0.985 
55 A-HRP 1.27 0.21 -1.03 21.62 0.981 
 5-HRP 0.94 0.14 -0.97 15.84 0.971 
a IC50 values are expressed in µg/L. Shadow boxes show the immunoassay features of the best 
combination. 
 
The best assay gave a detectability* of 15.84 µg/L in the middle point of the assay. 
According to the urinary levels recorded for non-occupationally exposed persons (see 
Section 1.2.5.3) an assay with IC50 value around 1 µg/L or lower would be desirable. 
                                                 
* We would like to note that in this thesis the term detectability refers to the limit of detection or to 
the IC50 value of the method and the term sensitivity refers to the slope of the calibration curve of 
the assay. 
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Therefore, we decided to explore the indirect ELISA format with the aim to find an 
antiserum/coating antigen combination with a better detectability. Although the indirect 
format introduces an additional step in the procedure, the absence of the enzyme during 
the competition made it more promising regarding possible matrix effects from real 
biological samples [174]. 
 
 
 
2.5. Development of an indirect ELISA for 2,4,5-
trichlorophenol 
 
In the indirect ELISA the coating antigen (CA) is immobilized to the surface of the plate 
and the concentration of the analyte is measured indirectly by the quantification of the 
bound specific Ab with a second enzyme-labeled Ab (anti-IgG) (see Figure 1.4.B). 
 
Initially we decided to evaluate a battery of 33 CAs obtained by the covalent coupling of 
11 competitors (see Figure 2.5) to the proteins BSA (bovine serum albumin), OVA 
(ovalbumin) and CONA (conalbuin). Haptens 1–4 and 7-12 were conjugated to the three 
proteins by the AE method and hapten 5 was conjugated by the MA method in a 
hapten:protein(lysine) molar ratio 2:1. CAs of hapten A were not prepared because of 
limited quantities of hapten A available. Unfortunately, the prepared CAs had a limited 
solubility in 10 mM PBS buffer at 1 mg/mL concentration. This was attributed to their 
high degree of conjugation (see Table 2.5). The hapten molecules in the conjugation 
reaction displace the free amino groups of the proteins that define their water solubility. 
The chlorine atoms makes the resulting conjugate more lipophilic (hydrophobic) limiting 
in this way the protein solubility in buffer. 
 
Due to this lack of solubility, we filtered the working aliquots of 1 mg/mL and evaluated 
the resulting protein concentration by the Bio-Rad Protein Assay. The Bio-Rad Protein 
Assay is a binding assay based on the differential color change of a dye in response to 
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various concentrations of protein. It relies on the Bradford method based on the shift of 
the absorbance maximum from 465 nm to 595 nm when an acidic solution of Coomassie 
Brilliant Blue G-250 binds to a protein [285]. In our case we used the microassay 
procedure with a linear response between 1 µg/mL and 40 µg/mL. As the assay displays 
protein-to-protein variation we used standard curves for each protein. The analysis 
demonstrated that the conjugates 3-BSA, 7-, 11- and 12-CONA were completely 
insoluble in aqueous buffer and they were not used further. The protein concentrations of 
the remaining CAs were in the range 120 – 800 µg/mL with a higher solubility found for 
all CAs prepared by the MA method. The hapten densities of the BSA conjugates were 
determined by MALDI-TOF-MS (see Table 2.5.).  
 
Table 2.5. Hapten densities of the BSA conjugates measured by MALDI-TOF-MS.  
Hapten Hapten density % conjugationb 
1 30 85-100 
2 25 71-83 
3 14 40-47 
4 16 46-53 
   5 a 7 20-23 
7 25 71-83 
8 17 49-57 
9 21 60-70 
10 26 74-87 
11 27 77-90 
12 28 80-93 
a All the conjugates were synthesized by the AE method, except hapten 5-BSA whcih were 
prepared by the MA method. In both methods the hapten:protein molar ratio employed during the 
conjugation reaction was 2:1 in terms of lysine residues of the protein. b The % conjugation is 
calculated based on the assumption that the BSA has 30 – 35 free lysine groups. 
 
The analysis of the hapten density demonstrates that the degree of conjugation of the CAs 
obtained by the AE method was really quite high. This correlates to the statement 
expressed above that the high degree of conjugation results in less soluble protein 
conjugates. 
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2.5.1. Screening of the antiserum avidity for the coating 
antigens  
 
The recognition of the CAs by the As was evaluated in a non-competitive indirect ELISA 
realized in 1D configuration (see Figure 2.8). The CAs were immobilized on the 
microtiter plate at a concentration 1 µg/mL and serial dilutions of each As were added.  
 
The Amax values obtained for all As/CA combinations are presented in a color scale in 
Table 2.6. In general, the CAs were better recognized by the As than the respective ETs. 
This may be attributed to the fact that the CAs possess more binding centers than the ETs 
(the number of free lysine groups available for coupling in the proteins is higher than in 
the HRP). In general, higher recognition was mainly observed for the homologous or 
quasi-homologous CAs. Thus, As53-55 recognized better haptens 5, 8, and 2 and As56-
58 recognized in higher degree the haptens with blocked phenolic group (1, 2, 11, and 
12). 
 
The avidity of As53-58 for the better-recognized protein conjugates was evaluated by 
two-dimensional checkerboard titration experiments (2D) (see Experimental Section). 
The binding curves for each As/CA combination were obtained (see Figure 2.9).  
 
Coating antigen
IgG
IgG-HRP
Substrate
Product  
 
Figure 2.8. Noncompetitive indirect ELISA 
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Table 2.6. Absorbances obtained in noncompetitive indirect ELISA 1D experiment 
for all As/CA combinations.  
Immunogen A-KLH B-KLH 
As 
CA 
53 54 55 56 57 58 
1-BSA       
1-CONA       
1-OVA       
2-BSA       
2-CONA       
2-OVA       
3-BSA nd nd nd nd nd nd 
3-CONA       
3-OVA       
4-BSA       
4-CONA       
4-OVA       
5-BSA       
5-CONA       
5-OVA       
7-BSA       
7-CONA nd nd nd nd nd nd 
7-OVA       
8-BSA       
8-CONA       
8-OVA       
9-BSA       
9-CONA       
9-OVA       
10-BSA       
10-CONA       
10-OVA       
11-BSA       
11-CONA nd nd nd nd nd nd 
11-OVA       
12-BSA       
12-CONA nd nd nd nd nd nd 
12-OVA       
The plate was coated with CA at 1 µg/L. The absorbances correspond to 1/1000 
dilution of the As. All the CAs are prepared by the AE merhod except the CAs of 
hapten 5. 
 
       
       
Absorbance   0 0.1 0.2 0.5 0.8 1.5 2.0 2.5 
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The concentrations of the CAs were chosen to produce about 70% of the saturated signal. 
Antisera dilution factors were selected to rend absorbance values in the range between 0.7 
and 1 unit (see Table 2.7.A and B). 
 
It can be observed that As56-58 have lower avidity than As53-55. This could be explain 
with the differences in the punctual charges of the competitors haptens and the 
immunizing hapten B at the assay pH (see Section 2.1, Figure 2.3B). Thus, most of the 
competitor haptens had the phenolic group free and according to their pKa values (see 
Table 2.9) an important fraction of their molecules is ionized at pH 7.5. Only haptens 8, 9 
and 10 had a pKa sufficiently high to remain mainly in their protonated forms. The 
competitors with the hydroxyl group blocked, such as haptens 1, 2, 11 and 12 were the 
best recognized by As56-58. As expected As53-55 showed higher avidity for the haptens 
with the free phenol group, especially if the chlorine atoms were at the same positions as 
in the target analyte. 
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Figure 2.9. Results from the 2D experiment for As53/7-OVA noncompetitive assay. The red 
circle shows the combination of immunoreagents´ concentration chosen for the competitive 
assay. 
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Table 2.7. A. Concentration of the immunoreagents selected in non-
competitive indirect ELISA (2D) 
As CA As dilution CA conc. Amax 
53 1-BSA 1/4000 0.188 0.82 
 2-BSA 1/8000 0.188 0.70 
 5-BSA 1/4000 0.188 0.96 
 8-BSA 1/25000 0.094 0.80 
 1-CONA 1/1000 0.375 0.95 
 2-CONA 1/2000 1.500 1.05 
 5-CONA 1/1000 0.188 0.85 
 8-CONA 1/32000 0.094 0.90 
 9-CONA 1/1000 0.375 0.83 
 10-CONA 1/10000 0.047 0.91 
 2-OVA 1/4000 0.750 0.82 
 5-OVA 1/4000 0.750 0.74 
 7-OVA 1/1000 0.375 1.02 
 8-OVA 1/4000 0.375 0.80 
 12-OVA 1/1000 1.500 0.49 
54 2-BSA 1/8000 0.375 0.90 
 5-BSA 1/8000 0.094 1.00 
 7-BSA 1/16000 0.023 0.80 
 8-BSA 1/32000 0.023 0.92 
 10-BSA 1/16000 0.023 0.85 
 2-CONA 1/2000 0.750 0.82 
 5-CONA 1/4000 0.047 0.90 
 8-CONA 1/16000 0.094 0.85 
 10-CONA 1/4000 0.047 0.91 
 5-OVA 1/4000 0.188 0.69 
 7-OVA 1/4000 0.188 0.70 
 8-OVA 1/10000 0.375 0.80 
 10-OVA 1/4000 0.047 0.59 
55 1-BSA 1/1000 0.375 0.93 
 2-BSA 1/4000 0.188 0.90 
 5-BSA 1/16000 0.047 0.87 
 8-BSA 1/16000 0.094 1.02 
 10-BSA 1/16000 0.023 0.82 
 1-CONA 1/1000 0.750 0.72 
 2-CONA 1/2000 0.094 0.70 
 5-CONA 1/16000 0.047 0.81 
 8-CONA 1/16000 0.094 0.85 
 9-CONA 1/2000 0.094 0.72 
 10-CONA 1/8000 0.023 0.83 
 2-OVA 1/2000 0.188 0.90 
 5-OVA 1/4000 0.375 0.80 
 8-OVA 1/4000 0.378 0.83 
 10-OVA 1/4000 0.094 0.75 
a All the conjugates were prepared by the AE method except those 
marked in italics that were prepared by the MA method. 
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Table 2.7. B. Concentration of the immunoreagents selected in 
noncompetitive indirect ELISA (2D) 
As CA As dilution CA conc. Amax 
56 1-BSA 1/1000 0.75 0.80 
 2-BSA 1/8000 0.094 1.03 
 5-BSA 1/1000 0.375 0.60 
 1-CONA 1/1000 0.750 1.00 
 2-CONA 1/4000 0.094 0.75 
 2-OVA 1/4000 0.187 0.75 
 5-OVA 1/1000 1.500 0.65 
 8-OVA 1/1000 0.375 0.72 
 10-OVA 1/1000 1.500 0.50 
57 1-BSA 1/4000 0.375 0.90 
 2-BSA 1/4000 0.047 1.00 
 5-BSA 1/1000 0.375 0.98 
 11-BSA 1/4000 0.047 0.95 
 1-CONA 1/4000 0.375 0.94 
 2-CONA 1/8000 0.094 0.80 
 5-CONA 1/1000 0.187 0.92 
 2-OVA 1/4000 0.375 1.00 
 11-OVA 1/4000 0.375 1.00 
 12-OVA 1/1000 0.750 1.20 
58 1-BSA 1/1000 1.500 0.55 
 2-BSA 1/4000 0.375 0.80 
 2-CONA 1/4000 0.094 0.75 
 5-CONA 1/1000 0.094 0.70 
 2-OVA 1/2000 0.094 0.92 
 11-OVA 1/1000 0.750 0.76 
 12-OVA 1/1000 1.500 0.98 
a All the conjugates were prepared by the AE method except those 
marked in italics that were prepared by the MA method.  
 
2.5.2. Indirect competitive ELISA: Effect of the hapten 
heterology 
 
Those As/CA combinations showing reasonable titers were used for screening the ability 
of 2,4,5-TCP to inhibit the antibody binding to the coated plates (see Figure 1.4.B). The 
concentrations of the immunoreagents (CA, As) used in these assays are presented in 
Table 2.7. A and B. In this format it was possible to select some combinations with the 
As raised against both immunizing haptens. However, in agreement with the results from 
the molecular modeling studies, only As53-55, raised against hapten A, were able to 
provide competitive assays within the studied concentration interval (0.025 – 100 000 nM 
2,4,5-TCP). Table 2.8 shows the features of all the competitive immunoassays obtained. 
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Table 2.8. Immunoassay features of the competitive indirect ELISA 
As CA a Amax Amin Slope IC50 b r2 
53 1-BSA 0.61 0.03 -1.2 9.28 0.985 
 2-BSA 0.57 0.04 -0.97 11.5 0.979 
 5-BSA 1.02 0.08 -0.63 6.94 0.980 
 8-BSA 0.85 0.01 -0.85 15.4 0.984 
 1-CONA 1.13 0.09 -1.02 11.79 0.994 
 2-CONA 1.78 0.04 -0.95 32.34 0.995 
 5-CONA 1.98 0.59 -0.78 30.62 0.990 
 8-CONA 1.13 0.03 -0.95 116.80 0.985 
 9-CONA 0.70 0.02 -0.96 5.35 0.994 
 10-CONA 0.86 0.01 -0.71 7.93 0.989 
 2-OVA 0.79 0.04 -1.15 14.17 0.979 
 5-OVA 0.68 0.03 -0.64 2.42 0.989 
 7-OVA 0.94 0.06 -1.2 0.83 0.990 
 8-OVA 0.75 0.01 -0.6 6.47 0.992 
 12-OVA 0.57 0.13 -0.86 4.38 0.995 
54 2-BSA 1.3 0.04 -0.8 32.18 0.998 
 5-BSA 1.3 0.21 -0.68 8.49 0.995 
 7-BSA 1.05 0.01 -0.78 3.36 0.996 
 8-BSA 1.07 0.001 -0.5 6.71 0.959 
 10-BSA 0.95 0.01 -0.85 12.14 0.998 
 2-CONA 1.03 0.02 -0.87 19.61 0.985 
 5-CONA 1.33 0.07 -0.84 10.04 0.990 
 8-CONA 1.24 0.09 -0.9 41.42 0.910 
 10-CONA 1.44 0.01 -0.9 43.42 0.983 
 5-OVA 0.56 0.03 -0.90 4.56 0.998 
 7-OVA 0.69 0.01 -1.0 3.05 0.990 
 8-OVA 0.54 0.01 -0.7 12.23 0.960 
 10-OVA 0.63 0.01 -1.0 4.87 0.990 
55 1-BSA 0.98 0.2 -0.96 4.05 0.910 
 2-BSA 0.82 0.02 -1.2 8.66 0.990 
 5-BSA 0.75 0.01 -0.9 16.35 0.990 
 8-BSA 0.99 0.01 -0.8 12.06 0.970 
 10-BSA 0.86 0.01 -0.97 28.24 0.998 
 1-CONA 0.987 0.32 -1.4 13.5 0.900 
 2-CONA 0.75 0.04 -1.1 15.82 0.970 
 5-CONA 0.9 0.02 -0.7 21.66 0.996 
 8-CONA 1.4 0.19 -0.6 31.81 0.989 
 9-CONA 0.79 0.02 -1.0 61.78 0.970 
 10-CONA 1.11 0.01 -0.76 78.3 0.990 
 2-OVA 1.01 0.04 -1.3 9.64 0.940 
 5-OVA 0.99 0.02 -0.9 21.22 0.940 
 8-OVA 0.73 0.04 -1.2 8.53 0.970 
 10-OVA 0.90 0.03 -1.0 20.53 0.970 
a All the conjugates were prepared by the AE method instead of those marked in italics that were prepared by 
the MA method. No competition was observed for As56, 57, 58. 
b IC50 values are expressed in µg/L. The combinations with IC50 < 10 µg/L are presented in bold and the 
combinations with IC50 < 5 µg/L are in blue. Shadow boxes show the immunoassay features of the best 
combinations used for further optimization.  
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It has been suggested that there is a correlation between immunoassay detectability and 
the degree of competitor heterology regarding punctual charge distribution and structural 
geometry [260]. In this work we tried to provide objective data about hapten heterologies 
and their correlation with the IC50 values of the immunoassays obtained. Thus, all haptens 
1-12 and the target analyte were optimized to find their minimum potential energies using 
a semi-empiric PM3 model. The ratio phenol:phenoxide was calculated for each hapten 
according to their pKa values and used to determine the ultimate punctual charges of the 
molecule (see Table 2.9).  
 
Table 2.9. Relative similarities between the target analyte and the haptens regarding punctual 
charge distribution 
Hapten pKa a RO- (%) b RMSEc, pH=7.5 Hapten density d 
1 - - 0.436 30 
2 - - 0.425 25 
3 6.59 89.05 0.081 14 
4 5.51 98.99 0.113 16 
5 6.63 88.11 0.120 7 
7 7.37 57.43 0.157 25 
8 7.82 32.37 0.224 17 
9 7.99 24.45 0.320 21 
10 7.99 24.45 0.249 26 
11 - - 0.411 27 
12 - - 0.421 28 
A 7.38 56.86 0.093 10 
2,4,5-TCP 7.1 71.5  - 
a pKa values of the haptens are calculated in their amide form. b Percentage of the phenoxide 
species when the pH is 7.5. c The similarity between the haptens and the analyte has been 
expressed as the root mean square error (RMSE) of the differences between the punctual charges 
of the corresponding atoms of both molecules (hapten vs analyte) at pH=7.5. The punctual charge 
on each atom was calculated considering the percentage of the neutral molecule and their anion 
form at pH=7.5 according to their pKa values. d Hapten densities of the BSA conjugates are 
measured by MALDI-TOF-MS. All the conjugates are synthesized by the AE method, except 
hapten 5 conjugate which are prepared by the MA method. In both methods the hapten:protein 
molar ratio employed during the conjugation reaction is 2:1 in terms of lysine residues of the 
protein.  
 
The heterology, as the difference between the charge distribution of each hapten and the 
analyte, has been expressed as the root mean square error (RMSE) of the addition of the 
errors for each equivalent position of the aromatic rings (competitor vs target analyte). 
Thus, the following heterology order according to the electronic distribution on these 
molecules can be defined: hapten 1 > hapten 2 ≥ hapten 12 > hapten 11 >> hapten 9 > 
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hapten 10 > hapten 8 > hapten 7 > hapten 5 > hapten 4 > hapten A > hapten 3. 
Surprisingly, the homology of hapten 3 to the analyte was greater than those of hapten A, 
used as immunizing hapten. This fact is strongly related to the pKa values of these 
substances. While hapten A has approximately only half of the molecules ionized at pH 
7.5, hapten 3 and 2,4,5-TCP have 89 % and 71%, respectively, in the ionized form. Based 
on these results, the use of hapten 3 as immunizing hapten could have been considered. 
However, it must be noted that using hapten 3 as immunizing hapten would had the risk 
of introducing additional undesirable epitopes for antibody recognition. 
 
According to these results we can observe that the best competitive assays were afforded 
by competitors with a high homology with the target analyte (see Table 2.8). Thus, 
haptens 5 and 7 provided the most sensitive assays except for the As55. Unfortunately, 
we did not have sufficient hapten A to prepare coating antigens by the AE method to 
prove if this was also true for this competitor. Furthermore, the CAs of haptens 3 and 4 
were not tested on competitive assays due to their low recognition observed in 1D 
experiments (see Table 2.7). In the case of hapten 3 this may be attributed to the limited 
solubility observed in aqueous buffer and the poor recognition of hapten 4 is probably 
due to the short spacer arm of this hapten (see Figure 2.5). However, in addition to the 
hapten homologies, other factors may affect the availability of the competitor (as part of 
the protein conjugate) for the antibody interaction. Thus, the hapten density or the protein 
nature of the CA, are additional aspects to be considered. Similarly, the hydrophobic or 
hydrophilic nature of the compound may also determine its tendency to be hidden or not 
inside the tertiary structure of the protein. 
 
2.5.3. Indirect competitive ELISA: Effect of the hapten 
density 
 
Immunoassays As53/5-OVA and As53/7-OVA were selected for further optimization and 
evaluation because of their detectability, good signal-to-noise ratio, acceptable slope and 
reproducibility (see Table 2.8.). Initially our aim was to improve immunoassay 
detectability. It has been reported that the degree of hapten density of the competitors can 
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affect the immunoassay detectability [259,286,287]. The carrier protein OVA has 20 
lysine residues, most of which are available for hapten coupling [155]. The CAs from the 
first battery were prepared at hapten:protein molar ratio 2:1 resulting in high degree of 
conjugation of the BSA conjugates as was determined by MALDI-TOF-MS (see Table 
2.9). Therefore, we decided to prepare a new battery of 5- and 7- coating antigens with 
lower degree of conjugation simply by varying the initial molar ratio of both species in 
the conjugation procedure using the MA and AE method. We synthesized 5-BSA, 5-
OVA, 7-BSA and 7-OVA by the AE method at four different hapten:protein ratios: (1:1), 
(1:2.5), (1:5), (1:10) and 5-BSA and 5-OVA by the MA method at three different 
hapten:protein ratios: (1:1), (1:2.5), (1:5). We did not prepare CAs with (1:10) ratio by 
the MA method, because according to our experience the MA method usually gives lower 
yields. 
 
Although the hapten:lysine molar ratio in this second battery was lower, we encountered 
again solubility problems with the CAs. The protein concentrations had to be determined 
again by Bradford assay after filtration. This test revealed that 5-BSA (1:1) (AE) was 
completely insoluble in 10 mM PBS. As previously observed, the CAs prepared by the 
MA method showed a higher solubility in aqueous buffers than the AE ones. In general, 
the OVA conjugates were more soluble probably due to its high number of the –COOH 
groups. The resulting degree of conjugation for the BSA and OVA conjugates was 
determined by MALDI-TOF-MS (see Table 2.10.). 
 
The avidities for the new CAs were tested only with As53 using by 2D experiments. As 
expected higher concentrations of the less conjugated CAs were required to give 
appropriate absorbances using similar As dilutions [226,287]. Using the most suitable 
immunoreagent concentrations we obtained competitive assays for each combination. 
Their parameters are presented in Table 2.10. It can be observed that, as reported by 
other members of our group [1], the MA method afforded lower conjugation yields. For 
example, the 5-BSA conjugate prepared at molar ratio 1:2.5 by the MA method had a 
hapten density of 5, while the same conjugate prepared by the AE method had a hapten 
density of 13. Moreover, for conjugates with the same hapten:protein molar ratio, those 
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prepared by the MA method gave assays with better detectability (compare the IC50 
values of 5-BSA/-OVA (MA) with those of 5-BSA/-OVA (AE)). These results 
demonstrate that it is not always necessary to use a heterologous coupling procedure to 
obtain a suitable immunoassay. 
 
Table 2.10. Effect of the hapten density of the competitor on the immunoassay features. 
CA Hapten: protein a δ b 
% 
conjug. c Amax Amin Slope IC50 r
2 
5-BSA (MA) 2:1 7.5 21-25 1.02 0.08 -0.63 6.94 0.980 
 1:1 9 26-30 1.04 0.01 -0.46 1.30 0.980 
 1:2.5 5 14-17 0.92 0.01 -0.52 1.94 0.987 
 1:5 3 9-10 0.92 0.02 -0.45 1.56 0.989 
5-OVA (MA) 2:1 n.d.e  0.68 0.03 -0.64 2.42 0.989 
 1:1 6 30 0.82 0.01 -0.56 1.76 0.990 
 1:2.5 3 15 0.87 0.02 -0.54 1.92 0.990 
 1:5 3 15 0.61 0.01 -0.5 0.45 0.990 
5-BSA (AE) 1:1d n.d.e  - - - - - 
 1:2.5 13 37-43 1.13 0.01 -0.48 15.52 0.981 
 1:5 8 23-27 0.8 0.01 -0.64 11.1 0.988 
 1:10 5 14-17 1.1 0.01 -0.56 9.13 0.989 
5-OVA (AE) 1:1 20 100 1.19 0.01 -0.65 16.81 0.997 
 1:2.5 12 60 1.28 0.02 -0.72 9.70 0.980 
 1:5 6 30 1.24 0.01 -0.60 10.30 0.985 
 1:10 3 15 0.79 0.01 -0.68 4.80 0.988 
7-BSA (AE) 2:1 25 72-84 n.d.e n.d.e n.d.e n.d.e n.d.e 
 1:1 22 63-73 0.37 0.03 -1.69 0.24 0.964 
 1:2.5 13 37-44 0.59 0.01 -0.98 0.28 0.985 
 1:5 7 20-23 0.3 0.01 -0.71 0.1 0.986 
 1:10 4 11-13 0.1 0.01 -1.19 0.06 0.919 
7-OVA (AE) 2:1 n.d.e  0.94 0.06 -1.20 0.9 0.990 
 1:1 12 60 0.77 0.03 -1.24 0.57 0.990 
 1:2.5 10 50 0.72 0.01 -1.13 0.29 0.990 
 1:5 3 15 0.65 0.02 -1.00 0.21 0.990 
 1:10 3 15 0.74 0.02 -1.20 0.23 0.990 
In all cases the antiserum used was As 53. Shadow boxes show the immunoassay features of the 
immunoassay used for further optimization. a Hapten:protein molar ratio used for the conjugation 
reaction. The molar ratio of the protein has been calculated in terms of the lysine residues 
available. b Hapten densities (δ) are expressed as mol of hapten per mol of protein, and the data 
reported has been measured on the corresponding BSA or OVA conjugate respectively by 
MALDI-TOF-MS. c The % conjugation is calculated based on the assumption that the BSA has 30 
– 35 free lysine groups and OVA has 20 free groups. d 5-BSA (AE) (1:1) was not soluble. e nd, not 
determined. 
 
The hapten density and the ratio Amax/IC50 as a function of the hapten:protein molar ratio 
used in the conjugation of the CAs are presented in Figure 2.10. As it can be seen a 
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decrease in the substitution degree of the free lysine groups in the proteins corresponds to 
a decrease in the hapten density of the CA resulting in a improvement of the 
immunoassay detectability (increases the ratio Amax/IC50). This is observed for all the 
combinations studied. The same effect has been observed on competitive indirect 
immunoassays for 2,4-dichlorophenoxyacetic acid [226], sulfamerazine [286], 
chlorpyrifos [287] and 2,4,6-TCP [259]. This is consistent with the statement that the 
least hapten centers are available in the coating antigen, the least amount of analyte in 
solution is needed to compete for the limited number of antibody binding sites. 
 
In general, at the lowest conjugation ratio the OVA conjugates performed better than the 
BSA conjugates. Finally, hapten 7 afforded the assays with the lowest IC50 values and the 
OVA conjugate presented the highest Amax/IC50 ratio. Therefore, the coating antigen 7-
OVA (AE) with molar ratio (1:2.5) was selected for further studies. Lower molar ratios 
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Figure 2.10. Hapten density determined by MALDI-TOF-MS and Amax/IC50 as a function of 
the hapten/lysine molar ratio used in the conjugation of the CAs 
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did not increase significantly the immunoassay detectability and required higher 
concentrations of immunoreagents to obtain the same maximum absorbance in the assay.  
 
2.5.4. Optimization and evaluation of the indirect 
competitive ELISA As53/7-OVA 
 
It is well known that immunoassay performance may be affected by many physico-
chemical features of the media and by a variety of experimental conditions. Here we 
focus our studies on the evaluation of the immunoassay behavior under several 
conditions, such as immunoreaction time, detergent, pH, ionic strength, etc. 
 
2.5.4.1. Effect of the preincubation time 
 
It has been reported that the detectability of an immunoassay can be improved by 
preincubation of the analyte with the As prior to the competition step [272,288]. In our 
case no significant effect on the immunoassay detectability was observed after an 
overnight incubation of the As with the analyte at 4ºC (IC50 0.29 µg/L versus 0.31 µg/L) 
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Figure 2.11. Effect of the preincubation of the As and the analyte before the competitive
step. The preincubation took place overnight at 4°C. The data correspond to the average of
two replicates. 
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(see Figure 2.11). The same effect was observed for ELISAs developed in our group for 
other phenolic compounds, such as 4-nitrophenol [289] and 2,4,6-TCP [259,277]. 
 
2.5.4.2. Effect of the length of the competition step 
 
The influence of the length of the competition step was also studied. As shown in Figure 
2.12 the best detectability (the lowest IC50) were obtained with shorter incubation periods. 
A reduction of the duration of the competitive step from 2 h to 10 min led to a decrease in 
the IC50 value of three times, but at the same time a decrease of the maximum assay 
signal (Amax) was also produced. Therefore, a competitive incubation period of 30 min 
was chosen as a compromise because of the greater Amax /IC50 ratio encountered (see 
Figure 2.12). 
 
2.5.4.3. Effect of the detergent Tween 20 
 
Tween 20 is a nonionic surfactant commonly used in immunoassay protocols to reduce 
non-specific interactions. For most pesticide immunoassays its usual concentration is 
0.05%. It was demonstrated in several works that lower concentrations of Tween 20 
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Figure 2.12. Variation of the immunoassay parameters (IC50 and Amax) as a function of the 
length of the competitive step. The analyte, 2,4,5-TCP and the antibody were incubated 
for different periods of time (between 10 and 120 min) in the antigen-coated plates. The 
results reported are extracted from the four-parameter equation used to fit the standard 
curves. Each standard curve was run in duplicate. 
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improve the immunoassay detectability for nonpolar small organic analytes such as 
endosulfan [290] and chlorpyrifos [287]. In contrast, highly polar analytes, such as 
chlorophenols [260,277], nitrophenols [289,291] and 3,5,6-tricloro-2-pyridinol [182] are 
less influenced by the presence of detergents in the immunoreaction media because of 
their inability to establish non-hydrophobic interactions with the detergent. Our results 
are in agreement with the above statement. Figure 2.13 shows that Tween 20 
concentrations lower than 0.05% have no effect on the immunoassay detectability for the 
polar 2,4,5-TCP. Concentrations higher than 0.5% significantly decreased the 
detectability reaching IC50 values close to 6 µg/L without affecting Amax. Thus, 
subsequent experiments were performed at 0.025% Tween 20 final concentration 
(preparing the curve in PBS and adding the As diluted in 0.05% PBST). 
 
2.5.4.4. Effect of the pH 
 
The effect of the pH on the immunoassay performance is presented on Figure 2.14. The 
parameters of the 2,4,5-TCP standard curves are quite stable in media with pH values 
between 6.6 and 10.5. At pH lower than 5.5 the assay is totally inhibited. This behavior is 
similar to the one reported by our group for other immunoassays for phenolic compounds 
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Figure 2.13. Effect of the concentration of Tween 20 on the indirect competitive ELISA. 
Standard curves and the As were prepared in PBS with different concentrations of 
Tween. 
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[259,260,289,291]. The greater tolerance to the basic conditions (2,4,5-TCP pKa=7.1: 
pH> pKa) has been interpreted as a larger participation of the phenolate form in the 
formation of the analyte-antibody complex. At pH 7.5 about 72% of the 2,4,5-TCP 
molecules exist as phenolate forms, while only 55% of the competitor hapten 7 are 
ionized, according to its pKa value (pKa=7.4). This difference may be one of the reasons 
favoring the competition of the target analyte versus the competitor. 
 
2.5.4.5. Effect of the ionic strength 
 
The effect of the ionic strength on the immunoassay performance was evaluated in media 
with conductivity values ranging from 0 to 80 mS/cm (0 to 50 mM PBS) (Figure 2.15). It 
was observed that in the absence of salts the assay was almost inhibited due to a high 
increase of the assay noise (Amin/Amax = 0.7). This behavior confirms the above-
mentioned implication of the ionic species in the stabilization of the antigen-antibody 
complex. A marked increase of the detectability (decrease in IC50) was produced from 10 
to 20 mS/cm and the IC50 remains almost constant from 30 to 80 mS/cm. The Amax 
slightly diminishes from 1 to 0.5 units within this range, but its values allow a usable 
assay. The greatest variability of the immunoassay performance was observed in media 
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Figure 2.14. Effect of the pH on the 2,4,5-TCP immunoassay. Several standard curves were 
prepared using PBS 10 mM at different pH values and added to the antigen-coated plates. 
The As dilutions were also prepared with the same buffers and Tween 20 was added to each 
of them at 0.05%. Data correspond to the average effect observed for each pH value, on two 
assays run in separate microtiter plates. 
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ranging from 10 to 20 mS/cm. Therefore it was considered necessary to place the assay 
conditions under ionic strength regions not as much affected by this parameter. The initial 
10 mM PBS assay buffer (conductivity near 15 mS/cm) was not the most appropriate. In 
contrast a 20 mM PBS buffer with conductivity values between 20 and 30 mS/cm placed 
the assay under conditions where small variations of the conductivity of the media would 
not produce important variations on the immunoassay parameters. 
 
2.5.4.6. Summary of the immunoassay features 
 
As a result of the immunoassay evaluation described above we can conclude that some 
parameters allowed the improvement of the ELISA detectabilty. While the time of 
preincubation and competition do not affect significantly the imunoassay, we have 
established the conditions of best immunoassay performance regarding Tween 20 
concentration, pH and conductivity. The factors determining the best immunoassay 
performance are summarized in Table 2.11 and the corresponding standard curve is 
presented in Figure 2.16. Under these conditions we have studied the reproducibility of 
the immunoassay As53/7-OVA running nine calibration curves in two-well replicates in 
three different days. The parameters of the standard curves are summarized in Table 
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Figure 2.15. Variation of the immunoassay features with the ionic strength of the media
(expressed in mS/cm). Different concentrations of PBS (0, 5, 10, 20, 50 mM) were used to
prepare standards and As solutions. Each standard curve was run in duplicate in the same
microtiter plate. The data presented are extracted from the four-parameter equation used to
fit the standard curve. 
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2.11. The IC50 value is 0.23 µg/L (1.165 nM), the dynamic range is between 0.093 and 
0.725 µg/L (0.471-3.671 nM) and the limit of detection is 0.053 µg/L (0.268 nM). 
 
 
Table 2.11. Optimum conditions and features of the 2,4,5-TCP immunoassay (As53/7-OVA) 
Condition Values Parameter Values a 
Preincubation time 0 min Amax 0.838±0.020 
Competition time 30 min Amin 0.031±0.009 
pH 7.5 IC50, µg/L 0.231±0.011 
Ionic strength 20 mS/cm 
(20 mM PBS) 
Dynamic range b 0.093±0.004 to  
0.725±0.106 
Tween 20 0.025% Slope 1.399±0.070 
  LOD c, µg/L 0.053±0.004 
  r2 0.995±0.001 
a The parameters are extracted from the four-parameter equation used to fit the standard curve. 
The data presented correspond to the average of nine calibration curves run in three different days. 
Each curve was build using two-well replicates. b The dynamic range is defined by the 
concentrations corresponding to 20 and 80% of the assay response at zero dose. c The limit of 
detection (LOD)is the analyte concentration corresponding to 90% of the assay response at zero 
dose. 
 
2.5.4.7. Specificity study 
 
Immunoassay specificity was evaluated by testing 27 structurally related compounds as 
competitors in the ELISA. We have selected a variety of chlorophenols, bromophenols 
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Figure 2.16. Standard curve for the As53/7-OVA (1:2.5) immunoassay. The corresponding
characteristics are presented in Table 2.11. 
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and phenol. Standard curves for all the selected compounds were run in the range 0.04 
and 10 000 nM and compared to the 2,4,5-TCP curve. The cross-reactivity values were 
calculated according to the following formula: 
( )
( ) 100_
5,4,2%
50
50 ×−=
compoundphenolicIC
TCPICCR  
The results regarding the IC50 for each analyte and the crossreactivity (%) values 
demonstrate that the immunoassay is quite specific (see Table 2.12).  
 
Table 2.12. Interference caused by structurally related chemicals, expressed by their IC50 and the 
percentage of cross-reactivity a. 
# b 
Phenolic 
Compounds 
IC50 (nM) % CR 
Brominated 
analogues IC50 (nM) % CR 
5 PCP 101.3 1.5 PBP 361.9 0.42 
2,3,4,6-TtCP 8 18.9    
2,3,4,5-TtCP 33 4.6    4 
2,3,5,6-TtCP 304 0.5     
2,4,5-TCP 1.52 100    
2,4,6-TCP 8.9 17 2,4,6-TBP 5.5 27.7 
2,3,4-TCP 168.9 0.9 2,4,6-TIP 6.3 24 
2,3,5-TCP 1520 0.1 2,4,6-TFP >10000 <0.01 
2,3,6-TCP 380 0.4     
2,4,5-TCA 524.5 0.29    
3 
2,4,6-TCA 5066,7 0.03    
2,4-DCP 43.4 3.5 2,4-DBP 14.5 10.5 
2,5-DCP 168.9 0.9 2,5-DBP 8 15 
2,6-DCP 337.8 0.45 2,6-DBP 108.6 1.4 
2 
3,4-DCP >10000 <0.01 2-B-4-CP 14.9 10.2 
2-CP 2533.3 0.06    
3-CP >10000 <0.01    1 
4-CP >10000 <0.01 4-BP 475 0.32 
0 phenol >10000 <0.01    
a Cross-reactivity is expressed as % of the IC50 of 2,4,6-TCP/IC50 phenolic compound;  
b Number of halogens. B, bromo; C, is chloro; DCP, dichlorophenol; TCP,trichlorophenol; TtCP, 
tetrachlorophenol;, PCP, pentachlorophenol; BP, bromophenol; DBP, dibromophenol; TBP, 
tribromophenol; PBP, pentabromophenol; TIP, triiodophenol; TFP, trifluorophenol; TCA, 
trichloroanisol. 
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It can be observed that the degree of recognition was directly related to the presence of 
two chlorine atoms (one at ortho and another at para position) and one hydrogen atom 
in meta position as in the target analyte (see Figure 2.17). For example, 2,3,4,6-
tetrachlorophenol (TtCP) possessing these three atoms on one of its moieties was the 
most recognized compound with 19 % cross-reactivity value, while 2,3,4,5-TtCP lacking 
the hydrogen atom in meta was less recognized (4.6%) and 2,3,5,6- TtCP lacking the 
chlorine atom at para position and possessing two chlorine atoms at meta positions 
cross-reacted only 0.5%. Similarly, among the trichlorophenols 2,4,6-TCP is the most 
recognized (17%) possessing both orto and para chlorine atoms and a meta hydrogen, in 
the same range as 2,3,4,6-TtCP. The lack of the hydrogen in meta (2,3,4-TCP) or of the 
chlorine atom in para (2,3,5-TCP and 2,3,6-TCP) decreases significantly the 
recognition. Analytes with only two, one or none chlorine atoms had a negligible 
(≤3.5%) or void interference in the assay. It also worth noting that blocking the hydroxy 
group as an ether reduced drastically the recognition. Thus, 2,4,5-trichloroanisol was 
only recognized at 0.29%, although it possesses the three chlorine atoms in the same 
position as the target analyte. This lack of recognition could be attributed to the fact that 
the phenolate species are the forms participating mostly in the stabilization of the 
immunocomplex. As was demonstrated by theoretical models, blocking the hydroxyl 
group produced significant electronic differences with the target analyte. Similarly to 
ELISAs for 2,4,6-TCP developed in our group [259,260,277], brominated phenols were 
also highly recognized in this assay. Thus, 2,4-dibromophenol (DBP) and 2,5-DBP 
cross-reacted 10.5% and 15%, respectively, while their homologous chlorinated analytes 
2,4-DCP and 2,5-DCP were only recognized in 3.5% and 0.5%, respectively. Similarly, 
2,4,6-tribromophenol (TBP) was recognized 27.7% while 2,4,6-TCP interfered only 
17%. Unfortunately, at the time of writing this thesis we have not been able to test 2,4,5-
TBP, but we would expect recognition greater than 100%. 
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2.5.4.8. Precision 
 
Once we set the optimum performance conditions of the immunoassay (see Table 2.11), 
we studied its precision. The within assay precision was evaluated by the analyses of 
spiked PBS samples in triplicate inside a plate and the precision between different assays 
was calculated based on the analyses of the same samples in different days.  
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Figure 2.17. Chemical structures of the analyte, the immunogen used for As 53 production 
and the crossreactants. The fragments of the structures colored in red are possibly 
recognized by the As. From left to the right the cross-reactivity is decreasing. 
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Table 2.13. Precision of 2,4,5-TCP immunoassay 
Spiked concentration, µg/L  
0.1 0.3 1.5 
Na 9 9 9 
Mean 0.094 ± 0.018 0.285 ± 0.031 1.453 ± 0.174 
% CV (within assay) b 15 5.1 7.9 
% CV (between assay) 20 10.9 12 
a Samples were prepared in PBS and analyzed in three-well replicates in three consecutive days. 
b The % CV is the average of the % CV of all measurements. 
 
The coefficients of variation obtained are below 12% except in the case when the 
measurement takes place at the limits of the working range of the assay. 
 
2.5.4.9. Accuracy 
 
Similarly, the accuracy of the assay was tested by recovery experiments. Eight PBS 
samples with increasing 2,4,5-TCP concentrations varying from 0.1 to 50 µg/L were 
analysed by the ELISA and the measured values were compared to the spiked 
concentrations (see Figure 2.18). The correlation was very good (r2 = 0.999) and the 
slope of the regression curve was close to 1 (slope =1.07) that is an indication of the assay 
accuracy. 
2,4,5-TCP spiked, µg/L
2,
4,
5-
TC
P
fo
un
d,
µ g
/L
0 10 20 30 40 50 60
0
10
20
30
40
50
60
y=1.07x-0.21
r2 0.999
 
Figure 2.18. Correlation between the spiked and the measured concentration values. Samples 
were prepared by spiking 20 mM PBS with different concentrations of 2,4,5-TCP. The data 
shown correspond to the average and the standard deviation of the results obtained from the 
immunoassay run in three different days. The dotted line corresponds to a perfect correlation 
(slope = 1). 
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______________________________________________________________________ 
 
3. Evaluation of the effect of 
environmental and biological matrices 
on the immunochemical determination 
of 2,4,5-TCP and 2,4,6-TCP 
 
______________________________________________________________________ 
 
 
 
 
The final objective of any immunoassay is to obtain correct results when measuring a 
particular analyte in a real sample. However, the IA performance may be affected by 
interferences from the sample matrix [25,174,292]. The matrix effect represents the 
deviation from the parameters of the standard curve in buffer caused by the sample 
properties or its components (except the analyte). Interferences on IAs are categorized 
into specific and non-specific. All of them may affect Ab-Ag interaction and/or the 
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enzyme activity if enzyme labels are used. Specific interferences (cross-reactants) refer to 
those kind of sample components which are recognized by the Ab. Non-specific 
interferences involve other components that bear no structural resemblance to the analyte 
and physicochemical parameters, such as pH, ionic strength, chaotropic agents, organic 
compounds, etc.  
 
As the interfering substances in many cases are completely unknown, the matrix effects 
of real samples should be evaluated when environmental and biological monitoring is 
performed by an immunochemical method. There are several approaches to asses matrix 
effects. If a “blank” (zero analyte concentration) sample matrix is available, standard 
curve run in the matrix of interest is compared to the standard curve in buffer. If there is 
no matrix effect, no differences should be observed between the parameters of both 
curves. Another possibility is to measure fortified samples and compare the expected and 
measured recovery values. In an IA with interferences, recovery suffers deviations (it 
should be around 100%) and differences between observed and measured values usually 
decrease with dilutions. If an appropriate “blank” sample is not available, a sample can be 
used, preferably one in which the analyte is present in very low levels. The method of 
standard additions is then recommended for evaluating the effect of the matrix [293]. 
Briefly, in this method the sample is split and one split is fortified with a known 
concentration of analyte. Both are measured by ELISA and the difference between them 
should be the level of the fortification. If it is not, a matrix effect may be assumed. 
Another way to verify if there is a matrix effect is to analyze the sample at several 
dilutions. A plot of the absorbance obtained from each dilution should be parallel to the 
slope of the calibration curve in the absence of matrix effects. 
 
Once the presence of a matrix effect is confirmed, the next step is to find out the best way 
to eliminate it. Matrix effects in IAs can be overcome by sample dilution, purification or 
changes in the assay format. Sample dilution is the easiest way to overcome negative 
matrix effects, but it limits the assay detectability. Another alternative is to run the 
standard curve in the matrix of interest, so that the influence on quantification would be 
normalized. Finally, adding some additives to the working buffer could mimic the matrix 
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of interest and in this way the buffer calibration curve will be placed close to the matrix 
one. Nevertheless, it should be noted that interferences may vary with reagent batches and 
matrix sources and thus must be checked frequently by a combination of running 
appropriate blanks and controls, and confirming positive samples by an alternate 
analytical method. This is crucial when ELISA is used for monitoring samples of 
unknown origin when corresponding blanks are not available. 
 
In general, when ELISA is applied to environmental and/or biological monitoring the 
objective is to find out the easiest and less time-consuming sample treatment resulting in 
a correct analyte determination. In this chapter we describe the evaluation of the effect of 
environmental (water) and biological (milk, serum and urine) matrices on the 
performance of the two immunoassays for trichlophenols (2,4,5- and 2,4,6-TCP ELISA) 
developed in our group. As mentioned in the Introduction an indirect ELISA for 2,4,6-
TCP (As43/8-BSA(1:5)) had been developed before by R.Galve [277]. The As was raised 
against 3-(3-hydroxy-2,4,6-trichlorophenyl)propanoic acid) (hapten 5) (see Figure 2.5) 
covalently coupled by the MA method to KLH. The indirect ELISA uses a heterologous 
coating antigen prepared by conjugation of 3-(2-hydroxy-3,6-dichlorophenyl)propanoic 
acid (hapten 8) to BSA using the AE method. The optimum hapten density for the coating 
antigen was found to be 3 mols hapten/mol of protein. The assay parameters and the 
optimum conditions of its performance are summarized in Table 3.1. 
 
Table 3.1. Optimum conditions and features of the 2,4,6-TCP immunoassay (As43/8-BSA) 
Condition Values Parameter Values a 
Preincubation time 0 min Amax 0.796±0.174 
Competition time 30 min Amin 0.018±0.021 
pH 7.5 IC50, µg/L 1.132±0.361 
Ionic strength 15 mS/cm 
(10 mM PBS) 
Dynamic range 0.288±0.045 to 3.117±0.679 
Tween 20 0.05% Slope 1.22±0.23 
As43 1/4000 LOD, µg/L 0.175±0.027 
8-BSA 0.625 µg/mL r2 0.991±0.006 
a The parameters are extracted from the four-parameter equation used to fit the standard curve. The 
data presented correspond to the average of 34 calibration curves run in different plates in a 3-
months period. Each curve was built using two-well replicates. 
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The assay shows a limit of detection of 0.175±0.027 µg/L and it is performed in about 1.5 
h. (see Experimental Section for detailed procedure). Regarding the effect of the 
physicochemical properties of the media a tolerance to basic conditions was observed. 
The assay performs well between pH 7.5 and 9.5 and it is inhibited at pH lower than 6. 
The immunoassay detectability do not change significantly when the ionic strength of the 
media is in the range of 12 - 25 mS/cm. The ELISA for 2,4,6-TCP is quite specific but 
some cross-reactivity with other chlorinated phenols such as 2,3,4,6-TtCP (21%), 2,4,5-
TCP (12%) and 2,3,5-TCP (15%) is observed. Brominated phenols (BP) are even more 
recognized than the corresponding chlorinated analogues (e.g. 2,4,6-TBP, 710%; 2,4-
DBP, 119 %). 
 
The development of the indirect ELISA for 2,4,5-TCP (As53/7-OVA(1:2.5)) have been 
described in the previous chapter (see Section 2.5.4 for the influence of several 
physicochemical parameters, see Table 2.12 for the immunoassay features, and Table 
2.13 for cross-reactivity data). 
 
In this chapter we report the evaluation of the 2,4,5- and 2,4,6-TCP ELISAs for 
environmental and biological monitoring programs. As environmental samples we have 
evaluated water samples from different sources. In this case the objective was to prove if 
these ELISA methods would be able to reach a limit of detection close to the values set 
by the EU as maximum concentration of pesticides in drinking water (0.1 µg/L for 
individual compounds and 0.5 µg/L for total). 
 
For biomonitoring purposes we have considered suitable to evaluate ELISA performance 
in several body fluids, such as milk, serum and urine. In contrast to the much more 
lipophilic organochlorinated compounds (such as PCP, HCH, HCB, DDT, DDE, PCBs) 
that are widely detected in milk and serum (or plasma) [94, Wrbitzky, 1995 
#2535,124,127,294-296], there are very few examples on the detection of 
trichlorophenols in these matrices [64,134,135]. Based on the reference values established 
for PCP in serum (12 µg/L) and for several organochlorinated pesticides in human milk 
(for all of them the reference values are lower than 1 µg/g fat) [20], we could assume that 
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the limit of detection to be accomplished for TCP in these samples should be similar. In 
addition, the evaluation of the ELISA in serum samples could be useful not only for 
biomonitoring but also for toxicological studies. Completely different is the case of the 
excretion of trichlorophenols in urine that has been covered by several authors 
[75,121,123,124] (see Introduction for more information). Attending to the information 
found in the literature our purpose was to evaluate the interferences caused by this matrix, 
keeping in mind that a LOD near 1 µg/L would be desirable in order to measure levels of 
exposure of the general population. 
 
 
3.1. Performance of the 2,4,5- and 2,4,6-TCP ELISAs 
in water samples 
 
As it was mentioned in the Introduction chlorophenols have been identified as usual 
contaminants of surface waters [39], industrial wastewater [32] and drinking water [52]. 
According to Directive 76/464/CEE and US-EPA method 8041, 2,4,5-TCP and 2,4,6-
TCP are included in the lists of the most important phenolic contaminants to be controlled 
in waters. 
 
With the aim to evaluate the effect of the matrix we selected two types of water samples, 
a well water and drinking water from water-supply mains. The pH and the conductivity of 
both water samples are presented in Table 3.2. The conductivities of these samples were 
lower than the buffer conductivity.  
 
Table 3.2. Properties of the water samples studied 
Water pH Conductivity, mS/cm 
well 6 2.31 
water supply 7.3 0.52 
2x PBS a 7.4 30 
a 2xPBS is 20mM PBS buffer. 
 
As mentioned in Chapter 2, the 2,4,5-TCP ELISA is inhibited in the absence of any 
salts. Therefore, the water samples were buffered by adding 10% (v/v) of 100 mM PBS. 
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In this way their pH and conductivity was adjusted to the buffer values. A white 
precipitate was formed when adjusting pH of the well water sample and it was removed 
by centrifugation. Figure 3.1.A. shows the standard curves for 2,4,5-TCP obtained for 
both water samples after this small treatment. It can be observed that their behavior is 
equal to the standard curve prepared in the assay buffer indicating the absence of 
undesirable matrix effects. Similarly, buffering of natural water samples has been 
demonstrated to be efficient to overcome the interferences on the ELISA for 2,4,6-TCP 
(see Figure 3.1.B) [1]. Only for the case of the well water sample this treatment showed 
to be not completely efficient. 
 
In order to prove the reliability of the method, drinking water was spiked with 2,4,5-TCP 
at several concentration levels. Spiked samples were conditioned as already described and 
analyzed by ELISA without further treatment. Results from the analysis are shown in 
Table 3.3. The comparison between the amount of 2,4,5-TCP measured by ELISA and 
the amount added indicates a good agreement, with recovery values in the range between 
92% and 105%. The average intra-assay CV was 6.7%, ranging from 2.2% to 12.7%. 
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Figure 3.1. Results from the studies of the matrix effect produced by well and drinking
water on the ELISAs for 2,4,5-TCP (A) and 2,4,6-TCP (B). Samples were buffered by
adding 10% (v/v) of 100 mM PBS and used directly in the immunoassay. (B) is reprinted
from [1] 
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Table 3.3. Accuracy of the analysis of 2,4,5-TCP in drinking water samples by the immunoassay 
(As53/7-OVA) 
Spiked a, µg/L Measured (mean ± SD) b, µg/L Recovery, % 
0.2 0.184 ± 0.023 92 
0.4 0.372 ± 0.008  93 
1 1.053 ± 0.027  105.3 
5 5.190 ± 0.490  103.8 
a Spiked drinking water samples were conditioned for pH and ionic strength by adding 10% (v/v) 
of 100 mM PBS and analysed without further treatment. Concentrations were calculated from the 
PBS standard curve. b Data correspondto three determinations performed in the same ELISA plate. 
 
The accuracy of the ELISA for the determination of 2,4,6-TCP in water samples was 
evaluated by eight spiked samples. Each sample was split in two parts, one of which to be 
analyzed by ELISA and the other one, by a GC-ECD method. Samples were directly 
measured by ELISA, while for GC-ECD determination the samples were extracted in 
toluene in the presence of an internal standard, then derivatized and finally injected in the 
chromatograph (see and Annex I). The results obtained are presented in Figure 3.2. It 
can be observed that ELISA (slope=0.89) shows better accuracy than the GC-ECD 
method (slope= 0.7). This can be explained by the fact that ELISA measurements take 
place directly in the aqueous samples without special treatment. For instrumental analysis 
an extraction step is necessary and in our study we have used a standard curve built on 
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Figure 3.2. Accuracy of the 2,4,6-TCP ELISA method compared to the GC-ECD method.
Spiked samples were prepared in PBS and splitted in two parts to be analyzed by both
methods. Samples were directly measured for ELISA, while for GC-ECD samples were
extracted in toluene in the presence of an internal standard, derivatized and then injected in the
chromatograph. ELISA shows better accuracy than the GC-ECD method. Correlation between
both techniques agrees to the following equation y=1.26x–4.27 and has a regression coefficient
of r²=0.993 
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2,4,6-TCP standards in toluene (not coefficient of extraction efficiency is applied). 
Correlation between both techniques agrees to the following equation y=1.26x–4.27 and 
has a regression coefficient of r²=0.993. 
 
In conclusion, the results from the water matrix effect studies demonstrate the suitability 
of both immunoassays for a direct and precise determination of 2,4,5-TCP and 2,4,6-TCP 
in water samples. The detectability of the IA methods for 2,4,5-TCP and 2,4,6-TCP in 
water are summarized in Table 3.4.  
 
Table 3.4. Detectability features of the TCP ELISAs in drinking water samples (µg/L) 
Parameters 2,4,5-TCP 2,4,6-TCP 
LOD 0.07 ± 0.01 0.18 ± 0.03 
IC50 0.32 ± 0.02  1.13 ± 0.36 
Dynamic range 0.13 ± 0.01 - 1± 0.15 0.29 ± 0.05 – 3.12± 0.68 
The reported parameters correspond to the standard curves run in buffered water. 
 
The detection limits of both ELISAs are below the LOD of the standard chromatographic 
methods established by EPA for environmental monitoring of trichlorophenols (0.64 µg/L 
2,4,6-TCP)[144,145]. Finally, water contamination with trichlorophenols can be 
evaluated according to the EU legislation (Directive 80/778/CCE) on maximum levels of 
contaminants in drinking water samples.  
 
 
3.2. Performance of the 2,4,5-TCP ELISA in milk 
samples 
 
Organochlorine compounds (insecticides, pesticides, PCBs) are lipid-soluble and tend to 
accumulate in the food chain and store in tissues and lipid-rich organs. Milk secretion is 
the most important route of excretion of those type of compounds in women. The 
presence of organochlorines in human breast milk has been reported from various 
countries [94,294,297-299], since analysis of breast milk supply information on the 
exposure of different populations to organochlorine contaminants. In addition, several 
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studies demonstrate the transfer of dioxins/furans to milk of cows grazing near a 
municipal solid waste incinerator or following ingestion and exposure to 
pentachlorophenol-treated wood [87,88,300].  
 
In order to evaluate the performance of the immunoassay for 2,4,5-TCP in milk we used 
skimmed milk (see Table 3.5 for its properties).  
 
Table 3.5. Properties of skimmed milk 
pH 6.8 
Conductivity 5.25 mS/cm 
proteins 31 g/L 
fat ≤ 5 g/L 
Ca 1.2 g/L 
 
Several standard curves were prepared in milk diluted in 2x PBS (1/5, 1/20, 1/100). 
Although under these conditions the pH and the conductivity values of the milk samples 
were closed to those of the buffer, the signal was completely inhibited. This suggested 
that the milk interfered with the Ab-Ag binding reaction. According to the literature [301] 
matrix effects in milk are likely produced by the fat and the protein content of the sample. 
In addition, the analyte properties can also be crucial for the good performance of the 
assay in milk. Thus, it has been reported that there were substantial fluctuations in the 
absorbance values at low analyte levels due to the difficulty in spiking raw milk (a two-
phase fat and aqueous system) with a highly hydrophobic analyte, such as sulfamerazine 
[286]. On the other hand, immunoassays in milk have been described for the highly polar 
diflubenzuron [302], paraquat [303], aldrin and dieldrin [304], and atrazine [305]. 
 
With the aim to eliminate the observed interferences we decided to remove proteins by 
alkaline (0.2M KOH) precipitation of the milk sample but unfortunately no improvement 
was observed (see Figure 3.3.A).  
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Another source of matrix effect could be the high content of calcium ions in milk (for 
example the 2,4,6-TCP ELISA is inhibited by Ca2+ ions, see Section 3.4.3). Some authors 
have reported the removal of Ca2+ ions by precipitation with Na2SO4 [302] or with oxalic 
acid [306]. We treated the milk samples with Na2SO4 and after centrifugation of the 
CaSO4 precipitate the supernatant was diluted in PBS buffer. The resulting curves are 
presented in Figure 3.3.B and show that no improvement in immunoassay performance 
was accomplished. These results suggested that for the analysis 2,4,5-TCP in milk it 
would be necessary to develop more complex clean-up procedures such as filtration, fat 
removal, 2,4,5-TCP extraction, etc. Therefore, we decided to go forward evaluating other 
biological samples as potential matrices for biomonitoring of trichlorophenols as 
indicators of exposure (see Introduction). 
 
 
3.3. Performance of the 2,4,5- and 2,4,6-TCP ELISAs 
in human serum 
 
As it was mentioned in the Introduction human exposure assessment can be performed 
by analysis of trichlorophenols in blood serum [64,134] and plasma [135]. In addition, 
2,4,5-TCP, nM
Ab
so
rb
an
ce
10 -3 10 -2 10 -1 10 0 10 1 102 10 3
0.00
0.25
0.50
0.75
PBS 2x
milk, 1/5
milk, 1/10
milk, 1/50
milk, 1/100
A protein removal
 2,4,5-TCP, nM
Ab
so
rb
an
ce
10 -3 10 -2 10 -1 10 0 10 1 10 2 10 3
0.00
0.25
0.50
0.75
PBS 2x
milk, 1/5
milk, 1/20
milk, 1/100
B Ca2+ removal
 
 
Figure 3.3. Matrix effects on the 2,4,5-TCP ELISA caused by milk after different sample
treatments and subsequent dilutions with 2xPBS buffer. A. Protein precipitation was produced
by NaOH; B. Ca2+ions were precipitated by Na2SO4;. Detailed procedures are described in
Experimental Section. 
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toxicological studies on organochlorine contaminants require the determination of their 
metabolites (chlorophenols) in animal tissues (blood, liver, etc.) [78].  
 
3.3.1. ELISA for 2,4,5-TCP 
 
With the aim to determine trichlorophenols in serum by ELISA, we approached the 
evaluation of the immunoassay performance in a commercially available pooled human 
serum sample (pH=7.8; conductivity: 11 mS/cm). Initially, we tested the effect of the 
matrix just diluting the serum in the assay buffer. The pH and salinity of serum dilutions 
were the same as the buffer values. As it is shown in Figure 3.4, the serum did not have a 
significant effect on the Amax of the assay, although the non-specific adsorption (Amin) 
increased. The serum standard curves were parallel to the one prepared in PBS and 
shifted towards higher concentration region, diminishing in this way the assay 
detectability. Thus, the standard curve prepared in 20 times diluted serum produced an 
IC50 value of 25 µg/L. This behavior was attributed to the high concentration of albumins 
in human serum (range 3500-5500 mg/mL for adults in central Europe) [307]. It is well 
known that albumins have the ability to bind many substances and play an important role 
as carrier proteins. The analyte, present in the samples or in the standards, could bind the 
serum albumins preventing in this way the reaction with the antibody. As a consequence, 
the real analyte concentration would be underestimated if the buffer standard curve is 
used for quantification (serum curves are shifted to the right). Therefore, we focused on 
the evaluation of sample treatment procedures to reduce the protein content of the serum 
samples.  
 
Protein removal is perhaps the crudest clean-up procedure applied in biofluid analysis and 
it can be realized by filtration (dialysis) or protein precipitation (by heat, acids, alkalis, 
organic solvents) [308]. Our aim was to find the best procedure to eliminate proteins in 
terms of immunoassay compatibility and analyte recoveries. Ultrafiltration of the serum 
using nitrocellulose microfilters (10 kDa cut-off, Millipore) improved significantly (3 
times) the immunoassay detectability (see Figure 3.4.B),  but the reproducibility was not 
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Figure 3.4. Matrix effects on the 2,4,5-TCP ELISA caused by the human serum after several
sample treatments and subsequent dilutions with PBS buffer. A, Serum without any treatment;
B. Ultrafiltration; Protein precipitation was produced by: C, heating the serum at 65ºC; D,
KOH; E, trichloroacetic acid; F; perchloric acid; G, absolute ethanol. Detailed protein removal
procedures are described in Experimental section. 
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very good and the recovery from spiked and filtered serum samples was low probably due 
to analyte adsorption on the microfilters. Similar problems were encountered after protein 
denaturation by heat. Partial protein removal by heating the serum at 65°C during 30 min 
reduced the matrix effect on the ELISA (compare Figure 3.4.C with 3.4.A). However, 
the recoveries ranged from 20 % to 55 % when 1/20 PBS serum dilution was used and the 
quantification was performed with a standard curve run in PBS (see Table 3.6). Complete 
protein removal was achieved by heating up to 100ºC for 15 min. In this case 1/10 PBS 
serum dilution was enough to eliminate completely the matrix interferences (data not 
shown), but the recoveries were lower than 34% (see Table 3.6).  
 
Table 3.6. Accuracy of 2,4,5-TCP analysis in human serum by the immunoassay. 
Protein removal Spiked, µg/L Measured (mean ± SD) e, µg/L Recovery, % 
6 1.206 ± 0.704  20 
12 2.604 ± 0.660 21.7 Heat 65ºC a 
20 11.06 ± 2.762 55.3 
5 1.691 ± 0.105 33.8 
12 3.602 ± 0.410 30 Heat 100ºC b 
20 5.720 ± 0.425 28.6 
12 11.364 ± 0.477 94.7 
20 13.360 ± 0.922 66.8 HClO4 c 
40 13.040 ± 2.060 32.6 
3.2 3.080 ± 0.600 f 95.50 
8 7.844 ± 0.512 f 98.05 EtOH d 
32 24.440 ± 0.784 f 76.57 
a Spiked serum samples were deproteinized by heating at 65ºC for 30 min, diluted 20 times with 
PBS. Further dilutions were performed using 1/20 PBS diluted serum. The concentrations were 
evaluated from a standard curve run in PBS. b Spiked serum samples were deproteinized by 
heating at 100ºC for 15 min and diluted 10 times with PBS. Further dilutions were performed in 
1/10 PBS diluted serum. The concentrations were evaluated from a standard curve run PBS.  
c Spiked serum samples were deproteinized by 6% perchloric acid and the supernatant diluted 80 
times with PBS. The concentrations were evaluated from a standard curve run in PBS. 
d  Spiked serum samples are precipitated by absolute ethanol (1:1, v/v) and the supernatant diluted 
with PBS to final 25% EtOH and 1/8 serum concentration. The concentrations were evaluated 
from a standard curve run in 25% EtOH/PBS. e Data obtained from three determinations 
performed in the same ELISA plate, except f that was obtained from two different samples 
precipitated with ethanol and each samples was analyzed in triplicates on the same ELISA plate.  
 
Protein precipitants, such as acids and bases, commonly used in preparing biological 
samples prior to analysis, were also tested. We observed that alkaline denaturation with 
0.2M KOH [309] removed most of the proteins in the serum, but the serum supernatant 
had to be diluted more than 80 times to avoid matrix effect. This was probably caused by 
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the high increase of the ionic strength of this sample (see Figure 3.4.D). When 
trichloroacetic acid was used as protein precipitating agent [310], the ELISA was even 
more inhibited in spite that the pH and the conductivity had been previously adjusted (see 
Figure 3.4.E). Deproteinisation using 3% (w/w) perchloric acid [311] performed slightly 
better, although it was still needed to dilute the serum supernatant at least 80 times to 
obtain an acceptable standard curve close to the one obtained with the assay buffer (see 
Figure 3.4.F; the pH and the conductivity had also been adjusted to the buffer values for 
all dilutions). Additionally, the recovery values of this sample treatment were low, 
especially at high 2,4,5-TCP concentration levels (40 µg/L - 32.6%, see Table 3.6). A co-
precipitation of the trichlorophenol with the serum proteins may occur due to its polar and 
lipophilic properties. 
 
Finally, we approached deproteinization of the serum by organic solvents. We chose 
ethanol because of its ability to precipitate more than 99% of proteins without changing 
the pH of the sample [308]. Additionally, hydro-alcoholic extracts are often compatible 
with the immunoassay performance. In general immunoassays tolerate a concentration at 
about 10% of alcohols [177,180,265,312,313]. The effect of the EtOH content on the 
immunoassay for 2,4,5-TCP is presented in Figure 3.5.  
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Figure 3.5. Variation of the 2,4,5-TCP immunoassay features as a function of the EtOH
concentration in PBS buffer. Different concentrations of EtOH/PBS (0, 10%, 25%, 50%)
were used to prepare standards and As solutions. Each standard curve was run in duplicate
in the same microtiter plate. The data presented are extracted from the four-parameter
equation used to fit the standard curve. 
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A clear decrease in maximumum signal and detectability (IC50) is observed when 
increasing amounts of the solvent are added to the assay buffer, although reasonable 
values of Amax and IC50 can be accomplished up-to 25% EtOH. A 25% EtOH content 
produces an assay with IC50 value 2-3 times higher than the IC50 of the buffer assay 
keeping similar Amax. Even at 50% EtOH content the immunoassay is not inhibited. 
 
Taking in consideration the 2,4,5-TCP levels found in the general population and the 
reference values accepted in some countries (see Section 1.2.5.3), we considered that a 
LOD between 0.1 and 0.2 µg/L could still be good enough for biological monitoring 
studies. Therefore, human serum was treated with absolute ethanol to a 50% 
concentration, centrifuged and the supernatant diluted 2 times with PBS. This solution 
represents 1/4 serum dilution and it contains a 25% EtOH. Further serum dilutions were 
performed using 25% EtOH/PBS to maintain the organic solvent concentration. The 
serum standard curves compared to the 25% EtOH/PBS curve are presented in Figure 
3.4.G. It can be observed that, under these conditions a 1/4 dilution eliminates the 
interferences caused by the serum matrix. Additionally, this sample treatment improves 
significantly immunoassay performance when compared to the 1/5 diluted serum assayed 
without any treatment (see Figure 3.4.A). 
 
A 1/8 diluted deproteinized serum was chosen to test immunoassay accuracy. Three 
spiked and one non-spiked serum samples were prepared in duplicates for each 
concentration value, treated to remove proteins as described before and measured with the 
ELISA using the standard curve run in 25% EtOH/PBS. As it is shown in Table 3.6, the 
percentage of the coefficient of variation is quite low and the recovery values ranged 
from 76% to 98%. From these results it can be concluded that this procedure is 
appropriate to analyze 2,4,5-TCP in serum samples. A LOD of about 0.8 µg/L can be 
accomplished in serum using this procedure (see Table 3.7 at the end of this section). 
This value can be improved if further dilutions of the serum supernatant are performed in 
PBS reducing thus the ethanol content until a 12.5% (LOD= 0.05 µg/L x 8 = 0.5 µg/L). 
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3.3.2. ELISA for 2,4,6-TCP 
 
Next, we evaluated the serum matrix effect on the immunoassay for 2,4,6-TCP. As can be 
seen at Figure 3.6.A the serum matrix effect is quite similar to that observed for the 
2,4,5-TCP ELISA: at least 80-fold serum dilution would be necessary for a correct 2,4,6-
TCP quantification in serum samples. 
 
Therefore, we have decided to apply the most effective serum treatment procedure 
established above, the protein precipitation by EtOH. First, it was necessary to evaluate 
the effect of EtOH content on the performance of 2,4,6-TCP ELISA (see Figure 3.7). The 
increase in the percentage of EtOH affected negatively the immunoassay parameters 
limiting its detectabilty. Ethanol concentration values higher than 15% clearly modified 
the assay parameters and at 56% EtOH the absorbance values of the standard curve fitted 
very poorly to a sigmoidal curve. It should be noted that the 2,4,5-TCP ELISA tolerates 
ethanol concentrations even at 50% EtOH (see Figure 3.5). Therefore, a lower EtOH 
concentration in the serum sample after the protein removal had to be used to avoid its 
negative effect on the 2,4,6-TCP ELISA. Thus, we followed the same protein 
precipitation procedure (50% EtOH) but then the sample was diluted with PBS buffer 
until 12% EtOH.  
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Figure 3.6. Matrix effects on the 2,4,6-TCP ELISA caused by the human serum. A, Serum
without any treatment.; B, Protein precipitation was produced by absolute ethanol. Detailed
protein removal procedure described in Experimental section. 
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The effect of the serum on the immunoassay after this treatment is presented in Figure 
3.6.B. Surprisingly, this immunoassay showed higher matrix effect than the 2,4,5-TCP 
ELISA and a higher serum dilution (1/32) was needed to accomplish the same behavior 
as that of the 12%EtOH/PBS buffer (compare to Figure 3.4.G). Therefore, the observed 
matrix effect results in a higher LOD for 2,4,6-TCP in serum samples (4.6 µg/L) (see 
Table 3.7). It is possible that a further optimization of the ELISA protocol applied to 
serum extracts or an introduction of a clean-up procedure would allow an improvement in 
method detectability.  
 
Table 3.7. Detectability features of the TCP ELISAs in serum samples (µg/L). 
Parameters 2,4,5-TCP a 2,4,6-TCP b 
LOD 0.80 ± 0.16 4.576 ± 0.68 
IC50 6.46 ± 0.25 85.12 ± 2.55 
Dynamic range 1.2 ± 0.14  -  40 ± 6.96 15.04± 2.73  -  288.8 ± 40.46 
a The reported values are obtained multiplying the parameters of the 1/8 serum standard curve by 
8. Serum is precipitated by ethanol. b The reported values are obtained multiplying the parameters 
of the 1/32 serum standard curve by 32. Serum is precipitated by ethanol. 
 
In conclusion, the detection concentrations accomplished with both ELISAs following the 
optimized procedure of serum treatment (EtOH precipitation) are much lower than the 
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Figure 3.7. Variation of the 2,4,6-TCP immunoassay features as a function of 
EtOH concentration in the PBS buffer. Different concentrations of EtOH/PBS in 
the range 0-50% were used to prepare standards and As solutions. Each standard 
curve was run in duplicate in the same microtiter plate. The data presented are 
extracted from the four-parameter equation used to fit the standard curve. 
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established reference value for PCP in serum (12 µg/L) and we believe that this would 
allow the biomonitoring of trichlorophenols in the general population. 
 
 
3.4. Performance of the 2,4,5- and 2,4,6-TCP ELISAs 
in human urine 
 
As was mentioned in the Introduction, trichlorophenols are considered to have 
significant toxicological effects and potential carcinogenicity to humans. Chlorophenols 
are mainly excreted in urine as such or as sulfate or glucuronide conjugates, the amount 
of conjugation depending on the particular chlorophenol and its concentration in urine 
[64]. Urinary excretion of chlorophenols can be produced also as a consequence of the 
exposure to other chlorinated substances, such as phenoxyacid herbicides, 
hexachlorocyclohexanes and chlorobenzenes [74,122,314]. Similarly, there have been 
many attempts to correlate the trichlorophenol levels in urine with a potential exposure to 
dioxin [35,36,107-110]. 
 
3.4.1. Characterization of urine samples  
 
Urine samples are very complex matrices that may interfere with immunoassays. Urine 
physicochemical properties from various individuals are quite different. The pH values 
usually vary from 5 to 7 and the ionic strength may range between 5 to 30 mS/cm. 
Individual differences in urine samples are related to particular habits and distinct 
physiological conditions. Creatinine content (an indicator of renal clearance) is usually 
employed for correction of urine dilution. This parameter may vary significantly from one 
to another urine sample (from 0.3 to 4 g/L, average value 1g/L). The variation in the 
creatinine concentration is caused by differences in the sweating rate, the fluid intake and 
the renal efficacy.  
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Taking into consideration this variability we decided to proceed with the evaluation of the 
trichlorophenol immunoassays performance using two types of representative urine 
samples. Sample A was collected over two days from a healthy male volunteer and then 
mixed to have a large and homogeneous urine sample. Sample B was a pooled human 
urine from different individuals purchased by Bio-Rad Laboratories, Irvine, USA. The 
most important characteristics (pH, conductivity and creatinine) of both samples are 
shown in Table 3.8. 
 
Table.3.8. Properties of the urine samples used in this studies 
Properties Sample A a Sample B b 
pH 6.2 6.6 
Conductivity, mS/cm 25 13.6 
Creatinine, g/L 1.8 0.8 
a Sample A is collected over two days from a healthy male volunteer. b Sample B is pooled human 
urine from different individuals. c Creatinine concentration was determined by the Jaffé method 
(see Experimental Section) 
 
As it was mentioned in the Introduction, exposure to organochlorinated compounds is 
quite common within the general population through the contaminated environment or 
edible products. Thus, there was a risk of presence of chlorophenols in these urine 
samples, if we wanted to use them as "blank" samples for matrix effect studies. 
Therefore, on a first instance, both urine samples were characterized by GC-MS to 
establish the presence of the most important halophenolic compounds potentially 
interfering with the ELISAs. According to the specificity studies (see Table 2.12. and 
[277]) the most important specific interferents are 2,4,6-TCP (2,4,5-TCP respectively) 
2,3,4,6-tetrachlorophenol (2,3,4,6-TtCP), 2,4,6-tribromophenol (2,4,6-TBP) and 2,4-
dibromophenol (2,4-DBP). Thus, both urine samples were hydrolyzed to release potential 
chlorophenols from their corresponding glucuronides and sulfate conjugates. The 
hydrolysis was performed with concentrated sulfuric acid according to the procedure 
described in the Experimental Section. Next, samples from both urines, hydrolyzed and 
non-hydrolyzed were extracted with toluene and derivatized with N, O-bis-
(trimethylsilyl)trifluoroacetamide (BSTFA) prior to GC-MS analysis (see Annex 1). 
Figure 3.8 shows the selected ion chromatograms of urine sample A after acid hydrolysis 
compared to the mixture of standards selected according to cross-reactivity ELISA 
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studies. The characteristic ions for each chlorophenol were monitored in the 
corresponding window. In addition to the retention time, the ratio of the ions selected and 
the fragmentation pattern were used for identification. The qualitative analysis revealed 
the presence of halophenols in both urine samples. The appearance of chlorophenols is in 
agreement with the observation made by some authors [74,122] regarding the exposure of 
the general population through the contaminated environment or edible products. It was 
more surprising the presence of bromophenols, although some sources for this 
contamination could be the use of organobrominated compounds as flame retardant 
agents [315,316] and also peoples´ diet, since bromophenols have been identified in 
prawns, ocean fish, benthic organisms and other seafood [317,318].  
 
Table 3.9.A shows the urinary concentrations of free and conjugated halophenols 
determined for sample A and B. In general, the levels found are lower than the mean 
concentrations reported for the general population: 0.61 µg/L 2,4,6-TCP [123] and 2 µg/L 
2,4,6-TCP [121]. It should be noted that the 2,4,6-TCP concentration is higher in the 
hydrolyzed urine. The degree of conjugation is about 75% for urine A and 50% for urine 
B. These conjugation levels are in agreement with [64].  
 
 
Figure 3.8. Gas chromatograms obtained for the standards and the hydrolyzed urine sample 
A using MS detection in the SIM mode following the ions of the corresponding halophenolic 
compounds interfering the assay. Peaks: 1 - 2,4,6-TCP (m/z 253, 255, 268), 2 - 2,4,5-TCP 
(m/z 253, 255, 268), 3-2,4-DBP (m/z 307, 309, 324), 4 - 2,3,4,6-TtCP (m/z 287, 289, 304), 5 
- 2,4,6-TBP (m/z 387, 389, 402), 6 - 2,3,5,6-TtCP (m/z 287, 289, 304), 7 – ISt (m/z 203, 
259, 261). For details see Annex I. 
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Table 3.9.A. Concentration levels (µg/L) of chlorophenols found in urinnes A and B by GC-MS.  
Urine A Urine B Phenols 
hydrolyzed non-hydrolyzed hydrolyzed non-hydrolyzed 
2,4,6-TCP 0.24 0.06 0.24 0.12 
2,4,5-TCP 0.06 nd nd nd 
2,4-DBP nd a 0.1 nd 0.12 
2,3,4,6-TtCP 0.2 nd 0.12 nd 
2,4,6-TBP 0.06 nd 0.12 nd 
The GC-MS results are calculated assuming that complete acid hydrolysis and extraction took 
place for all halophenols. The extraction ratio used was urine:toluene=100:1. a nd, not detected 
 
In order to estimate the interference of these halophenols in our ELISAs we calculated 
their equivalents in terms of 2,4,6-TCP and 2,4,5-TCP immunoreactivity (IR) equivalents 
according to the cross-reactivity data obtained for both immunoassays. The results are 
shown in Tables 3.9.B and 3.9.C for the 2,4,6- and 2,4,5-TCP ELISA, respectively. 
 
Table 3.9.B. Urinary chlorophenol levels expressed as 2,4,6-TCP-IR equivalents 
Urine A Urine B 
Phenols Cross reactivity hydrolyzed non-hydrolyzed hydrolyzed 
non-
hydrolyzed 
2,4,6-TCP 1 0.24 0.06 0.24 0.12 
2,4,5-TCP 0.12 0.0072 nd nd nd 
2,4-DBP 1.19 nd 0.1 nd 0.12 
2,3,4,6-TtCP 0.206 0.04 nd 0.025 nd 
2,4,6-TBP 7.1 0.43 nd 0.852 nd 
Total 2,4,6-TCP-
IR equiv. a  0.72 0.16 1.12 0.24 
a Total TCP-IR equivalents are calculated as the sum of the cross-reactivity of each compound 
multiplied by its concentration (µg/L). The LOD of 2,4,6-TCP ELISA is 0.175 µg/L 
 
Table 3.9.C. Urinary chlorophenol levels expressed as 2,4,5-TCP-IR equivalents 
Urine A Urine B 
Phenols Cross reactivity hydrolyzed non-hydrolyzed hydrolyzed 
non-
hydrolyzed 
2,4,6-TCP 0.17 0.041 0.010 0.041 0.0204 
2,4,5-TCP 1 0.06 nd nd nd 
2,4-DBP 0.10 nd 0.011 nd 0.013 
2,3,4,6-TtCP 0.19 0.038 nd 0.023 nd 
2,4,6-TBP 0.28 0.017 nd 0.033 nd 
Total 2,4,5-TCP-
IR equiv. a  0.155 0.021 0.097 0.033 
a Total TCP-IR equivalents are calculated as the sum of the cross-reactivity of each compound 
multiplied by its concentration (µg/L). The LOD of 2,4,5-TCP ELISA is 0.053 µg/L. 
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For the case of non-hydrolyzed urines, in both samples the amount of specific 
interferences expressed as equivalents of 2,4,6- or 2,4,5-TCP-IR is below the LOD of the 
ELISAs (0.18 and 0.05 µg/L, respectively). Only the 2,4,6-TCP-IR equivalents for 
sample B are slightly above this value. However, since the halophenol content of these 
samples is sufficiently low, we can consider both non-hydrolyzed urines as “blank 
samples”, free of chlorophenols. 
 
In contrast, for the hydrolyzed urine sample A the specific interferences were equal to 0.7 
and 0.15 µg/L of 2,4,6- and 2,4,5-TCP-IR equivalents, respectively. For the hydrolyzed 
urine sample A the detected halophenols corresponds to 1.12 µg/L 2,4,6-TCP-IR 
equivalents and to 0.09 µg/L 2,4,5-TCP-IR equivalents. These concentration values are 
too high and they exceed the LOD of the respective ELISAs. Therefore, these levels had 
to be taken into account in the evaluation of the matrix effect and a criterion such as the 
method of the "standard additions" mentioned at the beginning of this chapter should be 
applied. 
 
3.4.2. Evaluation of the matrix effect produced by non-
hydrolyzed urine 
 
Initially, we tested the effect of non-hydrolyzed urine sample B on the performance of 
2,4,5- and 2,4,6-TCP ELISAs. Once the urine sample was defrosted, its pH was adjusted 
to the standard buffer conditions (pH=7.5) and the solid materials observed were removed 
by centrifugation. Subsequently the urine was serially diluted in PBS and the pH and the 
conductivity adjusted to maintain them close to the PBS buffer values to exclude possible 
matrix effects due to these physicochemical parameters. The PBS diluted urine solutions 
were used to prepare standard curves and run them in the ELISA to compare their 
parallelism to the buffer standard curve. The sigmoidal curves obtained are shown on 
Figure 3.9.A. The 2,4,5-TCP ELISA was very tolerant to the urine matrix of sample B. 
Only a small decrease in the absorbance was observed at the highest urine concentration 
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used (1/5 PBS diluted) but this small effect was completely eliminated after a 1/20 PBS 
dilution.  
 
From practical point of view, we could considered that this urine sample could be 
analyzed with this assay just by diluting the matrix 5-times with PBS and employing this 
matrix as sample diluent. Under these conditions a LOD of 0.26 µg/L and an IC50 of 1.28 
µg/L 2,4,5-TCP in urine could be defined. Considering the reference value set for this 
analyte in Germany (4.5 µg/L) based on the urinary levels of the general population [81], 
it can be predicted that the method could be useful for the determination of 2,4,5-TCP in 
the urine of occupationally non-exposed persons without any sample treatment.  
 
To prove this fact, human urine sample B was spiked at several concentration levels. The 
spiked samples were diluted 5 times in PBS buffer and measured by the ELISA using a 
standard curve prepared PBS. To ensure appropriate quantification within the linear range 
of the standard curve further dilutions of the spiked urine samples were performed in a 
1/5 PBS diluted blank urine to maintain constant the effect of the matrix. The recoveries 
observed are close to 100% and the %CV is between 7.2% and 12.7% (see Table 3.10). 
These results demonstrate the accuracy of this ELISA method to measure 2,4,5-TCP in 
urine samples.  
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Figure 3.9. Interferences caused by non-hydrolyzed sample B on the ELISAs: A. 2,4,5-TCP 
and B. 2,4,6-TCP. Urine sample B was serially diluted with PBS buffer and the pH and 
conductivity were adjusted. 
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Table 3.10. Accuracy of the 2,4,5-TCP ELISA in human urine. 
Spiked a , µg/L Measured (mean ± SD) b, µg/L Recovery, % 
0.75 0.815 ± 0.049  108.7 
1.5 1.545 ± 0.129  103 
4 4.0566 ± 0.556  101.4 
10 9.64 ± 0.875  96.4 
a spiked urine samples (sample B) were diluted 5 times with PBS. Higher dilutions (for higher 
spiked levels) were performed in urine 1/5. The concentrations were evaluated from a standard 
curve run in PBS. b data obtained from three determinations performed in the same ELISA plate. 
 
Similarly to the serum matrix effect (see Section 3.3), the urine matrix interfered much 
more with the ELISA for the detection of 2,4,6-TCP. Although the pH and the 
conductivity were adjusted to place the urine within the working conditions of the 
immunoassay, a significant matrix effect was observed (see Figure 3.9.B). About 100 
fold dilution of the urine sample B was needed to accomplish the same behavior of the 
immunoassay as in buffer. Since the 2,4,6-TCP-IR equivalents of sample B determined 
by GC-MS are below or close to the LOD of the immunoassay (see Table 3.9B), the non-
hydrolyzed urine sample B could be considered as “blank” matrix. Therefore, the strong 
matrix effect observed was attributed to unidentified non-specific interferences. 
Therefore, the direct ELISA analysis of non-hydrolyzed urine samples followed by 100-
fold buffer dilution results in a high LOD (about 17.5 µg/L 2,4,6-TCP). Under these 
conditions the assay would be suitable only for the determination of free 2,4,6-TCP in the 
urine of occupationally exposed persons of particular industrial sectors with a high risk of 
exposure. In Table 3.11 are summarized the detection concnetrations of 2,4,5- and 2,4,6-
TCP in non-hydrolyzed urine. 
 
Table 3.11. Detectability features of the TCP ELISAs in non-hydrolyzed urine samples (µg/L). 
Parameters 2,4,5-TCP a 2,4,6-TCP b 
LOD 0.26 ± 0.024 17.5 ± 2.7 
IC50 1.28 ± 0.064 113.2 ± 36.1 
Dynamic range 0.52 ± 0.048  -  5.3 ± 0.854 28.8 ± 4.5 to 311.7 ± 67.9 
a The reported values are obtained by multiplying the parameters of the 1/5 diluted urine standard 
curve by 5. Urine is diluted in PBS. b The reported values are obtained multiplying the parameters 
of the PBS standard curve by 100. 
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As it was mentioned above, urine samples from different individuals can vary widely in 
composition. Thus, we have decided to test the performance of the 2,4,5- and 2,4,6-TCP 
immunoassays with another urine (sample A). Surprisingly, a significant matrix effect of 
the non-hydrolyzed urine sample A was observed on the 2,4,5-TCP ELISA requiring a 
100 fold dilution of the sample to eliminate the interferences. In the case of 2,4,6-TCP 
ELISA the matrix effect observed was again higher than for the 2,4,5-TCP immunoassay 
(see Table 3.12). 
 
Table 3.12. Summary of the matrix effect of non-hydrolyzed and hydrolyzed urine samples on the 
2,4,5-TCP and 2,4,6-TCP ELISAs.  
ELISA Treatment Urine sample 
2,4,5-TCP 2,4,6-TCP 
A 1/100 > 1/100 Non-hydrolyzed 
B (pooled) 1/5 1/100 
A n.d. > 1/128 Acid hydrolysis 
B (pooled) > 1/100 1/200 
A n.d. > 1/200 Enzymatic hydrolysis B (pooled) n.d. > 1/200 
Matrix effect is expressed as the dilution factor needed to eliminate the interferences. 
 
The different behavior of sample A and B prompted us to check the effect of several non-
hydrolyzed urine samples with different creatinine content taken from different 
individuals (see Figure 3.10). The pH and the conductivity of these urine samples were 
adjusted to the assay buffer values. The results shown in Figure 3.10 clearly demonstrate 
that the effect of urine samples from different origins is not universal. As a general rule 
we have observed that there is a relation between the creatinine value and the intensity of 
the matrix effect produced. Urine samples with creatinine values higher than 2 g/L 
inhibited completely both assays. Different matrix effects on immunoassays by urines 
from different individuals have been also reported by other authors [177,179,319]. 
 
In conclusion, both ELISAs could be applied directly to the analysis of non-hydrolyzed 
urine samples when the LOD required for biomonitoring is around 18 ug/L for 2,4,6-TCP 
and 0.26 ug/L for 2,4,5-TCP (see Table 3.11). However, since one of our purposes was to 
establish the real level of exposure of the general population and to identify sources of 
exposure in certain occupational sectors, we needed much better limit of detection for 
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2,4,6-TCP analyses. This limited detectability as well as the strong variation of the urine 
matrix effect with the sample origin (from different individuals) point for the necessity to 
introduce a sample treatment prior to ELISA analyses. 
 
3.4.3. Evaluation of the matrix effect produced by 
hydrolyzed urine 
 
Since trichlorophenols in urine are mainly conjugated [64], we decided to evaluate the 
immunoassay for hydrolyzed urine. Most of the methods reported involve acid hydrolisys 
using HCl [64,320] or H2SO4 [117,121,123]) and enzymatic hydrolysis [64,120]. Firstly, 
we have performed the deconjugation step under acidic conditions [117]. After acid 
hydrolysis by H2SO4 the pH of urines A and B were adjusted to 7.5 with NaOH and 
compared to the one run in the assay buffer. The hydrolyzed urines interfere with both 
ELISAs to seriously hinder their sensitivity and dynamic range. More than 100-fold 
dilution was needed to reach the buffer behavior (see acid hydrolysis in Table 3.11).  
 
The strong assay inhibition observed for hydrolyzed urine could be attributed to a 
possible ionic strength effect of the media, because acid hydrolysis followed by pH 
adjustment resulted in very high conductivity (300 mS/cm) while both immunoassays 
perform well until 30 mS/cm (see Chapter 2). We tried to eliminate the excess of sulfate 
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Figure 3.10. Matrix effect of non-hydrolyzed urine samples from different individuals on the 
ELISAs for 2,4,5-TCP (A) and 2,4,6-TCP (B). Standard curves corresponds to non-diluted 
urine samples with different creatinine content (0.8, 1.2 and 2.3 g/L). 
Evaluation of the effect of environmental and biological matrices ... 
 
 101 
ions introduced in the hydrolysis step precipitating them either as BaSO4 or CaSO4. For 
this purpose, the hydrolyzed urine sample A was split in two parts, one of them was 
treated with BaCl2.2H2O and the other one with Ca(OH)2. The precipitated BaSO4 and 
CaSO4 were removed by centrifugation. The pH of the supernatant was adjusted with 
NaOH to 7.5 resulting in a conductivity of 137 mS/cm. After 10-fold dilution of the 
sample with water the buffer conductivity was reached. However, the matrix effect 
remained very similar to the urine sample prior to its treatment with BaCl2.2H2O (data not 
shown). The immunoassay was totally inhibited in the case of Ca(OH)2 – treatment. 
 
It is expected that, in contrast to the acid hydrolysis, the enzymatic hydrolysis would 
yield a cleaner matrix (25 mS/cm, pH, less hydrolyzed interfering compounds) because it 
is performed under milder conditions and it is more specific. Based on this assumption we 
studied the matrix effect of both urine samples after enzymatic hydrolysis on the 2,4,6-
TCP ELISA [64]. Surprisingly, the matrix effect was even higher: about 200-fold dilution 
was needed to eliminate the interferences (see enzymatic hydrolysis in Table 3.11). This 
effect could be attributed to the presence of the enzyme glucuronidase in the solution that 
could suppress the antibody – antigen binding. The high levels of cross-reactants found in 
the hydrolyzed urine (e.g. 0.72 µg/L 2,4,6-TCP-IR equivalents for sample A and 1.12 
µg/L for sample B, see Table 3.9.B and 3.9.C) could result in a small inhibition but does 
not explain the strong effect produced by the hydrolyzed urines on the 2,4,5- and 2,4,6-
TCP ELISAs. Therefore, the matix effect observed was due to non-specific interferences. 
 
At this point we considered the idea of using a "representative" urine sample as "assay 
buffer" and diluent with the hope that this method would allow the direct analysis of TCP 
in urine samples. To accomplish this aim it was necessary to change the immunoassay 
conditions on such a way that the assay would not be inhibited. 
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3.4.4. Development of 2,4,6-TCP ELISA in urine as assay 
media 
 
We decided to use sample B as a standard urine matrix because it is a pooled sample 
collected from different individuals and was commercially available in high volumes. On 
a first step we performed an indirect non-competitive ELISA (2D experiment) directly in 
the urine with the pH and the conductivity adjusted and with the necessary percentage of 
Tween 20 (pH=7.5, 14 mS/cm, 0.05% Tween 20). The objective was to choose the 
appropriate concentration of the immunoreagents needed for the competitive assay. A 
signal of Amax at about one unit was given with 1/1000 dilution of the As43 and with 1.5 
µg/mL of the coating antigen 8-BSA. These concentrations were higher than those used 
when PBS was the assay buffer (see Table 3.1). On a second step we performed 
competitive assays with the selected conditions using again urine sample B as an assay 
buffer. The parameters of the immunoassay are shown in Table 3.13. The detectability 
obtained was a little bit lower than that of the ELISA performed in PBS but inside the 
acceptable values. The rest of the parameters such as slope and background noise were 
also good. 
 
Table 3.13. Features of the 2,4,6-TCP immunoassay performed in urine sample B 
Condition Values Parameter Values a 
Preincubation time 0 min Amax 1.05 
Competition time 30 min Amin 0.06 
pH 7.5 IC50, µg/L 2.48 
Ionic strength 14 mS/cm Dynamic range 0.8 - 10 
Tween 20 0.05% Slope 1.1 
As43 1/1000 LOD, µg/L 0.3 
8-BSA 1.5 µg/mL r2 0.997 
a The parameters are extracted from the four-parameter equation used to fit the 
standard curve run in two-well replicates. 
 
The following step was to compare the 2,4,6-TCP ELISA performance in the standard 
urine (sample B) to its performance in other urine samples. Three urine samples from 
different individuals (see their properties in Table 3.14) were diluted 2-fold in the 
standard urine sample B (used as buffer) and their pH and conductivity were adjusted. 
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The physicochemical parameters of the urines prior and after this treatment are shown in 
Table 3.14. 
 
Table 3.14. Properties of the urine samples studied. 
Untreated urine Treated urine a Urine 
samples 
Creatinine, 
g/L pH Conductivity, mS/cm pH 
Conductivity, 
mS/cm 
St.urine B 0.8 6.6 13.6 7.5 14.4 
1 0.3 8 5.4 7.6 16 
2 1.2 5.2 26 7.3 26.7 
3 2.8 5.8 19.2 7.5 17.9 
a After 2-fold dilution in "standard urine B" and adjustment of the pH and the conductivity. 
 
We selected urines with different creatinine values: low (0.3 g/L), medium (1.2 g/L, 
similar to the "standard urine B") and high (2.8 g/L). After the pH and conductivity 
adjustment all urines, except sample 2, had values close to those of the "standard urine 
B". Sample 2 differed only in the conductivity value that was much higher than the 
others, but still inside the working interval of the 2,4,6-TCP ELISA (see Chapter 3).  
 
To assess the effect of these individual urine matrices on the 2,4,6-TCP ELISA we 
prepared again standard curves and compared them to the curve run in urine B. The 
standard curves obtained are presented in Figure 3.11. As it can be observed the 
“diluted” urine sample (0.3 g/L creatinine) gives an immunoassay with higher signal than 
in the standard urine matrix (0.8 g/L creatinine) and the samples with higher creatinine 
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Figure 3.11. Matrix effect on the ELISA for 2,4,6-TCP of non-hydrolyzed urine samples 
from different individuals with different creatinine content using urine sample B as 
standard matrix. 
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content have less signal. The decrease in the signal produced by the urine sample 2, could 
be attributed to its higher conductivity value, since the creatinine concentration was 
similar to that of urine B, used as standard. 
 
These studies demonstrate that, although the concentration of the immunoreagents had 
been adapted to the urine media, urine samples from different individuals still cause 
important variations in the immunoassay response. In conclusion, the approach of using a 
“standard” urine matrix could not be applied to the analysis of urine samples of different 
origin. 
 
3.5. Summary 
 
In this chapter we have evaluated the performance of 2,4,5- and 2,4,6-TCP ELISAs in 
environmental (water) and biological matrices (milk, serum and urine).  
 
TCP analysis in drinking water by the ELISAs require only buffering of the samples. The 
recovery of spiked drinking water samples and the validation of the immunoassays by 
GC-ECD demonstrated excellent accuracy of the ELISA method. The assessed LOD of 
0.07 µg/L 2,4,5-TCP and 0.18 µg/L 2,4,6-TCP in water allow the evaluation of drinking 
water contamination with chlorophenols according to the requirements of the EU on the 
maximum admissible levels. 
 
Unfortunately, strong signal inhibition was observed for the 2,4,5- and 2,4,6-TCP 
ELISAs when applied directly to skimmed milk samples. Precipitation of milk proteins 
and calcium ions did not improve the immunoassay performance. Further studies on milk 
clean-up procedures, such as filtration, fat removal, or analyte extraction are needed. 
 
The effect of non-treated human serum on the ELISAs consisted in a parallel shift of the 
serum standard curves toward higher concentrations with respect to the buffer standard 
curve. Serum interference on the IAs was eliminated by protein removal. Several 
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procedures were tested (ultra filtration; heat, acid, alkaline and organic solvent 
precipitation). The most effective serum treatment regarding matrix effect and analyte 
recovery is the precipitation with absolute ethanol (1:1, v/v) and further dilution of the 
serum with PBS: 8-fold in the case of 2,4,5-TCP ELISA and 32-fold for the 2,4,6-TCP 
ELISA. It should be noted that the immunoassay for 2,4,5-TCP tolerates better the serum 
matrix interferences. Therefore, the LOD in serum samples are 0.8 µg/L 2,4,5-TCP and 
4.6 µg/L 2,4,6-TCP. Considering the reference value set for PCP in serum (12 µg/L) [20], 
we hope that these LOD values could be applied to the biomonitoring of the general 
population and to toxicological studies. 
 
The urine samples mainly used in the matrix effect studies were initially characterized by 
GC-MS for the presence of cross-reacting chlorinated substances. Non-hydrolyzed urines 
could be considered as "blank" samples but hydrolyzed samples had TCP-IR levels 
higher than the LOD of the IAs. The observed matrix effect of the urine (signal 
inhibition) can be eliminated in a certain extent after corresponding dilution of the sample 
with PBS and pH adjustment. In this way, free (non-conjugated) TCPs can be determined 
in non-hydrolyzed urine with LOD of 0.26 µg/L 2,4,5-TCP and 17.5 µg/L 2,4,5-TCP. 
Although these level allow the urinary determination of 2,4,5-TCP in the general 
population, the higher LOD for 2,4,6-TCP limits the application of the 2,4,6-TCP ELISA 
only to the occupational exposure assessment in industrial sectors with high levels of 
contamination. Hydrolyzed (acid and enzymatically) urines produced strong matrix effect 
on the 2,4,5- and 2,4,6-TCP ELISAs that could not be attributed to the presence of cross-
reactants in the samples. Furthermore, it was observed that urine samples from different 
origin have different matrix effect on the IAs related to the creatinine value of the sample. 
Finally, it was explored another alternative to overcome urine matrix effects, e.g. the 
2,4,6-TCP ELISA was developed in a "standard pooled urine sample". However, our 
studies shows that urien samples from different individuals cause significant variations in 
the IA response. Therefore, the results obtained with urine samples up to now suggest the 
introduction of a sample clean-up step prior to ELISA measurements. 
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________________________________________________________________________ 
 
4. Development of  
SPE (C18 and IAC)-ELISA method 
for urinary detection of 
chlorophenols 
 
__________________________________________________________________ 
 
 
 
 
 
Solid-phase extraction (SPE) is continuously growing in importance, and is currently a 
routine sample preparation technique employed in numerous environmental and 
bioanalytical applications, such as determination of trace amounts of pesticides and other 
organic contaminants in water, drugs and endogeneous compounds in biological samples 
[321,322]. SPE, introduced in the early 1970s, avoids and/or minimizes the disadvantages 
of the liquid-liquid extraction (LLE). Compared to LLE, SPE offers faster and easier 
manipulation, and higher concentration factors; it requires much smaller amounts of 
organic solvents. SPE techniques offer large choice of sorbents and the possibility of 
introducing new formats, such as the 96-well SPE plates and the microfibers for solid-
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phase microextraction. Furthermore, solid-phase eluent can be selected to be compatible 
with the analytical system to be used. 
 
The general SPE procedure consists in four steps (see Figure 4.1): conditioning 
(activation of the sorbent by passing through an appropriate solvent), retention (during 
sample application the analytes are retained by the sorbent), removal of interfering 
compounds (washing off interferences less attracted to the sorbent), and elution 
(desorption) of the anlyte(s) leaving interferences with greater attraction bound to the 
sorbent. The different mechanisms of retention and elution are due to intermolecular 
forces between the analyte, the active site on the surface of the adsorbent and the liquid 
phase or matrix. The hydrophobic, polar and ionogenic properties of both the solute and 
the sorbent play a crucial role for effective SPE. In general, non-selective SPE is based on 
CONDITIONING
Conditioning the sorbent prior to 
sample application ensures 
reproducible retention of the 
compound of interest (the isolate).
RETENTION
Adsorbed isolate
Undesired matrix constituents
Other undesired matrix components
RINSE
Rinse the columns to remove
undesired matrix components
ELUTION
Undesired components
Purified and concentrated 
isolate ready for analysis  
 
Figure 4.1. General principle of a SPE procedure 
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Van der Wals hydrophobic (reversed-phase bonded silica sorbents, graphitized carbon 
black, polymeric sorbents) or electrostatic interactions (ion exchange). Sometimes it is 
possible to separate the analytes into two or more groups by judicious choice of the solid 
phase and the eluting conditions and/or a better sample conditioning such as pH or ionic 
strength [323,324]. However, analyte retention is based on hydrophobic interactions and 
their selectivity is often too low for trace analysis in many complex environmental, food 
and biological samples. Co-extraction of analytes and matrix interferences generally 
occurs, and this can even become a major problem when analytes of interest are at trace 
level and interferences at high concentrations. Additional clean-up procedures are 
required, but, then the sample pre-treatment involves several steps and consequently the 
risk of loss or contamination increases and the reliability of the results is reduced. Thus, 
the goal is to achieve extraction and clean up in a single step. That can be achieved by 
using highly selective SPE sorbents based upon molecular recognition, such as 
immunosorbents (immunoaffinity extraction sorbents) [201-203,325,326] and 
molecularly imprinted polymers (MIP) [327-329]. The first approach involves antigen-
antibody interactions. Antibodies are covalently bonded onto an appropriate sorbent to 
form the so-called immunosorbent (IS). Single analytes can be targeted but thanks to the 
cross reactivity of the antibodies, immunoextraction sorbents have been also designed to 
target group of structurally related analytes. Due to antibody specificity, the problem of 
the co-extraction of matrix interferences is circumvented. The high selectivity provided 
by immunoextraction has led to attempt to synthesize antibody mimics in recent years, 
such as MIPs. This second approach involves the preparation of polymers with specific 
recognition sites for certain molecules. Like immunosorbents, the recognition is due to 
shape and a complex of hydrogen, hydrophobic and electrostatic interactions. However, 
they have the advantages to be prepared more rapidly and easily, using well-defined 
methods, and to be stable at high temperature, in a large pH range and in organic solvents. 
At the moment the application of MIP-based SPE to biosamples is still limited and further 
research focusing on the analytical performance is warranted [329]. 
 
In the previous chapter we demonstrated that the direct analysis of 2,4,5- and 2,4,6-TCP 
in body fluids with the corresponding ELISAs was troublesome at the desired limits of 
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detection (at about 1 µg/L in urine). The observed significant interferences prevented the 
analysis unless the matrix was diluted appropriately with the assay buffer diminishing in 
this way the method detectability. On the other hand, it was found that the undesirable 
urine matrix effect depends on each individual. Therefore, the need to develop a clean-up 
procedure to improve the detectability of the immunoassays and to avoid individual 
variability was considered crucial to provide a robust and reliable analytical method for 
biomonitoring studies. 
 
In this chapter we present the evaluation and the development of clean-up procedures for 
the urine samples prior to ELISA detection. According to our aim the clean-up step 
should fulfill the following requirements: i) to extract efficiently the target analyte from 
the urine matrix; ii) to rend extracts compatible with the ELISA method; iii) to be easily 
adaptable to the 96-well format of the ELISA microplates in order to avoid the loss of 
analysis efficiency; iv) to ensure the desired limits of detection. These studies have been 
carried out with the 2,4,6-TCP ELISA, although we believe that the results obtained 
could be exploited to other immunoassays aimed to be used for biomonitoring purposes.  
 
 
4.1. Evaluation of a C18 reversed-phase SPE as 
urinary clean-up method prior to ELISA analysis of 
2,4,6-TCP 
 
Most of the nonselective SPE methods developed for organic pollutants, such as phenols 
and acidic herbicides, from aqueous samples utilizes reversed-phase (bonded silica, 
polymeric resins, graphitized carbons) and ion-exchange sorbents (for recent reviews see 
[148,330]. SPE with ion exchange particles has been used to extract ionic analytes or 
analytes that can be converted to ionic form by adjusting the sample pH [330]. As 
phenols are acidic compounds, sorbents with quaternary ammonium sites work as anion 
exchangers and are used to retain phenols in water samples adjusted to basic pH. Thus, an 
anion exchanger with quaternary ammonium groups was applied to extract 2,4,6-TCP 
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from non-hydrolyzed urine in order to diminish its interference in the ELISA [1]. Urine 
sample was loaded to the cartridge at pH 8 where the TCP is at its anionic form. An 
acidic solution (citrate buffer, pH= 3.5) was used to elute phenols from the anion-
exchange column converting them back to their molecular form. However, this urine 
clean-up was not sufficient to eliminate completely the matrix effect on the ELISA and at 
least 10 fold urine dilution was needed to reach buffer behavior. 
 
Reversed-phase SPE is used to isolate relatively nonpolar analytes from a polar sample 
(water, urine). Octadecylsilane silica (ODS or C18) is by far the most widely used non-
polar reversed-phase sorbent. It has been successfully applied for trace enrichment of 
chlorophenols from non-hydrolyzed and hydrolyzed human urine [120,121]. Octylsilane 
(C 8), cyclohexyl, phenyl and cyano are other silica-based sorbents that have also been 
used for SPE of phenols in water samples [148]. With the aim to eliminate efficiently 
urine matrix components interfering with the 2,4,6-TCP ELISA we approached the 
development of reversed-phase (C18) SPE procedure. C18-SPE methods have been 
successfully applied for isolating small organic molecules from human urine prior to 
ELISA measurements [176-178,313]. Most of these protocols use methanol as eluting 
solvent, because it is usually tolerated by the immunoassays until a certain percentage. 
Thus, we evaluated the effect of the methanol on the 2,4,6-TCP ELISA (see Figure 4.2).  
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Figure 4.2. Effect of methanol on the ELISA for 2,4,6-TCP. Different concentrations of 
MeOH (0-50%) in the assay buffer PBS were used to prepare standard curve and As solutions. 
The data presented are extracted from the four-parameter equation used to fit the standard 
curves. 
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Increasing MeOH concentration in the assay buffer did not affect the signal Amax, but 
results in an increase of the IC50 values. Nevertheless, the immunoassay features were not 
seriously affected until 20% MeOH concentration.  
 
In many SPE procedures of organic acids the acetic acid (AcOH) is used at low 
concentrations (0.1%) in the eluting buffer to improve their interactions with the 
hydrophobic solid-phase. Thus, it was also evaluated if this organic modifier could 
interfere in the ELISA. The results demonstrated that the presence of very low 
concentration of AcOH (0.01%) in the assay buffer in fact increases the detectability of 
the 2,4,6-TCP ELISA [1]. We have also proved that the presence of both organic solvents 
(MeOH and AcOH) in the PBS buffer does not affect significantly the immunoassay 
parameters. For example, an assay buffer containing 8.5% MeOH and 0.01% AcOH was 
completely tolerated by the 2,4,6-TCP ELISA without significant modification in the 
immunoassay features (Amax= 0.55, IC50= 1.25 µg/L, LOD= 0.15 µg/L, dynamic range 0.3 
– 4 µg/L, slope= -1.1, r2= 0.996). 
 
After these preliminary experiments we approached the evaluation of the extraction 
efficiency of the C18-SPE of 2,4,6-TCP from urine samples. We also investigated the 
efficiency of this procedure as a clean-up step necessary to eliminate ELISA matrix 
interferences. 
 
4.1.1. Recovery studies 
 
For our studies we have selected commercial Sep-PakPlus Cartridge (Waters S.A.) with 
C18 as sorbent. Preliminary experiments performed by R. Galve in our laboratory 
demonstrated that it was necessary to introduce a washing step with a high content of 
MeOH to eliminate an important fraction of the ELISA interferences and that the retained 
2,4,6-TCP starts eluting at about 60% MeOH in the mobile phase [1]. However, this fact 
was only proved evaluating the effect of the matrix on the ELISA and performing very 
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few recovery studies. In addition, the possible presence of specific interferences in the 
urine sample used was not considered.  
 
Therefore, we focused our studies on the determination of the recovery of the purification 
process by two methods: ELISA and GC-ECD. Initially, we evaluated the C18-SPE 
procedure using PBS standard of 40 µg/L 2,4,6-TCP. To ensure a complete elimination of 
the urine interferences we used a procedure that consisted in the following steps: 
conditioning of the C18 cartridge with MeOH followed by 0.1% aqueous AcOH; loading 
of 10 mL sample; washing with 50% MeOH/H2O, and finally elution of the retained 
2,4,6-TCP with 65% MeOH/0.1% AcOH/H2O solution. Each eluted fraction (1 mL) was 
measured by ELISA after a 10-fold dilution with PBS buffer and was quantified using a 
standard curve run in 6.5% MeOH/0.01% AcOH/PBS buffer. As can be seen from the 
results presented in Table 4.1.A the 2,4,6-TCP eluted in the first three fractions (F1, F2 
and F3) corresponding to a recovery of 103%. No 2,4,6-TCP was detected in the washing 
fractions demonstrating that all the analyte has been retained during loading.  
 
Table 4.1.A. Recovery of C18-SPE of 2,4,6-TCP from PBS. 
Elution 65% MeOH 
Sample loaded PBS 
Fraction ELISA GC-ECD 
F1 23.3 23.5 
F2 15.2 11.8 
F3 2.7 3.2 
F4 1.7 n.d. 
F5 0.5 n.d. 
Total, µg/L 41.2 38.5 
Recovery, % 103 96.3  
10 mL PBS standard of 40 µg/L 2,4,6-TCP is loaded. Elution is performed with 65% MeOH/0.1% 
AcOH/water solution. Each fraction is of 1 mL. The 2,4,6-TCP concentration (µg/L) in the eluted 
fractions is determined by ELISA and GC-ECD. The recovery is based on the concentration in the 
shadowed fractions and is calculated vs the spiked amount. 
 
The eluted fractions were also measured by GC-ECD after a toluene extraction and 
sylilation of 2,4,6-TCP (see Experimental Section). A good agreement between ELISA 
and GC-ECD values was obtained (see Table 4.1.A). The cartridge was effectively 
regenerated by washing with absolute MeOH (the control blanks were free of analyte). 
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With these results we moved towards the application of the same protocol to urine 
samples. 
 
As was mentioned in the previous chapter, urine may contain a variety of unknown 
components that could be retained by the C18 reversed-phase, because this SPE is not 
specific. It was important to evaluate the possible co-elution of interferences when the 
C18-clean-up was applied to real urine samples. We decided to use urine A as a model 
urine matrix in C18-SPE studies because its content in total 2,4,6-TCP-IR equivalents was 
lower than in sample B (see Table 3.9B), and its behavior could be considered closer to a 
“blank matrix” regarding specific interferences. Thus, we applied the above clean-up 
procedure to a non-spiked and to a spiked (40 µg/L 2,4,6-TCP) non-hydrolyzed sample. 
The concentration of each eluted fraction after 10-fold dilution was determined by the 
2,4,6-TCP ELISA run in 6.5% MeOH/0.1% AcOH/PBS in PBS. Figure 4.3A shows the 
recovery values calculated vs the spiked amount. The non-spiked urine produced a 
positive response in the ELISA that could be attributed to specific and/or to non-specific 
interferences. However, the ELISA responses in spiked urine sample were not equivalent 
after multiple dilutions, suggesting the presence of non-specific interferences. In addition, 
the total amount of 2,4,6-TCP-IR equivalents extracted in the 5 mL (F1+F2+F3+F4+F5) 
from non-spiked urine corresponds to 18.1 µg, which is much more than the expected 
amount present in 10 mL non-hydrolyzed urine sample A (1.6 µg, see Table 3.9B). 
Therefore, the clean-up performed had not been sufficient to remove the urinary 
interferences in spite of having used a washing step with a 50% MeOH.  
 
Taking into consideration the elution of non-specific interferences, we evaluated the real 
recovery of 2,4,6-TCP as a difference between the response of the spiked and non-spiked 
urine (see Table 4.1.B). The recovery of 111% corresponding to the first three fractions 
(3 mL) eluted with 65%MeOH was similar to the recovery obtained loading PBS 
standards (103%). In spite of the co-elution of non-specific interferences, we expected to 
be able to measure urine samples by applying a higher dilution factor to the eluted 
fractions. When 3 fractions are collected the final dilution of the urine is 3 times (10 mL 
loaded, 3 mL collected, 30 mL used for ELISA determination). 
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Table 4.1.B. Recovery of 2,4,6-TCP in the C18-SPE urinary purification.  
Elution 65% MeOH 75% MeOH 85% MeOH 
Sample loaded NH a urine NH a urine NH a urine AH b urine 
Fraction ELISA ELISA ELISA ELISA GC-ECD 
F1 21.2 38.2 49.3 42.2 33 
F2 14.4 11.0 0.5 3.8 n.d. 
F3 8.8 2.2 0.3 1.3 n.d. 
F4 6.6 1.7 0.3 n.d. n.d. 
F5 1.5 0.2 < 0.15 n.d. n.d. 
Total, µg/L 44.4 49.2 49.3 42.2 33 
Recovery, % 111 123 123.3 105.5 82.5 
Urine sample A (non-spiked and spiked with 40 µg/L 2,4,6-TCP) was loaded. Elution is performed 
with different concentrations of MeOH/0.1% AcOH/water solution. Each collected fraction is of 1 
mL. The concentration of 2,4,6-TCP (µg/L) in the eluted fractions is determined by ELISA and 
GC-ECD and corresponds to the difference between spiked and non-spiked sample. The recovery 
is based on the concentration in the shadowed fractions and is calculated vs the spiked amount. 
a NH urine is non-hydrolyzed urine; b AH urine is acid hydrolyzed urine. 
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Figure 4.3. Elution profile of C18-SPE clean-up of urine sample A (spike and non-spiked) with 
different MeOH concentration in the elution solvent. Non-hydrolyzed urine: (A) 65% MeOH, 
(B) 75% MeOH, (C) 85% MeOH; Hydrolyzed urine: (D) 85% MeOH.The concentration in 
each eluted fraction was determined by the 2,4,6-TCP ELISA and the recovery vs spiked 
amount was calculated. A washing step using 50%EtOH was applied before eluting the 
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A reduction of the elution volume could allow increasing of the dilution factor applied to 
eliminate non-desired matrix effect before ELISA measurements. Moreover, it could be 
possible that varying the elution conditions the non-specific interferences would elute 
differently. All these considerations encouraged us to optimize the elution conditions 
directly with the urine sample. Thus, non-spiked and spiked (40 µg/L 2,4,6-TCP) urine 
samples were loaded to the C18 cartridge and eluted with different MeOH concentration 
(65%, 75%, 85%) in the elution buffer. The concentration of 2,4,6-TCP in the eluted 
fractions was measured by ELISA standard curves run in 6.5% MeOH/0.01% 
AcOH/PBS, 7.5% MeOH/0.01% AcOH/PBS and 8.5% MeOH/0.01% AcOH/PBS buffer, 
respectively (see Table 4.1.B). The overestimation in the recovery (110-123%) will be 
explained in Section 4.1.2. by the matrix effect of the urine extract to the immunoassay 
(see Figure 4.4).  
 
The effect of the MeOH concentration in the elution buffer on the elution profile of 2,4,6-
TCP for the non-hydrolyzed urine is presented in Figure 4.3 A, B, C. Increasing MeOH 
concentration resulted in a reduction of the volume needed for a complete 2,4,6-TCP 
elution. More than 90% of the spiked amount eluted in 3 mL using 65% MeOH and in 1 
mL when 85% MeOH was employed. The same was valid for the elution of the 
interferences from non-spiked urine sample. It should be noted that the contribution of the 
non-specific adsorption (calculated as the ratio of the ELISA response for non-spiked vs 
spiked urine) in each fraction increases with the number of the eluted fraction (see Table 
4.2).  
 
Table 4.2. Immunoreactivity (expressed in %) measured in the ELISA due to non-specific 
interferences present in the urine extracts after C18-SPE. 
Urine MeOH % F1 F2 F3 F4 
65% 3.37 2.91 3.71 4.35 
75% 2.15 6.06 14.23 13.99 Non-hydrolyzed 
85% 1.5 19.05 12.8 nd 
Hydrolyzed 85% 3.65 8.57 7.09 nd 
The percentage is calculated for each fraction according to the following formula: [2,4,6-TCP-IR 
equiv (non-spiked urine)/ 2,4,6-TCP-IR equiv (spiked urine)]*100%. 
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For example, using 75% MeOH elution of non-hydrolyzed urine the percentage of the 
non-specific interferences to the total immunoreactivity measured for spiked sample was 
2.15% for fraction F1 and 13.99% for F4. That means that increasing the elution volume 
collected (lower MeOH elution concentration) would result in an overestimation due to 
higher non-specific adsorption. If we consider the volume needed to extract the total 
spiked amount of 2,4,6-TCP (3 mL at 65% MeOH, 2 mL at 75% MeOH and 1 mL at 
85%MeOH), it can be observed that at 85% MeOH elution the contribution of the 
nonspecific adsorption is lowest, and it is only 1.5% (compare shadow boxes in Table 
4.2). Thus, we chose 85% MeOH elution for further studies. 
 
Thus, the C18 SPE procedure using 85% MeOH for analyte elution was applied as a clean-
up of acid hydrolyzed (spiked and non-spiked) urine sample A. The recovery vs the 
spiked amount of 2,4,6-TCP for each fraction is presented in Figure 4.3.D. Similarly to 
the non-hydrolyzed urine (see Figure 4.3.C), 2,4,6-TCP eluted mainly in the first fraction 
together with most of the non-specific interferents (non-spiked urine). The presence of 
non-specific interferents can be confirmed by the fact that the amount of 2,4,6-TCP-IR 
equivalents detected in non-spiked acid hydrolyzed urine was twice (20.8 µg) the amount 
of the cross-reactants evaluated by GC-MS in the same sample (7.2 µg). Furthermore, it 
should be noted that the contribution of the non-specific adsorption in the eluted fraction 
F1 for the acid hydrolyzed urine (3.65%) was higher than those for the non-hydrolyzed 
urine (1.5%) (see Table 4.2). This was expected, since the hydrolyzed sample is a less 
clean matrix than the non-hydrolyzed one. Finally, if the 2,4,6-TCP concentration 
measured in spiked acid hydrolyzed urine is corrected with the IR measured in non-
spiked urine, good recovery can be observed (see Table 4.1.B).  
 
4.1.2. Matrix effect of C18-SPE purified urine on the 2,4,6-
TCP ELISA 
 
In order to evaluate the efficiency of the C18-SPE clean-up method we tested the matrix 
effect of the urine extract (85% MeOH elution) on the immunoassay. According to the 
established procedure (10 mL urine loaded, 1 mL extract collected and diluted 10 times 
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with PBS) the C18-SPE does not pre-concentrate the sample. Thus, non-hydrolyzed and 
acid hydrolyzed non-spiked samples (urine A) were loaded on the C18- cartridge and the 
eluted fractions (F1, 1 mL) were diluted with PBS to the initial sample volume (10 mL). 
Further dilutions were performed with 8.5% MeOH/0.01% AcOH/PBS in order to 
maintain constant solvent concentration. Standard ELISA curves were run in the diluted 
extracts and compared to the curve run in 8.5% MeOH/0.01% AcOH/PBS. Figure 4.4. 
shows that an important improvement had been achieved by introducing this clean-up 
method, because now urine analysis can be accomplished just by a 25-fold dilution with 
PBS. Previously, we demonstrated that both non-hydrolyzed and hydrolyzed urine 
samples had to be diluted 100 and 128 times, respectively (see Table 3.11). Therefore, 
after a C18 clean-up step the LOD accomplished for the analysis of 2,4,6-TCP in both 
hydrolyzed and non-hydrolyzed urine is of 3.75 µg/L 2,4,6-TCP (LODMeOH/AcOH/PBS x 25 = 
0.15 x 25= 3.75 µg/L). This means that the SPE clean up allows 5-6 times lower detection 
limit than the direct analysis of 2,4,6-TCP in urine without any purification.  
 
We can assume that the matrix effect observed for non-hydrolyzed urine is due to the 
presence of non-specific interferences in the eluted extract (the 2,4,6-TCP IR equiv. in 
non-hydrolyzed urine sample A (0.16 µg/L) are close to the LODMeOH/AcOH/PBS of the 
ELISA = 0.15 µg/L) (see Section 3.4.1). However, the slightly higher matrix effect 
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Figure 4.4. Matrix effect of urine sample A after C18-SPE clean-up on the 2,4,6-TCP ELISA: 
(A) non-hydrolyzed, (B) acid hydrolyzed. 10 mL urine was loaded to the C18-cartridge, 
washed by 50% MeOH, and eluted by 85% MeOH. The eluted fraction F1 was reconstituted 
to the original volume with PBS, so its final MeOH concentration was 8.5%. Further dilutions 
(more than 5 times) were performed with 8.5% MeOH/0.01% AcOH/PBS in order to maintain
constant the organic solvent content. 
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produced by the hydrolyzed urine (see Figure 4.4.B) could be attributed not only to non-
specific interferences, but also to the specific interferences present in this sample. As 
mentioned, these substances would produce an immunoreactivity equivalent of 0.72 µg/L 
2,4,6-TCP that is above the LOD of the immunoassay.  
 
Finally, the efficiency of the SPE procedure can be observed in Figure 4.5 that presents 
the GC-ECD chromatograms obtained for non-purified urine and for urine purified by 
1
A
B
 
Figure 4.5. GC-ECD chromatograms obtained for: A. Non-purified urine: 100 mL of acid
hydrolyzed urine A were extracted with 1 mL of toluene. The obtained extract was 10-fold
diluted with toluene; B. after C18-SPE: 10 mL of acid hydrolyzed urine A spiked with 1 µg/L
2,4,6-TCP were used. The collected elution fraction (85% MeOH) was diluted 10-fold with PBS
and extracted with 1 mL of toluene. The concentration of 2,4,6-TCP in the toluene extract
corresponds to 10 µg/L; In both cases the toluene extracts were derivatized with BSTFA and the
overall sample concentration is 10 times (urine: toluene=10:1). Peaks: (1) 2,4,6-TCP. 
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C18-SPE. Although, an important part of the matrix components are eliminated by the 
clean up step, there is still a presence of non-specific interferences in the C18-extract. 
 
In conclusion, the matrix effect studies showed that the introduction of a C18-SPE 
procedure is an effective way to eliminate an important part of the interferences produced 
on the ELISA by the urine sample A. Good recovery and accurate quantification could be 
achieved after appropriate (at least 25 fold) dilution of the urine extract prior to ELISA 
determination of 2,4,6-TCP. The procedure (C18-SPE-ELISA) described in this chapter 
would allow the determination of free chlorophenols in non-hydrolyzed urine and total 
(free and conjugated) chlorophenols in hydrolyzed urine samples with a LOD at about 4 
µg/L. This LOD is low enough for occupational exposure assessment, if we consider that 
the general population can have background levels of 2,4,6-TCP up to this value 
(reference value set for Germany is 4.5 µg/L [81]). However, it would be important to 
find more effective urine treatment procedure to allow trichlorophenol quantification at 
lower levels in order to perform risk assessment of the non-occupationally exposed 
population and to confirm the reference values set by Wrbitzky et al [81]. One possible 
approach to improve the LOD of the method could be to reduce even more the matrix 
effect still observed in the C18 purified urine. The idea to extract selectively the analyte 
from the urine making use of the antibodies already obtained was a challenge. As 
mentioned in the Introduction selective SPE methods have proved to be useful tool for 
urine sample preparation prior to chromatographic analysis [214,331-336]. In our group 
P.Bou had successfully applied immunosorbents to purify and pre-concentrate the 
antifouling agent Irgarol 1051 from sea water samples prior to ELISA analysis [206]. In 
spite of the higher complexity of the urine we focused on this sample treatment strategy 
as a good approach to accomplish our purposes. 
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4.2. Evaluation of an IAC-SPE procedure as urinary 
clean-up method prior to ELISA analysis of 2,4,6-
TCP 
 
The first step in the development of an IAC-SPE method is the preparation of the 
immunosorbent. It is prepared by covalently immobilizing the Ab on the surface of a rigid 
or semirigid support. The selected support should be chemically and biologically inert, 
easily activated, mechanically stable, uniform in particle size, and its pore size should be 
large enough to allow access to the Ab and the Ag [337]. It should be hydrophilic in order 
to avoid any non-specific interactions, and be pressure resistant for direct use in on-line 
techniques. Two types of affinity supports have been shown to be appropriate for making 
ISs (for review see [200-202,207]. The first one includes traditional supports used in IAC, 
such as carbohydrate-related materials (i.e. agarose and cellulose) and synthetic organic 
supports (e.g., acrylamide polymers, copolymers or derivatives, polymethacrylate 
derivatives and polyethersulfone matrixes). Many of these supports are commercially 
available under various trademarks. As they cannot be operated at high flow-rates 
because of their limited stability (high pressure generates compacting and fouling), they 
are called low-performance supports. The second category of appropriate sorbents is 
pressure resistant, so-called high-performance supports. They include derivatized silica, 
glass beads, and hydrophilic organic polymers (vinyl and polystyrene based). These 
materials are attractive for use with standard HPLC equipments. 
 
Appropriate coupling chemistry to attach the Ab is essential for any affinity separation. 
Ideally the immobilization conditions should keep the biospecific activity of Abs. The 
activation and coupling chemistry procedures determine the efficiency of the 
immobilization procedure. A variety of supports are commercially available from 
different suppliers (Pharmacia, Biorad, Pierce, etc.). Usually, activation of the support 
occurs through its functional groups (i.e. hydroxyl groups: agarose, silica; carboxy 
groups: alkaline hydrolysis of polyacrylamide, etc.), which are appropriately derivatized 
to introduce a spacer arm with the desired chemistry. The existing coupling methods can 
be mainly grouped in two categories: random and oriented Ab immobilization. The 
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easiest and most frequently used is the first route, random immobilization. In this case the 
covalent attachment of the Abs is realized by reacting of their free amino groups (lysine 
residues are distributed throughout the Ab molecule) with supports that are activated with 
agents such as carbonyldiimidazole, cyanogens bromide or N-hydroxysuccinimide 
(NHS), or with supports that have been treated to produce reactive epoxide or aldehyde 
groups on their surface. Oriented immobilization procedures that keep free the Fab sites 
for antigen recognition, use several strategies, such as binding of Abs via their 
carbohydrate moieties located on the Fc region (heavy chain) to amine or hydrazide 
containing supports, covalent coupling with iodoacetyl- or maleidimide-activated 
supports through the thiol groups of antibody fragments, or non-covalent binding of the 
Fc region of the antibodies to streptavidine or protein A- or G-based sorbents. 
 
The solid-phase extraction properties of the immunosorbents are bonding density, 
capacity, recovery, breakthrough volume, elution conditions, IS regeneration, flow-rate, 
and non-specific interactions. The bonding density is defined by the number of antibodies 
linked to the surface of the sorbent and it determines the antigen-binding capacity. It 
depends on the specific surface area of the sorbent accessible for the immobilization of 
the Abs. The reasonable minimal pore size is in the order of 2-5 times antibody diameter 
for immunoextraction of small molecules. The second factor defining binding density is 
the degree of purification of the Ab solution. Non-purified antisera is used in many cases, 
but reduced bonding density can be expected due to co-immobilization of other proteins. 
Better Ab density will occur using the purified IgG fraction obtained by ammonium 
sulfate precipitation or using protein A (G) affinity column. Although it has been 
suggested that the use of hapten specific affinity chromatography isolated fraction of the 
polyclonal Abs increases IS capacity, it is not often used, because exists the risk of an 
incomplete recovery of the highest affinity fraction of the antisera. Using monoclonal 
Abs, these drawbacks are circumvented. Furthermore, Ab fragments (Fab or Fv) can also 
be used. The theoretical coupling capacity of the support is usually provided by the 
commercial supplier, but the amount of immobilized Ab should be nevertheless 
measured. The determination of the amount of Abs immobilized onto a matrix consists in 
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measuring the Ab concentration of the bonding solution by spectrophotometry UV at 280 
nm. 
 
The capacity of the IAC column indicates how much analyte can be retained by the IS. It 
strongly depends on the support, the Ab immobilization procedure employed, the total 
number of immobilized active Abs (specific for the target analyte) (the availability of the 
Ab binding sites). Moreover, the random orientation and steric hindrances may prevent 
the Ag from access to Ab binding sites. But, for a standard immobilization procedure , the 
theoretical binding capacity can be estimated. If, for example in the case of polyclonal 
Abs, with the hypothesis that (i) 10% of a purified IgG fraction is considered specific, (ii) 
the Ab activity is fully retained and (iii) active site accessibility is complete, then taking 
into account the coupling density, the molecular weight of the Ab (150 kDa) and two 
binding sites per Ab, it is possible to estimate the theoretical capacity of the IS. Usually 
the binding capacity is determined experimentally by loading the column with varying 
amount of the antigen. In general, the experimental capacity is lower than the theoretical 
one [201]. On the other hand, due to Ab cross-reactivity, structurally related analytes 
present in a sample will compete for the same Ab binding sites, modifying the behavior 
of the IS. In this case the real IS capacity should be evaluated using a mixture of these 
structural analogs [338]. 
 
The immunoextraction procedure consists of four steps: sample loading, washing, elution, 
and regeneration. (see Figure 4.6). During the loading step, the binding reaction between 
the immobilized Abs and the analyte from the sample takes place. For effective Ab-Ag 
recognition (interaction) it is recommended the applied sample to have properties close to 
the physiological conditions (i.e. neutral pH application buffer with low-to-moderate 
ionic strength). The flow-rates govern the speed of the Ab-Ag reaction. The binding 
reaction is less efficient with faster flow-rates. Flow rates between 0.4 and 4.0 mL/min 
are common. In general, it is best to determine the optimum flow-rate for each separation.  
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Another important aspect related to the loading step is the breakthrough volume, i.e. the 
maximum sample volume that can be percolated without loss in recovery. In general, 
immunoaffinity extraction (IAE) is used to extract compounds at trace levels. So, the 
greater the breakthrough volume and the capacity are, the better the limit of detection is. 
Sample volume is different depending on the field of application. Biological samples are 
limited to the low-mL order for blood and plasma samples and up to a maximum of 50 
mL for urine samples. Therefore, the breakthrough volume is not a basic parameter for 
biological applications, but it is important in environmental analysis. Two parameters can 
affect the recovery, which are the IS capacity and/or affinity of Abs towards compounds. 
Insufficient retention induces a low breakthrough volume and an incomplete recovery. 
 
sample
loading
washing
elution
regeneration
 
 
Figure 4.6. IAC-SPE procedure. 
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The function of the washing stage is to remove unwanted material from the matrix and 
nonspecifically bound compounds (see Figure 4.6). The washing step is characterized by 
the composition of the buffer and the number of column volumes necessary to remove 
nonspecifically bound substances. If their equilibrium adsorption association constant is 
lower than the equilibrium adsorption association constant of the Ab-Ag binding (Ka), the 
buffer used for column loading is adequate for the washing procedure. If not, harsher 
conditions should be applied to remove the unwanted non-specifically bound impurities 
avoiding joint elution of the specifically retained analyte. 
 
Some of the most important parameters in IAE are the elution conditions. During the 
sample percolation, the Ab-Ag complex is formed by electrostatic forces, secondary 
hydrogen bonds and Van der Waals forces. To desorb the analyte, this complex has to be 
disrupted, i.e. the strategy of elution is based on creating a local environment that reduces 
the association constant Ka. The choice of elution buffer is important in analytical 
applications of IAC, since it is usually desirable to elute the analyte as quickly as possible 
while avoiding any irreversible damage to the immobilized antibody support. Common 
eluents used in IAC are acidic or basic buffers, high ionic strength solutions, chaotropic 
agents, detergents, organic solvents and displacer agents [200,201]. In the literature large 
molecules are traditionally desorbed using aqueous solutions, whereas desorption of low 
molecular weight organic molecules from the IS is better-achieved using organic solvents 
altering the polarity of the system. Unfortunately, a universal system that ensures an 
efficient desorption of the analytes does not exist. Every IS should be checked for the best 
elution conditions. 
 
The last step in IAC-SPE is the column regeneration. Regeneration is the re-equilibration 
of the column at the conditions required for loading in a new purification cycle. This 
entails, at the very least, removing the elution buffer from the column. Immunosorbent 
reusability depends on the concentration and conformation of the immobilized Abs, on 
the chemical and mechanical stability of the support used and the elution conditions. The 
key parameter to follow the evolution of an IS is its capacity. 
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4.2.1. Immunosorbent preparation. Determination of the 
coupling efficiency and the theoretical capacity of the 
column 
 
As immunosorbent for 2,4,6-TCP urine extractions we used polyclonal As45 [259]. We 
have isolated the IgG fraction from As45 by ammonium sulfate precipitation in order to 
remove serum albumins. As solid support for IAC-SPE we chose a commercially 
available NHS-activated Sepharose HiTrap column (1 mL bed) consisting of pre-
packed highly cross-linked agarose. This material is resistant to high pressure gradients 
and due to its hydrophilic properties non-specific interactions are avoided. The IgG was 
immobilized to the Sepharose gel by covalent coupling of their free amino groups with 
the NHS-activated solid phase leading to random antibody orientation. Throughout this 
thesis three IAC-Ab45 columns were prepared following manufacturer’s instructions. 
Briefly, a solution of the purified As45 in carbonate buffer (pH=8.3) was injected onto 
the HiTrap column at a constant flow rate. The remaining active sites were deactivated by 
alternate and repetitive injections of ethanolamine and acetate buffers. The coupling 
efficiency of the HiTrap column was estimated as the difference between the total amount 
of IgG initially loaded onto the column and the amount of IgG found in the eluted buffer 
after the coupling took place. The IgG concentration in both solutions was determined by 
UV measurement at λ=280 nm. Previously, the NHS co-eluting with the antisera solution 
after coupling was removed using a HiTrap desalting column prepacked with 
SephadexG-25 Superfine. A coupling efficiency of 94.5 ± 0.98% (N=3) was achieved. 
This corresponds to a maximum theoretical binding capacity of approximately 1.24 ± 
0.12 µg (6.27 ± 6.14 nmol) (N=3) 2,4,6-TCP, based on the amount of IgG coupled (9.4 
mg) and the assumptions that bivalent binding takes place; 10% of the polyclonal IgG are 
specific [339] and 50% of the immobilized IgG are not accessible due to steric hindrance, 
or due to a random antibody orientation.  
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4.2.2. Characterization of the immunosorbent. Optimization 
of an IAC-SPE procedure using PBS standards of 2,4,6-TCP 
 
4.2.2.1. Evaluation of the experimental column binding capacity and 
establishment of the desorption conditions 
 
The aim of the elution is to have efficient desorption with a high recovery in a volume as 
small as possible, without denaturation of the Abs. Efficient desorption of the retained 
analyte from the immunosorbent requires that the total volume of eluent needed should be 
kept small to avoid extensive dilution of the analyte in the final extract. Our aim was to 
find out best elution conditions regarding effective IAC-SPE, but also regarding 
compatibility of the eluent with the ELISA method. Initially we approached the elution 
with an aqueous acidic buffer in order to obtain a final aqueous extract that could be 
measured by ELISA. 
 
A. Elution with an acidic buffer: glycine/HCl, pH=3 
 
One of the most often employed strategies for analyte elution from immunosorbents is 
lowering the pH below 2.5 with a glycine-HCl buffer. Since the Sepharose gel stability 
was limited below pH=3, we decided to test the elution of the analyte with 0.05 M 
glycine-HCl at pH=3. Another important point was to place the physicochemical 
properties (pH, conductivity) of the eluted fractions within the immunoassay conditions. 
As the 2,4,6-TCP ELISA performs better at neutral and basic conditions, it was necessary 
to neutralize the eluted fractions. By adding 0.2N aq NaOH until pH=8.6 a buffered 
media could be obtained (glycine-NaOH, pH=8.6-10.6). Both acidic and basic glycine 
buffers have a very low conductivity (3.5 mS/cm) but it could be corrected by the 
addition of NaCl until the necessary ionic strength of the IA media (15 mS/cm). 
Therefore, we established a protocol where to each milliliter of the eluted fractions a 
solution of 87 µL of 0.2N aq NaOH (18M NaCl) was added to obtain a buffer system 
containing 0.05M glycine-NaOH (18M NaCl) (pH=8.6 and conductivity of 15 mS/cm).  
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Before moving forward it was necessary to determine how the ELISA behaved in this 
buffer system. Figure 4.7 shows the standard curves obtained with the PBS and the 
glycine-NaOH(NaCl) buffer. There is slight displacement of the curve to higher 
concentration range resulting in the following immunoassay parameters: Amax= 0.77, 
IC50= 2.47 µg/L, LOD= 0.5 µg/L, dynamic range 0.7 – 10 µg/L, slope= -1.13, r2= 0.997. 
The assay detectability was still good enough under these new conditions. 
The next step was to evaluate the accuracy of this protocol. Thus, 2,4,6-TCP standards 
were prepared in 0.05M glycine-HCl, pH=3 and after adding the corresponding amount 
of NaOH and NaCl, they were measured on the ELISA and their concentration was 
determined from a standard curve run in glycine-NaOH(NaCl) (pH=8.6, 15 mS/cm). 
Table 4.3 shows the measured concentration values compared to the initial spiked 
amounts. A good agreement can be observed between these values indicating the 
accuracy and the variability of the procedure. 
 
Table 4.3. Accuracy of the analysis of 2,4,6-TCP in glycine solutions 
Spiked, µg/L Measured (mean ± SD), µg/L 
1 0.78 ± 0.13 
1.25 1.13 ± 0.15 
2.5 2.4 ± 0.25 
5 4.95 ± 0.35 
10 10.57 ± 0.57 
Samples prepared in 0.05M glycine-HCl (pH=3) were treated with 0.2N aq NaOH/18M NaCl until 
pH=8.6 and conductivity of 15 mS/cm before ELISA measurements. 
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Figure 4.7. Effect of the 0.05M glycine-NaOH (NaCl) buffer (pH=8.6, 15 mS/cm) on the 
2,4,6-TCP ELISA. 
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Therefore, we loaded the IAC column with 5 mL of 2,4,6-TCP PBS solutions at three 
different concentration levels corresponding to 97% (1.2 µg), 40% (0.5 µg) and 4% (0.05 
µg) of the theoretical immunosorbent capacity. After washing the column with 5 mL 
PBS, we eluted the analyte using 10 mL 0.05M glycine-HCl buffer (pH=3). As it is 
shown in Figure 4.8 10 mL were sufficient to remove the trapped analyte completely 
from the immunoextraction column. The recovery was greater than 80% for the three 
samples loaded.  
 
However, the elution profile was strongly dependent on the loading level, i.e. the lower 
the loading level, more volume had to be percolated through the column to disrupt Ab-Ag 
binding. Thus, it can be observed that at a loading level of 97% the analyte starts to elute 
from the first fraction but at 40% it starts to elute later (in fraction 2) and at 4% loading it 
appears in fraction 5. Moreover, 2,4,6-TCP elutes slowly being distributed within a 
different number of fractions, also depending on the loading level. Higher analyte 
loadings produce narrower elution bands and vice versa. These results indicate that 
0.05M glycine-HCl buffer (pH=3) cannot effectively dissociate the Ag-Ab complex. For 
practical reasons the elution of the analyte must take place in the same way for all loading 
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Figure 4.8. Elution profile of 2,4,6-TCP with glycine/HCl buffer (pH=3). The IAC was 
loaded with 5 mL of PBS standards of 2,4,6-TCP at three different loading levels, washed 
with PBS, and eluted with glycine/HCl, pH=3. Each elution fraction is of 1 mL. After 
adjustment of pH and conductivity the fractions were measured by ELISA standard curve 
run in glycine-NaOH/NaCl (pH=8.6, 15 mS/cm). Recovery for each elution fraction is 
calculated vs spiked amount. The total recovery represents the sum of the recovery in all 
elution fractions. 
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levels. Therefore, we decided to explore other more efficient elution systems such as 
organic solvents frequently described in the immunoaffinity purification of organic 
molecules from complex samples. 
 
B. Elution with an organic solvent: Ethanol  
 
Elution has been in many cases achieved by increasing the content of an organic modifier 
in the solution. Pure methanol, methanol-water [331,336,340], ethanol-water 
[206,208,340], acetone-water [341], and acetonitrile-water [215] mixtures have been used 
successfully for the desorption of low molecular weight compounds from an 
immunosorbent. As mentioned before, in previous experiments performed in our group 
ethanol-water mixture was proven to be useful to desorb Irgarol 1051 from the same type 
of immunosorbent [206]. Thus, we decided to use this elution system.  
 
As it was described in Chapter 3 (see Figure 3.7), the 2,4,6-TCP ELISA tolerates EtOH 
concentration in the PBS up to 10-15%. Thus, a simple dilution of the final ethanol 
extract would be compatible with the subsequent ELISA analysis. In order to define the 
ethanol content under which the desorption takes place we applied a step elution to an 
IAC column loaded with 0.05 µg 2,4,6-TCP (5 µg/L, 10 mL PBS, 4% column loading). 
We selected this amount because it was close to the reference value of 2,4,6-TCP in 
urine. As can be seen from Figure 4.9 the elution started at about 30% EtOH and about 
16% of the loaded analyte eluted in 3 mL (F11, F12, F13). Subsequent elution with 50% 
EtOH gave too broad profile (four fractions of 1 mL were needed to collect 66% of the 
amount loaded). In addition, this EtOH concentration was not enough to desorb all the 
analyte bounded to the immunosorbent. Finally, at 70% EtOH the remaining 16% of the 
loaded 2,4,6-TCP eluted. Therefore, we decided to use 70%EtOH/water as elution solvent 
in further studies. 
 
As before the optimum volume of 70% EtOH elution solvent was determined at three 
loading levels for both of the IAC columns prepared (see Figure.4.10). At high loading 
levels (97%, 1.2 µg 2,4,6-TCP) complete elution was achieved in just one mL fraction. At  
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lower loading level (4%, 0.05 µg 2,4,6-TCP) the elution volume needed for 100% 
recovery was 3 mL. This difference was probably due to the fact that mainly the higher 
affinity antibodies are participating at low loading levels. An important aspect of this 
result is that now the elution started in the first fraction (F1) for all loading levels 
indicating the higher efficiency of this system in dissociating the Ag-Ab complex. 
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Figure 4.9. Step elution of 2,4,6-TCP with different EtOH concentration in the elution buffer. 
The IAC is loaded with 0.05 µg 2,4,6-TCP (5 µg/L, 10 mL PBS, 4% loading level). Each 
elution fraction is of 1 mL. Elution was performed with 10 mL 10% EtOH/water, followed by 
10 mL 30% EtOH/water, 10 mL 50% EtOH/water, and finally by 10 mL 70% EtOH/water. 
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Figure 4.10. Elution profile of IAC-SPE of 2,4,6-TCP with 70% EtOH. PBS standards 10 mL 
(0.05, 0.5 and 1.2 µg 2,4,6-TCP) were loaded to the IAC column, washed with PBS and 
eluted with 70% EtOH. Eluted fractions (F) were diluted 10 fold with PBS and analyzed by 
ELISA using standard curve run in 7% EtOH/PBS buffer. The 10 mL collected fraction after 
loading (L) corresponds to the amount which is not retained by the immunosorbent. Loading 
(L) and washing fractions (W) (10 mL) were measured directly by ELISA using standard 
curve run in PBS buffer. Recoveries (%) are calculated vs spiked amount. Data presented 
correspond to the average of two different IAC columns. 
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As it was expected to detect low urine levels in real samples from the non-exposed 
population, we decided to collect 3 mL elution volume for further experiments. In 
addition, we should note that 2,4,6-TCP was not detected in the volume collected after 
loading of the standard neither in the collected washing fractions (see Figure 4.10). This 
indicated that the chlorophenol was retained completely by the immunosorbent. Even at 
the highest loading levels studied (97%) that correspond to the theoretical capacity of the 
column, the analyte was completely recovered in the elution fractions. Therefore, it can 
be concluded that in PBS the binding capacity of the IAC column is 1.2 µg or greater 
(note that an arbitrary correction factor of 50% of sterically hindered antibody molecules 
had been applied in the calculation of the theoretical capacity). 
 
The IAC column breakthrough volume was determined by loading 0.05 µg 2,4,6-TCP in 
PBS samples with different volumes (5, 10, 20 and 50 mL). No dependence on the 
sample volume was found. The recoveries were still over 93% in all experiments and the 
analyte eluted in the first 3 mL. This result indicates that a high sensitivity could be 
achieved because large sample volumes could be loaded to the column and then collected 
in just 3 mL fraction. 
 
4.2.2.2. Specificity of the IAC column 
 
As it was previously described, halogenated phenols structurally related to 2,4,6-TCP are 
usually present in urine samples. Therefore, it was necessary to evaluate the selectivity of 
the IAC-SPE procedure established above. The specificity studies were carried out by 
GC-ECD analysis of the eluted fractions after toluene extraction and derivatization of the 
chlorophenols with BSTFA. 
 
The specificity of the IAC column was evaluated towards 15 halophenols. Initially, PBS 
standard solutions of each compound were loaded individually at a 20% loading level. 
Each column was washed with PBS and the halophenol was eluted with 3 mL 70% EtOH. 
Then the eluted fractions were diluted 10 times with PBS until 7% EtOH and extracted 
with toluene for GC-ECD analysis. Previously we have proven that the recoveries of 
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toluene extraction of di-, three-, and tetra-chlorophenols from 7% EtOH water solutions 
were higher than 80% (see Annex 1). The results of the experiments performed with 
individual analyte loading and PBS column washing are presented in Table 4.4.  
 
Table 4.4.. Specificity of the IAC column expressed in percentage recovery for each compound.  
 IAC (As45) ELISA (As43) 
PBS Urine c Loading Individual a Mixture b Mixture b Indirect 
Washing 
 
Compound 
PBS PBS 20%EtOH 20%EtOH 
 
Direct d 
A e B f 
PCP 81 100 25 20 10 4 <0.05 
2,3,4,6-TtCP 98 103 81 83 86 89 21 
2,3,4,5-TtCP 104 101 < 10 n.d. n.d. n.d. n.d. 
2,3,5,6-TtCP 91 116 < 10 n.d. 3 <0.4 <0.05 
2,4,6-TCP 100 95 80 78 100 100 100 
2,4,5-TCP 107 103 < 10 g n.d. 41 49 12 
2,3,4-TCP 83 82 < 10 g n.d. 0.5 <0.4 n.d. 
2,3,5-TCP 94 105 < 10 g n.d. 12 <0.4 13 
2,3,6-TCP 97 98 < 10 g n.d. <0.001 3 n.d. 
2,4,6-TBP 79 86 68 71 1550 391 710 
2,5-DCP < 12 g n.d. n.d. n.d. 0.7 <0.4 n.d. 
2,6-DCP < 12 g n.d. n.d. n.d. 2.3 <0.4 <0.05 
3,4-DCP < 12 g n.d. n.d. n.d. <0.001 <0.4 n.d. 
2,4-DBP 93 103 17 n.d. 136 n.d. 119 
2,6-DBP 37 n.d. n.d. n.d. 5 n.d. <0.05 
2,4,6-TCA 16 n.d. n.d. n.d. <0.001 n.d. n.d. 
PBS solutions of the halogenated compounds were loaded to the column and eluted by 70%EtOH. 
After 10-fold water dilution they were extracted with toluene, derivatized with BSTFA and their 
concentration was determined by GC-ECD analysis. The recovery was calculated as the ratio of 
the peak area of the compound in the eluted fraction to the peak area corresponding to the loaded 
standard extracted with toluene. Rows in gray indicate the compounds that are strongly retained by 
the IAC column and are also the main cross-reactants in the ELISAs. n.d.- not determined; 
a The loading level for each compound is 20%; b The total loading level for the mixture is 20%; the 
individual loading level is 1.7%; c 10 mL acid hydrolyzed urine spiked with a mixture of the 
halophenols is loaded; d Immunoassay As43/5-HRP. Data reported is from [259]. e Immunoassay 
As43/2-BSA. Data reported is from [260]. f Immunoassay As43/8-BSA. Data reported is reprint 
from [277]. g The limit of quantification in these experiments correspond to a recovery of 12% 
(DCPs) and 10% (TCPs).  
 
The specificity of the IAC column is lower than those of the ELISA in both direct and 
indirect formats. Thus, all penta-, tetra- and tri-chlorophenols were retained in more than 
80%. The dichlorophenols were not detected in the elution fractions. Regarding 
bromophenols, 2,4,6-TBP and 2,4-DBP were completely retained, as expected from the 
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cross-reactivity data of the ELISA. In contrast, 2,6-DBP was only retained in a 37%. It 
must be noted that this analyte was not recognized in the ELISA, in spite of the greater 
recognition of the brominated analogues due to the lack of the halogenated atom at para 
position.  
 
It is well known that the Ab affinity for a given analyte is not the same when it is present 
individually in the solution and when it is in presence of other structurally related 
compounds [332]. In immunoassays individual analyte cross-reactivity is a function of 
the concentration of the cross-reactant present [342]. In IAC it is also demonstrated that 
there is such type of threshold concentration of the cross-reactant above which there is an 
effect on the analyte recovery [343]. The capacity measured for each analyte using a 
mixture of compounds strongly depends on the competition for the Ab binding sites, i.e. 
on the number of compounds and on their concentrations [338]. Since chlorophenols 
appear in urine as a mixture and in low levels, we determined IAC recoveries loading a 
mixture of halophenols, corresponding all together to 20% total column loading (each 
compound - 1.7% loading) and washing the column with PBS. No difference respect to 
the individual loading was observed under these conditions. All compounds were retained 
by the IAC column in higher than 80% (see Table 4.4). It is important to note that the 
recovery of the analyte 2,4,6-TCP (95%) was not affected by the presence of other similar 
compounds in the loaded mixture. The results clearly indicate a high affinity of the 
immunosorbent (Ab45) for all these halophenols. 
 
It has been reported that a step desorption varying the MeOH concentration in the elution 
buffer can be a means for assessing the affinity order of analytes within a group (weakly 
bound compounds are recovered with lower % MeOH and the strongest bound analytes 
are recovered with 70% MeOH) [344]. Moreover, potential non-specific interferences 
present in the urine could be washed out more efficiently by introducing a washing step 
with certain EtOH content. Before we had demonstrated that the elution of the analyte did 
not start until at least 30% EtOH in the elution buffer. Thus, when we decided to 
introduce a washing step with 20% EtOH, a higher selectivity was observed (see Table 
4.4). Only 2,4,6-TCP, 2,4,6-TBP, 2,3,4,6-TtCP, PCP and 2,4-DBP remained retained by 
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the IS. The organic modifier in the washing buffer disrupted the interactions between the 
Ab and the most weakly bounded analytes. The chlorophenols retained now followed the 
same recognition pattern as in the ELISA (see rows in gray, Table 4.4). The presence of 
hydroxyl group and three chlorine atoms at ortho and para positions in the aromatic ring 
of the halogenated compound was a necessary condition to remain bound to the IS (see 
Figure 4.11).  
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Figure 4.11. Chemical structures of the analyte, the immunogen used for Ab45 production and
the cross-reactants tested on IAC column. The fragments colored in red are the ones mostly
recognized by the Ab and determine analyte retention onto the immunosorbent. The recovery (%)
presented corresponds to 20% EtOH washing of the IAC column loaded with a PBS mixture of
the halogenated phenols (1.7% individual loading level, 20% total loading). 
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Although some authors have pointed that the cross-reactivity observed in a classical 
immunoassay does not necessarily has to mimic that seen in immunoaffinity extraction 
format using the same Ab [202], in our case the specificity of the IS (Ab45) was similar 
to the cross-reactivity of Ab43 shown in the three different ELISA formats developed in 
our group (see Table 4.4). Ab43 demonstrated higher affinity towards the same 
compounds. Although the Ab used for the preparation of the IAC column was obtained 
from another rabbit (Ab45), both antibodies (Ab43 and 45) were raised against the same 
immunogen (hapten 5-KLH). These observations demonstrate the importance of the 
structure of the immunogen for the Ab selectivity. 
 
Finally, the IAC specificity was also investigated loading the column with acid 
hydrolyzed urine sample (loading in a mixture, 20% EtOH washing). The behavior 
observed indicated that the urine matrix did not affect the selectivity of the Ab-Ag 
recognition. The halogenated compounds were retained by the immunosorbent in a 
similar manner as when they were loaded in PBS sample (see Table 4.4). 
 
In summary, the IS prepared can trap several analytes from the same structural group 
when PBS washing is applied. Thus, this procedure can be used as a class-selective IAC-
SPE of chlorophenols from urine samples that later can be analyzed by chromatographic 
(GC, HPLC) or immunochemical methods. A more selective extraction can be performed 
by washing with 20% EtOH buffer without any loss of recovery in the analyte of interest. 
If ELISA is used as a detection method after both types of IAC-SPE procedures, only the 
halogenated phenols with significant immunoassay cross-reactivity would be detected. 
However, if chromatographic methods were employed, the choice of IAC-SPE protocol 
(PBS or EtOH washing) would allow performing a class-selective or more specific 
analysis. Finally, it is important to note that the problem with the specific interference 
effect on the 2,4,6-TCP ELISA discussed in the previous chapter will persist after IAC-
SPE of urine, because ELISA cross-reactants are also extracted by the immunosorbent. 
This will be considered when matrix effect studies with urine samples will be performed. 
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4.2.2.3. Immunosorbent regeneration and stability 
 
When water-organic modifier mixture is used for elution, the presence of non-polar 
solvents reduces the hydrophobic binding component of the Ab-Ag interaction. However, 
it also affects the stability of the hydrophobic bonds that maintain the Ab tertiary 
structure resulting in the release of the antigen. These harsh eluting conditions can 
irreversibly denature Abs, but as small volumes are required, contact times can be 
minimized. In our studies, the regeneration of the IS was performed by passing 10 bed 
volumes of PBS through the column. Between uses the column was stored at 4°C in PBS 
in the presence of NaN3. 
 
To study the IS regeneration and stability, 2,4,6-TCP standards prepared in PBS were 
used regularly as quality controls of the IS binding capacity within several applications of 
urine (non-hydrolyzed/hydrolyzed) samples. Figure 4.12. shows the long-term stability 
of the IAC column monitored by loading it with 2,4,6-TCP in PBS at three concentration 
levels corresponding to 97%, 40% and 4% of the maximum capacity (1.2, 0.5 and 0.05 
µg). In the first 10-20 analyses a 50% decrease of the maximum capacity followed by 
stabilization is observed. This phenomenon is often observed [331,336] and can be 
explained by irreversible denaturation and ligand leakage during the early runs. This 
capacity decrease will not affect the recovery of 2,4,6-TCP from real urine samples 
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Figure 4.12. Performance of the IAC as a function of the number of analyses. For each 
control determination the IAC column was loaded with a standard PBS solution. The 
2,4,6-TCP concentration in the eluted fractions were determined by ELISA.  
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because the actual concentrations present in most of the population are placed between 0 - 
4% (non-exposed) and 40% (exposed). As it is demonstrated in Figure 4.12 at medium 
(40%) and low (4%) loading levels recoveries remain constant of around 90 - 100% up to 
50 analyses. Thus, the IAC capacity and recoveries were not affected adversely and the 
column can be efficiently regenerated and used for many cycles of urinary chlorophenol 
extraction. 
 
 
4.2.3. Evaluation of the IAC-SPE procedure with urine 
samples 
 
4.2.3.1. Matrix effect studies 
 
Non-specific interactions can occur between the IS support, the Ab proteins, the analyte 
and the sample matrix. Most commonly hydrophobic and ionic forces are responsible for 
undesirable adsorption, which results in a decrease of the selectivity and the LOD. Due to 
their hydrophilic character agarose-based ISs have been shown to minimize the 
interactions generated by the solid support. 
 
With the aim to evaluate the efficiency of the IAC- clean up we have tested the matrix 
effects of the IAC-purified urine samples A and B (non-hydrolyzed and hydrolyzed) on 
the 2,4,6-TCP ELISA. With this purposes we loaded 30 mL urine into the IAC column, 
washed it with PBS, collected the elution fractions (3 mL 70% EtOH) and then diluted 
them 10 times with PBS (neat). Further dilutions used for the ELISA were performed in 
7% EtOH/PBS in order to keep the solvent concentration constant. In this way the IAC-
SPE procedure consists just in a clean up step without concentration (30 mL urine loaded 
– 30 mL recovered for ELISA analysis). The standard curves compared to the one run in 
7% EtOH/PBS are presented in Figure 4.13 A, B, C, and D. Although a small inhibition 
of the Amax is observed for all the cases studied (non-hydrolyzed, acid and enzimatically 
hydrolyzed urine A; alkaline hydrolyzed urine B), the significant matrix effect previously 
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observed for the non-purified urine (see Table 3.12) and for the C18-SPE extracted urine 
(see Figure 4.4) has been eliminated. 
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Figure 4.13. Matrix effect on the 2,4,6-TCP ELISA of urine sample A (A, B, C, E, F) and
urine samle B (D, G) after IAC-SPE clean-up in different concentrations. (A) non-
hydrolyzed (NH), (B, E) acid hydrolyzed (AH), (C, F) enzimatically hydrolyzed (EH), (D,
G) base hydrolyzed (BH). 30 mL of urine sample was loaded to the IAC column, washed
with PBS (A, B, C) or with 20% EtOH (E, F) and eluted with 70% EtOH. The collected 3
mL elution fractions were diluted 10 times with PBS. Further dilutions were preformed with
7% EtOH/PBS. The IAC-SPE for sample B (D, G) was realized with mini-columns using
volumes proportional to the single IAC-SPE procedure (see Chapter 5). 
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At the light of these results we thought on impoving the clean-up of the matrix by 
increasing the strenght of the washing buffer. Thus, the co-extraction of interfering 
analytes (specific or non-specific) could be reduced or removed by applying a washing 
solution made of water with a small percentage of organic solvent. Based on our previous 
studies on the specificity of the IAC column (Table 4.4) we decided to apply a 20% 
EtOH washing step to the hydrolyzed urine samples in order to improve clean-up and to 
achieve higher selectivity. Following the above described procedure we evaluated the 
matrix effect on the ELISA after washing the IAC with 20% EtOH (see Figure 4.13. E, 
F, G). The inhibition of the Amax seems to be smaller than in the case of PBS washing. It 
is important to remind that EtOH washing of the IAC column provide higher selectivity 
of the clean up step and especially one of the main ELISA cross-reactants (2,4,5-TCP) is 
not co-eluted under these conditions (Table 4.4). 
 
In an attempt to explain the origin of the small reduction of the Amax still observed on the 
ELISA, we considered the presence of chlorophenols in urine samples A and B (Table 
3.9) co-eluting with the analyte 2,4,6-TCP from the IAC column (Table 4.4). Thus, we 
compared the 2,4,6-TCP-IR equivalent values obtained by the IAC-ELISA method and 
those determined by GC-MS analysis of samples A and B after direct toluene extraction 
(see non-purified urine TCP-IR equiv. GC-MS Table 4.5). The results are presented in 
Table 4.5. We evaluated the 2,4,6-TCP-IR equivalents for the urines using the standard 
curves prepared in 7% EtOH/PBS (ELISA in Table 4.5). On the other hand, we corrected 
the concentration of each CP determined by GC-MS considering its IAC recovery, and 
the ELISA cross-reactivity (TCP-IR equiv. GC-MScorrected in Table 4.5). Under PBS 
washing conditions all endogeneously present CPs (cross-reactants) are IAC-extracted 
(see Table 4.4). For 30 mL urine sample loaded at low loading level (4%) and PBS 
washing 85-100% IAC recovery can be applied for NH sample and 55% IAC recovery - 
for AH urine (according to the results presented in Figure 4.15). The IAC recovery 
considered for AH urine sample at 20%EtOH washing is 65% (see Figure 4.16.B). 
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Table 4.5. The 2,4,6-TCP-IR equivalents according to GC-MS, ELISA cross-reactivity and IAC 
specificty are compared to the 2,4,6-TCP-IR determined by the 2,4,6-TCP ELISA after IAC-SPE 
of urine sample A and B. 
IAC purified urine Non-purified urine 
PBS wash 20%EtOH wash Urine 
sample TCP-IR equiv. 
GC-MS 
TCP-IR equiv. 
GC-MScorrected d 
ELISA TCP-IR equiv. GC-MScorected d 
ELISA 
NH 0.16 0.14- 0.16 e 0.3 b n.d. n.d. 
AH 0.72 0.4 f 0.66 0.46 g 0.4 A 
EH n.d. a n.d. a 0.58 n.d. a 0.43 
B AH 1.12 0.62 f 1.1 c 0.73 g 0.9 c 
a TCP-IR for EH urine are not determined, but if complete hydrolysis is assumed they should be 
equal to the TCP-IR equivalents determined for AH urine by GC-MS. b This value is close to the 
LOD of the ELISA 7%EtOH/PBS = 0.2 µg/L. c Alkaline hydrolysis 
d The values for TCP-IR equiv. are estimated as follows: (CP concentration in urine according 
GC-MS, µg/L – Table 3.9A) x (IAC recovery corresponding to each CP) x (ELISA cross-
reactivity – Table 3.9B). This is calculated for each CP and the values are summarized to obtain 
the total TCP-IR. e 85-100% IAC recovery is considered for all CPs according to Figure 4.15 (30 
mL NH urine sample loaded, 4% loading level, PBS wash). f 55% IAC recovery is considered for 
all CPs according to Figure 4.15.B. (30 mL AH urine sample loaded, 4% loading level, PBS 
wash). f 65% IAC recovery is considered for all CPs according to Figure 4.16.B. (30 mL AH 
urine sample loaded, 4% loading level, 20%EtOH wash) 
 
 
The TCP-IR values measured by ELISA correlate quite well to the values expected 
according to GC-MS (see Table 4.5). In general, the ELISA values are slightly higher or 
equal to the GC-MS estimated values. The overestimation is observed especially in the 
case of PBS washing. It is possible that other ELISA cross-reactants are present in the 
IAC urinary extracts (not considered by us in the GC-MS urine characterization), such as 
2,3,5-TCP, which has 12% ELISA cross-reactivity and it is retained by the IAC column 
under PBS washing conditions (see Table 4.4). Therefore, we can conclude that the IAC 
purified urine samples have no matrix effects on the 2,4,6-TCP ELISA. The observed 
“matrix effect” is only specific and it is due to the low levels of chlorophenols present in 
the samples. In addition, it can be observed that there is no significant difference in the 
concentrations determined by IAC-ELISA of acid and enzymatically hydrolyzed urine 
sample A. This is another confirmation for the “specific matrix effect” observed, if 
efficient hydrolysis in both cases is assumed. 
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Finally, we have confirmed our statement by GC-ECD and GC-MS analysis of the IAC-
extracted urine sample A (30 mL, AH, PBS wash). The presence of 2,4,6-TCP, 2,4,5-
TCP, 2,3,4,6-TtCP, 2,3,5,6-TtCP and 2,4,6-TBP was observed and their concentrations 
corresponds to 0.56 µg/L 2,4,6-TCP-IR equiv. which agrees with the ELISA measured 
value of 0.66 µg/L. Furthermore, a comparison of the GC-ECD chromatograms for the 
IAC-extracted urine and the C18-SPE extracted urine demonstrates the efficiency and 
specificity of the IAC-SPE (see Figure 4.14). While urine matrix components are co-
eluting under C18-SPE producing a matrix effect on the ELISA (Figure.4.4), with IAC-
SPE only the specific compounds are eluted (Figure.4.13). 
 
4.2.3.2. Recovery studies. Effect of loading level, volume loaded and 
type of urine hydrolysis. 
 
A. Non-hydrolyzed urine 
 
Once we demonstrated that there was no matrix effect of the IAC- extracted urine on the 
2,4,6-TCP ELISA, we approached IAC-recovery studies. The evaluation of the IAC-SPE 
procedure was performed using urine sample A characterized by GC-MS in Chapter 3. 
Different volume of non-hydrolyzed urine (pH=7.5, 25 mS/cm) and spiked at two 
concentration levels corresponding to 4% and 40% of the maximum column capacity 
were passed through the IAC column. The unbound material was washed with PBS 
buffer. The eluted 2,4,6-TCP was determined by ELISA after a 10-fold dilution with PBS 
and using a standard curve run in a 7%EtOH/PBS buffer. The recoveries were calculated 
with respect to the spiked amount and substracting the TCP-IR equivalents present as 
background level in sample A.  
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Figure 4.14. GC-ECD chromatograms obtained for: A. Non-purified urine: 100 mL of acid 
hydrolyzed urine A were extracted with 1 mL of toluene. The obtained extract was 10-fold 
diluted with toluene; B. after C18-SPE: 10 mL of acid hydrolyzed urine A spiked with 1 µg/L 
2,4,6-TCP were used. The collected elution fraction (85% MeOH) was diluted 10-fold with 
PBS and extracted with 1 mL of toluene. The concentration of 2,4,6-TCP in the toluene extract 
corresponds to 10 µg/L; C. after IAC-SPE: 10 mL of acid hydrolyzed urine A spiked with a 
mixture of 2,4,6-TCP, 2,3,4,6-TtCP and 2,4,6-TBP (0.25 µg/L each) were used. The collected 
fraction of 3 mL after the IAC-SPE procedure (20% EtOH washing) was diluted 10-fold with 
PBS and extracted with 1 mL of toluene. Peaks: (1) 2,4,6-TCP, (2) 2,3,4,6-TtCP and (3) 2,4,6-
TBP The concentration of each chlorophenol in the toluene extract corresponds to 7.5 µg/L; 
All toluene extracts were derivatized with BSTFA, In the three cases the overall sample 
concentration is 10 times (urine: toluene=10:1). Peaks: 1 – 2,4,6-TCP, 2 – 2,3,4,6-TtCP, 3 -
2,4,6-TBP. 
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As can be seen from Figure 4.15A, there are two main factors affecting the recovery 
from non-hydrolyzed urine: the volume loaded and the spiked concentration. In general, 
the recovery is higher at lower loading levels. An explanation could be found considering 
that at low loading levels only the antibodies with high affinity participate in the binding 
of the analyte, while at high loads the analyte is also retained by antibodies with low 
affinity, and the binding forces of those can be more affected by other components of the 
urine matrix affecting thus the recovery. Similar to the IAC of spiked PBS samples, 
where no breakthrough effects were observed until 50 mL loaded volume, the 2,4,6-TCP 
recovery of non-hydrolyzed urine spiked with 50 ng 2,4,6-TCP (4% lading level) is 
higher than 80% for all the volumes tested (from 1 mL to 50 mL). In contrast, at 40% 
loading level (500 ng 2,4,6-TCP) breakthrough effects become evident upon sample 
volume increases. Such type of breakthrough volume is defined at about 5 mL, where the 
recovery drops to 70% and further at 25 mL, where it becomes only 30%. 
 
Since the immunoreaction taking place during sample loading may be interfered by 
unknown urine components, this effect could be minimized if urine sample would be 
loaded diluted. Furthermore, urine conductivity (25 mS/cm) is slightly higher than usual 
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Figure 4.15. Effect of sample volume and loading level on the recovery of the IAC-SPE
procedure (PBS washing and 70% EtOH elution) applied to urine sample A. (A) non-
hydrolyzed urine; (B) acid hydrolyzed urine. 100% loading level corresponds to 1.2 µg
2,4,6-TCP. The 2,4,6-TCP concentrations in the purified urine are measured by ELISA.
Recovery is calculated with respect to the spiked amount substracting the background level
of TCP-IR equiv. in urine sample A. The standard deviation corresponds to three column
replicates. 
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buffer conditions that favour Ab-Ag interactions (15 mS/cm). Thus, spiked urine samples 
(500 ng 2,4,6-TCP, 5mL) were loaded as such and after 2- and 10-fold water dilution. 
The recoveries obtained were 67.7%, 67.8% and 68.8%, respectively. As no improvement 
was achieved, we decided to apply non-hydrolyzed urine to the IAC in 2-fold dilution in 
further experiments. 
 
B. Hydrolyzed urine 
 
We have applied the same IAC-SPE procedure (PBS wash) to acid hydrolyzed (AH) 
urine A. After acid hydrolysis the urine was adjusted to pH 7.5, the precipitated salts were 
removed by centrifugation and the supernatant was spiked at 4% and 40% loading levels 
as before. As the conductivity of the solution remained very high (100 mS/cm), we 
diluted the urine sample 3 times with water prior to loading the column. The recoveries 
obtained are compared to those of the non-hydrolyzed urine in Figure 4.15.B. At 4% 
loading level the breakthrough volume for the AH urine was smaller than those for the 
NH urine: while the recovery for NH urine was higher than 80% when up to 50 mL were 
loaded, the recovery for AH urine was near 50% when 30 mL were loaded. At medium 
loading levels (40%) the recovery reached this value with just 5 mL AH urine sample. In 
addition, no effect of urine dilution prior to IAC was observed. Therefore, IAC column 
capacity for acid hydrolyzed urine is lower than for non-hydrolyzed one. 
 
As was previously demonstrated, 20% EtOH washing of the IAC column resulted in an 
IA extraction with higher specificity. We also observed that clearer (colorless) extracts 
were obtained from acid hydrolyzed urine after ethanol washing. Thus, we decided to test 
the efficiency of the IAC-SPE of AH spiked urine with 20% EtOH washing. The effect of 
the volume and the sample concentration on the recovery is presented in Figure 4.16. The 
results are quite similar to the recoveries obtained with PBS washing (see Figure 4.15 B). 
The results also revealed that 10 mL of urine with a 4% loading level could be purified 
without loss of analyte (recovery higher than 80%). In an attempt to determine the 
maximum capacity of the column when 10 mL of AH urine were loaded, we also tested 
2,4,6-TCP loading corresponding to 8% of the theoretical capacity. We observed that the 
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recovery dropped below 50% under these conditions. The recovery was below 60% even 
when 5mL of AH urine spiked with 8% loading level was loaded. Therefore, it can be 
considered that for the AH urine the maximum capacity is near 50 ng and the 
breakthrough volume is around 10 mL. This means that levels up to 5 µg/L 2,4,6-TCP (10 
mL, 50 ng 2,4,6-TCP) in acid hydrolyzed urines can be determined quantitatively by the 
IAC-ELISA method. 
 
The TCP-IR equivalent urinary concentration in general population [75,124] and 
occupationally exposed persons [36,117] could exceed 5 µg/L. In an attempt to achieve 
higher recoveries we decided to study the IAC-SPE of enzimatically hydrolyzed (EH) 
urine. Although we expected more efficient immunoaffinity extraction from this cleaner 
matrix, the recovery obtained was a little bit higher, but the improvement was not 
significant. Since enzymatic hydrolysis would increase the cost of routine urine analysis, 
we approached alkaline (base) hydrolysis (BH). Thus, 10 mL of NH, AH and BH urine 
samples were spiked at different concentrations of 2,4,6-TCP and purified by IAC-SPE 
(20% EtOH washing). Figure 4.17 shows the effect of the loading level on the recoveries 
obtained for these three types of urine. Excellent recoveries were obtained for all type of 
urines until a 4% loading level. Furthermore, the IAC column can extract efficiently even 
200 ng 2,4,6-TCP (16% loading) from NH and BH urine samples. In contrast, the IAC 
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Figure 4.16. Effect of sample volume and loading level on the recovery of the IAC-SPE
(20% EtOH washing and 70% EtOH elution) for acid hydrolyzed urine A. The 2,4,6-
TCP concentration in the purified urine was measured by ELISA. Recovery was
calculated with respect to the spiked amount resting the background level of TCP-IR in
urine sample A. The standard deviation corresponds to two column replicates. 
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capacity for AH urine remained limited to 50 ng 2,4,6-TCP (4% loading). These results 
suggested that alkaline hydrolysis seems to be more appropriate than the acid hydrolysis 
of the urine for the IAC-SPE protocol. 
 
Finally, each type of hydrolysis (alkaline and acid) was evaluated regarding possible loss 
of the analyte. Spiked urine samples (60 ng and 200 ng 2,4,6-TCP) were hydrolyzed by 
both methods. Simultaneously, non-spiked samples were treated in the same way and 
spiked with the same concentrations after the hydrolysis took place. All the samples were 
IAC purified and their concentrations were determined by ELISA. The data presented in 
Table 4.6 demonstrates that both hydrolysis methods have similar recoveries.  
 
Table 4.6. Hydrolysis evaluation.  
Recovery ± SD (%) Loading, % 
Acid hydrolysis Alkaline hydrolysis 
5 81.2±4.7 71.2±11.6 
16 76.9±5.3 75.3±5.7 
Urine samples (10 mL) spiked at two concentrations (60 ng and 200 ng 2,4,6-TCP corresponding 
to loading levels 5% and 16%) were hydrolyzed by KOH and H2SO4. Simultaneously, non-spiked 
samples were treated in the same way and spiked after hydrolysis. All the samples were IAC 
purified and their concentrations were determined by ELISA. The recoveries are calculated as 
(spiked+hydrolyzed)/hydrolyzed+spiked)]*100. Data are the result of three replicates. 
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Figure 4.17. Effect of the loading level on the recovery of IAC-SPE (20% EtOH washing 
and 70% EtOH elution) for non-hydrolyzed and hydrolyzed (acid, alkaline) urine sample 
A. Sample volume loaded is 10 mL. 2,4,6-TCP concentration in purified urine is measured 
by ELISA. Recovery is calculated with respect to the spiked amount resting the 
background level of TCP-IR in urine sample A. The standard deviation corresponds to two 
column replicates. 
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However, since the alkaline hydrolysis allows quantitative immunoaffinity extraction at 
higher loading levels (see Figure 4.17), the use of this type of hydrolysis of urine samples 
is more convenient for the detection of 2,4,6-TCP in urine of occupationally exposed 
persons. 
 
In conclusion, we established the following IAC-SPE procedure for clean up of urine 
samples (see Figure 4.18): 10 mL hydrolyzed or non-hydrolyzed urine sample is loaded 
to the IAC column, then the column is washed with 5 mL 20% EtOH; the analyte is 
eluted by 3ml 70%EtOH; the IAC column is regenerated by 10 mL PBS. The eluted urine 
extract is 10-fold diluted with PBS and the concentration of 2,4,6-TCP is measured on the 
ELISA. In this procedure urine is diluted 3 times (10 mL urine is finally converted in 30 
mL purified urine). The overall LOD of the IAC-ELISA method is determined by the 
LOD of the ELISA run in 7% EtOH/PBS (0.2 µg/L 2,4,6-TCP), by the 3-fold urine 
dilution in the IAC procedure, by the IAC-recovery (see Figure 4.17) and by the recovery 
in the hydrolysis step if total (free + conjugated) chlorophenol concentration is quantified 
• Load: 10 mL urine 
• Wash: 20% EtOH (5 mL)
• Elution: 70% EtOH (10 mL; collect 3 mL)
• Regeneration: PBS (10 mL)
Hydrolysis
urine
eluted fractions 
(70% EtOH/PBS)
single column
IAC-SPE
hydrolyzed 
urine
10-fold dilution with PBS
eluted fractions 
(7% EtOH/PBS)
ELISA GC-ECD (GC-MS)
 
 
Figure 4.18. IAC-SPE procedure. 2,4,6-TCP concentration in purified urine can be
determined by ELISA and/or gas-chromatography (GC-ECD/MS). 
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(see Table 4.6). The range of the method (low LOD and maximum detectable 
concentration) where quantitative analysis (overall recovery > 70%) can be performed is 
summarized in Table 4.7.  
 
Table 4.7. Range of quantitative detection for the IAC-SPE-ELISA method for different types of 
urine samples 
Urine sample LOD a, µg/L MDC b, µg/L 
Non-hydrolyzed 0.66 50 
Acid hydrolyzed 0.83 5 
Alkaline hydrolyzed 0.99 20<MDC<50 
The range correspond to the protocol where 10 mL urine sample is loaded to the HiTrap column, 
washed with 20% EtOH, and eluted in 3 mL 70% EtOH. a The LOD7%EtOH/PBS=0.2 µg/L is 
corrected with the corresponding IAC and hydrolysis recoveries. b MDC (maximum detectable 
concentration with recovery >70%) 
 
Free 2,4,6-TCP can be determined with a LOD of 0.66 µg/L 2,4,6-TCP-IR equivalents in 
10 mL non-hydrolyzed urine (if 90% IAC recovery is considered). Non-hydrolyzed urine 
can be extracted efficiently (recovery > 70%) until 50 µg/L (500 ng in 10 mL). For 
hydrolyzed urine the LOD is about 0.83 µg/L for acid and 1 µg/L for alkaline one (if 10 
mL sample volume is loaded and recoveries from Table 4.6 and Figure 4.17 are 
considered). If acid hydrolysis is used, 2,4,6-TCP can be extracted efficiently in the range 
between 0.83 and 5 µg/L urinary concentration. In the case of alkaline hydrolysis 
quantitative analysis can be performed in the range 1 - 20 µg/L 2,4,6-TCP urinary 
concentration. As for higher concentrations the recovery is about 60%, those samples 
giving concentration values higher than 20 µg/L will have to be repeated after dilution of 
the urine with PBS.  
 
The chlorophenols extracted from urine samples following the established IAC-SPE 
protocol can be analyzed also by GC-ECD (GC-MS) after toluene extraction and 
derivatization (see Annex 1). Thus, the concentration of the halogenated phenols mainly 
extracted by the IAC column can be determined. The LOD of the IAC-SPE-GC method 
depends on the hydrolysis recovery, the IAC recovery, the pre-concentration factor used 
in the toluene extraction and on the instrumental LOD. For example, if we consider the 
recoveries related to the IAC-SPE procedure, the instrumental LOD in the GC-ECD for 
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2,4,6-TCP (0.5 µg/L) and a pre-concentration factor of 5 in the toluene extraction, then 
the overall LOD of the IAC-SPE-GC-ECD would be 0.11 µg/L, 0.14 µg/L and 0.17 µg/L 
2,4,6-TCP for NH, AH and BH urine respectively. 
 
4.2.3.3. Validation of the IAC-SPE-ELISA for 2,4,6-TCP analysis in 
urine by GC-ECD 
 
For a validation study the protocol described above was applied to the analysis of spiked 
urine samples (see Figure 4.18). 10 mL of NH and AH urine sample A was spiked at four 
levels 2, 5, 10 and 20 µg/L 2,4,6-TCP (corresponding to 1.6%, 4%, 8% and 16% IAC 
column loading). After IAC selective extraction the eluted fractions were diluted 10 times 
with PBS buffer and split in two parts: one part (0.5 mL) was measured directly by 
ELISA and the other part (29.5 mL) was extracted with toluene and after derivatization 
the chlorophenol concentration was determined by GC-ECD (see Annex 1). The data 
presented in Figure 4.19. clearly demonstrate the potential of the method developed. The 
linear regression analysis of hydrolyzed and nonhydrolyzed urine samples by both 
methods showed a very good correlation. Correlation between both techniques agrees to 
the following equation y=0.878x+1.19 with a regression coefficient r2 = 0.990 for NH and 
to y=0.91x+0.56 with a regression coefficient r2 = 0.977 for AH urine. 
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Figure 4.19. Validation of IAC-ELISA by GC-ECD. Urine samples (non-hydrolyzed and acid
hydrolyzed) were spiked with 2,4,6-TCP and IAC purified. The eluted fractions were determined
both by ELISA and by GC-ECD. For GC-ECD calibration toluene extracts of 2,4,6-TCP PBS
standards were used. For high concentrations (10 and 20 µg/L 2,4,6-TCP) an IAC-recovery
coefficient was applied according to Figure 4.16. 
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4.2.3.4. IAC-SPE application to urine samples from different 
individuals with not known exposure to 2,4,6-TCP 
 
In the course of the IAC-SPE method development we used urine sample A collected 
from one individual. Finally, we decided to apply the optimized procedure to urine 
samples from different individuals with not known exposure to 2,4,6-TCP. Previously, 
we had shown that when urines from different individuals with different creatinine 
content affected on a different manner ELISA performance. In this case, we used seven 
urine samples (C, D, E, F, G, H, I) with the pH in the range from 5.7 to 6.5 and 
conductivity between 7.1 and 24.3 mS/cm. The creatinine content was determined 
according to the protocol described in the Experimental Section. As it is shown in Table 
4.8 the creatinine concentration covers a broad range (0.2 –2.3 g/L), thus the urine 
samples can be considered as representative in this validation study.  
 
Table 4.8. Recoveries obtained for urines from non-occupationally exposed persons.  
Urine sample Creatinine a, g/L Recovery b, % 
C 0.2 109.25 
D 0.3 115.5 
E 0.8 116 
F 1 89.25 
G 1.3 81.75 
H 1.5 85 
I 2.3 80.25 
10 mL acid hydrolyzed urine samples spiked with 5 µg/L 2,4,6-TCP (4% lading level) were 
purified by IAC-SPE (20%EtOH washing, 70%EtOH elution) and analyzed by ELISA. 
a The creatinine concentration was determined according to the procedure described in the 
Experimental Section. b The recovery is calculated vs the spiked amount 
 
The samples were hydrolyzed with H2SO4 and after IAC-SPE they were measured by 
ELISA. In this case it was possible to use AH since it was not expected to find any 
sample with concentration values higher than 5 µg/L. Thus, as expected in none of them 
2,4,6-TCP was detected (LOD = 0.83 µg/L, see Table 4.7). Then 10 mL of each acid 
hydrolyzed urine sample were spiked with 50 ng 2,4,6-TCP (4% loading level) and 
analyzed by IAC-ELISA method. The recoveries obtained were higher than 80% (see 
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Table 4.8). These results demonstrate the versatility of the IAC-ELISA method 
developed and its applicability to urine samples of different origin. 
 
In conclusion, in this chapter a standard protocol for an IAC-SPE-ELISA was established 
(see Figure 4.18). The LOD of the method as well as the maximum detectable 
concentration defined by the IAC column capacity and by the type of hydrolysis used (see 
Table 4.7) allow the quantitative determination of free and conjugated 2,4,6-TCP in the 
general population and in persons with occupational exposure to organochlorinated 
compounds. Every 10 loadings a quality control of the IAC-SPE procedure has to be 
made using PBS standards of 2,4,6-TCP. The IAC-SPE-ELISA method was validated 
with GC-ECD and is applicable to urine samples from different individuals. 
 
  
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
 
5. Development of HTS-IAC-ELISA 
method for urinary detection of 
chlorophenols 
 
________________________________________________________________________ 
 
 
 
 
The need for fast and efficient sample preparation methods in bioanalytical analysis is 
growing rapidly as it is often the bottleneck step avoiding speeding up the overall analysis 
process [345]. In the last years there is an increasing trend in developing parallel sample 
processing approaches. Although the 96-well format has been utilized for many years for 
immunoassays and in vitro binding assays, its use for SPE is relatively new. SPE devices 
in a 96-well plate format were introduced in 1996 and they enjoyed widespread 
application and rapid acceptance in biotechnology and pharmaceutical laboratories where 
high-throughput screening (HTS) is seeking. The traditional bulky SPE cartridges have 
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been replaced by small-volume SPE cartridges with a packed bed lower than 50-100 ng 
and by membrane-extraction discs. The 96-well SPE formats have been designed to fit 
automated plate handling system and to reduce the void volume as well the sorbent bed 
masses in order to have the minimum desorption volume. In addition to these advantages 
(fast sample preparation, parallel processing of 96 samples at once, automation, and 
volume reduction) the simultaneous sample processing overcomes the problems with 
analyte/biological sample stability found in serial processing methods. 
 
Sample preparation in the 96-well format is mainly used in conjunction with liquid 
chromatography- tandem mass spectrometry (LC-MS-MS) [346] or coupled to optical 
detection [347]. The commercialisation of 96-channel robotic liquid handling 
workstations [348] as well as the wide selection of 96-well SPE sorbents [349] afford the 
rapid development and automation of SPE methods to eliminate traditional time-
consuming and labor-intensive sample preparation steps for environmental water [350], 
plasma [351-353] and urine samples [354,355].  
 
All these applications of 96-SPE formats are based on non-selective SPE sorbents (C2, C8, 
C18, ion-exchange, etc.). However, the trends in SPE-research are not only oriented 
towards reduction of the SPE format and the automation for a high throughput, but also 
towards the development of more selective extraction procedures, such as those using 
immunoextraction sorbents [322]. There are no many examples in the literature regarding 
immunoaffinity extraction performed in 96-well format. A high-throughput mass 
spectrometric immunoassay system for the analysis of proteins directly from plasma has 
been reported recently [356]. In this work a 96-well format robotic workstation has been 
used to prepare antibody-derivatized affinity pipette tips for subsequent use in the 
extraction of specific proteins from plasma and deposition onto 96-well format MALDI-
TOF-MS targets. The approach represents a rapid (~ 100 samples/2h, reagent preparation-
to-data) and accurate means of characterizing specific proteins present in large numbers 
of individuals for proteomic and clinical/diagnostic purposes.  
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Another rapid screening technique in 96-well format is the Enzyme-Linked 
Immunofiltration Assay (ELIFA) [357,358]. Although immunofiltration implies 
similarities to immunoaffinity extraction, it is not used as a clean up procedure and it can 
be regarded as an own immunoassay format. The immunofiltration methodology is based 
on the use of membranes with immobilized Abs, which are subject to a usual competitive 
immunoassay with colorimetric detection. It has been applied for semi-quantitative and 
quantitative determination of several compounds in environmental, food and clinical 
samples [359,360].  
 
In the previous chapter we have described the development of an IAC-SPE-ELISA 
method for urinary determination of 2,4,6-TCP. Although the ELISA analysis allows the 
simultaneously quantification of 96 samples, the overall method was limited by the 
tedious, manually performed immunoaffinity urine extraction in single column format. To 
meet the ever-increasing demands for higher throughput in biological monitoring (clinical 
analysis), it is crucial to streamline all aspects of the process, from sample treatment to 
analyte measurement. Therefore, we have approached the development of HTS-IAC-SPE 
(96-column format), which would allow the direct quantification of the 96 urine extracts 
by subsequent ELISA. We have chosen the Versaplate 96-Well SPE system (Varian, Palo 
Alto, CA) because it permits the cartridges to be easily snapped into a separate 96-well 
base plate [361,362]. Furthermore, the system is available with separate empty columns, 
which can be packed with the desired immunosorbent. 
 
Transferring methods from standard SPE cartridges to 96-well format is often nontrivial. 
Differences in packing and sorbent bed dimensions, in pressures and flow-rates can create 
significant differences in method performance. Therefore, a re-optimization procedure 
should be undertaken. Furthermore, the HTS-IAC-SPE method development should 
include inter- (intra-) day precision and recovery evaluation of matrix samples at different 
concentration levels. 
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5.1. Immunosorbent preparation 
 
As solid support for HTS-IAC-SPE we have used NHS-activated Sepharose 4 Fast Flow 
(Pharmacia Biotech, Uppsala, Sweden). It is a bead-formed highly cross-linked 4% 
agarose matrix, quite similar to the phase of the commercial HiTrap column used in the 
previous chapter, but with approximately two times higher substitution level (16-23 µmol 
NHS/mL drained gel). The IgG fraction of As45 was covalently immobilized to the 
Sepharose gel (see Experimental Section) keeping the ligand density (ratio Ab mg/NHS 
µmol) the same as in the single column coupling. Throughout this thesis the Ab coupling 
was performed at different scale (using 1 mL, 5 mL, 12 mL and 24 mL Sepharose 
suspension) with a coupling efficiency at about 97% in all cases. Using the prepared 
immunosorbent we have packed 96 mini-IAC columns with 0.2 mL drained gel bed (see 
Experimental Section and Figure 5.1). This corresponds to maximum theoretical 
binding capacity for each mini-column (0.2 mL bed) of approximately 1 µg (5.1 nmol) 
2,4,6-TCP, based on the amount of IgG coupled (9.7 mg) and the assumptions that 
bivalent binding takes place, 10% of the polyclonal IgG are specific and 100% of the 
immobilized IgG are accessible. If we assume a 50% steric hindrance or wrong Ab 
orientation, the theoretical binding capacity would be: 0.5 µg (2.22 nmol) 2,4,6-TCP. 
 
            
 
Figure 5.1. VersaPlate 96-SPE System 
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5.2. Characterization of mini-IAC columns. 
Optimization of HTS-IAC-SPE procedure with PBS 
standards of 2,4,6-TCP 
 
The prepared mini-IAC columns were assembled in a 96-format SPE vacuum manifold 
(VersaPlate System, Varian) (see Experimental Section and Figure 5.1). The detailed 
general HTS-IAC-SPE procedure is described in details in the Experimental Section. All 
steps of the IAC cycle were performed using a multichannel pipette and controlling the 
applied vacuum to maintain constant flow rate in the range of 1-2 mL/min. 
 
5.2.1. Evaluation of the binding capacity of mini-IAC 
columns 
 
Taking in consideration the similarities between the HiTrap (1 mL) and the mini-IAC 
columns (0.2 mL) we performed an initial evaluation with PBS standards of 2,4,6-TCP 
with the aim to adapt the IAC-SPE procedure established above to a smaller scale. Based 
on our experience with the IAC-SPE development we used initially PBS for washing and 
70% EtOH for elution. We investigated the elution profile for four different loading 
levels corresponding to 150% (0.75 µg), 100% (0.5 µg), 20% (0.1 µg) and 2% (0.01 µg) 
of the theoretical immunosorbent capacity. The sample volume loaded in these 
experiments was 6 mL. The concentration of 2,4,6-TCP was determined by ELISA in the 
loading fraction collected after passing the mini-column (L), in the washing fractions (W) 
and in the the elution fractions (F). Each collected fraction was 0.2 mL (1 bed volume). 
The recoveries obtained are presented in Figure 5.2. When the column is loaded with 750 
ng 2,4,6-TCP, 20% of this amount is not retained by the IS and it is detected in the 
fraction collected after loading (L); about 12% is washed with PBS buffer (W) and the 
remaining amount (69.7%) is eluted resulting in a total recovery of 101%. A small 
amount of 2,4,6-TCP was also detected in L and W fractions when the mini-columns 
were loaded with 500 ng. However, the recoveries in the elution fractions were still high 
(90%). At a loading concentration lower than 0.5 µg, the analyte is completely retained 
by the immunosorbent: 2,4,6-TCP is not detected in the volume collected after loading of 
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the standard (L) neither in the collected washing fractions (W) and the eluted amount 
corresponds to a complete recovery (around 95%). Therefore, the experimentally 
determined maximum binding capacity corresponds to the theoretically evaluated value 
of 0.5 µg 2,4,6-TCP. 
 
Similarly to the HiTrap column, the elution profile of the mini-IAC columns is influenced 
by the loading level (compare Figure 5.2 to Figure 4.10) and a volume, three times the 
column volume (3 x 0.2 mL = 0.6 mL) was also needed to ensure complete recovery of 
the trapped analyte from the immunoextraction column. Therefore, we decided to collect 
0.6 mL of the elution fractions in further experiments. 
 
As the mini-IAC columns were packed manually, it was important to evaluate the 
variation in the capacity of different columns. We designed an experiment where different 
columns placed in different positions of the rack holder were loaded with different 
amounts of 2,4,6-TCP. In Table 5.1 are presented the recoveries obtained for HTS-IAC-
SPE of 2,4,6-TCP from PBS standards of different concentration.  
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Figure 5.2. Elution profile of 2,4,6-TCP IAC-SPE by mini-IAC columns (VersaPlate
System). PBS standards 6 mL (750 ng, 500 ng, 100 ng, 10 ng 2,4,6-TCP) were loaded to the
columns, washed with PBS and elute with 70%EtOH. Eluted fractions of 0.2 mL were
collected. Each was diluted with PBS buffer and measured on the ELISA using standard
curve run in 7%EtOH/PBS. The 6 mL collected fraction after loading (L) and washing
fractions (W) (6 mL) were determined directly by ELISA standard curve run in PBS.
Recovery is calculated vs spiked amount of 2,4,6-TCP. Data correspond to the average of
three mini-IAC columns processed simultaneously. 
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Table 5.1. Recovery obtained for HTS-IAC-SPE of 2,4,6-TCP from PBS 
standards (PBS washing, 70%EtOH elution in 0.6 mL).  
Loading level, % 2,4,6-TCP, ng N a Recovery ± SD, % 
100% 500 10 101.05 ± 4.74 
20 100 3 84.81 ± 13.25 
2.4 12 16 97.75 ± 16.84 
0.72 3.6 16 95.77 ± 26.04 
a N is the number of mini-IAC columns used 
 
It should be noted that at the maximum capacity the columns were very reproducible 
(%CV = 4.69, N=10). The highest CV of 27.19% (N=16) was observed for the lowest 
loading level (0.72%). In general, we can conclude that, in spite of the manual packing, 
the reproducibility within columns was very good. 
 
5.2.2. Effect of EtOH washing for different loading levels 
 
In single column IAC-SPE we determined that 2,4,6-TCP starts to elute at 30% EtOH, 
when a 4% loading level was applied (see Figure 4.9). This allowed washing the HiTrap 
column with 20% EtOH to achieve higher specificity. The smaller scale of HTS-IAC 
(smaller maximum capacity of the mini-IAC columns and smaller sample volume to be 
loaded, 6 mL) required a more rigorous evaluation of the effect of EtOH in the washing 
step. Taking advantage of the fact that in HTS-IAC simultaneous processing of many 
columns is possible, we decided to define more precisely the ethanol content under which 
the desorption starts for several loading levels (100%, 40%, 10%). Three 2,4,6-TCP 
standards (0.5 µg, 0.2 µg and 0.05 µg 2,4,6-TCP in 6 mL PBS each) were loaded in 
triplicate. We applied a step elution increasing the EtOH concentration from 10% to 70% 
and collecting 0.6 mL for each EtOH concentration. All columns were processed 
simultaneously using the VersaPlate System. The recoveries calculated based on the 
ELISA determination of the 2,4,6-TCP eluted in each fraction are presented in Figure 
5.3. The higher the loading level, the lower the EtOH concentration needed to start the 
elution. For example, at 100% loading level 10% of the loaded amount is already eluted 
with 10% EtOH, whereas at 10% loading, 30% EtOH is needed to start the elution. This 
could be explained by the heterogeneity in the affinity of the polyclonal Abs of the 
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immunosorbent. At high loading levels all the Abs (low and high affinity) are 
participating in the immunoextraction and at low EtOH concentration part of the 
interactions (the weak ones) are disrupted. At low loading levels only high affinity Abs 
trap the analyte from the sample, thus higher EtOH concentration is necessary to disrupt 
Ab-Ag interaction. 
 
From practical point of view, the washing step could be performed with 20% EtOH 
without loss of analyte until 10% loading level (50 ng, 6 mL, 8 µg/L). This result agrees 
with the observation in single column IAC-SPE, where for 4% loading level the elution 
starts at 30% EtOH. At 40% loading level (200 ng, 6 mL, 32 µg/L) 6.83% of the loaded 
analyte can be washed with 20% EtOH. However, 32 µg/L is a quite high concentration 
only possible when monitoring groups of population with very high risk of exposure. 
Therefore, we decided to use a 20% EtOH as washing buffer in the HTS-IAC-SPE 
procedure. 
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Figure 5.3. Step elution of 2,4,6-TCP with different EtOH concentration in the elution buffer
in HTS-IAC-SPE (VersaPlate System). PBS standards 6 mL (500 ng, 200 ng, 50 ng 2,4,6-
TCP) were loaded to the mini-IAC columns. The column was washed first with 0.6 mL
10%EtOH, then with 0.6 mL 20% EtOH, followed by 0.6 mL 30% EtOH and finally eluted
with 0.6 mL 70%EtOH. Each collected fraction (0.6 mL) was diluted with PBS buffer and
measured on the ELISA using standard curve run in 1%, 2%, 3% and 7%EtOH/PBS
respectively. Recovery is calculated vs spiked amount of 2,4,6-TCP. Data correspond to the
average of three mini-IAC columns processed simultaneously. 
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5.2.3. Column stability 
 
In the previous chapter we have shown that the 70% EtOH elution does not affect the 
capacity of the HiTrap column and it can be regenerated and used for up to 55 cycles 
without loss of stability (see Figure 4.12). Thus, we expected that the mini-IAC columns 
prepared with the same immunosorbent, would have similar stability. As we did with the 
HiTrap column, we included regularly cycles where quality controls (QC) at different 
loading levels were applied to the mini-columns. In Figure 5.4. is presented the long-
term stability of three mini-IAC columns monitored by loading them with three levels of 
2,4,6-TCP in PBS (0.5, 0.1, 0.05 and 0.01 µg ) corresponding to 100%, 20%, 10% and 
2% loading levels.  
 
As it is shown in the figure, quantitative recovery (in the range of 80-100%) was 
maintained for up to 35 analyses for all levels. Therefore, the IAC capacity was not 
affected adversely and the columns can be efficiently regenerated and used for many 
cycles of urinary chlorophenol extraction. However, in HTS-IAC-SPE washing and 
elution procedures are performed until the columns get dried (in order to avoid error in 
the collected volume), which can have negative effect on the immunosorbent stability. In 
addition, the back pressure formed is not equal for all the columns, because different 
resistance is created by the manually put frits (different packing). The applied pressure to 
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Figure 5.4. Capacity of mini-IAC columns as a function of the number of analyses. 
PBS standards 6 mL (500 ng, 100 ng, 50 ng, 10 ng 2,4,6-TCP) were loaded to the 
mini-IAC columns and eluted with 70%EtOH. Recovery is calculated vs spiked 
amount of 2,4,6-TCP. Data correspond to the average of three mini-IAC columns 
processed simultaneously. 
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all the mini-columns in the 96-rack is not homogeneous. Some columns get more dried 
under elution. All these can create problems with column stability. We have observed that 
the recovery of 6% from the 96 mini-IAC columns prepared (at 2.4% lading level) 
became lower than 40% after 30 cycles. This drawback of the HTS-IAC format 
can be improved with better packing of the columns or using more resistant 
sorbent. 
 
5.3. Application of HTS-IAC-SPE to urine samples 
 
In the previous chapter we have demonstrated that the concentration and the volume of 
the urine sample and also whether it is hydrolyzed or not affect the extraction recovery of 
2,4,6-TCP in the IAC-SPE. No breakthrough effects until 50 mL were observed for non-
hydrolyzed urine at low loading levels corresponding to the concentration usually found 
in the general population. In contrast, a breakthough volume of 30 mL was observed for 
acid hydrolyzed urine (see Section 4.2.3.2). As in biological monitoring studies it is 
important to determine the total chlorophenol concentration, here we have focused our 
studies only on hydrolyzed urine. Considering the effect of the type of the hydrolysis on 
the single IAC-SPE procedure (see Figure 4.17), here we decided to apply only alkaline 
hydrolyzed urine. Because of the smaller scale of HTS-IAC-SPE set up it was important 
to define the effect of the sample volume and the 2,4,6-TCP concentration on the 
recovery. The evaluation of the HTS-IAC-SPE was realized using the pooled urine 
sample B. We have already discussed the matrix effect of the alkaline purified urine by 
mini-IAC columns on the 2,4,6-TCP ELISA (see Figure 4.13 D, G). 
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5.3.1. Recovery studies. Effect of loading level, 
breakthrough volume 
 
Alkaline hydrolyzed urine B was spiked with three different amounts of 2,4,6-TCP (200 
ng, 75 ng, 20 ng) corresponding to 40%, 15% and 4% loading level. Each amount was 
loaded in different volumes (6 mL, 12 mL and 18 mL) to the mini-IAC columns. The 
immunoaffinity extraction was performed washing with 20% EtOH and eluting with 0.6 
mL 70% EtOH. The 2,4,6-TCP concentrations were determined by ELISA. The recovery 
was calculated considering the background level of 2,4,6-TCP-IR equiv. in the 
hydrolyzed urine sample B according to GC-MS (0.24 µg/L ) and is presented in Figure 
5.5. It can be observed that the breakthrough volume is placed between 12 and 18 mL for 
the three loading levels tested. If 12 mL sample was used, quantitative recovery (>80%) 
could be achieved for concentrations lower or near 6.25 µg/L (75 ng, 15% loading level). 
When the loading level reached 40% of the maximum capacity (200 ng) using the same 
volume, the recovery already dropped to 70%. On the other hand, if 6 mL sample was 
used, efficient extraction without loss of analyte could be achieved for concentrations 
until 33 µg/L 2,4,6-TCP (200 ng, 40% loading level).  
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Figure 5.5. Effect of sample volume and loading level on the recovery of mini-IAC
columns forming part of HTS-IAC-SPE. Alkaline hydrolyzed urine sample B was spiked
with different amount of 2,4,6-TCP (200 ng, 75 ng and 20 ng) and loaded at different
volumes, washed with 20% EtOH and eluted with 0.6 mL 70% EtOH. The concentration
was determined by ELISA. Recovery is calculated vs spiked amount of 2,4,6-TCP resting
the background level of TCP-IR in urine sample B. Data correspond to the average of
three mini-IAC columns processed simultaneously. 
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Lower sample volume means more rapid extraction. Thus, we selected 6 mL as 
appropriate volume to be loaded, since it ensures the quantitative recovery of the analyte 
even at concentrations present in exposed persons. Extraction in 0.6 mL and further 10-
fold dilution with PBS buffer will result in no pre-concentration neither dilution of the 
initial analyte concentration. Therefore, the overall LOD of the HTS-IAC-ELISA/GC 
analysis will be determined mainly by the LOD of the method used for analysis. In the 
case of ELISA (7% EtOH/PBS) the LOD would be around 0.2 µg/L 2,4,6-TCP-IR 
equivalents considering a 100% recovery in the purification process. If GC method was 
used each extracted chlorophenol would be detected with the corresponding LOD (see 
Annex II). Figure 5.6 shows the scheme of the finally established procedure for the 
analysis of 2,4,6-TCP in urine samples. About 12 mL of urine are sufficient to extract 
chlorophenols in duplicate and to analyze them by ELISA (in triplicate) and to compare 
the result with GC-MS or GC-ECD. After ELISA measurements the remaining 7% 
EtOH/PBS solution can be extracted with toluene and derivatized. 
 
Urine samples with negative ELISA response will indicate a level of exposure lower than 
the LOD (about 0.2 µg/L). Urine samples giving values between 0.2 and 30 µg/L could in 
principle be accurately quantified. Finally, urine samples with concentration values near 
or higher than 30 µg/L, will have to be repeated with a lower load (e.g. 3 mL urine) for a 
quantitative recovery and accurate analysis.  
 
5.3.2. Validation of HTS-IAC-ELISA method 
 
5.3.2.1. Precision and accuracy of the urine analysis by HTS-IAC-ELISA 
 
The objective of the experiments presented here was to determine the precision and the 
accuracy of the whole procedure (HTS-IAC-ELISA) taking into account column 
variability (each column could behave differently), position of the columns in the 96-
column rack (flow-rate could vary depending on the position in the rack) and day-to-day 
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variability. With this purpose the following analyses were performed in three separate 
days according to the HTS-IAC-ELISA procedure described in Figure 5.6.  
One experiment consisted of the simultaneous analysis of 3 sets of samples. Each set was 
composed of non-spiked urine samples and quality controls (QCs) of defined 2,4,6-TCP 
concentrations in PBS buffer (bQCs) and in urine (uQCs). The uQCs were prepared in 
pooled urine B after its alkaline hydrolysis in big batch (200 mL). Both bQCs and uQCs 
were prepared at three 2,4,6-TCP-concentration levels: low (LQC - 0.7 µg/L), medium 
(MQC - 2 µg/L) and high (HQC - 8 µg/L) that correspond to IAC-loading levels 0.84%, 
2.4% and 9.6% respectively. Loading of the 96-column rack was performed according to 
the design shown in Figure 5.7. Thus, urine QCs (uLQC, uMQC, uHQC), buffer QCs 
(bLQC, bMQC, bHQC) and non-spiked urine samples were loaded in 24, 3 and 15 
replicates, respectively. Some of the non-spiked urine samples were spiked in triplicate 
after the HTS-IAC-SPE procedure. All extracted samples were measured on ELISA using 
• Load: 6 mL urine 
• Wash: 20% EtOH (1.2 mL)
• Elution: 70% EtOH (0.6 mL)
• Regeneration: PBS (1.2 mL)
Hydrolysis
urine
eluted fractions 
(70% EtOH/PBS)
HTS-IAC-SPE
hydrolyzed 
urine
10 fold dilution with PBS
eluted fractions 
(7% EtOH/PBS)
ELISA GC-MS(GC-ECD)
 
 
Figure 5.6. Procedure established for HTS-IAC-SPE (VersaPlate System) of 2,4,6-TCP from 
urine samples. The 2,4,6-TCP concentration in the extracted urine can be determined by 
ELISA or by gas chromatography technique (GC-MS or GC-ECD). 
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standard curve run in 7%EtOH/PBS. This analysis was repeated in three consecutive days 
varying the sample distribution through the 96-IAC plate. The precision and accuracy 
data for the buffer and urine QC samples are summarized in Table 5.2.  
 
 
Figure 5.7. Experimental scheme for precision and accuracy study of HTS-IAC-SPE urine clean-
up. Quality controls at three concentration levels were used: LQC - 0.7 µg/L, MQC - 2 µg/L and 
HQC - 8 µg/L 2,4,6-TCP. Buffer quality controls (bLQC, bMQC, bHQC) were prepared in PBS 
buffer. Urine quality controls (uLQC, uMQC, uHQC) were prepared in alkaline hydrolyzed urine 
sample B.  
 
Table 5.2. Precision and accuracy of the 2,4,6-TCP analysis by HTS-IAC-SPE urine clean-up 
followed by ELISA.  
 urine QCs buffer QCs 
Spiked concentration, µg/L N d 0.7 2 8 N d 0.7 2 8 
Mean 72 0.61 1.55 7.06 9 0.65 1.74 7.62 
Mean recovery a, % 72 87.5 77.4 88.3 9 92.7 87.2 95.3 
Interday precision (% CV)b 24 22.9 20.6 17.4 3 17.1 19.2 13.7 
Intraday precision (% CV)c 72 11.3 6.2 10.4 9 5.4 9.35 12.5 
a The recovery for urine QCs is calculated as [(pre-extracted spiked urine)/(post-extracted 
spiked urine)]*100; The recovery buffer QCs is calculated as (measured/nominal value)*100. 
b The % CV is the average of the % CVs for each concentration for each day (within one 96-
SPE procedure). c The % CV corresponds to the recovery obtained for each concentration for 
three days (between three 96-SPEs). d N is the number of mini-IAC columns used for each 
concentration. 
 
The recovery (accuracy) for the buffer QCs was determined as the ratio of the measured 
vs the nominal value. The recovery for urine QCs was assessed by comparing the 
concentration of 2,4,6-TCP extracted from spiked urine samples (pre-extraction spike) to 
the non-spiked urine samples processed identically and spiked with the corresponding 
concentration after their processing (post-extracted spike). The results show that the 
method is consistent and reliable. The accuracy (recoveries >80%) allows quantitative 
 1 2 3 4 5 6 7 8 9 10 11 12 
A             
B             
C             
D             
E             
F             
G             
H             
 PBS buffer 
 bLQC 
 bMQC 
 bHQC  
 Urine 
 uLQC 
 uMQC 
 uHQC  
 Non-spiked urine 
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determination of 2,4,6-TCP in urine samples by HTS-IAC-SPE coupled to ELISA. Both 
inter- and intra-assay precision (% CV) are lower than 20% except in the case when the 
measurements takes place at the ELISA limit of detection.  
 
No significant difference between urine concentration obtained using the HTS-IAC-SPE 
method and the previous traditional single column IAC-SPE method was observed. Thus, 
the TCP-IR level of urine sample B was 0.9 µg/L determined by the single IAC column – 
ELISA protocol (see Table 4.5) and 0.81±0.13 µg/L (N=6) evaluated by HTS-IAC-
ELISA (the HTS-IAC was performed in three different days in 4 replicate each day).  
 
5.3.2.2. Analysis of urine samples from different 
individuals. Validation ELISA/GC-MS of the HTS-IAC-SPE 
procedure.  
 
About 117 urine samples from different individuals that belong to various occupational 
groups were used to validate the HTS-IAC-SPE-ELISA procedure by comparing the 
2,4,6-TCP-IR equivalents measured by this method with the concentration of 
immunoreactive chlorophenols found when measuring the same samples by GC-MS. We 
selected MS detection in order to identify and confirm the presence of halogenated 
phenols in the urines that are the main ELISA cross-reactants.  
 
The urine samples from different individuals were analyzed following the procedure 
described in Figure 5.6. The samples were hydrolyzed with KOH and processed 
following the HTS-IAC-SPE protocol. The eluted fractions (70% EtOH) were diluted 10 
times with PBS and split in two parts. About 500 µL were sufficient for the ELISA 
analysis in triplicate and the rest of the sample was extracted with toluene and derivatized 
with BSTFA to identify and quantify the cross-reactants (2,4,5-TCP, 2,4-DBP, 2,3,4,6-
TtCP and 2,4,6-TBP) by GC-MS (see Annex 1).  
 
The correlation between the values determined by ELISA (2,4,6-TCP-IR equivalents) and 
the concentration of 2,4,6-TCP determined by GC-MS indicates a significant 
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overestimation by the ELISA method (see Figure 5.8.A). This result is not surprising, 
because the immunoassay response corresponds not only to the concentration of 2,4,6-
TCP, but also to the concentration of the cross-reactants present in the sample. If we 
consider the concentration of each cross-reactant determined by GC-MS analysis and the 
cross-reactivity of the 2,4,6-TCP ELISA (see Table 3.9.B), assuming similar IAC-SPE 
extraction recovery, we can calculate the 2,4,6-TCP-IR equivalents that will contribute to 
the ELISA response. Thus, the GC-MS 2,4,6-TCP-IR equivalents were obtained as the 
sum of the % CR multiplied by the cross-reactant concentration determined by GC-MS 
for each cross-reactant in the sample. The correlation between the 2,4,6-TCP-IR 
equivalents determined by ELISA and by GC-MS (ELISA TCP-IR and GC-MS TCP-IR) 
is shown in Figure 5.8.B and it indicates an excellent correlation between both 
techniques following the equation y=1.14x-0.21 with a regression coefficient r2=0.912. 
From these experiments we can conclude that the HTS-IAC-ELISA procedure developed 
in this thesis can be an excellent tool to assess risk of exposure analyzing urinary 
biomarkers. In this case, the HTS-IAC-ELISA method is addressed to the efficiently 
screening of chlorophenols in urine as potential biomarkers of exposure to certain 
organochlorine compounds or to dioxins. The usefulness of 2,4,6-TCP as biomarker has 
not been demonstrated yet, although as mentioned in the introduction many research 
groups have reported the appearance of this urinary metabolite in certain occupationally 
exposed groups or in the general population due to the contact with residues with 
herbicides or preservatives metabolized to chlorophenols.  
 
In Table 5.3 are summarized the main features of the HTS-IAC-ELISA method 
compared to the single column IAC-SPE-ELISA method. The significant increase in 
sample throughput, the decrease of urine sample volume required for the assays and the 
absence of dilution in the clean-up step, are the main advantages of the HTS-IAC-SPE. 
The method developed allows the processing at about 100 samples/day with overall LOD 
of 0.3 µg/L 2,4,6-TCP-IR equivalents. About 6 mL of urine are sufficient to provide 
enough replicates for ELISA, even performed in different days and to compare the result 
in the case of positive result, by a reference method such as GC-MS. The selective 
extraction results in no false positive results. 
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Table 5.3. Features of the urinary analysis of 2,4,6-TCP by single column IAC-ELISA and HTS-
IAC-ELISA 
Parameters single IAC-ELISA HTS-IAC-ELISA 
sample volume 10 mL 6 mL 
clean-up 3-fold dilution no dilution 
speed of IAC clean-up 96 samples / 8 days 96 samples/ 1 h 
speed of total analysis 96 samples / 9 days 96 samples/ 1 day 
LOD a, µg/L 0.99 0.3 
LOQ b, µg/L 1.4 0.55 
MDC c, µg/L 20<MDC<50 30 
% CV d 5.1% - 18.4%  for 5 - 30 µg/L 
17.4% – 22.9%  
for 0.7 – 8 µg/L 
Number of false positives 0 0 
Number of false negatives 0 0 
a The limit of detection is evaluated according to the LOD of the ELISA (LOD7%EtOH/PBS=0.2 µg/L, 
90% of the signal at zero analyte concentration) and the corresponding IAC an hydrolysis 
recoveries. b The limit of quantification is evaluated according to the LOQ of the ELISA 
(LOQ7%EtOH/PBS=0.37 µg/L, 80% of the signal at zero analyte concentration) and the corresponding 
IAC an hydrolysis recoveries. c MDC (maximum detectable concentration with recovery >70%) 
d The coefficient of variation (% CV) corresponds to the interday analysis. 
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Figure 5.8. Validation HTS-IAC-SPE-ELISA/HTS-IAC-SPE-GC-MS. Urine samples from 
different individuals (N=117) were hydrolyzed by KOH and their 2,4,6-TCP concentration was 
determined by HTS-IAC-SPE coupled to ELISA. Cross-reactants in purified urines were 
identified and quantified by GC-MS. A. Correlation between 2,4,6-TCP-IR equivalents 
determeined by ELISA and 2,4,6-TCP concentration determined by GC-MS. B. Correlation 
between 2,4,6-TCP-IR equivalents determined by ELISA and by GC-MS. The GC-MS TCP-IR 
are defined as ∑(%CR x cross-reactant concentration determined by GC-MS). 
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The availability of efficient and reliable biomonitoring tools such as HTS-IAC-ELISA 
may help to collect sufficient toxicological and exposure data to assist on the 
establishment of biomarkers and also to assess risks derived from exposure.  
 
5.3.4. Preliminary case-study biomonitoring of 
chlorophenols in different population groups  
 
We applied the HTS-IAC-ELISA method to the biological monitoring of three population 
groups living in two different towns of Cataluña, Spain. The people under study belong to 
different employment sectors: a petrochemical industry (town A, N=43 samples collected 
in 2001), services (town B, N=41 samples collected in 2002) and general population 
living in the vicinity of a waste incinerator (town B, N=33 samples collected in 1999). No 
additional information on the health status and particular habits of these individuals was 
available for us at the time when this study was performed.  
 
The urines were treated following the procedure described in Figure 5.6. Each urine 
sample was analyzed by ELISA and by GC-MS after chlorophenol extraction in duplicate 
by HTS-IAC-SPE. PBS standards of 2,4,6-TCP (2 and 5 µg/L) were used as quality 
controls to test the HTS-IAC-SPE procedure. The recovery for the control samples was 
89.77 ± 12.86%. The ELISA LOD (90% inhibition) was 0.2 µg/L (0.16 ug/g creat) and 
the LOQ (80% inhibition) was 0.6 µg/L. According to our procedure the urinary LOD of 
the GC-MS method (see Annex 1) was at about 0.1 µg/L (0.08 ug/g creat) for 2,4,6-TCP 
and 2,4,5-TCP and 0.2 µg/L (0.16 ug/g creat) for 2,4-DBP, 2,3,4,6-TtCP and 2,4,6-TBP. 
 
To get accurate data on the chlorophenol excretion by the general population it was one 
of our concerns to avoid contaminations of the biological specimen. As phenolic 
compounds were not detected in the blanks, we assume that chlorophenol excretion of the 
examined population is really caused by environmental uptake of these substances 
themselves or halogenated compounds transformed to phenolic substances in the human 
body. 
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The primary analytical variable to be considered in biomonitoing is the percentage of 
specimens with levels greater than or equal to the limit of detection of the method used. 
We observed that according to ELISA determination 92% of both petrochemical and 
services workers groups and practically all urine samples from the general population 
living in the surroundings of a waste incinerator had detectable concentrations of 2,4,6-
TCP-IR equivalents. Moreover, the GC-MS analysis of the urine purified by HTS-IAC-
SPE confirmed this fact and revealed the presence of chloro- and bromo-phenols in the 
three groups. The frequency of detection (positive sample vs total number of samples) for 
the extracted halogenated phenols is present in Table 5.4. 
 
Table 5.4. Frequency of detection (%) of all the analytes determined by HTS-IAC-SPE-GC-MS 
for the three groups examined.  
Compound Petrochemical 
workers 
Services 
workers 
General population close to 
incinerator 
2,4,6-TCP 100 89 86 
2,4,5-TCP 57 57 52 
2,3,4,6-TtCP 79 95 93 
2,4-DBP 60 76 79 
2,4,6-TBP 81 100 100 
The frequency of detection corresponds to the number of positive samples (with concentration 
higher than the LOD) with respect the total number of samples analyzed for each group. LOD for 
TCPs is 0.1 µg/L and for 2,3,4,6-TtCP, 2,4-DBP and 2,4,6-TBP it is 0.2 µg/L. 
 
It is striking that all the analytes were detected in more than 50% of the population, likely 
indicating frequent exposure of the general public to the parent compounds or their 
derivatives. Among the chlorophenols 2,4,6-TCP and 2,3,4,6-TtCP are most widely 
distributed (>80%). 2,4,5-TCP was found in 50-57% of the population. There is no 
significant difference between the three groups studied. For comparison, the frequency of 
detection of trichlorophenols in USA adults in 1995) was 20% for 2,4,5-TCP (LOD 1 
µg/L) and 9.5% for 2,4,6-TCP (LOD 2 µg/L) [75]. It is remarkable that our study led to 
similar results regarding 2,4,6-TCP: we found that 19% of the petrochemical workers, 
2.7% of the office workers and 6.9% of the incinerator vicinity group had concentrations 
higher than 1 µg/L 2,4,6-TCP (for the three groups the average is 10% 2,4,6-TCP higher 
than 1 µg/L). However, 2,4,5-TCP was less distributed in our populations: about 3% of 
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the individuals from the three groups had levels higher than 1 µg/L. A higher frequency 
of detection was observed for the general population living in Germany: 54% for 2,4,5-
TCP (LOD = 0.8 µg/L) and 37% for 2,4,6-TCP (LOD = 1.2 µg/L) [121]. However, it 
must be noted that the most important companies producing chlorophenols were located 
there (e.g. BASF) and the frequency of detection may be influenced by many other 
factors, such as geographical region, nutrition habits, etc.  
 
It must be pointed out that all chlorophenols found in the urine samples are environmental 
contaminants and may be introduced in the human body through the contact with the 
sources of exposure or through edible products. As was mentioned in the Introduction 
2,4,5-TCP and 2,4,6-TCP are also reported to be metabolites of HCB, lindane, 
pentachloronitrobenzene, PCP, 1,3,5-trichlorobenzene, pentachlorobenzene, 1,2,4-
trichlorobenzene which are ubiquitous contaminants in the environment. TtCP detected in 
the urine samples are supposed to result from the same sources as TCP. Particularly, for 
the general population living in town B urinary PCP and TtCPs (2,3,4,6- and 2,3,5,6-) 
were found in all samples in a study performed in 1986 [128]. In the same study urinary 
TCPs were not detected, but HCB and PCP were present in all serum samples tested at 
levels higher than those reported in other countries (e.g. England) reflecting that HCB 
was one of the main pollutants in town B. Unfortunately, we have not find more recent 
studies regarding organochlorine exposure in this area. Furthermore, the levels of 
PCDD/Fs in blood and adipose tissue [91,363,364] and human milk [94] of the general 
population of town A have been found to be similar or higher than the levels reported for 
other populations (Madrid, Germany, Sweden, USA, Canada). High intakes of seafood 
and smoking habits should also be considered.  
 
It was surprising the presence of bromophenols in the urine samples studied. These 
pollutants have not been subject of serious risk assessment studies until now, but recently 
they have been defined as emerging environmental contaminants. Tribromophenol is 
being used as flame retardant in plastics and wood products. It is detected in river waters 
[365], in sewage sludge from wastewater treatment plants [366], in food [367], etc.. 
Bromophenols are considered degradation products and metabolites of brominated flame 
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retardants (polybrominated diphenyl ethers, polybrominated biphenyls, etc.) and are 
widely distributed in the environment (for recent reviews see [315,368,369]). 
Furthermore, one should consider that 1600 naturally occurring organobromine 
compounds are known today [370]. 
 
The results of the biological monitoring of chlorophenols evaluated by ELISA are 
presented in Figure 5.9, which shows the relative frequency distribution for the three 
groups studied, and in Table 5.5 are listed the corresponding statistic parameters. The 
concentrations in urine are given in µg/g creatinine to correct the results for urine 
dilution. The variation in the creatinine concentration may be caused by differences in the 
sweating rate, the fluid intake or the health status of the individuals. The urinary 
creatinine content of the analyzed samples ranged from 0.3 to 3.0 mg/mL urine. The 
mean urinary creatinine concentration of all the subjects was 1.24 mg/mL urine. 
 
Table 5.5. Urinary levels of 2,4,6-TCP-IR equivalents (mean concentration, range, concentrations 
at selected population percentiles) for the three groups.  
Population 
group N Mean ± SD Min 5% 25% Median 75% 95% Max 
Service 
workers 41 1.33±0.78 0.42 0.61 0.85 1.13 1.44 2.67 4.69 
Petrochemical
workers 43 1.90±1.68 0.18 0.65 0.92 1.33 2.02 5.68 8.06 
Living in 
vicinity of 
incinerator 
33 3.86±4.36 0.59 0.78 1.54 2.19 3.93 14.47 22.69 
The concentrations are determined by HTS-IAC-ELISA and expressed in µg/g creatinine. The 
detection limit is 0.17 µg/g creatinine based on the LOD of the ELISA (0.2 µg/L) and the mean 
urinary creatinine concentration of all the subjects (1.24 mg/mL urine). 
 
The relative frequency distribution for the three groups demonstrates that most of the 
population has levels around 1 µg/L. These are 75% of the services workers, 50% of the 
petrochemical workers and only 25% of the population living close to the incinerator. 
However, 30% of the last group have levels of 2 µg/L. Furthermore, the median and 95% 
percentiles values increase following the order: services < petrochemical < incinerator. 
The highest detected level (23 µg/L 2,4,6-TCP-IR equivalents) also belongs to the third 
group.  
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The results presented in Figure 5.9 and Table 5.5 clearly demonstrate that the 2,4,6-TCP-
IR equivalent levels in the urine of the population living in the surroundings of the 
incinerator are highest among the three groups. It is difficult to interpret these results, 
because we have no information about the real risk of exposure of these groups of 
workers to organochlorine compounds and, as mentioned above, differences on their 
health status and particular habits must also be taken into consideration. It is well known 
that workers in a refinery are mainly exposed to benzene, toluene, pentane, and hexane 
[371,372]. If no occupational exposure of petrochemical workers is assumed and they are 
considered exposed only to environmental contamination as the general population like 
service workers from town B, their higher TCP-IR levels could be attributed to regional 
differences in the contamination levels. It is important to note that town A is situated in a 
region of chemical industry. 
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Figure 4.28. Relative frequency distribution of 2,4,6-TCP-IR equivalents determined by
HTS-IAC-ELISA urine analysis for petrochemical workers, services workers and general
population leaving close to waste incinerator. ________ Median (50-percentile); ------ 95-
percentile. 
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On the other hand, this study clearly indicates that the general population living in the 
vicinity of a waste incinerator has levels higher than the population living in the same 
town and working in the service sector. It is well documented that chlorophenols, 
hexachlorobenzne, polyaromatic hydrocarbons and dioxins are potentially emitted from 
incineration plants [373,374], although the amount of internal exposure and of potentially 
resulting health effects for the workers of the plant and the general population is a matter 
of controversy [35,102,118,123,375]. In general, the excretion of chlorophenols could be 
regarded as an indirect indicator of current exposure to dioxins [36], although to our 
knowledge it is not reported any rigorous epidemiological study where this fact can be 
proved. 
 
It is worth noting that the general population living close to the incinerator in our study 
was also subject to biomonitoring of PCDD/PCDF and PCB levels in blood as a part of 
evaluation of the effect of the incinerator performance on the public health [376-378]. 
These studies revealed that for the period of 4 years of incinerator functioning (1995-
1999) for the residents living close to the incinerator the blood levels of PCDD/PCDF 
increased with 40-48% and the PCB levels remain constant. However, given the low 
dioxin stack emissions from the plant, the fact that the blood dioxin levels were not found 
to depend on the residence distance to the incinerator, and that similar dioxin levels were 
found in a control population living in an area with not known source of industrial dioxin 
contamination, the authors concluded that it seemed unlikely that the increase in dioxin 
blood levels resulted from the incinerator's emissions. The authors attributed the observed 
levels to the consumption of contaminated food or other sources [379]. However, it is 
important to note that the increasing trend in PCDD/PCDF levels was surprising, 
considering that the general tendency has been a decrease in levels over the past few 
years in other developed countries [92]. 
 
As was mentioned above, all urine samples were analyzed with GC-MS in order to 
confirm the presence of halogenated phenols by an independent technique. The urinary 
concentrations of 2,4,6-TCP, 2,4,5-TCP, 2,3,4,6-TtCP, 2,4-DBP and 2,4,6-TBP (mean, 
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minimum and maximum, 5th, 25th, 50th (median), 75th, 95th – percentiles in µg/g 
creatinine) for the different groups are reported in Table 5.6.  
 
Table 5.6. Urinary levels of all the analytes (mean concentration, range, concentrations at selected 
population percentiles) for the three groups.  
Analyte / group N Mean Min 5% 25% Median 75% 95% Max 
2,4,6-TCP          
Services 37 0.18 <d.l. <d.l. 0.11 0.13 0.17 0.58 1.24 
Petrochemical 41 0.74 <d.l. 0.1 0.26 0.48 0.78 2.36 4.89 
Vicinity of 
incinerator 
29 0.43 <d.l. <d.l. 0.17 0.26 0.49 1.28 2.33 
2,4,5-TCP          
Services 37 0.08 <d.l. <d.l. <d.l. 0.08 0.11 0.32 0.52 
Petrochemical 41 0.27 <d.l. <d.l. <d.l. 0.15 0.42 0.83 1.77 
Vicinity of 
incinerator 
29 0.52 <d.l. <d.l. <d.l. 0.08 0.24 0.72 11.04 
2,3,4,6-TCP          
Services 37 0.25 <d.l. <d.l. 0.18 0.21 0.29 0.63 0.67 
Petrochemical 41 0.33 <d.l. <d.l. <d.l. 0.22 0.33 0.97 2.2 
Vicinity of 
incinerator 
29 0.31 <d.l. <d.l. <d.l. 0.19 0.3 1.11 1.33 
2,4-DBP          
Services 37 <d.l. <d.l. <d.l. <d.l. <d.l. 0.1 0.27 0.4 
Petrochemical 41 <d.l. <d.l. <d.l. <d.l. <d.l. <d.l. 0.18 0.28 
Vicinity of 
incinerator 
29 0.18 <d.l. <d.l. <d.l. 0.13 0.16 0.72 0.93 
2,4,6-TBP          
Services 37 0.22 <d.l. <d.l. 0.15 0.19 0.25 0.48 0.52 
Petrochemical 22 0.16 <d.l. <d.l. <d.l. 0.15 0.21 0.37 0.4 
Vicinity of 
incinerator 
29 0.42 <d.l. <d.l. 0.17 0.24 0.48 1.44 2.0 
The concentrations are determined by HTS-IAC-GC/MS and expressed in µg/g creatinine. The 
detection limit is 0.08 µg/g creatinine for TCPs and 0.16 µg/g creatinine for DBP, TtCP and TBP 
based on the LOD of the GC-MS and the mean urinary creatinine concentration of all the subjects 
(1.24 mg/mL urine). 
 
For better comparison of the level of each analyte in the different groups we present the 
5th, 50th (median), and 95th percentile concentrations at Figure 5.10. The average 
excretion of 2,4,6-TCP in urine is highest for petrochemical workers (0.48 µg/g), 
followed by the general population living in vicinity of the incinerator (0.26 µg/g). The 
services workers excreted the lowest level of 2,4,6-TCP in urine (0.13 µg/g). The highest 
levels of 2,4,5-TCP are observed again for petrochemical workers (0.15 µg/g) according 
to the median concentrations, although the incinerator group has the highest maximum  
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concentration of 2,4,5-TCP (11 µg/g). It is important to note that the mean concentrations 
for 2,4,6-TCP (0.74 µg/g) and 2,4,5-TCP (0.27 µg/g) determined by us for the 
petrochemical workers are very similar to the values recently reported by Schumacher et 
al for some persons living in the same town (0.6 µg/g and 0.4 µg/g for 2,4,6-TCP and 
2,4,5-TCP, respectively) [118]. These mean levels are referred to the administrative 
workers from a waste incinerator situated in town A. If we consider them as 
representative for the general population of this area, we can conclude that the 
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Figure 5.10. Description of the concentrations of chloro- and bromo- phenol in the urine 
of petrochemical workers, services workers and general population living in vicinity of 
waste incinerator. The top of each bar is the 95th percentile, the bold bar in the middle is 
the median, and the lower bar is the 5th percentile. The concentrations are determined by 
HTS-IAC-GC/MS and expressed in µg/g creatinine. The detection limit is 0.08 µg/g 
creatinine for TCPs and 0.16 µg/g creatinine for DBP, TtCP and TBP based on the LOD 
of the GC-MS and the mean urinary creatinine concentration of all the subjects (1.24 
mg/mL urine). 
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petrochemical workers subject of our study have urinary TCP levels similar to those 
found for non-occupationally exposed persons and therefore, they do not suffer any 
occupational exposure to organochlorine compounds. 
 
The excretion of 2,3,4,6-TtCP seems to be similar for the three groups stuided. It is very 
important to note that the urinary levels (median, 75th, 95th, maximum) of brominated 
phenols (2,4-DBP and 2,4,6-TBP) are highest for the incinerator vicinity population 
followed by the services workers and finally by the petrochemical workers. These results 
suggest that the general population living in the surroundings of the incinerator suffers 
higher exposure to these compounds, although the source is uncertain. There are only 
limited amount of data on emissions of brominated compounds from incinerators and 
most of the data in the literature were generated in laboratory experiments [380]. On the 
other hand, it is possible that the lowest bromophenol levels in the petrochemical workers 
is due to the fact that they live in another city (town A), where may be the contamination 
of the drinking water and food with this emerging pollutants is lower.  
 
In addition, these high levels of bromophenols in the urine of the incinerator vicinity 
group explains the results from the urinary TCP-IR evaluation by the ELISA method, 
which indicated that this group is subject to highest exposure (see Figure 5.9). Although 
the 2,4,6-TCP levels in the incinerator group are lower than the petrochemical group 
according to GC-MS analysis, due to the high cross-reactivity of these brominated 
compounds in the 2,4,6-TCP ELISA (700% for 2,4,6-TBP and 119% for 2,4-DBP), the 
chlorophenol effect is compensated and the total TCP-IR exposure results highest for the 
incinerator group. In fact, this incinerator is a modern facility where the residues have to 
be minimized. 
 
Finally, compared to other studies on the general population the concentrations in the 
present study are either lower or of the same magnitude. For example, the highest values 
determined by us for 2,4,5-TCP in the urine of the petrochemical workers (median = 0.15 
µg/g (0.12 µg/L), 95th =0.83 µg/g (0.67 µg/L)) are lower than the reported values for 
German children (median = 0.25 µg/L, 95th = 1.1 µg/L) [123] and German adults (median 
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= 0.85 µg/L, 95th = 2.7 µg/L) [124]. Similarly, the urinary concentrations of 2,4,6-TCP 
for the petrochemical workers from our study (median = 0.48 µg/g (0.39 µg/L), 95th 
=2.36 µg/g (1.93 µg/L)) are lower or in the same order as the general population in 
Germany: median = 0.6 µg/L, 95th = 2.4 µg/L [124] and children (median = 0.6 µg/L, 95th 
= 1.7 µg/L) [123]. In general, the trichlorophenol levels detected in the catalan population 
studied do not exceed the established reference values for 2,4,5-TCP and 2,4,6-TCP in 
urine in Germany (5.0 µg/g creatinine) [36,81] and in USA (3.3 µg/g creatinine for 2,4,6-
TCP and 3.0 µg/g creatinine for 2,4,5-TCP [75]. The only exception is the maximum 
concentration of 2,4,5-TCP (11 µg/g creatinine) detected in one individual of the group of 
population living in the surroundings of a waste incinerator. 
 
Our aim was to validate the developed HTS-IAC-ELISA method and to compare the 
population's contamination levels from different regions of Cataluña. Another aim was to 
evaluate the reference values for trichlorophenols in the urine of the general population. 
Such values allow an estimation of the extent of background contamination. The reported 
values will serve as a basis against which to compare concentrations in subjects who may 
have been occupationally exposed to halogenated phenols or toxic compounds that 
metabolize to them.  
 
Although the results shown here draw a tendency on the potential risk or level of 
exposure of these population groups, we can not make any definitive conclusion because 
much more information and criteria should be taken into consideration. However, these 
results and the comparison between ELISA and GC-MS methods prove the potential 
usefulness of the procedure described and developed in this thesis. 
 
 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________________________ 
 
6. Quenching Fluorescence 
Immunoassay for Chlorophenols based 
on Laser-Induced Fluorescence 
Detection in Microdroplets 
 
_______________________________________________________________________ 
 
 
 
 
 
Fluorescent detection methods have led to major improvements in bioanalytical 
applications because of their extraordinary sensitivity and selectivity [381]. One of the 
most exciting aspects of fluorescence technologies is their ability to support decreasing 
sample sizes down to the single-molecule detection level [190,382-384], which in turn 
provides the opportunity for miniaturization and high throughput screening. Fluorescence 
immunoassays (fluoroimmunoassays, FIAs) employ a fluorescent signal for analyte 
detection. Homogeneous FIAs are separation-free, making automation easy and 
LIF-microdroplet-QFIA 
 182
permitting simple adaptation to existing instrumentation. A variety of homogeneous FIA 
systems have been developed based on detection schemes such as fluorescence 
polarization, fluorescence energy transfer, time-resolved fluorescence, fluorescence 
quenching or enhancement (see recent reviews [185,189,385]). Fluoroimmunoassays 
have become a common clinical chemistry procedure for the analysis of a wide range of 
analytes, such as drugs, hormones, and proteins. They have also found application in 
environmental analysis for the determination of pesticide contaminants in water 
[222,232,234,250,386-388] and their metabolites in urine sample [389,390]. Direct 
quenching FIA (QFIA) are assays in which the antibody-binding reaction significantly 
decreases the fluorescence signal of the labeled antigen due to changes in the 
microenvironment around the fluorophore. The direct quenching approach has proven 
suitable only for haptens of small size, because the antibody binding site lies sufficiently 
close to the label to influence its signal. Competitive direct QFIA based on the 
fluorescence quenching of a labeled hapten upon binding its antibody (Ab) have been 
developed for the detection of gentamycin [391] and cortisol [392] in serum, atrazine 
[393], 2,4-dichlorophenoxyacetic acid [231] and propazine [394] in nonpolar organic 
media, and pyrethroid metabolites in urine [390]. 
 
More recently, fluoroimmunoassays have been combined with laser-induced fluorescence 
(LIF) technology to make use of sensitive optical microscope and charge-coupled device 
(CCD) systems [395-399]. Hence, using modern lasers and CCD cameras it is possible to 
construct compact and highly sensitive detection systems. Laser excitation allows 
significant reduction of the illuminated sample-volume, minimizing the background 
interferences resulting from Raman and Rayleigh scattering, and impurity fluorescence. 
This results in an improved fluorescence-to-background signal-to-noise ratio, making 
detection at single molecule levels feasible [382,400,401]. LIF detection of single 
fluorescent molecules in solution has been performed in flowing streams, in sheath flow 
cuvettes, and in capillaries [402,403]. One of the main drawbacks of these flowing 
techniques is that the optically defined probe volume is smaller than the flow cell itself, 
so that many of the molecules may not be probed by the laser. As a result of these 
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limitations, research has been focussed on alternative detection schemes, including 
levitated [400,404-407] and falling [408-411] microdroplets.  
 
The microdroplet approach to single molecule detection in liquids is unique in several 
aspects. The probe volume in this case is defined by the droplet instead of by the laser 
beam, which means that all fluorophore molecules can be interrogated. Small detection 
volumes afforded by micrometer-sized droplets minimize background fluorescence. 
Contact of the sample to container walls is avoided, eliminating scattering from walls and 
possible binding of reagents to the wall. In addition, spontaneous emission in spherical 
microdroplets is significantly enhanced due to cavity resonances that increase optical 
emissions significantly. 
 
In the previous chapters we have shown that the 2,4,6-TCP ELISA requires sample pre-
treatment to allow urine analysis with sufficient detectability for biomonitoring 
occupationally exposed persons. In this chapter, we describe the improvement in a TCP 
assay by developing a LIF-microdroplet-QFIA. This novel biodetection system combines 
the selectivity of immunoassays and the sensitivity of laser-induced fluorescence 
detection in microdroplets. It has been evaluated for water and urine analysis. This work 
was realized in collaboration with the Department of Mechanical and Aeronautical 
Engineering and the Department of Entomology of University of California, Davis. 
 
 
6.1. Synthesis of the fluorescent tracers 
 
The feasibility of using a homologous (immunizing hapten is the same as the competitor 
hapten) direct enzyme immunoassay to determine 2,4,6-TCP has already been 
demonstrated in our group [259]. Thus, the same approach was initially planned to 
develop a fluoroimmunoassay by coupling hapten 5 (3-(3-hydroxy-2,4,6-
trichlorophenyl)propanoic acid) to a fluorescent label. For maximum sensitivity, the 
fluorophore should have a high molar extinction coefficient, high quantum yield and large 
Stokes shift. Fluorescent dyes from the fluorescein family (e.g. fluorescein, rhodamine, 
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Texas Red, etc.) have relatively high molar extinction coefficients (60 000-100 000 M-1 
cm-1) and fluorescence quantum yields greater than 85% [412]. In particular, fluorescein 
has an effective excitation wavelength range of about 488-495 nm, closely matching the 
emission of an Ar laser (488 nm). Frequently, fluoresceinamine is used for labeling 
haptens containing a -COOH group, employing dicyclohexyl carbodiimide (DCC) 
[222,390,413] or 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) [232] as an 
activating agent to form the amide bond. N-substituted carbodimides react with 
carboxylic acids to create a highly reactive O-acylisourea intermediate, which then react 
with the primary amine to form an amide bond with release of the isourea by-products 
according to the general reaction mechanism shown in Figure 6.1. A potential 
undesirable effect of carbodiimide coupling reactions is the spontaneous rearrangement of 
the O-acylisourea intermediates to an inactive N-acylurea.  
 
()n
COOH
(Cl)n
OH
N
C
N
R1
R2
DCC - R1=R2
EDC - R1
           
           
            R2
CH3
Cl
H
N
CH3
CH3
DIC - R1=R2
CH3
CH3
O-acylurea
active intermediate inactive N-acylurea
()n
O
N NH
O
R2
OH
(Cl)n
R1
NH NH
O
R2R2
amide bond formation isourea by-product
H2N
COOH
OH
O
O
N
R2
NH
R1
()n
O
O
OH
(Cl)n
fluoresceinamine
NH()n
O
OH
(Cl)n
OH
O
O
COO H
 
Figure 6.1. General reaction mechanism of carbodiimide-mediated coupling of carboxylic 
acids and amine nuclephile. 
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Initially we tried to find out the best reaction conditions (type of carbodiimide, solvent, 
reagents concentration, etc.) using as model hapten 3-hydroxyphenylacetic acid. The 
coupling reaction with fluoresceniamine (FNH2) in anh. THF was studied using DCC and 
EDC. An excess of carbodiimide with respect to the hapten was used to avoid the 
formation of anhydride products. Anhydrous solvents and Ar atmosphere were used to 
avoid competing hydrolysis of the activated ester intermediate, forming an isourea. The 
reaction conditions and yields calculated with respect to the FNH2 are presented in Table 
6.1.  
 
Table 6.1. Conjugation of 3-hydroxyphenylacetic acid (HO-PhCOOH) to FNH2 in THF. 
Reagents Molar ratio Time, T° HOPh-F yield a, % 
HO-PhCOOH : DCC : FNH2 1:1.25:1 20h, RT 20 
1:1.25:1 20h, RT 15 HO-PhCOOH : EDC : FNH2 1:2:1 3h, 30°C 15 
a The yield is calculated based on the ratio of the signals of the fluorescein conjugate of the 3-
hydroxyphenylacetic acid (HOPh-F) and of the FNH2 in the aromatic region of the 1H-NMR 
spectra of the reaction mixture. 
 
The coupling reaction was followed by TLC and 1H-NMR. The characteristic signals dd 
at δ 6.96 and d at δ 7.05 corresponding to the hydrogen at the closest positions to the NH2 
group in the aromatic ring of the fluoresceinamine molecule are shifted to δ 7.78 and δ 
8.28, respectively, when the amide bond is formed. In addition, the signal (s, 2H, -
CH2COO-) at δ 3.4 in the 3-hydroxyphenylacetic acid shifts to δ 3.57 (s, 2H, -
CH2CONH-) under coupling. In all the cases the reaction yield was very low (<20%). 
 
As the dicyclohexylisourea formed when DCC was used could not be easily removed 
(insoluble in ethylacetate, ether, toluene, hexane), we continued with the EDC. We 
studied the reactivity of the –COOH and NH2- groups when EDC was employed using 
phenylacetic and 3-hydroxyphenylacetic acid as model haptens and 2,6-diethylaniline 
instead of the flruorescein (see Table 6.2). Although 50% yield was achieved in the 
reaction between phenylacetic acid and 2,6-diethylaniline, the presence of the OH-group 
in the aromatic ring when 3-hydroxyphenylacetic acid was reacted produced a decrease of 
the yield to 30%. 
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Table 6.2. EDC coupling in THF. The reagent concentration was: -COOH:EDC:FNH2=1:1.25:1 
and the reactions were performed at RT. 
-COOH -NH2 Time yield a, % 
Phenylacetic acid 2,6-diethylaniline 4h 50 a 
3-Hydroxyphenylacetic acid 2,6-diethylaniline 4h 30 a 
Phenylacetic acid F-NH2 20h 30 b 
3-Hydroxyphenylacetic acid F-NH2 20h 15 b 
a The yield is calculated based on the ratio between the signal (s, 2H, -CH2CONH-) of the 
conjugate and the signal (s, 2H, -CH2COO-) in the respective acid according to the 1H-NMR 
spectra of the reaction mixture. b The yield is calculated based on the ratio of the signals of the 
fluorescein conjugate and of the FNH2 in the aromatic region of the 1H-NMR spectra of the 
reaction mixture. 
 
In addition, the amino group of the fluoresceinamine resulted less reactive than the amino 
group of the 2,6-diethylaniline. A possible explanation could be the limited solubility of 
fluoresceinamine in the solvent used (THF). To prove this fact we performed the reaction 
in presence of a co-solvent to increase fluoresceinamine solubility. We also decided to 
use diisopropyl carbodiimide (DIC) instead of EDC because is more soluble in organic 
solvents and allows the elimination of the non-reacted DIC and the diisopropylurea by-
product formed by evaporation facilitating subsequent purification steps of the product. 
However, aprotic organic solvents may favor the formation of the corresponding N-
acylurea derivative. Therefore, it was very important to determine precisely the 
appropriate co-solvent and its concentration. Table 6.3 presents the results obtained with 
different co-solvents and concentrations.  
 
Table 6.3. DIC coupling of 3-hydroxyphenylacetic acid (HO-PhCOOH) and FNH2 
Solvent Time HOPh-F yield a, 
% 
HOPhCOOH 
non-reacted 
N-acylurea 
100%DMF 20h 0 0 100 
10%DMF/THF 4h 53 10 37 
3%DMF/THF 4h 57 0 43 
3%DMSO/THF 4h 30 30 30 
5%ACN/THF 4h 30 5 65 
a The yield is calculated based on the ratio of the signals of the conjugate vs the FNH2 in the 
aromatic region of the 1H-NMR spectra of the reaction mixture. 
The reagent concentration was: -COOH:DIC:FNH2=1:1.5:1 
 
Since highest yields were achieved at 3% and 10% DMF, we decided to use DMF as co-
solvent at low concentrations (3-10%). 
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It has been demonstrated that in polarization fluorescence immunoassays higher 
sensitivity was achieved using short bridge length based tracers [233,414,415]. Therefore, 
we approached the synthesis of three different fluorescent tracers using DIC in THF 
containing 6% of DMF (see Table 6.4). The homologous hapten 5 (3-(3-hydroxy-2,4,6-
trichlorophenyl)propanoic acid) was coupled to fluoresceinamine with a reaction yield of 
50%. 
 
Table 6.4. DIC coupling of haptens and FNH2.  
Hapten Solvent Yield a, % 
hapten 5 
OH
Cl
Cl
Cl
COOH
 
6%DMF/THF 50 
hapten 5a
OH
Cl
COOH
Cl Cl
 
6%DMF/THF 10 
hapten 2 Cl
Cl
O COOH
Cl
 
10%DMF/THF 0 
The reagent concentration was: -COOH:DIC:FNH2=1:1.5:1 and the reactions were performed for 
20h at RT. a The yield is calculated based on the ratio of the signals of the conjugate vs the FNH2 
in the aromatic region of the 1H-NMR spectra of the reaction mixture. 
 
The formation of the conjugate was confirmed by the presence of the following signals in 
the 1H-NMR spectra: δ: 2.68 (t, J = 8.4 Hz, 2H, -CH2CONH-), 3.32 (t, J = 8.4 Hz, 2H, 
PhCH2-), 7.38 (s, 1HAr meta, hapten 5), 7.85 (dd, J1 = 8.4 Hz, J2 = 1.9 Hz, 1H, FNH2), 8.3 
(d, J = 1.8 Hz, 1H, FNH2). The product was purified by TLC and the overall yield after 
purification was 37.7%. Following the same procedure we have tried to synthesize the 
fluorescein conjugate of the hapten 5a with a shorter spacer arm (3-hydroxy-2,4,6-
trichlorophenylacetic acid), but the reaction yield vs FNH2 was only 10%. This could be 
attributed to some type of stearic hindrance of the chlorine atoms from the aromatic ring 
situated very close to the –COOH group. Furthermore, the synthesis of hapten 2 (2,4,5-
trichlorophenoxyacetic acid)-fluorescein was also unsuccessful. 
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6.2. Optical characterization of hapten 5-fluorescein 
(TCP-F) 
 
The fluorescence properties of the synthesized tracer hapten 5-fluorescein (TCP-F) were 
initially tested in a standard spectrofluorometer where the solution is subject to 
excitation/emission in a quartz cuvette of 1 mL. Maximum excitation was observed at 
~490 nm (see Figure 6.2.A) and maximum emission was obtained at ~515 nm (see 
Figure 6.2.B). Increasing the TCP-F concentration resulted in an increased intensity of 
the emitted fluorescence. At high concentrations (µM) dimmers are formed and the 
maximum emission at ~515 nm is auto-quenched. 
 
The fluorescence intensity of the fluorescein conjugate is very dependent on pH of the 
solution, showing enhanced intensity in basic conditions (see Figure 6.3). For each pH a 
linear relationship was observed between the maximum fluorescence intensity and the 
TCP-F concentration. Since the usual immunoassay media is the PBS buffer (pH=7.5) 
and suitable fluorescence intensity was observed at this condition, we have decided to 
perform our following studies only at pH=7.5. 
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Figure 6.2. Excitation and emission spectra of the fluorescein tracer TCP-F recorded in standard
spectrofluorometer. A. Excitation spectrum is obtained for 10-8M TCP-F in PBS (pH=7.5) buffer
at emission wavelength of 520 nm. B. Emission spectrum is obtained for several concentrations
of TCP-F in PBS (pH=7.5) buffer at excitation wavelength of 490 nm.  
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6.3. LIF detection of TCP-F in microdroplets  
 
Laser induced fluorescence in microdroplets was measured using the instrumental set-up 
presented in Figure 6.4. The microdroplets were generated by the vibrating orifice 
aerosol generator and illuminated by the laser beam (λ = 488 nm). The fluorescence was 
collected by a microscope objective lens and focused onto the entrance slit of the imaging 
spectrometer. Emission spectra were recorded with a thermoelectrically-cooled camera 
with a CCD detector. Microdroplet size and shape have very important effects on 
fluorescence detection. For a fixed orifice diameter these parameters are determined by 
the piezoelectric frequency of the droplet generator and the liquid flow rate. In our 
experiments a frequency of 40 kHz was used with a liquid flow rate of 0.25 mL/min (4.16 
x 10-3 cm3/s). According to a simple relationship between these parameters, the diameter 
of the generated droplet was 58.4 µm and its volume was 104 pL. With a shutter exposure 
time of 1 second, 40000 droplets passed the laser beam and, hence, the detected volume 
was 4.2 µL.  
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Figure 6.3. pH effect on the fluorescence intensity of the fluorescein tracer TCP-F. The 
fluorescence intensity was measured in a spectrofluorometer  (λexc=490 nm) for several 
concentrations of TCP-F at different pH. 
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Figure 6.4. Scheme of the instrumental set-up. Microdroplets are generated by a vibrating orifice
aerosol generator (orifice diameter = 10 µm) consisted of syringe pump and piezoceramic
oscillator. Droplets are illuminated by a laser beam (continuous Ar ion laser, λ = 488 nm) that is
focused to a laser beam waist of ~200 µm at the trajectory of the droplet stream. The beam
diameter is chosen to be larger than the droplet diameter to ensure that all fluorophores in the
sample are illuminated. A holographic laser band pass filter eliminates undesirable plasma lines
from the laser source and transmits only the laser line at 488 nm. The fluorescence is collected by
a microscope objective lens (N.A. of 0.55) and focused onto the entrance slit of the imaging
spectrometer. Spectra are recorded with a thermoelectrically-cooled camera with a 512 x 512
pixel charge coupled device (CCD) detector. A 488 nm holographic Raman notch filter placed in
front of the slit of the spectrometer blocks elastically scattered laser radiation. 
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Figure 6.5.A compares the fluorescence emission spectra obtained from droplets of the 
TCP-F conjugate and from droplets of the dye molecule fluoresceinamine (FNH2) used 
for labeling. As expected, the maximum emission for both molecules is at ~520 nm (close 
to the 488 nm laser excitation). The insert present the microdroplets image recorded with 
the CCD camera. Furthermore, a linear dependence of the maximum fluorescence 
intensity on the TCP-F concentration was observed for both laser powers used in this 
study (see Figure 6.5.B). The regression coefficients are 0.996 and 0.998 for laser power 
60 mW and 120 mW, respectively. Transit times were of the order of 100 µs, leading to a 
very short interaction time between excitation source and fluorophore, consequently 
avoiding photobleaching. The absolute detection limit of the fluorescein conjugate in the 
microdroplets is around 5 x 10-10 M (0.5 nM) corresponding to 5.2 x 10-20 mol TCP-F per 
microdroplet, while in a cuvette (2 mL ) or in a microwell (200 µL) the absolute detection 
limit was 2x10-12 mol and 2x10-13 mol, respectively, which demonstrates one of 
advantages of the microdroplet approach allowing detection close to single molecule 
levels. A concentration of TCP-F of 10 nM was chosen for further studies as a 
compromise between the goal of maximizing the signal-to-background ratio (to facilitate 
observation of the antibody quenching), and the recognition of the fact that low TCP-F 
concentrations would provide lower detection limits in the competitive assays.  
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Figure 6.5. A. Fluorescence emission spectra detected in microdroplets of 20 nM FNH2 (1)
and 20 nM TCP-F (2). The laser power is 60 mW, the exposure time is 1 sec. The insert
represents the microdroplets image obtained with the CCD camera. B. Fluorescence intensity
vs TCP-F concentration. The measurements were made in PBS buffer (pH=7.5), the exposure
time was 1 second and the laser power (P) was set at 60 and 120 mW. The data shown
correspond to the average and the standard deviation of three measurements. 
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6.4. LIF-microdroplet-QFIA 
 
6.4.1. Quenching effect on TCP-F fluorescence upon Ab 
binding 
 
It is well known that an immunochemical reaction between a fluorescent-labeled antigen 
and its specific antibody can cause a decrease in the fluorescence of the labeled antigen, 
whereas the free fraction retains its full signal [189]. The effect of the antibody binding 
reaction on the fluorescent properties of the TCP-F conjugate was tested on a 
noncompetitive LIF-microdroplet-QFIA for three different Abs specific for 2,4,6-TCP 
(Ab43, 44, 45). Figure 6.6 shows the quenching effect observed after 20 min of 
immunoreaction time between TCP-F (10 nM) and the three Abs (10 µg/mL). The 
decreased fluorescence intensity is presented as a ratio between the fluorescence intensity 
of TCP-F in presence of Ab (IAb) and the fluorescence intensity of TCP-F in the absence 
of Ab (ITCP-F).  
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Figure 6.6. Quenching effect on the fluorescence of the TCP-F conjugate upon Ab binding. 
The TCP-F and the Ab concentration were 10 nM and 10 µg/ml, respectively. Measurements 
were made after 20 min of immunoreaction. The decreased fluorescence intensity is presented 
as a ratio between the fluorescence intensity of TCP-F in presence of Ab (IAb) and the 
fluorescence intensity of TCP-F in the absence of Ab (ITCP-F). The preimmune serum is used as 
control of non-specific binding. 
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A pre-immune serum, used as a negative control, did not show fluorescence quenching, 
demonstrating the specificity of the observed effect using Ab43-45. The inhibition of the 
fluorescence signal was highest for Ab43, followed by Ab45, and is lowest for Ab44. A 
similar correlation (Ab43 > Ab45 > Ab44) was found regarding the Ab affinity for hapten 
5-HRP on a direct ELISA developed in our group [259]. Higher Ab affinity means 
stronger binding, resulting in larger changes in the microenvironment of the fluorescent 
label, which is expressed in a stronger quenching effect [416]. Hence, the Ab with the 
strongest quenching effect (Ab43) was chosen for further study. 
 
The kinetics and the fluorescence emission spectra of the TCP-F fluorescence quenching 
in microdroplets using different concentrations of Ab43 was investigated in order to 
ascertain the time needed for maximum quenching and to determine the most suitable Ab 
concentration for further competitive assays. Several mixtures of TCP-F/Ab43 were 
prepared in PBS with constant TCP-F concentration (10 nM) and Ab43 concentration in 
the range 0.6 - 15 µg/mL. The fluorescence emission from microdroplets of each solution 
was measured every 5 minutes. It was observed that at high Ab concentrations (15 
µg/mL), a steady-state level was reached in about 15 minutes, while with lower Ab 
concentrations more time (30-40 min) was needed to reach equilibrium (see Figure 6.7 
A). Thus, an incubation time of 45 min was selected to ensure complete immunoreaction 
between Ab43 and TCP-F. The emission spectra and the Ab titration curve for 10 nM 
TCP-F obtained after 45 min incubation time are presented in Figure 6.7. B and C. It 
should be noted that complete quenching of the signal was not accomplished even at very 
high Ab concentrations. Thus, in a situation where all binding sites of the antibody are 
saturated with TCP-F (i.e., Ab concentration 10 µg/mL) a maximum 70% quenching of 
the TCP-F fluorescence signal was accomplished (see Figure 6.7.C). This is in agreement 
with other direct quenching fluoroimmunoassays with small haptens where the 
fluorescence of the tracer is only partially quenched upon Ab binding [390,392,416]. In 
fact, complete quenching (100%) has only been reported on biotin-avidin systems 
characterized by even a stronger binding than the Ag-Ab; it has been attributed to the 
very tight association that brings avidin right to the surface of the biotin-fluorophore 
conjugate [416]. It can be expected that a hapten with a shorter spacer arm in the 
fluorescent tracer would give rise to a more efficient quenching due to closer proximity of 
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the fluorophore to the Ab in the Ab/TCP-F complex. Unfortunately, as already described 
our efforts to synthesize the respective fluorescein tracer using 3-(3-hydroxy-2,4,6-
trichlorophenyl) acetic acid have failed. For the competitive QFIA, an Ab concentration 
of 2.5 µg/mL was selected, producing a signal around 80% of the complete saturation 
(80% of the maximum quenching). We must also mention that the antibody solutions 
themselves did not show a significant fluorescence background (see Figure 6.7. B).  
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Figure 6.7. A. Kinetics of 10 nM AF fluorescence quenching by different concentrations of
Ab43 in 10 mM PBS buffer at room temperature. B. Fluorescence emission spectra of 10
nM TCP-F (1) and a mixture of 10 nM TCP-F and Ab43 at varying concentrations: 0.6
µg/mL (2), 2.5 µg/mL (3), 15 µg/mL (4); 15 µg/mL Ab43 in the absence of TCP-F (5). C.
Antibody titration curve for 10 nM AF at increasing Ab43 concentration. The
immunoreagents were incubated 45 min at room temperature. The decrease in the
fluorescence intensity is presented as a ratio between the fluorescence intensity of TCP-F in
presence of Ab (IAb) and the fluorescence intensity of TCP-F in the absence of Ab (ITCP-F).
All data shown correspond to the average of three measurements.  
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6.4.2. Competitive LIF-microdroplet-QFIA 
 
Using the above selected concentrations of the immunoreagents we have performed a 
homogeneous competitive QFIA with LIF detection in microdroplets. The standard curve 
obtained for PBS buffer is presented in Figure 6.8. The TCP-F tracer competes with the 
analyte (2,4,6-TCP) for a limited number of binding sites. At low analyte concentrations, 
the TCP-F conjugate is preferentially bound to the Ab and the fluorescence of the label is 
quenched. Higher analyte concentrations lead to a decreased occupation of the Ab 
binding sites by the TCP-F conjugate and an increase of the free TCP-F (homogeneous 
assay) in the solution, resulting in an increase of the fluorescence signal. The parameters 
of the standard curve performed in 10 mM PBS (pH=7.5) are: IC50 = 2.3 nM (0.45 µg/L); 
the dynamic range is between 0.54 and 11.5 nM (0.11 to 2.27 µg/L); the LOD is 0.2 nM 
(0.04 µg/L), slope = -0.9, r2=0.976.  
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Figure 6.8. Calibration curves of the LIF-microdroplet-QFIA for 2,4,6-TCP in 10 mM PBS buffer 
and in 50-fold diluted urine. The concentration of TCP-F and the Ab43 was 10 nM and 2.5 µg/mL, 
respectively. The immunoreagents and the analyte were allowed to compete for 45 min at room 
temperature. The fluorescence intensity is presented as a ratio between the fluorescence intensity of 
TCP-F in presence of Ab and analyte (ITCP) and the maximum fluorescence intensity of TCP-F in 
the absence of Ab (ITCP-F). The data shown correspond to the average of three measurements. 
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The LOD of an immunoassay is often determined by the relative affinity of the Ab for the 
analyte and the competing hapten-label conjugate. However, it also depends on other 
parameters, such as the label detection system. We have compared the main features of 
the QFIA performed in 96-well plate, the LIF-microdroplet-QFIA, and a conventional 
microplate ELISA [259] (see Table 6.5). It should be noted that the three immunoassays 
(ELISA and QFIAs) were performed under similar conditions: the immureagents used 
were hapten 5 and Ab43; the reaction media was PBS buffer (pH=7.5); the competition 
step took place for about 30-40 min. As it can be observed in Table 6.5, both microplate 
immunoassays (heterogeneous ELISA and homogeneous QFIA) have very similar LOD 
and IC50 values in spite of the different labels used (5-HRP and TCP-F).  
 
Table 6.5. Features of the immunochemical techniques for 2,4,6-TCP analysis. 
 QFIA 
 
ELISA a 
microplate LIF-microdropet 
IC50 (µg/L) 2.74  4.2 0.45 
LOD (µg/L) 0.2 (1 nM) 0.36 (1.8 nM) 0.04 (0.2 nM) 
LOD (ng) 4 x 10-2  
(2x10-13 mol) 
7.2x10-2  
(3,7x10-13 mol) 
1.68x10-4  
(9,7x10-16 mol) 
Tracer 5-HRP 5-Fluorescein 5-Fluorescein 
Procedure multiple wash and 
incubation steps 
homogeneous assay homogeneous assay 
Excitation - 485 nm (20nm band) laser, 488 nm 
Volume, µL 200  200 4.2 
a Data obtained from [259] 
 
According to the literature, conventional fluorophores give assays with detectability 
values between 10-9 to 10-10M, while enzyme-labeled immunoassays reach detectability 
values in the range of 10-10 to 10-11M due to their intrinsic amplification features [189]. 
However, ELISA requires several time-consuming washing and incubation steps – QFIA 
is a homogeneous assay involving just the competitive step and no washing of the plates. 
It is therefore ideally suited for high-throughput screening and miniaturization.  
 
A comparison between both QFIAs demonstrates significantly improved detectability in 
the LIF-microdroplet-QFIA (see Table 6.5). This could be a result of the superior signal-
to-noise ratio accomplished with the microdroplet system, primarily because the 
microplate QFIA suffers higher background fluorescence. Moreover, a non-specific 
adsorption of the immunoreagents or certain nonpolar analytes to the microwell walls 
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may also occur. Background interferences due to Raman and Rayleigh scattering and 
impurity fluorescence are minimized when using small microdroplet volumes. In 
addition, the excitation source in the plate reader had a wavelength of 485 nm (band 
width of 20 nm full width half maximum, FWHM), while the laser excitation wavelength 
was 488 nm with a very narrow linewidth (recall that background plasma emission from 
the laser was eliminated with a special holographic prism). The induced fluorescence in 
the first case was detected by a photomultiplier (535 nm, filter FWHM of 25 nm), 
whereas in the LIF-microdroplet-QFIA we used a CCD with low readout noise. The 
microdroplet format ensured that all fluorophores in the sample were exposed to the laser 
illumination, permitting detection limits to be extended to very low concentrations of 
fluorophore. This could be achieved in a microplate format, in principle, if the laser beam 
were expanded to illuminate the entire well, at the expense of much greater elastic light 
scattering at the laser wavelength. Although the notch filter had a higher rejection ratio 
for the laser wavelength, some background would be expected to interfere with the 
measurements. It should be noted that the microdorplet detection scheme was arranged so 
that the fluorescence was observed in the plane of polarization of the incident laser beam 
at an angle of 90°, leading to an additional reduction in elastic scattering as described by 
the Mie theory of light scattering. Finally, the microdroplet approach allows detection to 
be performed in a volume much smaller than the volume of the standard microwells (200 
µL) resulting in lower LOD. Thus, in absolute mass, the LIF-microdroplet-QFIA LOD is 
1.68 x 10-4 ng while for the microplate QFIA it is 7.2 x 10-2 ng. The small absolute 
volume and mass that can be detected with the microdroplets could be a crucial advantage 
in finger prick assays where detection in very small volumes is necessary. 
 
6.4.3. LIF-microdroplet-QFIA in urine samples  
 
Our aim was to demonstrate that the developed LIF-microdroplet-QFIA can be applied to 
the urinary determination of 2,4,6-TCP. The application of homogenous fluorescence 
immunoassays to the measurement of analytes in untreated biological materials is usually 
complicated due to the presence of endogenous fluorescent compounds and other species 
that quench the fluorescence of the labeled probe. In general, interferences from 
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endogenous substances may be minimized by sample dilution. Therefore, we have 
evaluated the background fluorescence signal from microdroplets of diluted urine (see 
Figure. 6.9.A). With laser excitation at 488 nm, the urine has a fluorescence emission in 
the region of 520-545 nm that decreases with urine dilution. Furthermore, the emission of 
the TCP-F tracer in diluted urine does not suffer any shift and the only effect observed is 
the increased fluorescence intensity of TCP-F due to the presence of matrix background. 
It can be seen that this effect can be eliminated by urine dilution: the emission spectra of 
TCP-F in 50-fold diluted urine and in PBS are almost identical. 
 
Urine components can affect not only the fluorescence background of the sample but also 
the Ab-Ag interaction. The interference produced by the urine matrix in the competitive 
immunoreaction in the 2,4,6-TCP ELISA has been demonstrated in the previous chapters 
of this thesis. In the present case, we investigated the effect of interference on the 
immunoreaction by comparing the fluorescence quenching produced in urine (10, 20 and 
50 times diluted) and in PBS buffer. The urine matrix interfered with the Ab-TCP-F 
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Figure 6.9. A. Urine effect on fluorescence emission measured in the LIF-microdroplet-QFIA. 
The graph shows the spectra that were recorded in urine diluted 20 times (1) and 50 times (2) 
with PBS. The spectra were obtained for a solution of 10 nM TCP-F in PBS (3), in 20 fold 
diluted urine (4), and in 50 fold diluted urine (5); B. Urine matrix effect observed as a 
diminution of the quenching of the fluorescence produced upon Ab binding of the TCP-F 
conjugate. The effect of the urine was tested after diluting the matrix 10, 20 and 50 times in 
PBS. The TCP-F and the Ab concentrations were 10 nM and 10 µg/mL respectively. The 
mixture was incubated 45 min at room temperature. The decreased fluorescence intensity is 
presented as a ratio between the fluorescence intensity of AF in the presence of Ab (IAb) and 
the fluorescence intensity of TCP-F in the absence of Ab (ITCP-F). 
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interaction resulting in a very small quenching effect at 10- and 20 fold urine dilution (see 
Figure. 6.9.B). However, a 50-fold PBS dilution of the urine gave rise to a similar 
fluorescence quenching effect as in the assay buffer, and thus it was used to prepare a 
competitive standard curve. As seen in Figure 6.8, the curves prepared in PBS buffer and 
in 50-times diluted urine are almost identical. The IC50 is 2.14 nM (0.42 µg/L) and the 
calculated LOD is 0.2 nM (0.03 µg/L) with a dynamic range between 0.41 and 15.1 nM 
(0.08 to 2.99 µg/L), the slope is -0.74, and the regression coefficient r2 is 0.975. Taking 
into account the dilution factor applied to the urine, the LOD of the analytical method is 
1.6 µg/L, which is sufficient for occupational exposure assessment studies.  
 
In summary, a LIF-microdroplet-QFIA has been developed that has proven to be fast, 
highly sensitive, and simple to perform (no separation steps are needed). It has been 
demonstrated that this approach offers better detection limits than those of microplate 
immunoassays. The results reported here indicate that urine samples can be directly 
analyzed for 2,4,6-TCP, without any sample treatment and with enough detectability to 
perform biological monitoring and risk assessment of exposure to chlorophenols and 
other organochlorinated substances that are excreted as trichlorophenol in urine. The 
technology presented in this is promising regarding development of high-throughput 
screening and miniaturized biosensor devices. Significant improvement in precision and 
reproducibility could be achieved by better droplet generation (for example, using ink-jet 
printer micropiezo technology) and charged microdroplet focusing by electrostatic fields, 
resulting in a better control of the volume and droplet stability. Future work will be 
dedicated towards smaller volume assay development and its application to miniaturized 
devices (microchip). This work is the first application of a steady-state QFIA with LIF-
microdroplet detection system to human urine samples, demonstrating the potential of 
this analytical approach for bioassays.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________________________ 
 
7. Annex I 
 
Chromatographic analysis 
of halogenated phenols 
 
________________________________________________________________________ 
 
 
 
 
With the aim to validate the immunochemical determination of chlorophenols in water 
and urine described in previous chapters, it was necessary to use an independent 
analytical method for analysis of halogenated compounds. As it was mentioned in the 
Introduction, gas chromatography (GC) with electron-capture detection (ECD) or mass 
spectrometry (MS) is a common tool for the analysis of halogenated phenolic compounds 
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in environmental and biological samples. In this annex we present the work performed to 
adapt both techniques (GC-ECD and GC-MS) to the quantification and identification of 
chlorophenols in water and urine samples. These methodologies were applied to the 
validation of the ELISA determination of 2,4,6-TCP in water samples (see Chapter 3, 
Section 3.1), in the characterization of urine samples A and B used as representative 
urine matrices in this thesis (see Chapter 3, Section 3.4.1), and finally in the evaluation 
of SPE (C18 and IAC) procedures used as urine clean up methods prior to ELISA (see 
Chapter 4). 
 
The choice of the phenols to be analyzed by GC was based on the cross-reactivity of the 
2,4,6-TCP ELISA method. Usually a complex mixture of congeners, ranging from 
monohalogenated to the heavily halogenated compounds, can be present in samples 
contaminated with chlorophenols that makes the chromatographic separation difficult. 
For our purposes it was essential to have an analytical method, which is isomer-specific 
and yet sensitive to the main ELISA phenolic cross-reactants (2,4,6-TCP, 2,4,5-TCP, 2,4-
DBP, 2,3,4,6-TtCP and 2,4,6-TBP). The GC analysis of halogenated phenols consisted in 
toluene extraction from water or urine samples (directly or after SPE), followed by TMS-
derivatization and ECD or MS detection. The evaluation of the analytical method 
(extraction and derivatization procedures, instrumental analysis) is presented in the 
following sections. 
 
7.1. Studies on the derivatization of the halogenated 
phenols 
 
Although the halogenated phenolic compounds are highly polar and their vapor pressures 
are low, a derivatization step is often used to achieve improved chromatographic 
performance eliminating tailing and resolution problems [154]. Reagents such as 
diazomethane [135], acetic anhydride [117], pentafluorobenzyl bromide [153], 
pentafluorobenzoyl chloride [121], heptafluorobutyric anhydride [133], and silylating 
reagents [417-419] have been employed to convert phenols to the corresponding 
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derivatives. Here we used the silylating agent N,O-bis-(trimethylsilyl)trifluoroacetamide 
(BSTFA) to transform hydroxyl groups into trimethylsilyl (TMS) ethers. For GC and MS, 
the addition of the TMS groups to polar compounds confers thermal and chemical 
stability in addition to enhanced volatility [420]. A notable advantage of BSTFA is the 
volatility of the by-products of the derivatization, trimethylsilyltrifluoroacetamide and 
trifluoroacetamide, which usually elute early in analyses, often with the GC solvent front. 
Heating is often used to achieve effective derivatization, but we have conducted 
derivatization at RT. As silylating reagents and derivatives are sensitive to the hydrolytic 
effects of moisture, the trimethylsilylating reaction was carried out in sealed vials directly 
in the toluene extract. The derivatized extracts were directly injected into the GC-ECD 
(MS) system.  
 
Due to the negative inductive effect of chlorine atoms in the aromatic ring, the acidity of 
the phenolic group increases from mono- to pentachlorophenols. This effect can result in 
a different reactivity in the course of the derivatization procedure, and therefore the yield 
of products had to be controlled. In addition, in serial GC analysis of many samples, the 
stability of the TMS derivatives is also an important aspect. Thus, the effect of the 
reaction time at RT on the yields of the TMS-derivatives was examined for a standard 
mixture of five halogenated phenols (2,4,6-TCP, 2,4,5-TCP, 2,4-DBP, 2,3,4,6-TtCP and 
2,4,6-TBP). As it is shown in Figure 7.1 complete derivatization was achieved in 3h for 
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Figure 7.1. Effect of time on the silylation of a standard mixture of halogenated phenols
(each at concentration 10 µg/L ) with BSTFA (in excess) at RT. GC-ECD conditions are
described in Experimental Section. ISt is 2,3,5,6-tetrachloro nitrobenzene. 
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all the compounds and the derivatives were stable at RT for about 20h. In addition the 
silylation works equally well for the analysis of all the phenols tested. Yields for TMS 
ethers of the phenols on triplicate derivatizations had a RSD less than 13% at 0.5 µg/L 
level. 
 
7.2. Extraction efficiency of the halogenated 
phenols from aqueous samples 
 
Chlorophenols are weak acids and can be extracted by organic solvents under acidic 
conditions (pH<3). Various organic solvents have been reported, including hexane [117], 
diethyl ether [320], isopropanol/n-hexane mixture [64], etc. In our studies toluene was 
used because it was found to be the most efficient extraction solvent for chlorophenols 
from water [133] and urine samples [117]. 
 
Chromatographic analysis was used in the validation of the ELISA applied to water 
samples and the SPE methods applied to urine samples. It was also used in the 
characterization of the immunosorbent specificity in IAC-SPE. Thus, the eluting fractions 
containing 70% EtOH in water had to be extracted with a suitable solvent for the GC 
analysis. With this objective, the extraction efficiency of the five halogenated phenols 
from PBS and 7% EtOH/water samples (10 times diluted fractions) was evaluated after 
spiking at different concentration levels (see Experimental Section for the extraction 
procedure). Extraction recoveries were in the range 70-110% (see Table 7.1). Phenols 
were extracted individually and as well as in a mixture at low levels mimicking the real 
urinary concentrations of urine sample A (see Section 3.4.1). Different extraction ratios 
were used in order to achieve lower LOD in the urine samples. Extraction efficiency was 
essentially the same at extraction ratios of 1:1, 5:1, 10:1 and 30:1 PBS:toluene. According 
to Bengtsson et al even at water-to-toluene ratio of 100:1 the toluene extraction efficiency 
is the same [133]. For each case the extraction was performed in triplicate and the CV 
was less than 14% at all levels. These results show that the method was sufficiently 
precise for quantitative purposes. 
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Table 7.1. Extraction efficiency of halogenated phenols from  
Sample Compound Conc., µg/L Recovery ± SD, % 
 1 69.5 ± 10 
 2.5 74± 6.7 
2,4,6-TCP 10 85.4 ± 5.4 
 40 72 ± 2 
 50 88 ± 4.3 
mixture a:   
  2,4,6-TCP 0.24 81± 8.4 
  2,3,4,6-TtCP 0.2 107.4± 12 
  2,4,6-TBP 0.1 84± 10.1 
PBS 
ISt 1 2.5 
64 ± 13 
68.7 ± 18 
2,4-DCP 8 110.9 ± 9.8 
2,4,6-TCP 8 95.2 ± 2.4 
2,4-DBP 8 81.8 ± 3.5 
2,3,4,6-TtCP 8 89.6 ± 4.4 
7%EtOH 
PCP 8 107.6 ± 7.0 
PBS and 7%EtOH/water standards at extraction ratio water:toluene 5:1. Data present the result of 
three experiments (N=3). Extraction procedure and GC-ECD conditions are described in 
Experimental Section.a The extraction ratio PBS:toluene is 30:1. 
 
It should be noted that as internal standard we used 2,3,5,6-tetrachloro nitrobenzene that 
has been used in chlorophenol chromatographic determination [114,147]. However, we 
found very low extraction recoveries for this compound with high deviation (CV=26%) 
(see Table 7.1). Although other compounds such as 2,4,6-TBP, 2,6-DBP and 2,3,6-TCP 
have been also used as internal standards [116,117,123], we did not use them because we 
needed an ISt that should not be an ELISA cross-reactant and on the other hand it should 
have similar behavior in the extraction procedure and finally to be well separated in the 
GC chromatograms from the other phenols. Considering all these requirements we 
decided to use 2,3,5,6-tetrachloro nitrobenzene as internal standard only in the GC 
measurements and to add it to the toluene extraction prior to injection in the 
chromatograph. 
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7.3. GC-ECD 
 
We used GC-ECD analysis of chlorophenols in the validation of the ELISA applied to 
water samples, in C18-SPE and IAC-SPE characterization. Figure 7.2 presents a GC-
ECD chromatogram of a standard mixture of the main ELISA cross-reactants at 10 µg/L 
individual concentration after TMS-derivatization for 4h. As it is shown good separation 
of the analytes was achieved on the capillary column with a polar stationary phase 
(BPX35) when applying the following temperature program: 100°C (1 min) to 250°C (at 
5°C/min), 250°C to 300°C (at 15°C/min) (see the rest of the conditions in the caption of 
Figure 7.2). 2,3,5,6-tetrachloronitrobenzene proved to be suitable internal standard (ISt) 
to monitor GC performance. The retention times of all di-, tri-, tetra- chloro- and 
bromophenols investigated are summarized in Table 7.2. Although the ECD is less 
sensitive to dichlorophenols by a factor of 100 compared to higher chlorinated phenols, 
the evaluation of the immunosorbent specificity was performed at detectable levels 
(concentrations higher than 20 µg/L in the toluene extract). 
 
Table 7.2. GC-ECD –retention time of the halogenated phenols used in 
the specificity characterization of the IAC-SPE. 
Phenolic compound Retention time, min 
2,5-DCP 7.5 
2,6-DCP 7.8 
2,4-DCP 7.9 
3,4-DCP 8.7 
2,4,6-TCP 10.6 
2,3,5-TCP 11.0 
2,4,5-TCP 11.2 
2,3,6-TCP 11.8 
2,3,4-TCP 12.9 
2,6-DBP 12.4 
2,4-DBP 12.6 
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Calibration curves for the ELISA cross-reactants were built using a standard mixture of 
the halogenated phenols in toluene at concentrations between 0.5 and 50 µg/L. The ISt 
was used at a concentration of 5 µg/L. Calibration graphs are obtained by plotting the 
quotients of the peak areas of the halogenated phenols and that of the internal standard as 
a function of the concentrations used (see Figure 7.3). The parameters of the standard 
curves and the detection limits for the halogenated phenols are presented Table 7.3.  
 
 
 
Figure 7.2. GC-ECD chromatogram of halogenated phenolic standards at 10 µg/L, 
derivatized with BSTFA for 3h. Peaks: 1 - 2,4,6-TCP; 2 - 2,4,5-TCP; 3 - 2,4-DBP; 4 – 
2,3,4,6-TtCP; 5 – ISt; 6 – 2,4,6-TBP; 7 – PCP. Injections (1 µL, splitless) at 250°C; 
capillary column BPX35 (25 m x 0.22 mm i.d.), 0.25 µm film thickness; carrier gas: helium 
at 130 kPa (20 cm/sec); make up gas: N2 5.0; detector temperature: 300°C; temperature 
program: 100°C (1 min) to 250°C (at 5°C/min), 250°C to 300°C (at 15°C/min). 
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Table 7.3. Properties of the calibration curves for GC-ECD analysis 
Phenols Calibration 
equation a 
r2 LOD b, µg/L 
2,4,6-TCP 0.299x+0.105 0.995 0.5 
2,4,5-TCP 0.252x+0.092 0.998 0.5 
2,4-DBP 0.177x+0.135 0.996 1 
2,3,4,6-TeCP 0.453x+0.053 0.999 0.3 
2,4,6-TBP 0.274x+0.021 0.997 0.5 
a x = mCP/mIS; b The LOD corresponds to the phenol concentration in the toluene standard 
producing a signal/noise ratio = 3 
 
The calibration curves are linear between the detection limits and 50 µg/L of the 
individual phenol. Low detection limits (~0.5 µg/L), which are essential for trace analysis 
of environmental and biological samples, were achieved using ECD for tri- and tetra- 
halogenated phenols. ECD response of 2,4-DBP was lower resulting in higher LOD. It 
should be noted that the reported LOD are related to the phenol concentration in the 
toluene standards. Further pre-concentration can be achieved in the extraction procedure 
(extraction ratio: 10:1 or higher).  
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Figure 7.3. Calibration for halogenated phenols. The concentration corresponds to the
phenol concentration in the toluene standard. GC-ECD conditions are described under
Figure 7.2. ISt is 2,3,5,6-tetrachloro nitrobenzene. Each standard was prepared in triplicate
and injected twice after 5h of silylation at RT. 
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7.4. GC-MS 
 
The GC-MS technique was used for quantitative analysis and for identification of 
halogenated compounds in the urine extracts. As the highest sensitivity is desired to 
monitor phenols at trace levels, analyses were performed by mass spectrometry in the 
selective ion monitoring (SIM) mode monitoring positive ions. Table 7.4 lists the 
analytical SIM conditions for the studied phenols.  
 
Table 7.4. GC-MS-SIM analysis of trimethylsilyl derivatives of phenolic compounds 
Parent 
Compound 
Nominal Mw 
of derivative 
Retention 
time, min 
Mass Ions 
monitored, m/z a 
Time monitored, min 
2,4,6-TCP 268 9.55 253, 255, 268 8.0 - 10.2 
2,4,6-TCP 268 9.98 253, 255, 268 8.0 - 10.2 
2,4-DBP 322 10.45 307, 309, 324 10.2 - 11.2 
ISt 259 11.45 203, 259, 261 11.2 - 12.0 
2,3,4,6-TtCP 400 12.64 287, 289, 304 12.0 - 13.2 
2,4,6-TBP 302 14.05 387, 389, 402 13.2 - 16.0 
a m/z values in italics correspond to M+; in bold correspond to [M+2]+; in italics and underline are 
[M-15]+; in bold and underline are [(M+2)-15]+ 
 
To enhance sensitivity a time varied selected multiple ions mass spectral method was 
employed. The retention times of the phenols were between 8 and 16 min. Because of the 
EI fragmentation process, an –CH3 group is lost. The resulting fragments show 
characteristic ion clustering caused by the chlorine and bromine isotopes. In general, the 
most abundant ion was used for ion monitoring and quantification, whereas the specific 
pattern was used for recognition.  
 
Figure 7.4 shows the selected ion chromatograms for a mixture of halogenated phenolic 
standards in toluene and for hydrolyzed urine sample A. Chlorinated compounds in the 
urine extracts were identified by comparing GC-MS data of standard chlorine-containing 
phenols with the unknown components separated from the urine extracts. The peak 
assignation was based on (a) match of the mass obtained of the unknown with that of the 
respective chemical standard; (b) agreement of the retention time obtained of the 
unknown with the retention time of the chemical standard; (c) the consistency of the 
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respective chlorinated and brominated isotopic pattern (i.e. di-,tri-, tetra-) of the standard 
parent ion with that obtained from the extracted ions. 
 
In addition to qualitative analyses of the selected phenols, the described technique was 
also used for their quantitative analysis. To prepare the calibration curves standard 
solutions of the halogenated phenolic compounds were prepared in PBS 5 mL), extracted 
with toluene (400 µL) (PBS:toluene = 12.5:1) and sylilated. The extracts were analyzed 
by GC-MS using the conditions described in Figure 7.4. The typical standard response 
curves and their parameters are shown in Figure 7.5 and Table 7.5. The relationship 
between the peak area ratio ACP/AISt and the phenol concentration in the PBS sample is 
linear over the range 0.2 and 5 µg/L.  
 
 
 
Figure 7.4. GC-MS-SIM chromatograms for halogenated standards and hydrolyzed urine
smaple A. Injector: splitless at 250°C; column: HP-5MS (30 m x 0.25 mm id), 0.25 µm film
thickness; carrier: helium; injection volume: 1 µL; temperature program: 100°C - 300°C
(7°C/min); ion source temperature: 200°C; ionization energy: 70 eV; ion separation:
quadropole rods; mass range monitored: see Table 7.4. Peaks: 1 – 2,4,6-TCP, 2 – 2,4,5-
TCP, 3 – 2,4,-DBP, 4 – 2,3,4,6-TtCP, 5 – 2,4,6-TBP, 6 – 2,3,5,6-TtCP, 7 – ISt (m/z 203,
259, 261). The chromatogram for sample A was obtained after extraction of the urine (100
mL) with toluene (1 mL). 
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Table 7.5. Calibration curves for GC-MS analysis 
Phenols Calibration equation a r2 LOD b, µg/L 
2,4,6-TCP 2.536x-0.375 0.999 0.1 
2,4,5-TCP 2.355x+0.019 0.999 0.1 
2,4-DBP 1.381x+0.028 0.999 0.2 
2,3,4,6-TeCP 1.133x-0.322 0.998 0.2 
2,4,6-TBP 0.696x-0.167 0.998 0.2 
a x is urinary concentration, µg/L; b The LOD corresponds to the phenol concentration in urine 
sample at extraction ratio 12.5:1 producing a signal/noise ratio = 3 
 
These type of calibration graphs were used to estimate the concentration of the 
halogenated phenols in the urine of the three population groups studied (see Chapter 5). 
Most of the urine samples were within this range. Samples with greater concentrations 
were diluted and reanalyzed. The least detectable concentration is 0.1 µg/L TCP in urine 
(see Table 7.5). For within-series imprecision values between 9.6% and 16.1% were 
obtained. The precision as well as the accuracy are very satisfactory with respect to the 
low concentrations to be determined and the sample treatment (extraction and 
derivatization). 
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Figure 7.5. Calibration curves based on extracted halogenated phenols from PBS 
standards. GC-MS conditions are described in Experimental. ISt is 2,3,5,6-tetrachloro 
nitrobenzene. Each standard was prepared in duplicate and injected twice after 5h of 
silylation at RT. 
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8. Annex II.  
 
Production of scFv fragments by phage 
display technology and their application as 
biorecognition elements in immunodetection 
systems 
 
________________________________________________________________________ 
 
 
 
 
 
Owing to their high specificity, antibodies immobilized on various supports have been 
widely used for different purposes. In the previous chapters of this thesis we have 
demonstrated their application in immunoassays (ELISA, QFIA) and in immunoaffinity 
chromatography. Immunosensors, in which antibodies are immobilized on optical fibers, 
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electrodes or semiconductor chips for the detection of antigens, represent another 
promising application [157,166]. Some of the most important challenges in the design of 
novel immunosensor systems are the oriented antibody immobilization onto the 
transducer surface in order to increase the antigen binding capacity, the controlled 
formation of an antibody monolayer and the use of the minimal active recognition unit 
(e.g. Fv) with the aim to achieve least surface concentration [421]. Furthermore, 
multilayer self-assembly immobilization procedures based on electrostatic layer-by-layer 
deposition were incorporated in the field of the immunsensors [422-424]. These 
approaches would allow better control of many immunosensor parameters, such as 
detection limit, sensibility, reproducibility, regeneration and non-specific adsorption.  
 
Novel antibody species with specifically designed properties for use in sensor and other 
applications can be generated by molecular genetic techniques quickly and at low cost. 
Recombinant phage display technology, developed during the past decade, has allowed 
the generation of a variety of antibody fragments (Fab, Fd, scFv) through their expression 
in bacteria derived from bacteriophage display repertoires [160,161]. Furthermore, the 
fusion of genetically encoded tags to antibody fragments offers an attractive solution. It 
was shown that fusions of the protein calmodulin with scFv fragments could be expressed 
by secretion from bacteria in high yield [425]. The highly acidic nature of the calmodulin 
tag (net charge –24 at pH 8.0) [425] could allow the ordered immobilization of the fusion 
protein scFv-calmodulin (scFv-CAL) on a positively charged surface of an immunosensor 
for the detection of a particular antigen. In this study as a model analyte was chosen the 
drug digoxin, a potent cardiac glycoside widely prescribed for the treatment of patients 
suffering from congestive heart failure, as well as some types of cardiac arrhythmias. Its 
narrow therapeutic range (5.10-4-2.10-3 mg/L) requires the precisely monitoring of 
digoxin in human serum. Therefore, the objective of the work presented in this Annex 
was the production of scFv fragments with anti-digoxin specificity by phage display 
technology, their genetically fusion to the negative tag calmodulin and the 
characterization and application of the fragments obtained as biorecognition elements in 
immunodetection systems (ELISA, SPR immunosensor). This work was developed in the 
group of Dr. G.Winter at the Medical Research Council Centre for Protein Engineering – 
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Cambridge, UK in collaboration with Dr. E. Domínguez from University of Alcalá de 
Henares and Dr. I. Katakis from University Rovira i Virgili. 
 
 
8.1. Production and characterization of anti-digoxin 
scFv antibody fragments and fusion protein anti-
digoxin scFv-calmodulin (scFv-CAL) 
 
The initial step in the production of anti-digoxin scFv antibody fragments by phage 
display technology is the selection of phage library with digoxin specificity (see Figure 
8.1). We have used two synthetic libraries (DVT and NKK) constructed in the phagemid 
vector pIT2 encoding scFv fragments with different diversity in the CDR2 and CDR3 
regions of the VH and VL domains (for details see Experimental Section, Figure 9.4). 
Both libraries were grown in E.coli TG1. The scFv fragments were displayed as fusions 
with the minor coat protein of the phage (pIII) as single polypeptide chains in which the 
heavy and light chain variable domains (VH and VL) were linked by a polypeptide linker 
(see Figure 8.1.A.). Antigen-driven selection was performed mimicking the immune 
system: phages displaying the scFv fragments were selected by binding to digoxin-BSA 
coated immunotubes. The eluted anti-digoxin phages were grown in bacterial culture and 
subjected to further rounds of selection to enrich affinity. The overall procedure mimics 
the affinity maturation process in the in vivo immune systems. The selected anti-digoxin 
phages (three rounds of selection) were grown in E.coli and soluble anti-Digoxin scFv 
fragments were expressed from individual colonies (see Figure 8.1.B.). The initial 
affinity screening was performed on ELISA and SPR directly with the bacterial 
supernatants containing the anti-digoxin scFv fragments isolated from 24 clones. 
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Figure 8.1. Production of anti-digoxin scFv fragments by phage display technology. A. 
Selection of phages with digoxin specificity (transformation of phagemid vector pIT2 to 
E.coli; surface display of scFv fragments; antigen driven selection and affinity maturation). B. 
Production of soluble monoclonal anti-digoxin scFv fragments. 
 
The results are summarized in Table 8.1.  
 
Table 8.1. Screening of 24 monoclonal soluble anti-digoxin scFv (bacterial supernatants) 
Library Method Antigen 
DVT NKK 
Digoxin-BSA 19 2 ELISA a 
Digoxin-HRP 12 3 
Digoxin-BSA 13 0 SPR b 
Digoxin 5 0 
a Number of colonies with Amax > 0.5 in ELISA (1D) with coating antigens Digoxin-BSA and 
digoxin-HRP at 25 µg/mL). b Number of colonies with positive binding at CM5 chips coated with 
Digoxin-BSA (100 µg/mL, 100 µL injected volume at pH=4) and with aldehyde activated digoxin 
(100 µg/mL, 100 µL injected volume) 
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Figure 8.2. ELISA (2D experiment with plates coated with digoxin-BSA and BSA) of 
soluble monoclonal anti-digoxin scFv fragments (bacterial supernatant). Procedure is 
described the Experimental Section. 
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Figure 8.3. BIAcore analysis of soluble monoclonal anti-digoxin scFv fragments 
(bacterial supernatant). CM5 chips were coated with Digoxin-BSA (A) and BSA (B) (100 
µg/mL, 100 µL injected volume at pH=4) until 13750 RUs. The increasing of ∆RU=40 
RU corresponds to the binding of the anti-digoxin scFv to the immobilized antigen 
(digoxin-BSA). No binding to BSA is detected. 
The ELISA screening indicates that the scFv produced from phages selected from the 
DVT library gave higher number of positive clones against both tested coating antigens 
(digoxin-BSA and digoxin-HRP). The specificity of scFv binding to digoxin-BSA in 
ELISA (2D format) is demonstrated in Figure 8.2.  
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Similar result was obtained with digoxin-HRP coated plates. The clones giving positive 
ELISA response were checked by SPR with BIAcore system (Pharmacia Biosensor). The 
scFv fragments were passed over biochips immobilized with digoxin-BSA, aldehyde 
activated digoxin and BSA as negative control (see Figure 8.3.). The SPR analysis 
reveals some false positive ELISA binding and indicated that only scFv produced from 
the DVT phage library gave positive SPR-response (see Table 8.1). These can be 
explained with the higher diversity of the DVT library (1.47x108 clones with 96% insert) 
with respect to the NKK library (1.37x108 clones with 88% insert). The V-genes of the 
clones producing anti-digoxin scFv fragments with positive SPR binding were screened 
by PCR. The electrophoresis of the PCR products confirmed the presence of both inserts 
VH and VK with a complete nucleotide length corresponding to 935 bp. The sequence 
analysis (Sanger method) showed that all clones have the same DNA sequence for the VH 
and VK diversified regions. Therefore, we can conclude that only one type of monoclonal 
anti-digoxin scFv fragment was obtained from the synthetic DVT genomic library (pIT2 
vector). 
 
With the aim to obtain anti-digoxin scFv fragment labelled with a negative tag 
(calmodulin) for its electrostatic ordered immobilization on immunosensor surfaces, we 
have approached the genetic fusion between the anti-digoxin scFv and the protein 
calmodulin (see Figure 8.4.).  
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Figure 8.4. Production of the fusion protein antidigoxin scFv-CAL 
The gene encoding the anti-digoxin scFv fragment was cleaved from the pIT2 vector and 
cloned into the calmodulin vector pDN152 [425]. The resulting vector was transformed 
into E.coli and the fusion protein anti-digoxin scFv-CAL was expressed by secretion from 
the bacteria. In this way the proteins were linked by a two residue polypeptide (Ala2) 
between the C-terminus of the VL domain and the N-terminus of calmodulin to place the 
antigen binding sites apart. The culture supernatant containing the fusion protein was 
assayed by ELISA using plates coated with digoxin-BSA and digoxin-HRP and it showed 
binding activity against digoxin. Furthermore, the fusion protein (45 kDa) was compared 
to the scFv fragment (28 kDa) in a PAGE electrophoresis (see Figure 8.5.A). 
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A.      B. 
  
Figure 8.5.A. Detection of the obtained recombinant fragments by PAGE 
electrophoresis. Lane 1 – makrer; lane 2 – anti-digoxin scFv-CAL; lane 3 – anti-digoxin 
scFv. The gel was stained with Coomassie blue. B. Purification of the fusion protein anti-
digoxin scFv-CAL from a bacterial supernatnat. Lane 1 – marker; lane 2 – scFv-CAL 
purified on DEAE Sepharose column; lane 3, 4, 5 – washings from DEAE Sepharose 
column; lane 6 - scFv-CAL purified on protein A column. 
 
The last step in the recombinant antibody fragments production is their purification from 
the culture broth. The calmodulin tag allows the fusion protein to be purified on an anion-
exchanegd resins. The fusion protein was concentrated and initially purified from the 
bacterial supernatant by DEAE chromatography eluting at 400 mM NaCl. As it can be 
observed in Figure 8.5.B. the obtained fraction does not represent very high degree of 
purification (lane 2). Thus, the scFv-CAL was further purified on protein A (lane 6). The 
anti-digoxin scFv fragment was directly purified on protein A. 
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8.2. Application of the fusion protein anti-digoxin 
scFv-CAL in ELISA and SPR-immunosensor for 
detection of digoxin 
 
With the objective to apply the anti-digoxin scFv-CAL protein as biorecognition element 
in an immunosensor based on the competition between the analyte (digoxin) and the 
labelled analyte (digoxin-HRP), initially we have tested it in a competitive direct ELISA. 
The concentrations of the immunoreagents (scFv-CAL and digoxin-HRP) were 
previously selected in 2D-titration of the immobilized scFv-CAL with digoxin-HRP. The 
parameters of the competitive ELISA curve and the assay conditions are presented in 
Table 8.2.  
 
Table 8.2. Conditions and features of the digoxin ELISA standard curve (scFv-CAL/digoxin-HRP) 
Condition Values Parameter Value a 
Competition time 2 h Amax 0.75 
pH 7.2 Amin 0.03 
Ionic strength 15 mS/cm IC50, mg/L 0.016 
Tween 20  0.05% Dynamic range, mg/L 1.2 x 10-4 – 0.8 
  slope 0.6 
  r2 0.996 
a The data correspond to a standard curve run in duplicate 
 
The immunoassay dynamic range covers the therapeutic range of the digoxin (5.10-4 – 
2.10-3 mg/L), which allows the quantification of the drug for toxicological control. 
Further evaluation of the reproducibility, precision and performance in serum samples is 
needed in order to apply the immunoassay for clinical purposes. 
 
As the genetically produced fusion protein scFv-CAL was intended to be electrostatically 
immobilized on a positively charged surface of a multilayer immunosensor through its 
negative (calmodulin) tag, we have determined its isoelectric point. The results from the 
isoelectric focusing for scFv, scFv-CAL and calmodulin are presented in Table 8.3.  
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Figure 8.6. Multilayer immunsensor. A. SPR sensogram (Injections of positively charged
redox polymer, anti-digoxin scFv-CAL and the antigen digoxin-HRP. Experimental conditions
are described the Experimental Section); B. Multilayer configuration.  
Table 8.3. Isoelectric points (pI) determined by IEF in agarose gel. 
Protein pI 
scFv 7.1 and 8.7 
ScFv-CAL 6.1 and 6.4 
Calmodulin (Sigma) 3.75 
 
It can be seen that the coupling of the calmodulin tag to the scFv produced a decrease of 
the isoeletric point. Therefore, the anti-digoxin scFv-CAL protein can be considered 
negatively charged at the usual pH working conditions (pH 7.4). 
 
Finally, we have tested the feasibility of the multilayer immunosensor structure based on 
electrostatic layer-by-layer deposition. The multilayer configuration presented in Figure 
8.6.B consists in gold microchip on which are successively deposited due to electrostatic 
interactions a negatively charged monolayer of 3-mercapto-1-propansulfonic acid (MPS), 
a positively charged redox polymer and anti-digoxin scFv-CAL immobilized through its 
negative tag. The deposition of these monolayers was monitored by SPR (BIAcore). The 
SPR response profile after consecutive injections of the redox polymer and the scFv-CAL 
protein is presented in Figure 8.6.A.  
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The formation of stable monolayers of the components and the binding of digoxin-HRP 
to the immobilized scFv fragment were detected. The variation of the response units 
(∆RU) corresponding to each monolayer formation are summarised in Table 8.4.  
 
Table 8.4. SPR multilayer formation. Data present the variation of the 
response units (∆RU) corresponding to each monolayer formed. 
Redox polymer scFv-CAL Calmodulin Digoxin-HRP 
3000 1700 - 300 
3000 - 700 0 
 
3000 RU and 1700 RU correspond to a saturation of the redox polymer and the scFv-
CAL protein layers, respectively. The monolayer of scFv-CAL was stable for 10 min at 
flow rate 30 µL/min PBS injection. This demonstrates the stability of the electrostatic 
interactions between both modules: the positive polymer and the negative fragment. The 
immunoreaction between the immobilized scFv-CAL and the injected digoxin-HRP 
corresponds to 300 RU. The specificity of the signal was tested in a multilayer 
configuration in which the scFv-CAL was substituted by commercially available 
calmodulin. No binding of digoxin-HRP was detected. These results proved that an 
ordered and strongly absorbed layer-by-layer configuration can be built by electrostatic 
deposition and controlled oriented immobilization of the anti-digoxin scFv fragment via 
its negative calmodulin tag can be achieved. Further optimisation of layer deposition, 
immunoreaction parameters and development of an electrochemical immunosensor with 
the same architecture should be followed. 
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9. Experimental methods  
and materials 
 
________________________________________________________________________ 
 
 
 
 
9.1. Instruments 
 
The pH and the conductivity of all buffers and solutions were measured with a pH-meter 
pH 540 GLP and a conductimeter LF 340, respectively (WTW, Weilheim, Germany). 
The centrifuge, model 5415D was from Eppendorf (Germany). Washing steps were 
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carried out using a SLY96 PW microplate washer (SLT Labinstruments GmbH, Salzburg, 
Austria). Absorbances were read at a single wavelength mode of 450 nm on a 
SpectamaxPlus (Molecular Devices, Synnyvale, CA USA). The competitive curves were 
analyzed with a four-parameter logistic equation using the software SoftmaxPro v2.6 
(Molecular Devices) and GraphPad Prism™ (GraphPad Sofware Inc., San Diego, CA, 
USA). Unless otherwise indicated, data presented correspond to the average of at least 
two well replicates. Loading of urine samples of volume higher than 20 mL to the 
HiTrap IAC column was performed using AktaTM Prime (Pharmacia) automated liquid 
chromatography system. 
 
For the development of quenching fluorescence immunoassay (QFIA), fluorescence was 
read using Spectrofluorometer FluoroMax-2 (Jobin Yvon-SPEX Instruments, S.A.) and 
SPECTRAFluor Plus plate reader (TECAN US, Inc.). For LIF-QFIA in microdroplets the 
following instruments were used: TSI Model 3450 Vibrating Orifice Aerosol Generator 
(orifice diameter 10 µm); continuous Ar ion laser, (Coherent Innova 70, λ = 488 nm); 
microscope objective lens (N.A. of 0.55); imaging spectrometer (SpectraPro-150, Acton 
Research Corp. MA); thermoelectrically-cooled camera (TEA/CCD-521-TKMI, 
Princeton Instruments Inc, NJ) with a 512 x 512 pixel charge coupled device (CCD) 
detector; ST130 Controller (Princeton Instruments Inc, NJ); holographic laser band pass 
filter (Kaiser Optical Systems Inc., MI)  and 488 nm holographic Raman notch filter 
(Kaiser Optical Systems Inc., MI). 
 
In the production of recombinant antibody fragments by phage display technology and 
their characterization the following instruments were used: PCR thermal cycler 
(Eppendorf), DNA Sequencer 373 (Applied Biosystems), incubator (Bioblock); 
thermostatic bath 911 (Bioblock); oven for culture growth (Selecta), IEF (isoelectric 
focusing) PhastSystem (Pharmacia Biotech), BIAcore System (Pharmacia Biosensor 
AB, Uppsala, Sweden). 
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9.2. Chemicals and immunochemicals 
 
The As 53-58 against 2,4,5-TCP were prepared in this thesis as described in Section 9.9. 
The As43-45 against 2,4,6-TCP were prepared previously in our group [259]. The rest of 
the immunochemicals were purchased from Sigma Chemical Co. (St. Louis, MO). 
Chlorophenols and bromophenols for cross-reactivity studies and fluoresceinamine 
isomer I (5-aminofluorescein) were purchased from Aldrich Chemical Co. (Milwaukee, 
WI, USA). The proteins KLH (keyhole limpet hemocyanine), BSA (bovine serum 
albumin), CONA (conalbumin), OVA (ovalbumin) and HRP (horseradish peroxidase) 
used in the preparation of the immunoreagents, coating antigens and enzyme tracers were 
purchased from Sigma Chemical Co. (St. Louis, MO). Bradford Protein Assay Dye 
Reagent for the determination of protein concentration was obtained from Bio-Rad 
Laboratoties GmbH (Munich, Germany). β-glucuronidase/sulfatase (type H2 from Helix 
pomatia) was purchased from Sigma (121 900 β-glucuronidase U/mL and 4 100 sulfatase 
U/mL. 
 
Digoxin (3β-[(O-2,6-didesoxi-β-D-ribo-hexopiranosil-(1-4)-O-2,6-didesoxi-β-D-ribo- 
hexopiranosil-(1-4)-2,6-didesoxi-β-D-ribo-hexopiranosil)oxy]-12β, 14-dihidroxi-5β-
card-20(22)enilode) and digoxin-BSA were purchased from Biogenesis and digoxin-HRP 
(digoxin:HRP=5:1) from YJ Bioproducts. Calmoduline and protein A-Sepharose CL-4B 
were purchased from Pharmacia Biotech; DEAE Sepharose Fast Flow, protein A-AP 
(alkaline phosphatase) and protein L-HRP were from Actigen Ltd. The bacterial strain 
E.coli suppressor strain TG1 for propagation of phage particles; the media for growth of 
cultures: 2xTY (tryptone and yeast extract) and TYE (tryptone, yeast extract and bacto-
agar)-plates; antibiotics (ampicilline, kanamycin), glucose, glycerol, tripsin, 4-
aminoantipirine, pNPP (p-nitrophenyl phosphate) substrate tablets and isopropyl-1-thio-
β-D-galactosidase (IPTG) were purchased from Sigma. Marker ∅X 174 RF DNA/HAE 
III Digest was obtained from Biotechnology. Taq dyedeoxy terminator cycle sequencing 
kit was obtained from Applied Biosystems. Restriction enzyme Sfi I/Not I and T4 DNA 
ligase were purchased from Biolabs. Immunopure IgG elution buffer was from Pierce. 
QIAprep spin miniprep kit, QIAquick PCR purification kit and QIAquick gel extraction 
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kit were products of Qiagen. Sensor chip CM5 (carboxymethylated dextran matrix), 
pioneer chip J1 (gold surface) and amine coupling kit were obtained from BIAcore. SDS 
polyacrylamide phast gel was from Pharmacia and the NuPAGE Electrophoresis 
System was from Novex, San Diego, CA. Polyprep-chromatography columns were 
obtained from Biorad and Nunc Maxisorp immunotest tubes from Life Technologies. 
Helper phage KM13 for the rescue of the phagemid libraries and the primers (pHENseq 
and LMB3) used in the PCR screening were available from Medical Research Centre-
Cambridge. The “synthetic” libraries (phagemid vector pIT2) were constructed by Dr. 
I.Tomlinson and the calmodulin vector pDN152 was a gift from Prof. Dr. D.Neri from 
MRC-Cambridge. 
 
Hapten 5 (3-(3-hydroxy-2,4,6-trichlorophenyl)propanoic acid) [259]; hapten 1 (2,4,6-
trichlorophenoxyacetic acid), hapten 2 (2,4,5-trichlorophenoxyacetic acid), hapten 9 (3-
hydroxy-2,6-dichlorophenylacetic acid), hapten 10 (3-hydroxy-4,6-dichlorophenylacetic 
acid) [260]; hapten A (3-(2-hydroxy-3,5,6-trichlorophenyl)propanoic acid), hapten 3 (3-
(2-hydroxy-3,5,6-trichlorophenyl)-2-propenoic acid), hapten 7 (3-(4-hydroxy-3,5-
dichlorophenyl)propanoic acid) and hapten 8 (3-(2-hydroxy-3,6-
dichloropheny)propanoic acid) [277]; hapten 11 and 12 [426] were prepared by R. Galve 
from our group. Hapten 4 (2-hydroxy- 3,5,6-trichlorobenzoic acid), was obtained from 
Aldrich Chemical Co. (Milwaukee, WI). Hapten B (2,4,5-trichlorophenoxypentanoic 
acid) was synthesized following the procedure described by Kramer et al [265]. 
 
The fluorescent tracers were prepared as follows: 
 
(3-(3-hydroxy-2,4,6-trichlorophenyl)propanoic 
acid) - fluorescein conjugate (TCP-F) 
Hapten 5 (19.37 mg, 0.1 mmol) and 
fluoresceinamine isomer I (34.8 mg, 0.1 mmol) were 
dissolved in anhydrous THF (5 mL) containing 6% 
DMF. After adding N,N’-diisopropylcarbodiimide (DIC) (22.8 µL, 0.15 mmol) the 
mixture was stirred for 16 h at room temperature under an argon atmosphere. The 
OH
Cl
Cl
O
NH
Cl
COOH
OH
O
O
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reaction was followed by TLC until a yellow spot (Rf=0.27) appeared on the 0.25mm pre-
coated silica gel 60 F254 aluminum sheets (Merck, Darmstadt, Germany) using 
toluene:ethyl acetate:acetic acid (5:5:1) as the mobile phase. The solvent was evaporated 
to dryness under reduced pressure and the residue was then dissolved in ethyl acetate and 
purified on 0.5 mm silica gel 60 F254 plates with the same mobile phase. The yellow band 
with Rf=0.73 obtained after four runs was extracted with ethyl acetate : methanol (1:1) 
and the extract evaporated to dryness to obtain an orange solid corresponding to the TCP-
F conjugate (22.58 mg, 37.7% yield), identified according to its spectroscopic data on a 
Varian Unity-300 (Varian Inc., Palo Alto, CA, USA) spectrometer (300 MHz for 1H and 
75 MHz for 13C).  
 
1H NMR (300 MHz, CD3OD) δ: 2.68 (t, J = 8.4 Hz, 2H, -CH2CONH-), 3.32 (t, J = 8.4 
Hz, 2H, PhCH2-), 6.55 (dd, J1 = 9 Hz, J2 = 2.4 Hz 2H, 
FNH2), 6.67 (d, J = 2.4 Hz, 2H, FNH2), 6.68 (d, J = 9 
Hz, 2H, FNH2), 7.14 (d, J = 8.4 Hz, 1H, FNH2), 7.38 (s, 
1HAr meta, hapten 5), 7.85 (dd, J1 = 8.4 Hz, J2 = 1.9 Hz, 
1H, FNH2), 8.3 (d, J = 1.8 Hz, 1H, FNH2).  
 
13C NMR (75 MHz, CD3OD) δ: 28.53 (t), 35.81 (t), 103.6 (d), 111.9 (s), 114.4 (d), 
116.7 (d), 121.8 (s), 124.7 (s), 125.4 (s), 126.3 (d), 127.5 
(d), 129.3 (d), 130.5 (d), 137.2 (s), 141.7 (s), 147.0 (s), 
150.6 (s), 154.7 (s), 159.9 (s), 171.5 (s), 173 (s). 
 
3-hydroxyphenylacetic acid - fluorescein conjugate 
(HOPh-F) 
3-hydroxyphenylacetic acid (15.2 mg, 0.1 mmol) 
and fluoresceinamine isomer I (34.8 mg, 0.1 mmol) 
were dissolved in anhydrous THF (3 mL) containing 
10% DMF. After adding N,N’-diisopropylcarbodiimide (DIC) (22.8 µL, 0.15 mmol) the 
mixture was stirred for 4 h at room temperature under an argon atmosphere. The reaction 
was followed by TLC until a yellow spot (Rf=0.3) appeared on the 0.25mm pre-coated 
OH
O
NH
COOH
OH
O
O
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silica gel 60 F254 aluminum sheets (Merck, Darmstadt, Germany) using toluene:ethyl 
acetate:acetic acid (5:5:1) as the mobile phase. The solvent was evaporated to dryness 
under reduced pressure and the residue was then dissolved in ethyl acetate and purified on 
0.5 mm silica gel 60 F254 plates with mobile phase dichloromethane:methanol:acetic acid 
(19:1:0.1). The yellow band with Rf=0.23 obtained after five runs was extracted with 
ethyl acetate : methanol (1:1) and the extract evaporated to dryness to obtain an orange 
solid corresponding to the HOPh-F conjugate (21 mg, 40 % yield), identified according to 
its spectroscopic data on a Varian Unity-300 (Varian Inc., Palo Alto, CA, USA) 
spectrometer (300 MHz for 1H and 75 MHz for 13C).  
 
1H NMR (300 MHz, CD3OD) δ: 3.66 (s, 2H, -CH2CONH-), 6.55 (dd, J1 = 8.7 Hz, J2 = 
2.4 Hz 2H, FNH2), 6.6 (d, J = 2.1 Hz, 2H, FNH2), 6.69 
(ddd, J1 = 8.1 Hz, J2 = 2.4, J3 = 0.4, 1HAr, para, hapten) 
6.74 (d, J = 9 Hz, 2H, FNH2), 6.85 (d, 2HAr ortho, 
hapten), 7.14 (dd, J = 8.1 Hz, 1H, FNH2), 7.19 (t, J1 = 
8.1 Hz, 1HAr meta, hapten), 7.87 (dd, J1 = 8.4 Hz, J2 = 
1.9 Hz, 1H, FNH2), 8.27 (d, J = 1.8 Hz, 1H, FNH2).  
 
13C NMR (75 MHz, CD3OD) δ: 44.7 (t), 103.6 (d), 112.6 (s), 115 (d), 115.6 (d), 116.9 
(d), 117.6 (d), 121.3 (d), 126.6 (d), 127.1 (d), 130.6 (d), 
130.8 (d), 132.2 (s), 137.8 (s), 141.6 (s), 144.3 (s), 155.4 
(s), 158.7 (s), 159.9 (s), 165.1 (s), 171.8 (s), 172.7 (s). 
 
 
9.3. Buffers 
 
PBS is 10 mM phosphate buffer, 0.8 % saline solution and unless otherwise indicated the 
pH is 7.5. Borate buffer is 0.2 M boric acid-sodium borate pH 8.7. Coating buffer is 50 
mM carbonate-bicarbonate buffer pH 9.6. PBST is PBS with 0.05 % Tween 20. Citrate 
buffer is a 40 mM solution of sodium citrate pH 5.5. The substrate solution contains 
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0.01% TMB (tetramethylbenzidine) and 0.004% H2O2 in citrate buffer. The water used 
was deionised, filtered and purified on a Milli-Q Reagent Grade Water System from 
Millipore. 
 
9.4. Other materials 
 
The dialysis membranes (12-14000 Da) used have 0.81 mL/cm capacity, diameter of 10 
mm and width of 16 mm. Polystyrene microtiter plates (96 wells) used in the ELISA 
experiments were purchased from Nunc (Maxisorp, Roskilde, DK). Microtiter plates (96 
wells) used in the Bradford protein assay were purchased from Dynatech (St. Peter Port, 
Guernsey, Channel Islands). The precision pipettes of different volume and the 
multichannel pipette (50-1200 µL) used in HTS-IAC-SPE are Eppendorf production and 
the multichannel pipette (25–200 µL) used in ELISA is from Micronic Systems (Lelistad, 
Holland).  
 
HiTrap desalting column (5 mL bed) prepacked with SephadexG-25 Superfine 
(Pharmacia Biotech, Uppsala, Sweden) was used for desalting of the purified IgG fraction 
of As45. Human serum ultrafiltration for matrix effect studies was performed with filters 
(10 kDa cut-off, Millipore). A Sep-Pak Plus C18 cartridge (Waters, S.A.) (360 mg 
nominal weight of sorbent, 10-15 mg analyte capacity, maximum sample volume 300 
mL, stable in the range pH 3-8) was used for urine clean-up. For IAC-SPE, HiTrap NHS 
activated Sepharose columns (1 mL bed) were purchased from Pharmacia Biotech 
(Uppsala, Sweden). The gel is based on highly cross-linked agarose beads with 6 atoms 
spacer arms attached to the matrix by epichlorohydrine and activated by N-
hydrohysuccinimide (NHS). The substitution level is approximately 10 µmol NHS-
groups/mL gel. For HTS-SPE-IAC NHS-activated Sepharose 4 Fast Flow (Pharmacia 
Biotech, Uppsala, Sweden) was used. It is highly cross-linked 4% agarose matrix with a 
ligand density 16-23 µmol NHS/mL drained medium, mean particle size 90 µm and pH 
stability 3-13.  
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VersaPlate 96-Well SPE System (Varian, Palo Alto, CA, USA) consists of a 96-well 
baseplate, removable 96 empty tubes and a vacuum manifold set. The vacuum manifold 
was connected to a water pump. The vacuum controller (mechanical gauges) was 
purchased from Hucoa-Erlöss. VersaPlate accessories, such as disposable waste 
reservoir, cartridge removal tool, 20 µm pore frits, 96 glass vials (0.75 mL) in a collection 
rack, 96-well microplate Teflon-coated silicone rubber seal, sealing tape pads, and sealing 
caps, were purchased from Varian.  
 
9.5. Molecular modeling and theoretical calculations 
 
Molecular modeling was performed using the Hyperchem 4.0 software package 
(Hyperube Inc, Gainesville, FL, USA). Theoretical geometries and electronic 
distributions were evaluated for 2,4,5-trichlorophenol and the haptens using 
semiempirical quantum mechanics MNDO [273] and PM3 [427] models. All the 
calculations were performed using standard computational chemistry criteria. Theoretical 
calculations regarding pKa values were carried out using the ACD/pKa 1.2 software 
package (Advanced Chemistry Development Inc., Toronto, ON, Canada) at the 
Department of Analytical Chemistry (University of Lund, Sweden). 
 
9.6. Preparation of protein conjugates 
 
9.6.1. Mixed anhydride (MA) method – general protocol 
 
Tributylamine (11.6 µL, 44 µmol) and isobutylchloroformate (6.4 µL, 48 µmol) were 
added dropwise under Ar atmosphere to a solution of the hapten (40 µmol) in anh. DMF 
(300 µL) in an ice bath. The reaction took place for 30 min at RT under stirring. The 
activated hapten was added dropwise to a solution of the protein (10 mg) in 1.8 mL borate 
buffer (pH=8.7). The coupling reaction took place under stirring for 4h at room 
temperature (see Figure 9.1). The conjugates were dialyzed against PBS 10 mM (4 times 
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Figure 9.1. Mixed anhydride method 
x 5L) and H2O (1 time x 5L), lyophilized and stored at –40ºC. Working aliquots 
(1mg/mL, PBS 10mM) were kept at 4ºC. 
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Figure 9.2. Active ester method used for the ET conjugation 
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9.6.2. Active ester (AE) method – general protocol 
 
The hapten (10 µmol) was reacted with NHS (N-hydroxysuccinamide, 5.7 mg, 50 µmol) 
and DCC (dicyclohexylcarbodiimide, 20.6 mg, 100 µmol) in anh. DMF (200 µmol) under 
stirring for 1h at room temperature. The suspension formed was centrifuged at 10000 rpm 
for 10 min and the supernatant was added drop wise to a solution of the protein (HRP, 2 
mg or BSA, OVA and CONA, 10 mg) in 1.8 mL borate buffer. The coupling reaction 
took place under stirring for 2h at room temperature (see Figure 9.2). The conjugates 
were dialyzed against PBS 10 mM (4 times x 5L) and H2O (1 time x 5L), lyophilized and 
stored at –40ºC. Stock solutions of the obtained ETs (1 mg/mL) were prepared in 
PBS/saturated (NH4)2SO4 (1:1) and stored in aliquots under argon atmosphere at 4ºC. 
Working aliquots of the coating antigens (1 mg/mL, PBS 10mM) were kept at 4ºC.  
 
9.7. Bradford protein assay 
 
Standard curves (1–40 µg/mL) for each protein (BSA, CONA, OVA) were prepared in 
PBS 10 mM. These standards and the samples of CAs (in serial dilutions) were placed in 
a microplate (160 µL/well) in triplicate and then Bradford Protein Assay Dye Reagent 
was added (40 µL/well). After 15 min the absorbance at 595 nm was measured. 
 
9.8. Hapten density analysis 
 
Hapten densities of BSA and OVA conjugates were determined by matrix-assisted laser-
desorption ionization time-of-fly mass spectrometry (MALDI-TOF-MS) by comparing 
the molecular weight of the standard protein (BSA or OVA) with that of the respective 
conjugates. The MALDI-MS (matrix-assisted laser desorption ionization mass 
spectrometer) used for analyzing the protein conjugates was a Perspective Biosystems 
Time of Flight (TOF) Mass Spectrometer Voyager-DE TM RP equipped with a laser unit 
which operates with an intensity of 2800. The instrument is controlled by a 
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BioSpectrometryTM Workstation provided with the software Voyager-DETM-RP (version 
4.03) developed by Perspective Biosystems Inc. (Framingham, MA, USA) and 
GRAMS/386TM (for Microsoft Windows, version 3.04, level III) developed by Galactic 
Industries Corporation (Salem, NH, USA). MALDI spectra were obtained by mixing 2 
µL of the matrix (trans-3,5-dimethoxy-4-hydroxycinnamic acid, 10 mg/mL in 
CH3CN/H2O 70:30, 0.1% TFA) with 2 µL of a solution of the conjugates or proteins (10 
mg/mL in CH3CN /H2O 70:30, 0.1% TFA). Hapten density (δ) is calculated according to: 
)hapten(
)Protein()CA(
Mw
MwMw −=δ , 
where Mw(CA) is the molecular weight of the coating antigen, Mw(Protein) is the 
molecular weight of the protein used for the conjugation, and Mw(hapten) is the 
molecular weight of the hapten. 
 
9.9. Polyclonal antisera 
 
Three female New Zealand white rabbits (As53-55) were immunized with A–KLH and 
other three rabbits (As56-58) were immunized with B-KLH. Evolution of the antibody 
titer was assessed by measuring the binding of serial dilutions of the antisera to microtiter 
plates coated with A–BSA and B-BSA. After an acceptable antibody titer was observed, 
the animals were exsanguinated and the blood was collected on vacutainer tubes with a 
serum separation gel. Antiserum was obtained by centrifugation and stored at -40°C in 
the presence of 0.02% NaN3. The antisera (As) were used in ELISA without further 
purification. Working aliquots were stored at 4ºC. 
 
Polyclonal antisera (As43, As44 and As45) against 2,4,6-TCP were obtained in our group 
by immunization of female New Zealand white rabbits with hapten 5 conjugated to KLH 
by the mixed anhydride method [259]. 
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9.10. Development of an ELISA for 2,4,5-TCP 
 
Non-competitive immunoassays were used to select immunoreagents and to establish the 
most appropriate concentrations. The objective of the experiments called "1D" was to 
select those immunoreagents (ETs, CAs, ans As) able to react giving enough response 
under the immunoassay conditions. The objective of the experiments called "2D" was to 
establish the most appropriate concentrations for competitive assays and to evaluate 
antibody avidity versus ETs and CAs. 
 
The competitive immunoassays used in this thesis were used to measure the analyte. The 
shape and features of the calibration curves were used to optimize the immunoassay 
conditions. In these assays the standard curves were fitted to a four-parameter logistic 
equation according to the following formula: 
y = (A-B/[1-(x/C)D])+B, 
where A is the maximal absorbance, B is the minimum absorbance, C is the concentration 
producing 50% of the maximal absorbance, and D is the slope at the inflection point of 
the sigmoid curve. 
 
In this work we have used direct and indirect ELISA formats. 
 
9.10.1. Direct ELISA 
 
General protocol 
Microtiter plates were coated with the respective dilution of the As in coating buffer (100 
µL/well) overnight at 4ºC. The following day the plates were washed 4 times with PBST 
(300 µL/well) and the ET (or ET and analyte) solutions prepared in PBST were added 
and incubated for 30 min at RT. The plates were washed again 4 times with PBST and the 
substrate solution (100 µL/well) was added and incubated 30 min at room temperature. 
The enzymatic reaction was stopped by adding 4 N H2SO4 (50 µL/well). Finally, the 
plates were read at absorbance 450 nm. 
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A. Non-competitive assays 
No analyte was added. The ETs were added to the coated plates appropriately diluted in 
PBST (100 µL/well). 
 
- Experiment 1D 
For each ET (haptens A, 1-5 and 7-12) microtiter plates were coated with each antisera 
(As53-58, 1/1000 dilution) in different columns. On the next day the plates were washed 
and the ETs were added to each column in serial dilutions (1/500 to 1/32000, stock 
solution 0.5 mg/mL). The plates were processed as it is described in the general protocol. 
 
- Experiment 2D 
The avidity of the As53-As58 versus the enzyme tracers was determined by measuring 
the binding of serial concentrations (2 to 0.030 µg/mL in PBST, 100 µL/well) of each ET 
(2-, 5-, A-HRP) to microtiter plates coated overnight at 4ºC with twelve different 
dilutions (1/1000 to 1/1024000 in coating buffer, 100 µL/well) of each of As. Last 
column of the plate was reserved to test non-specific absorbance of the ET to the 
microtiter plate. The plates were processed as it is described in the general protocol. 
 
B. Competitive assays 
To the coated plates the analyte was added (100 000 to 0.025 nM in PBST, 50 µL/well) 
followed by the ETs (appropriately diluted in PBST, 50 µL/well). 
 
9.10.2. Indirect ELISA 
 
 General protocol 
Microtiter plates were coated overnight at 4ºC with the appropriate concentration of the 
CA in coating buffer (100 µL/well). The plates were washed 4 times with PBST and a 
solution of the As appropriately diluted in PBST (or a solution of the analyte standrads 
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followed by the solution of the As) was added and incubated for 30 min at RT. Then the 
plates were washed again and a solution of goat anti-rabbit IgG coupled to horseradish 
peroxidase (antiIgG-HRP) in PBST (1/6000) was added to the wells (100 µL/well) and 
incubated for 30 min at room temperature. The plates were washed again and the 
substrate solution (100 µL/well) was added. Color development was stopped after 30 min 
at RT with 4N H2SO4 (50 µL/well) and the absorbance was read at 450 nm. 
 
A. Non-competitive assays 
No analyte was added. The CAs were added to the coated plates appropriately diluted in 
PBST (100 µL/well). 
 
- Experiment 1D 
For each As, each column of a microtiter plate was coated by a solution of CA in coating 
buffer at 1 µg/mL concentration (100 µL/well). After washing the As was added in serial 
dilutions (from 1/1000 to 1/64000 in PBST; 100 µL/well). Next the general protocol was 
followed. 
 
- Experiment 2D 
The avidity of the different As53-As58 for the coating antigens was determined by 
measuring the binding of serial dilutions (from 1/1000 to 1/64000 in PBST; 100 µL/well) 
of each As to microtiter plates coated overnight at 4ºC with twelve different 
concentrations (from 10 to 0.005 µg/mL in coating buffer; 100 µL/well) of the 1-5 and 7-
12 -BSA, -CONA and –OVA conjugates. The plates were processed as described above. 
Optimal concentrations for coating antigens and As dilution were chosen to produce 
around 0.7 to 1 units of absorbance in 30 min. One column of the plate was reserved to 
test non-specific binding of the As to the microplate. One raw of the plate served to test 
non-specific binding of the antiIg-HRP to the CA. 
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B. Competitive assays 
Analyte standards (100 000 to 0.025 nM, prepared in PBS), cross-reactants or samples 
were added to the coated plates (50 µL/well) followed by the corresponding antisera 
appropriately diluted in PBST (50 µL/well).  
 
9.10.3. Indirect ELISA for 2,4,5-TCP (As53/7-OVA) 
 
Microtiter plates were coated with 7-OVA (AE) (1:2.5) (0.6 µg/mL in coating buffer, 100 
µL/well) overnight at 4 ºC. The following day the plates were washed with PBST (4 
times, 300 µL/well). 2,4,5-TCP standards (400 to 0.04 nM, prepared in PBS), cross-
reactants or samples were added to the coated plates (50 µL/well) followed by the sera 
As53 (1/1000 in PBST, 50 µL/well). The plates were processed as described above. 
 
9.10.4. Optimization and evaluation of the indirect ELISA 
for 2,4,5-TCP (As53/7-OVA) 
 
Preincubation time: The As and the 2,4,5-TCP standard solutions were incubated 
under two different conditions (overnight at 4°C and 0 h at RT) and, subsequently, added 
to the antigen coated plates. The plates were processed as already described. 
 
Length of competitive step: The mixture of As and analyte standards were 
incubated during different periods of time (10, 20, 40, 60 and 120 min) at RT on the same 
antigen coated plate. The plates were processed as already described. 
 
Effect of Tween 20: PBST solutions containing different concentrations of Tween 20 
(2.5; 0.5; 0.05; 0.025; 0%) were used to dilute the As and prepare different 2,4,5-TCP 
standards that were run simultaneously in the competitive ELISA. 
 
Effect of pH: PBS solutions were prepared with pH values ranging from 2.5 to 10.5 
units. These solutions were used to prepare 2,4,5-TCP standard curves and the As 
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solution and employed for the competitive immunoassay. The curves with the different 
pH were all measured in the same ELISA plate and the experiments was repeated in two 
separate plates. The absorbances were adjusted to a four-parameter equation and the 
features of the resulting ELISAs were compared. 
 
Effect of ionic strength: PBS solutions at different concentrations (0, 5, 10, 20 and 
50 mM corresponding to conductivities of 0, 10, 19, 35, 80 mS/cm respectively) were 
prepared, their conductivity measured and used to prepare standards and to dilute the As. 
The solutions were employed in the above described ELISA and the calibration curves 
obtained with each PBS solution were compared after adjusting them to a four-parameter 
equation. 
 
Effect of ethanol: PBS solutions containing different concentrations of EtOH (v/v) 
(50%; 25%; 10%; 0%) were used to prepare standard curves and were run simultaneously 
in the competitive ELISA according to the procedure described above. 
 
Specificity Studies: Stock solutions of different phenolic compounds (2-
chlorophenol, 3-chlorophenol, 4-chlorophenol, 2,4-dichlorophenol, 2,5-dichlorophenol, 
2,6-dichlorophenol, 3,4-dichlorophenol, 2,4,5-trichlorophenol, 2,4,6-trichlorophenol, 
2,3,4-trichlorophenol, 2,3,5-trichlorophenol, 2,3,6-trichlorophenol, 2,3,4,5-
tetrachlorophenol, 2,3,4,6-tetrachlorophenol, 2,3,5,6-tetrachlorophenol, 
pentachlorophenol, 4-bromophenol, 2,4-dibromophenol, 2,6-dibromophenol, 2-bromo-4-
chlorophenol, 2,4,6-tribromophenol, pentabromophenol) were prepared (1 mM in 
DMSO) and stored at 4oC. Standard curves were prepared in PBS (10 000 to 0.04 nM) 
and each IC50 determined in the competitive experiment described above. The cross-
reactivity values were calculated according to the following equation:  
 
( )
( ) 100_
5,4,2%
50
50 ×−=
compoundphenolicIC
TCPICCR  
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Precision and Accuracy: PBS solution was spiked with 2,4,5-TCP at several 
concentration levels. Analyses of the samples were performed using the above-described 
ELISA in triplicates in three separated plates in three different days. 
 
9.11. ELISA for 2,4,6-TCP (As43/8-BSA)  
 
According to [277] microtiter plates were coated with 8-BSA(1:5) in coating buffer 
(0.625µg/mL, 100 µL/well) overnight at 4ºC covered with adhesive plate sealers. The 
following day the plates were washed with PBST (4 times, 300 µL/well). 2,4,6-TCP 
standards (1000 to 0.625 nM, prepared in PBS) or samples were added to the coated 
plates (50 µL/well) followed by the sera As43 (1/2000 in PBST, 50 µL/well). The plates 
were processed as described above. 
 
9.12. Sample Treatment Methods 
 
9.12.1. Water samples 
 
Drinking and well water samples were collected and their conductivity and pH values 
were measured. In order to adjust these parameters, samples were buffered by adding 
10% (v/v) of 10x PBS. 
 
9.12.2. Milk samples 
 
Homogenized skimmed milk was obtained by a local supermarket. It contained 31 g/L 
proteins, 1.2 g/L Ca2+ and fat ≤ 5 g/L. It was stored refrigerated and used prior to the 
manufacturer´s expiration date. 
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Protein removal by alkaline precipitation: A solution of 5N NaOH was added 
dropwise to a stirred milk sample until pH=12. The white precipitate formed was 
removed by centrifugation (12000 rpm, 5 min) and the supernatant was collected. It was 
diluted 5 fold by 2x PBS and the pH was adjusted to 7.5 using 5N HCl. Further milk 
dilutions (1/10, 1/50 and 1/100) were prepared with 2x PBS. All the samples were 
vortexed vigorously between dilutions. 
 
Ca2+- precipitation by Na2SO4: Na2SO4 was added to a stirred to the milk sample 
until final concentration 2 g/L. The CaSO4 precipitate formed was centrifuged (12000 
rpm, 5 min) and the supernatant filtered through Whatmann paper. The filtrate was split 
in two parts. One part was treated with NaOH (protein removal) as described above and 
the other split was used to prepare serial dilutions in 2x PBS until final milk dilution 
1/100. All dilutions had the pH and conductivity of the buffer. 
 
9.12.3. Human serum 
 
Lyophilized-pooled human sera was purchased from Sigma Chemical Co. (St. Louis, 
MO) and reconstituted with 5 mL milliQ water following the supplier instructions. The 
serum was stored at -4°C until use. Several sample treatments were assayed as follows:  
 
Protein removal by heat: Serum (1 mL) was diluted two times with water and 
heated on a sand bath (65ºC) for 30 min. After cooling it at 4ºC it was centrifuged (12000 
rpm, 5 min) and the white precipitate formed was removed. The supernatant was diluted 
in PBS until a final serum dilution 1/20. 
 
Alkaline protein precipitation: KOH was added to a stirred serum sample (0.5 
mL) until 0.2M KOH final concentration. The solution was stirred for 30 min. The 
precipitate formed was removed by centrifugation (12000 rpm, 5 min) and the 
supernatant collected. The pH was adjusted to 7.5 using 5N HCl. Further serum dilutions 
were prepared with PBS. 
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Acidic protein precipitation by trichloroacetic acid (TCA): Trichloroacetic 
acid (50 mg/mL) was added dropwise under magnetic stirring to human serum (0.5 mL) 
at 1:4 v/v ratio for 5 min. The precipitate was formed immediately and it was removed by 
centrifugation (12000 rpm, 5 min). The supernatant was diluted two-fold times in PBS 
and pH was adjusted to 7.5 by 5N NaOH. Thus the final solution was a 1/10 serum 
dilution. Further serum dilutions were prepared in PBS. 
 
Acidic precipitation by perchloric acid: Aqueous perchloric acid (6%) was 
added dropwise under magnetic stirring to human serum sample (0.5 mL) until a 1:1 v/v 
ratio for 5 min. The precipitate was formed immediately and it was removed by 
centrifugation (12000 rpm, 5 min). The supernatant was diluted 2-fold times in PBS and 
the pH was adjusted to 7.5 by 5N NaOH. The final solution was a 1/5 serum dilution 
containing 1.2% perchloric acid. Further serum dilutions were prepared in PBS. 
 
Ethanol deproteinization: Absolute ethanol was added dropwise under magnetic 
stirring to human serum sample (1 mL) until a 1:1 v/v ratio for 5 min. The precipitate 
formed was removed by centrifugation (12000 rpm, 15 min) and the supernatant was 
diluted two-fold times in PBS. Thus, the final solution was a 1/4 serum dilution 
containing 25% EtOH. Further serum dilutions were prepared with 25% EtOH/PBS.  
 
9.12.4. Human urine 
 
Sample A was collected over 2 days from a healthy male volunteer and then mixed to 
have a large and homogeneous urine sample. Sample B is pooled urine from different 
individuals (tested negative for specific drugs of abuse, 0.1%NaN3) and it was purchased 
by Bio-Rad Laboratories, Irvine, USA. Urine samples (C, D, E, F, G, H, I) were obtained 
(morning void) from persons with not known occupational exposure. Urine samples 
collected from petrochemical workers living in town A, service workers and population 
living in vicinity of a municipal incinerator (town B) were kindly supplied by the Instituto 
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de Higiene y Seguridad en el Trabajo in Barcelona. The urine sample used in the QFIA 
was a pool from different healthy individuals (24 h void). All urine samples were 
aliquoted and stored at -30°C.  
 
Creatinine determination: The concentration of creatinine was determined by the 
Jaffé method, in which creatinine reacts with alkaline picrate to form a coloured complex. 
The intensity of the colour is measured at 520 nm. The clinical method NºSM4-0141 for 
Technicon RA Systems [428] was adapted to a microplate assay determination: a 
solution of 0.4N NaOH was added to the plate (100 µL/well) followed by the urine 
samples (1/100 diluted in water, 50 µL/well). After 5 min at 25°C a solution of picric acid 
(2 g/L, 100 µL/well) was added and gently mixed. The absorbance was read immediately 
(∼1 min) at 520 nm (A520 = A1) and after 5 min it was measured again (A520 = A2). As 
standard 1 mg/mL creatinine solution was used (ASt). The creatinine concentration was 
calculated according to: 
12
12)urine mlcreatinie/ g(
AstAst
AAmC −
−=  
 
Hydrolysis (Deconjugation step): Glucuronides and sulfates of chlorophenols 
were cleaved by acidic, enzymatic or alkaline hydrolysis of urine samples. 
Acid hydrolysis: concentrated H2SO4 (0.52 mL) was added to the urine sample (10 
mL) until 1M H2SO4 final concentration and heated on a sand bath for 1h at 100ºC. After 
cooling the sample was neutralized (pH=7.5) by adding NaOH and centrifuged. 
Enzymatic hydrolysis: urine (3 mL), 1M acetate buffer (pH=5.2, 1 mL) and β-
glucuronidase/sulfatase (300 µL) were mixed and incubated for 17h at 37°C. The pH was 
finally adjusted to 7.5 with 1N NaOH. 
Alkaline hydrolysis: A solution of 15M KOH (2 mL) was added to urine (10 mL) and 
heated on a sand bath for 30 min at 100ºC. After cooling the sample was neutralized 
(pH=7.5) by adding concentrated H2SO4 and centrifuged to eliminate the precipitated 
salts and/or proteins. 
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9.13. ELISA performance in environmental and 
biological samples 
 
9.13.1. Matrix effect studies 
 
Standard curves of 2,4,5-TCP and/or 2,4,6-TCP were prepared in water samples, in cow 
milk, in human serum and in human urine samples treated as described above. The 
parallelism of the standard curves was studied by comparing the calibration curve 
features with those obtained in the assay buffer. For human serum samples deproteinized 
with ethanol the standard curve was run in 25% EtOH/PBS for the 2,4,5-TCP ELISA and 
in 12% EtOH/PBS for the 2,4,6-TCP ELISA. The competitive ELISAs were run 
following the protocols described in Section 9.10.4 and Section 9.11 respectively. 
 
9.13.2. Recovery studies  
 
Water, urine and serum samples treated as described above were spiked at different 
concentration levels with 2,4,5- and/or 2,4,6-TCP and applying the dilution factors 
needed to eliminate the corresponding matrix effect were measured by the ELISA. 
 
9.14. Development of SPE procedures for urine 
analysis by ELISA 
 
9.14.1. C18-SPE procedure 
 
A Sep-Pak Plus C18 cartridge (Waters, S.A.) was conditioned by passing MeOH (5 mL) 
followed by 0.1% aqueous acetic acid (5 mL). Acidified samples (10 mL, pH=3.5) (PBS 
standards, spiked and non-spiked urine) were then loaded into the column. The cartridge 
was washed with 5 mL of 50:50 MeOH:H2O (0.1% acetic acid) and 2,4,6-TCP eluted in 5 
mL of MeOH:H2O (0.1% acetic acid) containing different concentration of MeOH (65%, 
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75%, or 85%). All the steps were performed at a flow rate of 1 mL/min. Fractions of 1 
mL were collected, diluted 10 times (to the initial sample volume) with PBS and split in 
two parts for 2,4,6-TCP ELISA (see potocol in Section 9.11) and GC-ECD analysis. The 
C18 cartridge was regenerated by washing with 30 mL MeOH. 
 
9.14.2. IAC-SPE procedure  
 
A. Immunosorbent preparation 
 
Antibody purification: Polyclonal antiserum 45 was purified by 35% (NH4)2SO4 
precipitation as described [429]. The precipitated IgG fraction was restored with 10 mM 
PBS and dialized against 0.5 mM PBS with three buffer changes and one with MilliQ 
water. The aqueous solution was finally freeze-dried and stored at -30°C until use. 
 
Antibody immobilization: Subsequently the IgG (Ab45) was covalently coupled to 
the NHS-activated Sepharose column as recommended by the manufacturer (Pharmacia) 
(see Figure 9.3). Briefly, a solution of IgG (10 mg/mL, 1mL) in coupling buffer (0.2 M 
NaHCO3, 0.5 M NaCl, pH=8.3) was injected onto the HiTrap column at a flow rate of 1 
mL/min. The column was then left to stand 25 min at room temperature and washed with 
three column volumes of coupling buffer. The excess active groups that have not coupled 
to the ligand were deactivated by alternate (6 mL each) and repetitive (3 cycles) 
injections of 0.5 M ethanolamine (0.5 M NaCl, pH=8.3) and 0.1 M acetate (0.5 NaCl, 
pH=4) buffers. Finally, the column was washed with 2mL 10 mM PBS buffer and stored 
at 4°C in 0.05 M Na2HPO4 (pH=7) containing 0.1% NaN3 until needed. 
OCONH(CH2)5C
O
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Figure 9.3. Antibody coupling to the NHS-activated Sepharose. 
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B. Determination of antibody coupling efficiency 
 
The coupling efficiency to the HiTrap column was estimated as the difference between 
the total amount of IgG initially loaded onto the column and the amount of IgG found in 
the eluted buffer after the coupling took place. The IgG concentration in both solutions 
was determined by UV measurement at λ=280 nm. Previously, the collected solution 
after coupling of IgG to the column was purified from the co-eluting NHS groups 
absorbing at the same wavelength as proteins using a HiTrap desalting column 
prepacked with SephadexG-25 Superfine. 
 
C. Evaluation of analyte desorption conditions 
 
Glycine-HCl elution: 0.05M glycine-HCl (pH=3) was used for analyte elution. To 
each eluted fraction (1 mL) a basic aqueous solution (0.2M NaOH/1.8M NaCl) was added 
(87 µL) resulting in pH=8.6 and conductivity of 15 mS/cm. The 2,4,6-TCP concentration 
in each fraction was determined by ELISA using a standard curve run in glycine-
HCl/NaOH/NaCl (pH=8.6, 15 mS/cm). Previously the accuracy of the ELISA method in 
this buffer system was evaluated using 2,4,6-TCP standards prepared in 0.05M glycine-
HCl (pH=3) and treated as eluted fractions.  
 
Ethanol elution: The optimum elution conditions were investigated using different 
concentrations of EtOH (10%, 20%, 30%, 50%, 70%) in PBS after loading the column 
with 2,4,6-TCP standards prepared in PBS. The 2,4,6-TCP concentration in each eluting 
fraction was determined by ELISA using a standard curve run in the corresponding 
percentage of EtOH in PBS. Blanks and washings were evaluated from a curve prepared 
in PBS. 
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D. General IAC-SPE procedure 
 
The IAC process cycle consists of sample loading, washing, eluting and regenerating. The 
column was brought to room temperature and washed with 5 mL PBS. Then was 
preconditioned with 5 mL of 70% EtOH (or 0.05M glycine-HCl, pH=3) and 5 mL PBS. 
After loading the sample (spiked PBS or urine) the column was washed with 5 mL PBS 
(or 20% EtOH). The bound analyte was eluted with 70% EtOH (or 0.05M glycine-HCl, 
pH=3). Subsequently, the column was regenerated with 10 mL PBS. All the steps were 
performed at flow rate of 1 mL/min and at RT. Eluted fractions were diluted 10 times 
with PBS in the case of ethanol elution (or adjusted to pH=8.6 and conductivity 15 
mS/cm in the case of glycine-HCl elution) and analyzed by ELISA and/or by GC-ECD. 
 
E. Analyte binding capacity of the IAC column 
 
The capacity of the column was determined by loading PBS samples 10 mL with three 
levels of 2,4,6-TCP: 1.2, 0.5 and 0.05 µg. After washing away the unbound fraction, the 
bound fraction was eluted (E) following the general IAC procedure (see Section 9.14.D), 
diluted 10 times with PBS and the concentrations were measured by ELISA and 
evaluated from a standard curve run in 7% EtOH/PBS buffer. The collected loading (L) 
and washing (W) fractions were determined using a standard curve run in PBS. 
 
9.14.3. Matrix effect studies on the 2,4,6-TCP ELISA after 
SPE clean-up of human urine 
 
Standard curves of 2,4,6-TCP were prepared in the corresponding buffer (8.5% 
MeOH/0.1% AcOH/PBS or 7% EtOH/PBS) and in the combined eluted fractions 
obtained in the C18-SPE and IAC-SPE of the urine respectively. The competitive ELISA 
was run according the protocol described in Section 9.11 to compare the parallelism of 
the urine standard curves to the calibration curves run in the corresponding buffer. 
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9.14.4. Recovery studies on the SPE procedures 
 
Non-hydrolyzed and hydrolyzed urine samples were spiked with 2,4,6-TCP and 
processed according to the SPE (C18 or IAC) procedures described above (Section 9.14.1 
and Section 9.14.2.D respectively). After 10-fold dilution with PBS buffer the recoveries 
were determined by ELISA using 2,4,6-TCP standards prepared in the same medium 
(8.5% MeOH/0.1%AcOH/PBS for C18 SPE or 7% EtOH/ PBS for IAC). 
 
9.15. Development of a HTS-IAC-SPE procedure for 
efficient urine clean-up 
 
9.15.1. Immunosorbent preparation 
 
The IgG (Ab45) was covalently coupled to the NHS-activated Sepharose 4 Fast Flow as 
recommended by the manufacturer (Pharmacia) (see Figure 9.3). Coupling was 
performed using 24 mL of Sepharose suspension. All washing steps were performed with 
filtration funnel under vacuum (water pump). The procedure per 1 mL is briefly described 
as follows. The Sepharose suspension (1 mL) was washed with cold 1 mM HCl (12 mL). 
The drained gel (0.5 mL) was transferred to a tube and mixed with the solution of the 
purified IgG (20 mg/mL, 0.5 mL) in coupling buffer (0.2 M NaHCO3, 0.5 M NaCl, 
pH=8.3). The suspension was left shaking (100 rpm) for 3h at room temperature. After 
coupling took place, the Sepharose was washed with 3 mL of coupling buffer. Further, it 
was washed 3 x 1 mL 0.5 M ethanolamine buffer (0.5 M NaCl, pH=8.3), followed by 3 x 
1 mL 0.1 M acetate (0.5 NaCl, pH=4) buffer and again with 3 x 1 mL ethanolamine 
buffer. The non-reacted NHS-groups were blocked for 1h at room temperature with 
ethanolamine buffer. After 3 cycles of alternate washing with ethanolamine and acetate 
buffers the gel was washed 3 x 1 mL 10 mM PBS buffer. Finally, it was reconstituted to 
the initial suspension volume (1 mL) and stored at -4°C in 0.05 M Na2HPO4 (pH=7) 
containing 0.1% NaN3 until needed. The Ab coupling efficiency was estimated as 
described in Section 9.14.B. 
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9.15.2. Mini-IAC column preparation 
 
Mini-IAC columns (0.2 mL bed volume) were prepared by loading 0.4 mL coupled 
Sepharose suspension into the empty columns. The suspension should be very well mixed 
before use! The columns were packed by suction under vacuum (water pump) washing 
them with PBS. Once the gel drained, a frit (20 µm pore) was loaded manually over it to 
protect the column bed. 96 columns were packed in this way and inserted into the 
VersaPlate base plate. Finally, the VersaPlate 96-Well SPE System (Varian) was 
assembled. 
 
9.15.3. Analyte binding capacity of the mini-IAC columns 
 
The capacity of the column was determined by loading PBS samples (6 mL) with four 
2,4,6-TCP levels: 0.75, 0.5, 0.1 and 0.05 µg. After washing away the unbound fraction, 
the bound fraction was eluted (see the general HTS-IAC SPE procedure, Section 9.15.5), 
diluted 10 times with PBS and the concentrations were measured by ELISA and 
evaluated from a standard curve run in 7% EtOH/PBS buffer. 
 
9.15.4. Evaluation of desorption conditions of the mini-IAC 
columns 
 
The optimum elution conditions were investigated using different concentrations of EtOH 
in the elution buffer (10%, 20%, 30% and 70%) after loading the column with 2,4,6-TCP 
standards prepared in PBS. The 2,4,6-TCP concentration in each elution fraction was 
determined by ELISA using standard curve run in the corresponding percentage of EtOH 
in PBS. 
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9.15.5. General HTS-IAC-SPE procedure 
 
HTS-IAC-SPE procedures were performed with the VersaPlate 96-Well SPE System, 
which consists of vacuum manifold set equipped with a vacuum controller and water 
pump. All steps of the IAC cycle were performed under gentle low vacuum maintaining 
flow-rate in the range 1 - 2 mL/min. The vacuum manually controlled allowed the 
different solvents (buffers, samples) to pass through the IAC-extracton columns: the 
columns should be kept wet after conditioning and loading steps and dried after the 
washing and elution. To protect the immunosorbent for being dried at the conditioning 
and loading steps the vacuum was stopped as soon as the first columns were empty. All 
liquid loadings were done manually using eight-channel electronic pipette (Eppendorf). 
During sample loading, washing and regeneration steps waste was collected in a 
disposable reservoir. Before elution the waste reservoir was replaced with a collection 
rack of 96 glass vials (0.75 mL). Following the elution step, the extracts were diluted with 
PBS and kept at 4°C sealed with 96-well microplates silicone rubber seal. When not in 
use, the VersaPlate 96-Well IAC-SPE assembly was stored sealed with caps at 4°C in 
PBS containing 0.1% NaN3. 
 
The HTS-IAC-SPE cycle consists of sample loading, washing, eluting and regenerating. 
The columns were brought to room temperature and washed with 5 mL of PBS. Then 
were preconditioned with 1.2 mL of 70% EtOH and 1.2 mL of PBS. After loading the 
sample (spiked PBS or urine) the columns were washed with 1.2 mL of PBS or 
20%EtOH. The bound analyte was eluted with 0.6 mL 70% EtOH. Subsequently the 
columns were regenerated with 1.2 mL of PBS. Eluted fractions were diluted 10 times 
with PBS and analyzed by ELISA curve run in 7%EtOH/PBS and/or by GC-MS. 
 
9.15.6. Validation of the HTS-IAC-ELISA method using real 
urine samples 
 
In the validation studies were used 117 urine samples from different individuals (workers 
from petrochemical industry, workers from service sector, and population living close to 
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an incinerator. Each sample (12 mL) was hydrolyzed with KOH (see Section 9.12.4, 
Alkaline hydrolysis) and purified in duplicate following the general protocol of HTS-IAC 
(see Section 9.15.5). The 2,4,6-TCP-IR equiv. were determined by ELISA ( see Section 
9.11) and the halogenated phenols (2,4,6-TCP, 2,4,5-TCP, 2,3,4,6-TtCP, 2,4-DBP were 
2,4,6-TBP) analyzed by GC-MS (see Section 9.17.4). 
 
9.16. Quenching Fluorescence Immunoassay (QFIA) 
 
9.16.1. LIF-microdroplet-QFIA 
 
Stock solutions of hapten 5 - fluorescein conjugate (TCP-F) and 2,4,6-TCP were 
prepared in methanol. All working solutions were prepared in 10 mM PBS buffer. The 
fluorescence emission from microdroplets of TCP-F was determined in standard PBS 
solutions (laser excitation wavelength at 488 nm, emission wavelength of 520 nm). For 
antibody quenching studies a standard PBS solution of TCP-F (final concentration 10 
nM) was mixed with different concentrations of Ab solution in PBS (Ab43, Ab44 and 
Ab45). The reaction mixture was incubated at room temperature for 55 min. For kinetics 
estimation the fluorescence emission was measured every 5 min. Prebleed (preimmune) 
Ab was used as a control for the specificity of the quenching effect. For data presentation, 
the maximum fluorescence intensity (at 520 nm) measured in the presence of Ab (IAb) 
was divided by the maximum fluorescence intensity corresponding to TCP-F emission 
(ITCP-F) in the absence of Ab. 
 
9.16.2. QFIA Competitive Procedure 
 
PBS solutions of 2,4,6-TCP standards (10-5 - 10-11M) and the TCP-F (10 nM, final 
concentration) and Ab43 (2,5 µg/mL, final concentration) were mixed and incubated for 
45 min at room temperature. The steady-state quenched fluorescence intensity (ITCP) 
measured at 520 nm was used to construct the standard curve. The ITCP/ITCP-F values were 
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plotted against the 2,4,6-TCP concentration and fitted to a four-parameter logistic 
equation. Mean fluorescence responses correspond to 5 replicates. The IC50 and the limit 
of detection (LOD) were determined as the analyte concentration giving 50% and 90%, 
respectively, of the maximal quenching. The dynamic (linear) range corresponds to 20% - 
80%. 
 
In urine matrix effect studies pooled urine was used after centrifugation (5000 rpm, 10 
min) and pH adjustment to pH=7.5. Urinary Ab quenching and competitive QFIA were 
performed in urine diluted with PBS (1/10 – 1/100). 
 
9.17. Chromatographic analysis 
 
9.17.1. Preparation of standards of halogenated phenols 
 
Stock solutions containing each of the phenols at a concentration of 1 g/L were prepared 
in ethanol. Solutions in concentrations between 0.1 and 100 µg/L were prepared by 
further dilution with PBS (water). These working standards were treated in the same way 
as the urine samples (C18, IAC, or extracted with toluene) and determined by GC-ECD or 
GC-MS after derivatization. Stock standard solutions for quantitative analysis of the main 
halogenated phenols and the ineternal standard (2,3,5,6-tetrachloronitrobenzene) were 
prepared in toluene at concentration 1 g/L. Further dilutions were performed in toluene. 
Calibration curves for tri, tetra chlorophenols and di-, tri-bromophneols were set up in the 
range 0.5 to 50 µg/L using working standards prepared in toluene for GC-ECD and using 
extracted standards prepared in PBS for GC-MS. 
 
9.17.2. Phenol extraction and TMS-derivatization 
 
Halogenated phenols were extracted from acidified (pH=3) PBS standards and urine 
samples (directly or after C18-SPE or IAC-SPE clean up) in toluene by agitating the 
Experimental methods and materials 
 254
mixture on an automatic shaker at 300 rpm for 50 min (PBS-to-toluene extraction ratio = 
5:1, 12:1, 100:1). After separation of the phases by centrifugation, 100 µL of the toluene 
extract was silylated by adding 2 µL N,O-bis-(trimethylsilyl)trifluoroacetamide (BSTFA) 
and incubated for 3 h at room temperature. Then the internal standard 2,3,5,6-
tetrachloronitrobenzene was added to a concentration of 5 µg/L. The TMS-derivatives 
were then analyzed by GC-ECD or by GC-MS. If the measured values were above the 
liner range of the calibration graphs the toluene extracts were diluted with toluene and 
injected again. Calibration standards were analyzed with each analytical series. A reagent 
blank (derivatized as samples) was also analyzed in each analytical series.  
 
9.17.3. GC-ECD detection 
 
Injections (1 µL, splitless) were made on a HP 5890A gas chromatograph equipped with 
HP 7673A autosampler and with a ECD detector (6328Ni), and HP 3396 Series II 
integrator (recorder). A capillary column BPX35 (35% Phenyl(equiv.)Polysilphenylene-
siloxane) (SGE Europe Ltd, UK) was used 25 m x 0.22 mm i.d. x 0.25 µm (film 
thickness). GC conditions were set as follows: temperature program: 100°C (1 min) to 
250°C (at 5°C/min), 250°C to 300°C (at 15°C/min). Injection temperature was 250°C, 
detector temperature was 300°C. He was the carrier gas employed at 130 kPa (20 
cm/sec). The make up gas was N2 5.0. 
 
9.17.4. GC-MS analysis 
 
For the GC/MS analysis, injections (1 µL) were splitless (48 sec) with solvent delay (5 
min). A HP-5MS (cross-linked 5% Ph Me siloxane, 30 m x 0.25 mm id x 0.25 µm (film 
thickness)) column was used. The ion source temperature was set at 200°C, and He was 
the carrier gas employed at 1 mL/min. The ionization energy was 70 eV. GC conditions 
were as follows: temperature program: 100°C - 300°C (7°C/min); injector temperature, 
250°C; and the ions 253/255/268 (2,4,6-TCP and 2,4,5-TCP), 307/309/324 (2,4-DBP); 
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387/389/402 (2,4,6-TBP); 287/289/304 (2,3,4,6-TtCP); 203/259/261 (ISt) were monitored 
in the SIM mode. The mass spectrometer was operated in the Time Varied Selected Ions 
Monitoring Mode (i.e. with different group ions monitored for various time specific 
absolute intervals) (see Table 7.4). For the SCAN mode, the mass range explored was 45-
550. All data is reported as m/z (relative intensity). Great care was taken to ensure that 
the standards as well the extracts were run under identical conditions for purposes of 
identification as well as quantification.  
 
9.18. Production and application of recombinant 
antibody fragments (scFv, scFv-CAL) as 
recognition elements in immunodetection systems 
 
9.18.1. Production of anti-digoxin scFv fragments by phage 
display technology 
 
A. Selection of phage library with digoxin specificity 
 
The construction and selection of library of phages displaying scFv fragments has been 
previously described by Marks et al. [430]. Here we have used two “synthetic” libraries 
(DVT and NKK) constructed in the phagemid vector pIT2 (see Figure 9.4) based on a 
single human framework for VH and Vκ domains with different side chain diversity 
incorporated at the following positions in the antigen binding site (in total 18 aminoacid 
residues): for VH: CDR2 (H50, H52, H52a, H53, H55, H56, H58) and CDR3 (H95, H96, 
H97, H98); for Vκ: CDR2 (L50, L53) and CDR3 (L91, L93, L94, L96). The DVT library 
contained 1.47x108 clones and has 96% insert and the NNK library contained 1.37x108 
clones and 88% insert. Both libraries were stored as E.coli harbouring the phagemid. 
Library growth and phage production was realised following the protocols described in 
[431]. Both phagemid libraries were used in parallel and were subject to three rounds of 
selection against the antigen using immunotubes coated with digoxin-BSA. Each round of 
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selection comprises a cycle of binding of phage to the immobilized antigen, washing, 
elution of the bound phage by trypsin, and propagation of the enriched phage ready for 
the next round [432].  
 
 
B. Screening of soluble anti-digoxin scFv fragments 
produced from the selected phages and sequencing of 
clones 
 
Monoclonal soluble scFv fragments were produced after infection of E.coli TG1 with the 
selected phages from both libraries following the procedure detailed in [432]. The 
bacterial supernatants containing the soluble anti-digoxin scFv fragments were screened 
for binding to the antigen by ELISA and Surface Plasmon Resonance (SPR).  
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Figure 9.4. Phagemid vector pIT2 for the expression of scFv. RBS-ribosome binding site,
PelB – leader sequence, amp – ampicilline resistance gene, myc tag – enables detection
with anti-myc mAb, amber codon – enables switching between soluble scFv expression
induced by IPTG (E.coli non-supressor strain, read as a glutamine) and scFv fragments
displayed on the surface of the phage by fusion to the minor coat protein pIII after rescue
with helper phage (E.coli supressor strain, read as stop codon). 
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ELISA: Plates were coated overnight with digoxin-BSA, digoxin-HRP and as negative 
controls with BSA and HRP (concentration range 25-0.001 µg/L in PBS, 100 µL/well), 
washed 3 times with PBST and blocked with 2%Tween 20-PBS (200 µL/well) for 2h. 
After washing the plates were incubated with the bacterial supernatant (100 µL/well) for 
90 min at RT. After washing the binding of the scFv to digoxin-BSA (or to BSA) was 
detected with protein L-HRP (1:5000), which recognizes the Vκ chain of the fragment. 
TMB (100 µL/well) was used as substrate and the absorbancse were read at 450 nm. In 
the case of digoxin-HRP immunorecognition, protein A-AP, which recognizes the VH 
chain was used followed by pNPP substrate addition (100 µL/well) and the absorbances 
were read at 405 nm.  
 
SPR: SPR measurements were performed on the BIAcore system (Pharmacia 
Biosensor). The antigens (Digoxin-BSA and BSA) were immobilized to the CM5 sensor 
chips by chemical coupling (NHS/EDC) through their amine groups using the Amine 
Coupling Kit (Pharmacia Biosensor AB) and digoxin was coupled directly after activation 
in the form of dialdehyde following the recommended instructions of Pharmacia 
Biosensor AB [433]. The supernatants containing the anti-digoxin scFv fragments were 
injected (sample volume 30 µL) over the antigen-coated chips at constant flow rate of 10 
µL/min. After scFv binding the antigen coated chips were regenerated by 100 mM HCl 
for 1 min. 
 
Clones found to give positive SPR signal were screened by PCR using primers LMB3 
and pHENseq (25 cycles, at 55°C) and “fingerprinted” with restriction enzymes to 
identify different clones [430]. Heavy and light chains were sequenced [434] using Taq 
DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems) and an Applied 
Biosystems 373A DNA sequencer. The sequenced clones were analyzed with the 
program Mac Vector 3.5 (IBI Kodak, CT). 
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9.18.2. Production of the fusion protein anti-digoxin scFv-
calmodulin (scFv-CAL) 
 
The genes encoding the anti-digoxin scFv fragment were digested from the vector pIT2 
using the restriction endonucleases (Sfi1/Not1) and were subcloned into the Sfi1/Not1 
sites of the expression vector pDN152 using T4 DNA ligase [425]. The ligation of the 
genes encoding the anti-digoxin scFv fragment and the protein CAL were verified by 
PCR screening. The new vector (anti-digoxin scFv-CAL) was transformed into E.coli 
TG1 for antibody soluble expression. The obtained fusion protein was checked on ELISA 
and in PAGE electrophoresis. 
 
9.18.3. Expression and purification of anti-digoxin scFv and 
scFv-CAL 
 
Large cultures of TG1 harboring the obtained vectors encoding anti-digoxin scFv and 
anti-digoxin scFv-CAL, respectively, were grown and the antibody fragment and the 
fusion protein were expressed in presence of IPTG following the detailed protocols 
described in [425,432]. The culture supernatants containing the proteins were purified by 
ion exchange (DEAE chromatography) and further by affinity chromatography (protein 
A) [432]. The degree of purification was checked by PAGE electrophoresis. The purified 
anti-digoxin scFv and anti-digoxin scFv-CAL were pre-concentrated by ultrafiltration 
using CentriPrep (Amicon), stored in PBS and their concentration was determined with 
BCA Protein Assay Kit (Pierce). 
 
9.18.4. Characterization and application of the recombinant 
antibody fragments in ELISA and immunosensors 
 
A. ELISA 
Microtiter plates were coated overnight at 4ºC with the anti-digoxin scFv-CAL in an 
appropriate dilution (1/320) determined by experiments 2D (100 µL/well). The following 
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day the plates were washed with PBST (5 times, 300 µL/well) and different 
concentrations of digoxin standards (250 to 2.10-5 mg/L, prepared in PBST, 50 µL/well) 
were added followed by the digoxin-HRP solution in PBST (1/12800, 50 µL/well). After 
2h of incubation at RT the plates were washed again with PBST. The substrate solution 
was added (100 µL/well) and the enzymatic reaction was stopped after 10 min at RT with 
4 N H2SO4 (50 µL/well). The absorbance was read at 450 nm. 
 
B. Isoelectric focusing 
 
The isoeletric points of the recombinant proteins were determined using Electrophoresis 
IEF Phast System (Pharmacia) according to the procedure described in Phast System 
Separation technique File N100 of Pharmacia. PhastGel IEF calibration kit 3-10 was 
used. 
 
C. Multilayer construction in SPR 
 
The monolayer of 3-mercapto-1-propansulfonic acid (MPS) was formed by incubation of 
chip J1 (BIAcore) in 1 mM ethanol MPS solution for 1h. Then the chips were washed 
with ethanol and water to remove excess of MPS. Consecutive injections of a positively 
charged rdeox polymer, scFv-CAL (calmodulin) and digoxin-HRP were performed at 
flow rate 20 µL/min using MilliQ water as carrier. The concentration of the reagents and 
the injection volumes are presented in Table 9.1. 
 
Table 9.1. Experimental conditions for multiplayer formation 
Compound Concentration, µg/mL Injection volume, µL 
Redox polymer 20 100 
scFv-CAL 10 30 
calmodulin 10 30 
Digoxin-HRP 5 50 

  
 
 
 
 
 
 
 
 
 
 
 
 
______________________________________________________________________ 
 
10. Conclusions  
 
_____________________________________________________________________________ 
 
 
1. An indirect ELISA for 2,4,5-TCP has been developed with an IC50 of 0.23 µg/L and a LOD 
of 0.053 µg/L after rational design of the immunizing hapten chemical structure, and the 
investigation of a battery of homologous and heterologous competitor haptens. Precision 
study performed with buffer samples showed that the within and between assay coefficients 
of variation were below 12%. Accuracy studies demonstrated very good linear correlation 
(r2=0.999, slope 1.07) between spiked and measured 2,4,5-TCP in buffer samples. 
 
2. Computer assisted theoretical and molecular modeling studies have provided objective and 
reliable criteria to design an appropriate immunizing hapten to raise antibodies against 
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2,4,5-TCP, as it has been demonstrated by the experimental results regarding the avidity of 
the antisera raised for the target analyte. The theoretical data indicated that, independently 
from the pH of the media, haptens A and C mimicked very well the behaviour of the target 
analyte regarding geometric and electronic properties. In contrast, hapten B demonstrated a 
completely different behavior that was especially evident when the pH was higher than the 
pKa value of the target analyte. In agreement with this, the antisera raised against hapten B 
was not able to rend any competitive assay, while the antisera raised against hapten A 
provide several useful immunoassays with sufficient detectability and sensitivity for 
environmental and biological monitoring. 
 
3. It exists a correlation between the ELISA detectability and the competitor hapten heterology 
as it has been demonstrated by the molecular modeling and theoretical studies made with a 
battery of 11 different haptens and the IC50 values achieved on the corresponding ELISAs 
obtained with the antisera raised. For the case of the 2,4,5-TCP, the best competitive 
immunoassays were achieved with competitor haptens with high homology with the target 
analyte. Thus, haptens 5 and 7, that showed very similar electronic distribution at the assay 
pH, provided with As53 assays with higher detectability than other haptens with a higher 
degree of heterology. In spite of this we should not forget other factors such as the hapten 
density of the biomolecule conjugates, their tertiary structure or the protein nature. 
 
4. The conjugation degree of the competitors have a real influence on the ELISA features 
resulting in an improvement of the detectability when coating antigens with a low hapten 
density are used on indirect ELISA formats. In contrast, the conjugation method employed 
does not seem to have a direct effect on the 2,4,5-TCP immunoassay detectability. Hence, 
the a LOD of 0.053 µg/L was accomplished using 7-OVA (1:2.5), prepared by the AE 
method, with a hapten density of 10 mols/mol of protein.  
 
5. Immunoassays for phenolic compounds are strongly affected by the ionic strength of the 
media and by the pH as demonstrated in the evaluation made in this thesis of the behavior 
the 2,4,5-TCP ELISA and the results previously obtained in our group with other 
immunoassays for phenolic substances [259,260,289,291]. The 2,4,5-TCP immunoassay 
Conclusions 
 263 
parameters remain constant in media with pH values between 6.6 and 10.5 and conductivity 
values higher than 30 mS/cm. However at pH values lower than 5.5 the assay is totally 
inhibited and a marked increase of the IC50 value is produced below 20 mS/cm. 
 
6. The specificity studies performed with the 2,4,5-TCP immunoassay plus the results 
previously obtained in our group with ELISAs for other organochlorinated compounds 
[1,435] suggest that the greater recognition of homologous brominated compounds (halogen 
atoms are placed at the same positions) could be a general behavior of these type of 
antibodies. Regarding the specific recognition of other substances, the results indicate that 
these should be phenol-like compounds containing in their structure at least two chlorine 
atoms, at ortho and para positions, and one hydrogen atom in meta position. 
 
7. Distinct immunoassays are differently affected by the non-specific interferences of the 
sample matrices. For the case of complex matrix samples such as human serum and urine, 
the 2,4,5-TCP ELISA demonstrated to be less affected by undesirable matrix effects than 
the 2,4,6-TCP ELISA. 
 
8. Most of the undesirable matrix effects caused by complex samples on the performance of 
the trichlorophenol immunoassays can effectively be eliminated after simple sample 
treatment procedures as it has been demonstrated by the study of the parallelism of standard 
curves prepared in different matrices, the accuracy studies and the comparison of the results 
obtained by chromatographic methods. However, for certain applications the necessary 
detectability can be compromised. Direct immunochemical analysis of drinking water can 
be performed after just buffering the sample reaching LOD values of 0.07 µg/L and 0.18 
µg/L for 2,4,5-TCP and 2,4,6-TCP, respectively. Human serum could be analyzed after 
protein precipitation with absolute ethanol and further dilution of the supernatant with PBS 
achieving LOD values of 0.8 µg/L and 4.6 µg/L, respectively for 2,4,5-TCP and 2,4,6-TCP. 
Non-hydrolyzed urine samples can be analyzed after sample dilution with buffer with LOD 
of 0.26 µg/L for 2,4,5-TCP and 17.5 µg/L for 2,4,6-TCP. The same sample treatment 
applied to hydrolyzed urine samples resulted in LOD values about 100 times worse that 
those obtained in the assay buffer media. Finally, milk samples completely inhibited both 
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immunoassays and all the simple treatment procedures tested until now have not been able 
to remove the interferences causing this effect. 
 
9. The matrix effects caused by urine samples from different individuals affect immunoassay 
performance in a different extent. Therefore, accurate quantitative analysis is only possible, 
if samples are sufficiently diluted to diminish idiosyncratic differences, or if interferences 
are removed by other sample treatments, such as solid-phase extraction. The creatinine 
concentration of the urine appears to be a good indicator of the extent of the matrix effect 
produced by particular urine. 
 
10. C18-SPE could be an effective clean-up method to remove not all, but an important fraction 
of the nonspecific interferences present in both hydrolyzed and non-hydrolyzed urine, prior 
to the analysis of trichlorophenols by ELISA. The established C18-SPE-ELISA method 
allows accurate quantification of free chlorophenols in non-hydrolyzed urine and total (free 
and conjugated) chlorophenols in hydrolyzed urine samples with a LOD at about 4 µg/L for 
both types of urines. 
 
11. The SPE based on immunosorbents prepared by covalently coupling of antibodies to a 
highly cross-linked agarose, is an effective clean-up method to remove all non-specific 
interferences present in both hydrolyzed and non-hydrolyzed urine samples prior to the 
analysis of trichlorophenols by ELISA or by GC-MS (ECD).  
 
12. The selectivity of the immunosorbents can be modulated by the working protocol used. A 
class-specific clean-up procedure, where 2,4,6-TCP and other congeners of the same family 
are retained, can be performed if a washing step with PBS is employed. However by 
increasing the ethanol content in this buffer until a 20%, a selectivity similar to that of the 
2,4,6-TCP ELISA method can be achieved. 
 
13. The immunosorbents prepared in this thesis have sufficient capacity to effectively extract 
2,4,6-TCP from real urine samples allowing the biological monitoring of occupationally and 
non-occupationally exposed persons. Thus, the quantitative immunochemical analysis of 
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alkaline hydrolyzed urine can be performed in the range 1 - 20 µg/L 2,4,6-TCP urinary 
concentrations by the single column IAC-ELISA method and in the range 0.3 - 30 µg/L by 
the HTS-IAC-ELISA. 
 
14. The 2,4,6-TCP immunosorbents can be used for many cycles with real urine samples 
without a significant loss of their efficiency. The capacity of the single IAC column was not 
affected adversely for more than 50 cycles and that of the mini-columns used in the HTS-
IAC - for up to 35 analyses. The columns can be efficiently regenerated by washing with the 
elution buffer followed by PBS.  
 
15. The HTS-IAC-ELISA method (Versaplate 96-well SPE system) developed in this work is 
efficient, consistent and reliable. Its main advantages are the significant increase in sample 
throughput, the decrease of urine sample volume required for the assays and the absence of 
dilution in the clean-up step. It allows the processing of at about 100 samples/day with both 
inter- and intra-assay precision (% CV) lower than 20% except in the case when the 
measurements take place at the ELISA limit of detection. The validation of the HTS-IAC-
ELISA method by GC-MS using 117 urine samples from different individuals shows an 
excellent correlation (r2=0.912, slope 1.14) between the 2,4,6-TCP-IR equivalents estimated 
by both techniques. 
 
16. A preliminary biomonitoring of the general population of Cataluña using the HTS-IAC-
ELISA method revealed that the urinary chlorophenol levels are either lower or of the same 
magnitude as in the general population of other countries (Germany, US). The HTS-IAC-
GC-MS analysis revealed the presence of organochlorine compounds in almost 100% of the 
persons studied. The reported values will serve as a basis against which to compare 
concentrations in subjects who may have been occupationally exposed to halogenated 
phenols or toxic compounds that metabolize to them.  
 
17. A comparison between three population groups (petrochemical workers, services workers 
and population living close to an incinerator) demonstrated that the highest values (median, 
95%, maximum) of 2,4,6-TCP-IR equivalents determined by HTS-IAC-ELISA were 
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detected for the incinerator group followed by the petrochemical workers and finally by the 
services workers. However, according to the HTS-IAC-GC-MS studies the average 
excretion of 2,4,6-TCP in urine was highest for the petrochemical workers (0.48 µg/g), 
followed by the general population living in vicinity of the incinerator (0.26 µg/g) anf 
lowest for the services workers (0.13 µg/g). The urinary levels of brominated phenols (2,4-
DBP and 2,4,6-TBP) were highest for the incinerator vicinity population followed by the 
services workers and finally by the petrochemical workers. These results suggest that the 
general population living in the surroundings of the incinerator suffers higher exposure to 
these compounds, although the source is uncertain. Although the results shown here draw a 
tendency on the potential risk or level of exposure of these population groups, we can not 
make any definitive conclusion because much more information and criteria should be taken 
into consideration. However, these results and the comparison between ELISA and GC-MS 
methods prove the potential usefulness of the procedure described and developed in this 
thesis. 
 
18. The LIF-microdroplet-QFIA is a novel biodetection system that combines the selectivity of 
immunoassays and the sensitivity of laser-induced fluorescence detection in microdroplets 
(d = 58.5 µm). The method has proven to be fast, highly sensitive, and simple to perform 
(no separation steps are needed). This approach offers better detection limits than those of 
microplate immunoassays (LOD of LIF-microdroplet-QFIA is 0.04 µg/L 2,4,6-TCP vs 
LOD in microplate-QFIA is 0.36 µg/L 2,4,6-TCP).  
 
19. This work is the first application of a steady-state QFIA with LIF-microdroplet detection 
system to human urine samples, demonstrating the potential of this analytical approach for 
bioassays. Urine samples can be directly analyzed for 2,4,6-TCP, without any sample 
treatment (just 50-fold sample dilution) and with enough detectability (LOD 1.6 µg/L 2,4,6-
TCP) to perform biological monitoring and risk assessment of exposure to chlorophenols 
and other organochlorinated substances that are excreted as trichlorophenol in urine.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
 
11. Resumen  
 
________________________________________________________________________ 
 
 
11.1. Introducción 
 
El vertido de contaminantes al medio ambiente ha incrementado considerablemente 
durante las dos últimas décadas. Hace algunos años, la Comunidad Europea (CE) publicó 
la llamada “lista negra” que incluye 132 sustancias peligrosas (Directiva 76/464/CEE) 
cuyo vertido al medioambiente debe ser vigilado. Esta lista contiene diferentes 
compuestos organohalogenados entre los que se encuentran diversos clorofenoles. En 
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1996, la CE promulgó una nueva directiva que aumenta el numero de contaminantes cuyo 
vertido debe ser controlado, además de recomendar el establecimiento de programas para 
la vigilancia de determinados sectores industriales como es el del papel, el textil y el de 
las refinerías entre otros (Directiva 96/61/CE). Sin embargo, además del impacto 
medioambiental, el uso abusivo de productos químicos también afecta el estado de salud 
de la población. Los efectos varían desde una simple irritación debido a una intoxicación 
de tipo accidental hasta el desarrollo de cánceres específicos tras una exposición 
continuada a dosis aparentemente insignificantes. La exposición real (dosis interna) y el 
riesgo para la salud pueden ser evaluados mediante el control biológico (biological 
monitoring) que se define como la medida y valoración de estos agentes con los que la 
población entra en contacto, o de sus metabolitos, bien en tejidos, secreciones, productos 
de excreción aire aspirado o cualquier combinación de ellos [5-7].  
 
Con el fin de proteger la salud de la población diferentes agencias gubernamentales de 
Europa y Estados Unidos han establecido cuales deben ser los límites máximos de 
exposición a productos particulares, referidos a la concentración medioambiental 
permitida (OEL, occupational exposure limits) o a los niveles que ya realmente han 
penetrado en el organismo del individuo potencialmente expuesto (BLV, biological limit 
value) antes de ocasionar un efecto adverso[16,20,21]. Además en las últimas directivas 
(Directiva 98/24/EC, Directiva 2000/39/EC), la unión europea insta a los empresarios a 
establecer los programas de control necesarios para proteger la salud de sus empleados. 
Ello implica la necesidad de proveer al mundo empresarial y especialmente a los médicos 
laborales de técnicas sencillas que permitan un control eficaz tanto del medioambiento y 
como del grado de exposición de los individuos.  
 
Los métodos analíticos habituales para el control ambiental y biológico se basan en la 
utilización de técnicas cromatográficas (GC/MS, HPLC/MS, etc.) [7,23,24] que la 
mayoría de las veces no alcanzan los límites de detección necesarios, invierten un tiempo 
demasiado elevado para cada análisis y exigen una preparación previa de cada muestra 
con el fin de concentrar el analito y purificar la muestra. Frente a esto, las técnicas 
inmunoquímicas se caracterizan por permitir el análisis simultáneo y directo de 
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numerosas muestras de una manera sencilla y rápida ya que una de sus características 
principales es su elevada detectabilidad y especificidad. Así pues la UE y la EPA apoyan 
el desarrollo de nuevas estrategias analíticas que permitan una mayor eficacia de la 
vigilancia ambiental y biológica [26]. En los últimos años las técnicas inmunoquímicas 
han abierto paso en su aplicación en el campo del control biológico [25,26]. 
 
Las técnicas inmunoquímicas de análisis se caracterizan por su elevada detectabilidad, 
especificidad y rapidez (más de cien muestras pueden ser procesadas simultáneamente). 
Se basan en la utilización de anticuerpos específicos para detectar un determinado 
compuesto. El método empleado para la detección de esta reacción de reconocimiento 
molecular da lugar a una variedad de técnicas inmunoquímicas como los ensayos 
inmunológicos de tipo ELISA (Enzyme-Linked Immunosorbent Assay), la cromatografía 
de inmunoafinidad (IAC, ImmunoAffinity Chromatography) o los inmunosensores 
[26,157,185,196,198-200]. El bajo coste y la fácil utilización de este tipo de técnicas 
analíticas hacen que su utilización pueda ser asequible a medianas y pequeñas empresas, 
para el control de sus vertidos. Igualmente pueden constituir excelentes herramientas para 
una vigilancia eficaz de la exposición a estos tóxicos por parte de ciertos grupos de 
riesgo, mediante el análisis de estos compuestos en sus fluidos biológicos. En los últimos 
años se han desarrollado varios métodos inmunoquímicos para la detección de varios 
biomarcadores en orina [7,26,28,29,30, Knopp, 1995 #1846,176-184]. También se han 
desarrollado varios métodos inmunoquímicos para la determinación de compuestos 
organoclorados (DDT, PCP, 2,4-D, 2,4,5-T. PCBs, PCDDs, 2,4-DCP) en muestras 
ambientales y fluidos bilógicos [212,213,217,222,231-233,245,249,257,258]. 
 
Los triclorofenoles son un grupo de contaminantes de origen industrial que llegan al 
medioambiente debido a su masiva utilización como intermedios sintéticos en numerosos 
procesos industriales [31]. Además por si mismos se han usado exhaustivamente como 
pesticidas y bactericidas. Una de sus aplicaciones más conocidas ha sido su utilización 
como agentes conservantes de la madera y los productos textiles. Por otro lado se ha 
detectado la formación de triclorofenoles en procesos de combustión en presencia de 
iones cloruro y en los procedimientos de blanqueado y desinfección que todavía utilizan 
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hipoclorito o productos derivados [32,35,36]. A pesar de que en los últimos años su 
producción en los países desarrollados se ha reducido, los clorofenoles siguen siendo uno 
de los contaminantes del medio ambiente. Se han detectado en aguas de ríos [38-40], 
lagos [41], agua de bebida [49-51], aguas subterráneas [47,48], sedimentos [42-45], peces 
[40,46].  
 
Los triclorofenoles (2,4,5- y 2,4,6-TCP) son algunos de los 5 clorofenoles calificados por 
sus significantes efectos toxicológicos y cancerígenos [65]. Tienen también efectos 
mutagénicos [66]. La exposición ocurre a través de su absorción por la piel, la inhalación 
o ingestión de productos contaminados. Además de los clorofenoles, otros compuestos 
organoclorados se metabolizan y se excretan en la orina como clorofenoles en forma de 
glucurónidos y sulfatos [63,64]. El nivel de triclorofenoles en la orina puede ser usado 
como un importante indicador de una exposición a diferentes compuestos 
organohalogenados (HCB [80], HCH [74,78,79], dioxinas, herbicidas derivados del ácido 
cloropfenoxyacético [77], insecticidas organofosforados [75,76], etc.). Adicionalmente 
los triclorofenoles son los precursores directos de la formación de dioxinas, por lo que 
muchos autores han coincidido en denominarlos predioxinas [81,106]. Por otro lado, 
todos los productos derivados de triclorofenoles contienen dioxinas como impurezas. En 
la literatura existen opiniones contradictorias sobre el tema de la relación entre la 
exposición a clorofenoles y dioxinas y su excreción en orina y sangre y los efectos 
adversos relacionados con esto [103,110,111]. A pesar de eso existen numerosos 
ejemplos que ponen en evidencia que la exposición a clorofenoles, herbicidas de tipo 
clorofenoxiácido y otros derivados producen un elevado nivel de dioxinas en el suero 
[35,83,107-109]. 
 
La exposición laboral sucede mediante inhalación o contacto dermal en ambientes 
contaminados. Tal es el caso de trabajadores en plantas químicas [83,105,109], 
aplicadores de pesticidas o fungicidas [83] así como trabajadores de incineradoras 
industriales [36,113] y serrerías [108]. Los niveles detectados varían entre 0.2 y 850 µg/L 
según el sector industrial. También se ha probado la existencia de una exposición de la 
población general a través del medio ambiente contaminado en varios países: Alemania 
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[121,123,124], USA [122], España [118,128], etc. El valor de referencia establecido para 
2,4,5- y 2,4,6-TCP en orina en Alemania en base de los niveles encontrados en la 
población general es 4.5 µg/L (5 µg/g creatinina) [36,81]. 
 
11.2. Objetivos 
 
El trabajo realizado en esta tesis ha tenido los siguientes objetivos: 
1. Desarrollo de un inmunoensayo enzimático de tipo ELISA para la detección de 2,4,5-
TCP. 
2. Evaluación y validación de los inmunoensayos (ELISAs) para 2,4,5-TCP y 2,4,6-TCP 
en muestras ambientales y biológicas. 
3. Desarrollo de un método de purificación de muestras de orina mediante extracción en 
fase sólida para el análisis de 2,4,6-TCP mediante ELISA (SPE-ELISA).  
4. Desarrollo de un método HTS-IAC-SPE y su validación mediante su aplicación al 
control biológico de una serie de grupos representantes de la población general en 
Cataluña. 
5. Desarrollo de un inmunoensayo de fluorescente con detección inducida por laser en 
microgotas (LIF-microgotas-QFIA). 
 
11.3. Resultados 
 
11.3.1. Desarrollo de un ELISA para 2,4,5-TCP 
 
Uno de los pasos cruciales en el desarrollo de una técnica inmunoquímica es el diseño del 
hapteno empleado como inmunógeno, ya que la estructura química del mismo influye 
directamente en la especificidad y selectividad de los anticuerpos resultantes y en 
consecuencia en las características del ensayo en sí. Se han propuesto tres haptenos 
diferentes como posibles inmunógenos considerando que dichos compuestos habían de 
conservar la estructura química del 2,4,5-TCP en la medida de lo posible (Figura 11.1).  
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El efecto de la introducción del brazo espaciador en la conformación espacial y la 
distribución electrónica de la molécula, se ha evaluado mediante la optimización de la 
conformación de los tres haptenos hasta un mínimo energético, usando un software de 
simulación molecular. Se ha tenido en cuenta también el equilibrio ácido-base (pKa, 
entalpía de desprotonación) de los compuestos fenólicos en medio acuoso. Los estudios 
semiempíricos de modelización molecular demostraron que los haptenos A y C 
guardaban mayor semejanza con el analito en cuanto a su geometría molecular, 
distribución de las cargas puntuales y carácter ácido de la molécula. Se han considerado 
también los esfuerzos necesarios para la síntesis de dichos haptenos y se ha estimado que 
la introducción del brazo espaciador en posición meta necesaria para el hapteno C sería 
difícil. Por lo tanto, para comprobar los resultados de los estudios teóricos se han 
generado anticuerpos contra los haptenos A (As53, 54, 55) y B (As56, 57,58). 
 
En el desarrollo de los ensayos inmunoenzimáticos se han ensayado 11 competidores con 
diferente grado de heterología en la longitud y la posición relativa del brazo espaciador y 
en el número y la posición de los átomos de cloro respecto al inmunógeno usado (véase 
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Figura 11.1. Estructura química de los tres haptenos propuestos como inmunogenos. Las
flechas indican el lugar en que se ha introducido la modificación en la estructura química del
analito 2,4,5-TCP. 
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Figura 11.2.). En el formato de ELISA directo en condiciones no competitivas se ha 
observado reconocimiento sólo para los trazadores enzimáticos homólogos (hapteno A-
HRP/As53-55 y hapteno B-HRP/As56-58) o quasihomólogos (hapteno 5-HRP/As55). El 
mejor ELISA directo competitivo se obtuvo con la combinación hapten 5-HRP/As55 con 
los siguientes parámetros: Amax = 0.94, IC50=15.84 µg/L 2,4,5-TCP, pendiente = -0.97, r2 
= 0.971. 
 
Debido a la insuficiente detectabilidad del formato directo se ha desarrollado un ELISA 
indirecto. Inicialmente se ha hecho un screening (formato no competitivo) de 33 
antígenos de tapizado formados por los haptenos de diferente estructura fenólica 
conjugados a BSA, CONA, OVA frente los seis anticuerpos. El mejor reconocimiento se 
ha observado para las combinaciones homólogas y quasihomólogas (haptenos 5, 8/As53-
55, haptenos 1,2,11,12/As56-58). La afinidad de los As53-58 hacia los haptenos más 
reconocidos se ha evaluado en formato indirecto no competitivo (2D) donde se han 
elegido las concentraciones de los inmureactivos (antígeno de tapizado y As) para obtener 
una señal Amax entre 0.7 y 1. Bajo estas condiciones se han evaluado los inmunoensayos 
competitivos. Ninguna de las combinaciones de los As56-58, generados contra el hapteno 
B, dieron ensayos competitivos tal como ya se esperaba de los estudios de modelización 
molecular. Con los As53-55 se han conseguido 7 combinaciones con valores de IC50 
menores de 5 µg/L. Al igual que en el formato directo, los mejores ensayos competitivos 
se consiguieron con los competidores que representan mayor homología con el analito 
respecto a la distribución electrónica (haptenos 5 y 7/As53,54). Se ha puesto en evidencia 
que la detectabilidad de los ensayos competitivos está afectada por varios factores, tales 
como la estructura de la molécula (geometría y carga), el método de conjugación 
empleado en la preparación de los inmunógenos y antígenos de tapizado, la densidad de  
haptenos conjugados, el tipo de proteína empleada. Un estudio teórico sobre el grado de 
heterología en la distribución de carga y la geometría de los competidores respecto al 
analito ha constatado con datos objetivos que, efectivamente, los mejores ensayos 
competitivos se han conseguido con algunos de los competidores con mayor grado de 
homología. Igualmente, se ha demostrado que la detectabilidad de los ensayos mejora con  
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la disminución del grado de conjugación de los competidores alcanzando mejores valores 
en el caso de 3 ó 5 moléculas de hapteno por molécula de proteína (véase Tabla 11.1).  
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Figura 11.2. Estructuras químicas de los compuestos empleados como competidores 
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Tabla 11.1. Effecto de la densidad de haptenos del competidor 7-OVA(AE) sobre los parámetros 
del inmunoensayo (As53/7-OVA) 
Hapteno:proteína a δ b % conjug.  Amax Amin Pendiente IC50
c r2 
2:1 n.d.e  0.94 0.06 -1.20 0.9 0.990 
1:1 12 60 0.77 0.03 -1.24 0.57 0.990 
1:2.5 10 50 0.72 0.01 -1.13 0.29 0.990 
1:5 3 15 0.65 0.02 -1.00 0.21 0.990 
1:10 3 15 0.74 0.02 -1.20 0.23 0.990 
a Relación molar hapteno:proteína usada en la reacción de conjugación. b Densidad de haptenos 
(δ) está expresada en mol de hapteno por moles de proteína y está determinada de MALDI-TOF-
MS. c IC50 está expresada en µg/L. 
 
Entre los ELISAs competitivos indirectos se ha seleccionado como mejor combinación 
As53/7-OVA(1:2.5). Se ha estudiado el efecto de varios factores fisicoquímicos (tiempo 
de incubación, pH, fuerza iónica, Tween 20) sobre los parámetros de este inmunoensayo. 
Se ha demostrado que una etapa de preincubación del analito con el anticuerpo o una 
variación del tiempo de competencia no producen un efecto significativo sobre la 
detectabilidad del ensayo. El ELISA funciona mejor cuando el valor del pH corresponde 
a medio neutro o básico. A valores de pH inferiores de 6 y superiores de 10 el ensayo está 
inhibido. La fuerza iónica del medio tiene un importante efecto sobre la detectabilidad del 
analito: un aumento de la conductividad de 10 a 30 mS/cm produce una mejora en la 
detectabilidad de tres veces. Finalmente, concentraciones bajas de detergente (menores de 
0.05%) favorecen la detectabilidad del inmunoensayo.  
 
Tabla 11.2. Condiciones óptimas y características del inmunoenasayo As53/7-
OVA(1:2.5) 
Condición Valores Parámetros Valores a 
Tiempo de 
preincubación 
0 min Amax 0.838±0.020 
Tiempo de 
competencia 
30 min Amin 0.031±0.009 
pH 7.5 IC50, µg/L 0.231±0.011 
Fuerza iónica 20 mS/cm 
(20 mM PBS) 
Rango lineal 0.093±0.004 to  
0.725±0.106 
Tween 20 0.025% Pendiente 1.399±0.070 
  LOD, µg/L 0.053±0.004 
  r2 0.995±0.001 
a Los valores están extraídos de la ecuación de cuatro parámetros usada para ajustar la curva 
estándar y corresponden a la media de nueve curvas de calibración realizadas en tres días 
diferentes. Cada curva se ha realizado en dúplica. 
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En Tabla 11.2 están resumidas las condiciones óptimas del inmunoensayo y los 
correspondientes parámetros de la curva de calibración. 
 
La especificidad del inmunoensayo As53/7-OVA fue evaluada respecto a 27 compuestos 
(clorofenoles, bromophenoles y anisoles) con estructura similar al analito. Se ha 
demostrado que el ensayo presenta un alto grado de selectividad, aunque se observa cierta 
reactividad cruzada con algunos clorofenoles (2,3,4,6-TtCP – 18.9%, 2,4,6-TCP – 17%) y 
bromophenoles (2,4,6-TBP – 27.7%, 2,5-DBP – 15%, 2,4-DBP – 10.5%). El 
reconocimiento está directamente relacionado con la presencia de dos átomos de Cl 
situados en ortho y en para y un hidrógeno en meta. Se ha confirmado también la 
importancia del grupo fenólico para el reconocimiento del analito por el anticuerpo 
(2,4,5-TCA – 0.29%). La reactividad cruzada observada con algunos compuestos 
fenólicos deberá ser considerada al aplicar el inmunoensayo a muestras reales. 
 
Finalmente se ha caracterizado la precisión del ELISA para la detección de 2,4,5-TCP. 
Los coeficientes de variación CV (inter-ensayo) varían entre 5.1 y 15% y los CV (intra-
ensayo) varían entre 10.9 y 20% para un intervalo de concentraciones comprendidas entre 
0.1 y 1.5 µg/L. El estudio de exactitud realizado mediante el análisis de muestras ciegas 
preparadas en medio acuoso demostraron una excelente correlación (y=1.07x-0.21, 
r2=0.999) entre los valores estimados mediante el ELISA y los valores con que se habían 
dopado las muestras. 
 
11.3.2. Evaluación del efecto matriz de muestras 
ambientales y biológicas sobre la determinación 
inmunoquímica de 2,4,5-TCP y 2,4,6-TCP. 
 
Una de las limitaciones de las técnicas inmunoquímicas es el denominado efecto matriz, 
el cual origina falsos positivos como consecuencia de las condiciones y componentes del 
medio que se analiza. De este modo, las muestras reales ambientales y biológicas son 
matrices complejas donde se encuentran un gran número de sustancias que podrían 
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interferir con el inmunoensayo para clorofenoles. Con el objetivo de analizar 
chlorophenoles en muestras reales se ha evaluado el efecto matriz de varios tipos de 
muestras ambientales (agua) y biológicas (leche, suero y orina) sobre los parámetros de 
dos inmunoensayos: el ELISA para 2,4,5-TCP desarrollado en el capítulo anterior (As 
53/7-OVA) y el ELISA para 2,4,6-TCP (As43/8-BSA) desarrollado por R.Galve de 
nuestro grupo. Nuestro objetivo ha sido comprobar si los inmunoensayos son capaces de 
medir TCP en aguas considerando las exigencias de la UE sobre los valores máximos 
permitidos de pesticidas en aguas potables (0.1 µg/L para el compuesto individual y 0.5 
µg/L para la concentración total) (Directiva 80/778/CCE). Para el control biológico 
hemos considerado oportuno estudiar el comportamiento de los ensayos inmunoquímicos 
de TCP en leche, suero y orina. Nos hemos propuesto establecer un procedimiento que 
exija un tratamiento mínimo de la muestra y que el inmunensayo sea capaz de alcanzar 
límites de detección adecuados para el estudio de la población general: 12 µg/L para el 
serum (según los valores de referencia de los niveles de PCP en suero), 1 µg/g materia 
grasa para la leche (según los valores de referencia de pesticidas organoclorados) [20] y 1 
µg/L para la orina (según los niveles de referencia establecidos para la población general 
[75,81,121,123]). 
 
11.3.2.1. Muestras de agua 
 
Se han considerado dos tipos de muestras de agua: agua de bebida y agua del pozo. Se ha 
demostrado que una correcta determinación inmunoquímica de 2,4,6- y 2,4,5-TCP se 
puede conseguir solo con tamponar las muestras de agua con PBS para asegurar que los 
valores de pH y salinidad de la muestra sean los adecuados para el buen funcionamiento 
del inmunoensayo. La exactitud del método se ha estudiado con muestras de agua de 
bebida dopadas con 2,4,5-TCP. La recuperaciones obtenidas fueron entre 92 y 105.3% 
para niveles entre 0.2 y 5 µg/L 2,4,5-TCP. La validación del ELISA mediante la 
comparación de los resultados obtenidos tras el análisis de las mismas muestras por GC-
ECD (los clorofenoles han sido extraídos con tolueno de las muestras acuosas y 
silanizados) ha resultado en una correlación lineal entre los dos métodos muy buena 
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(y=1.26x-4.27, r2=0.993). Los parámetros característicos para la detección de muestras de 
agua por el ELISA de 2,4,5-TCP y 2,4,6-TCP están presentados en Tabla 11.3. 
 
Tabla 11.3.  Concentraciones detectables en muestras de agua (µg/L) por los 
inmunoensayos de 2,4,5- y 2,4,6-TCP 
Parámetros 2,4,5-TCP 2,4,6-TCP 
LOD 0.07 ± 0.01 0.18 ± 0.03 
IC50 0.32 ± 0.02 1.13 ± 0.36 
Rango lineal 0.13 ± 0.01 - 1± 0.15 0.29 ± 0.05 – 3.12± 0.68 
Los parámetros presentados se han extraido de las curvas estándares preparadas en agua de bebida 
tamponada. 
 
Los LOD para los dos inmunoensayos son inferiores a los LOD de los métodos 
estándares cromatográficos aceptados por la EPA para estos compuestos (ej. 0.64 µg/L 
2,4,6-TCP) y muy cercanos a los requerimientos de la UE en lo que se refiere a la 
contaminación de las aguas potables con residuos de clorofenoles. 
 
11.3.2.2. Muestras de leche 
 
El ELISA de 2,4,5-TCP fue evaluado en muestras de leche desnatada. A pesar de que el 
pH y la salinidad de la muestra de leche fueron ajustados como los del tampón PBS, el 
inmunoensayo quedaba completamente inhibido al introducir este tipo de muestras. Como 
posibles causas se podrían considerar la presencia de proteínas, grasa y la alta 
concentración de iones de calcio, etc. Se han probado varios tratamientos de la leche, 
tales como precipitación de las proteínas en medio básico (NaOH) y la precipitación de 
los iones de calcio en forma de CaSO4, pero hasta el momento no se ha conseguido 
solucionar este problema. 
 
11.3.2.3. Muestras de suero humano 
 
El efecto matriz del suero sobre los inmunoensayos para la detección de 2,4,5-TCP y 
2,4,6-TCP consistía en un efecto de desplazamiento de las curvas estándares hacia 
concentraciones más altas de analito siendo paralelas a la curva del tampón.  Este efecto 
podría atribuirse a los altos niveles de albúminas presentes en el suero. Se han utilizado 
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diferentes procedimientos para la eliminación de las albúminas: ultrafiltración, 
precipitación alcalina (KOH), ácida (HClO4, ácido tricloracético), precipitación térmica 
(65°C) (véase Figura 11.3).  
 
Aunque en algunos casos el efecto matriz fue eliminado en gran parte, el análisis de 
muestras dopadas con varias concentraciones de 2,4,5-TCP ha demostrado que las 
recuperaciones del analito eran menores de 50%. Finalmente, la precipitación de las 
albúminas del suero por disolventes orgánicos (EtOH absoluto) ha permitido una mínima 
dilución del sobrenadante (1/8) para una correcta cuantificación del 2,4,5-TCP. Con este 
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Figura 11.3. Efectos matriz del suero sobre el ELISA para 2,4,5-TCP. A, Suero sin tratar; B.
Ultrafiltración; C. Precipitación térmica a 65C; D. KOH; E. ácido tricloroacético; F. ácido
perclórico; G. etanol absoluto. 
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procedimiento se han conseguido recuperaciones comprendidas entre 76 y 98% para 
muestras dopadas con 3.2 - 32 µg/L 2,4,5-TCP. El procedimiento de precipitación de las 
proteínas con EtOH ha sido menos efectivo en el caso del ELISA de 2,4,6-TCP y una 
dilución de 32 veces ha sido necesaria para eliminar el efecto matriz observado dando 
lugar a un LOD más elevado. Los parámetros característicos para la detección de 2,4,5- y 
2,4,6-TCP en muestras de suero están resumidos en Tabla 11.4.  
 
Tabla 11.4. Concentraciones en muestras de suero (µg/L). 
Parámetros 2,4,5-TCP a 2,4,6-TCP b 
LOD 0.80 ± 0.16 4.576 
IC50 6.46 ± 0.256 85.12 
Rango lineal 1.2 ± 0.144  -  40 ± 6.962 15.04  -  288.8 
a Los valores presentados están obtenidos multiplicando los parámetos de la curva estándar en 1/8 
suero por 8. El suero está precipitado con EtOH. b Los valores presentados están obtenidos 
multiplicando los parámetos de la curva estándar en 1/32 suero por 32. El suero está precipitado 
con EtOH. 
 
Como se desprende de lso resultados que aparecen en la tabla, el método finalmente 
establecido permitiría la aplicación de ambos inmunoensayos en el control biológico y/o 
en la realización de estudios toxicológicos. 
 
11.3.2.4. Muestras de orina 
 
Para la evaluación del ELISA para 2,4,5-TCP y 2,4,6-TCP en muestras de orina se han 
utilizado dos tipos de muestras de personas no expuestas a clorofenoles (población 
general): muestra A (creatinina 1.8 g/L) y muestra B que presenta un pool de orinas de 
diferentes individuos (creatinina 0.8 g/L). Ya que se ha demostrado que la población 
general se encuentra frecuentemente expuesta a clorofenoles no es de extrañar que exista 
un cierto nivel de clorofenoles en la orina [75,81,121,123]). Por este motivo, se llevó a 
término una caracterización previa de las muestras para así determinar la posible 
presencia inherente en estas muestras (A y B) de cloro- y bromofenoles (2,4,5-TCP, 
2,4,6-TCP, 2,3,4,6-TBP, 2,4-DBP, 2,4,6-TBP) que, al producir cierta reactividad cruzada 
en los inmunoensayos, podrían interferir con los estudios destinados a evaluar el efecto 
matriz. Para ello se ha desarrollado un método analítico independiente basado en GC-
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ECD y GC-MS para la determinación de chloro- y bromofenoles. En breve, el 
procedimiento está basado en la extracción de los clorofenoles de la fase acuosa (PBS, 
orina) con tolueno y su posterior derivatización con BSTFA. Se han optimizado las 
condiciones de la extracción y la silanización respecto al tiempo y la temperatura para 
varios niveles de 2,4,6-TCP. La recuperación de muestras dopadas con 1 µg/L y 10 µg/L 
2,4,6-TCP es del 70 y 85%, respectivamente, con una SD del 10%. Siguiendo este 
procedimiento las muestras de orina A y B (no hidrolizadas e hidrolizadas) se han 
analizado por GC-MS y se ha detectado la presencia de varios cloro- y bromo-fenoles. 
Teniendo en cuenta la reactividad cruzada de estos compuestos en los ELISAs y su 
concentración en la muestras de orina se han estimado los equivalentes de 
immunoreactividad correspondientes (véase Tabla 11.5). 
 
Tabla 11.5. Niveles de clorofenol expresados como TCP equivalentes de inmunoreactividad 
orina A orina B Equivalentes totales 
de immunoreactividad hidrolizada no hidrolizada hidrolizada no hidrolizada 
2,4,6-TCP-IR equiv. 0.72 0.16 1.12 0.24 
2,4,5-TCP-IR equiv. 0.155 0.021 0.097 0.033 
Los LOD del 2,4,6- y 2,4,5-TCP ELISA son 0.17 µg/L y 0.053 µg/L respectivamente. 
 
Considerando los límites de detección de los inmunoensayos se ha estimado que las 
muestras de orina no hidrolizada se podrían considerar como una "matriz blanca", 
mientras que las muestras hidrolizadas podrían presentar cierta interferencia específica 
por lo que los niveles de compuestos crossreactantes determinados debían ser 
considerados en la evaluación del efecto matriz. 
 
Para evaluar el efecto de la orina sobre los inmunoensayos se han comparado en paralelo 
las curvas estándares de 2,4,6-TCP (2,4,5-TCP) preparadas en PBS y en la orina (no 
hidrolizada e hidrolizada por varios métodos) diluida con PBS. Los valores del pH y de la 
conductividad de las diferentes diluciones han sido ajustadas dentro del rango funcional 
del inmunoensayo. Tabla 11.6 resume el efecto matriz observado para todos los casos 
estudiados. 
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Tabla 11.6. Resumen del efecto matriz de orinas hidrolizada y no hidrolizada sobre los ELISAs 
para 2,4,5-TCP y 2,4,6-TCP.  
ELISA Tratamiento Muestra de orina 
2,4,5-TCP 2,4,6-TCP 
A 1/100 > 1/100 No hidrolizada 
B 1/5 1/100 
A n.d. > 1/128 Hidrólysis ácida (c.H2SO4) 
B > 1/100 1/200 
A n.d. > 1/200 Hidrólysis enzimática 
(β-glucuronidasa/sulfatasa) B n.d. > 1/200 
El efecto matriz está expresado como la dilución de la orina necesaria para alcanzar el 
comportamiento de la curva estándar en condiciones de tampón. 
 
Como se puede ver una misma muestra (ej. muestra B, no hidrolizada) tiene diferente 
efecto matriz sobre los dos inmunoensayos estudiados: para el caso de 2,4,5-TCP se 
necesita una dilución de la muestra de 5 veces y para el 2,4,6-TCP 100 veces. Muestras 
de orina no hidrolizada dopadas a varios niveles de 2,4,5-TCP se han medido por el 
ELISA después de una simple dilución y las recuperaciones obtenidas fueron entre 96% y 
109% con CV entre 7.2 y 12.7%. En Tabla 11.7 están presentados los niveles de 2,4,5-
TCP y 2,4,6-TCP que se podrían detectar en orina no hidrolizada mediante los dos 
inmunoensayos trás una simple dilución d e la muestra. 
 
Tabla 11.7. Concentraciones en muestras de orina no hidrolizada (µg/L). 
Parámetros 2,4,5-TCP a 2,4,6-TCP b 
LOD 0.26 ± 0.02 17.5 ± 2.7 
IC50 1.28 ± 0.06 113.2 ± 36.1 
Rango lineal 0.52 ± 0.05  -  5.30 ± 0.85 28.8 ± 4.5  -  311.7 ± 67.9 
a Los valores presentados están obtenidos multiplicando los parámetros de la curva estándar en 1/5 
orina por 5. La orina está diluida con PBS. b Los valores presentados están obtenidos 
multiplicando los parámetros de la curva estándar en PBS por 100. 
 
Considerando los valores de referencia (4.5 µg/L) establecidos en Alemania para la 
población no expuesta [81], podríamos concluir que este método podría ser aplicado para 
la determinación de 2,4,5-TCP en orina de personas no expuestas sin ningún tratamiento. 
Por otro lado, el mayor efecto matriz observado para el inmunoensayo de 2,4,6-TCP 
permitiría sólo la evaluación de los niveles de 2,4,6-TCP en trabajadores con exposición 
laboral suficientemente alta. Sin embrago, para la vigilancia de 2,4,6-TCP en la población 
general sería necesario una purificación previa de la muestra. 
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En el caso de las orinas hidrolizadas la inhibición de los inmunoensayos ha sido mayor 
que en el caso de las muestras no hidrolizadas. Los niveles de clorofenoles detectados por 
GC-MS no pueden justificar el efecto de inhibición de la Amax loque lleva a la conclusión 
de la presencia de  interferencias no específicas. Cabe destacar, y así puede observarse en 
la tabla, que muestras de orina de diferentes individuos con diferente concentración de 
creatinina han presentado un efecto matriz diferente, por lo que se pone en evidencia la 
necesidad de desarrollar un método de tratamiento de muestra tanto para orinas 
hidrolizadas como no hidrolizadas. Antes de abordar este tema, se ha explorado la 
posibilidad de eliminar el efecto matriz desarrollando los inmunoensayos no en el tampón 
PBS sino directamente en la orina B de origen comercial y considerada como una muestra 
estándar. Lamentablemente se ha observado de nuevo una variabilidad del efecto matriz 
para muestras de orina de diferentes individuos. Esto impide aplicar los inmunoensayos 
como un método general (universal) para la detección de triclorofenoles en muestras de 
orina sin previa purificación de la muestra. 
 
11.4. Desarrollo de métodos de extracción en fase sólida 
SPE-ELISA para la detección de clorofenoles en orina 
 
Para la purificación de la orina se han estudiado dos métodos de extracción en fase sólida: 
fase reversa e inmunoextracción. El objetivo ha sido i) conseguir una extracción eficiente 
del analito 2,4,6-TCP de la muestra de orina que sea compatible con el método ELISA; ii) 
que se adapte fácilmente al formato de 96 pocillos del las placas de ELISA para así 
mantener la eficiencia del método de screening; iii) que permita alcanzar los límites de 
detección deseados para la monitorización biológica de la población general (alrededor de 
1 µg/L). 
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11.4.1. Fase reversa (C18)-ELISA 
 
La extracción en fase sólida de C18 permite aislar el análito de la muestra en función de 
las diferentes polaridades del analito y la matriz. El procedimiento de purificación se ha 
evaluado inicialmente con tampón PBS y posteriormente con muestras de orina (dopada y 
sin dopar con 2,4,6-TCP) usando minicolumnas de tipo Sep-Pak . La concentración del 
analito en todas las fracciones recogidas ha sido determinada por ELISA después de una 
dilución (1/10) en PBS y/o por GC-ECD. Se ha determinando el perfil de elución del 
2,4,6-TCP empleando diferentes concentraciones del MeOH en el tampón de elución 
(véase Figura 11.4). Como se puede observar la purificación de la orina en fase reversa 
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Figura 11.4. Perfil de elución de C18-SPE clean-up de orina A (dopada y no dopada) para 
varias concentraciones de MeOH en el tampón de elución.Orina no hidrolizada: (A) 65% 
MeOH, (B) 75% MeOH, (C) 85% MeOH; Orina hidrolizada: (D) 85% MeOH. La 
concentración de cada fracción está determinada por ELISA y la recuperación está calculada 
respecto a la cantidad dopada. 
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permite una extracción completa del analito (recuperaciones alrededor de 100%) en 3 mL 
en el caso de elución con 65% MeOH, en 2 mL – 75% MeOH y en 1 mL – 85% MeOH. 
No obstante la orina no dopada también ha producido una respuesta positiva en el ELISA 
que podría ser debida a interferencia específicas y/o no específicas. Deberíamos anotar 
que la respuesta de muestras de orina dopadas no ha sido equivalente en las diferentes 
diluciones seriadas. Esta observación junto con el hecho de que la cantidad total (µg) de 
equivalentes de immunoreactividad de 2,4,6-TCP (2,4,6-TCP-IR equiv.) extraidos de la 
orina no dopada superan la correspondiente cantidad evaluada por GC-MS, nos ha 
llevado a la conclusión de que junto con el analito co-eluyen interferencias no-
específicas. Se ha tenido en consideración que la co-elución de componentes interferentes 
ha sido menor en el caso de elución con tampón 85% MeOH/PBS cuando el analito puede 
ser recogido en una sola fracción de 1 mL.  
 
Se ha evaluado también el efecto matriz de la orina purificada por C18 (veáse Figura 
11.5.). Tal como puede observarse en la Figura 11.5, es necesaria una dilución de 1/25 
para poder determinar 2,4,6-TCP en la orina. Podemos concluir que la introdución de esta 
etapa de purificación mejora el límite de detección de la técnica, ya que ahora es posible 
medir orina diluida tan solo 25 veces lo que supone un límite de detección alrededor de 4 
µg/L. La extracción en fase sólida permite mejorar la detectabilidad del 2,4,6-TCP en la 
orina 6 veces respecto al inmunoensayo directo. Este límite de detección permitiría el 
control biológico de personas expuestas laboralmente. No obstante, es necesario una 
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Figura 11.5. Efecto matriz de la orina A después de purificación por C18-SPE. (A) no 
hidrolizada, (B) hidrolysis ácida. El cartucho de C18 está cargado con 10 mL de orina, 
lavado con 50% MeOH, y eluído con 85% MeOH. La fracción F1 está diluída con PBS 
hasta 10 mL. Las diluciones superiores se han echo en 8.5% MeOH/0.01% AcOH/PBS. 
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purificación más efectiva de la orina para la evaluación de los niveles de triclorofenol en 
la población general. 
 
11.4.2. IAC-SPE-ELISA 
 
La purificación de la orina mediante cromatografía de inmunoafinidad (IAC) permite una 
purificación específica y por lo tanto más eficaz para la eliminación del efecto matriz 
observado. Inicialmente el procedimiento de IAC-SPE fue estudiado usando una columna 
Hi-Trap de una capacidad de 1 mL. La columna de inmunoafinidad se ha obtenido 
mediante la inmovilización de anticuerpos policlonales (fracción de IgG obtenida por 
purificación del antisuero As45) sobre un soporte de Sepharosa NHS-activada con 94 ± 
0.98% (N=3) de eficiencia de acoplamiento. Esto corresponde a una capacidad teórica de 
1.2 ± 1.22 µg (6.27 ± 6.14 nmol) 2,4,6-TCP (N=3) considerando la cantidad de Ab 
acoplado y asumiendo que el 10% de las IgG policlonales son específicas, que la unión 
Ab-Ag es bivalente y que 50% de las IgG no son accesibles debido a su orientación no 
efectiva y/o a un impedimento estérico.  
 
El procedimiento del análisis IAC-ELISA se ha optimizado respecto a varios parámetros: 
condiciones de elución, volumen de la muestra cargada a la columna, tipo de muestra 
(orina no hidrolizada e hidrolizada) y nivel de carga. Inicialmente se ha probado una 
elución con tampón glicina (0.05M Glicina-HCl, pH=3) para tres niveles de carga (97%, 
40% y 4% de la máxima capacidad de la columna). Se ha observado que el perfil de 
elución depende del nivel de carga produciendo una banda muy ancha para cargas 
pequeñas (4%). Debido a esto se ha buscado otro sistema de elusión más efectivo como 
podría ser la utilización de un disolvente orgánico como el EtOH. Inicialmente se ha 
estudiado el efecto de la concentración del EtOH en el tampón de elución con estándares 
de 2,4,6-TCP en PBS. Se ha demostrado que el analito empieza a eluir con un 30% 
EtOH/PBS y que 3 mL de 70% EtOH son suficientes para su extracción completa 
(recuperaciones superiores al 90% para los tres niveles de carga 4%, 40% y 97%). Por lo 
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tanto, se ha escogido este sistema para la elusión efectiva del analito del inmunosorbente 
cargado con muestras de orina. 
 
Mediante GC-ECD se ha evaluado la especificidad de la columna de inmunoafinidad 
respecto a 15 fenoles clorados (mono-, di-, tri-, tetra- sustituidos) bajo diferentes 
condiciones de carga (individual y en mezcla equimolar; en PBS y orina) y tampón de 
lavado (PBS y 20% EtOH/PBS). Se ha observado que el lavado de la columna de 
inmunoafinidad con PBS da lugar a una extracción menos específica (todos los isómeros 
de TCP, TtCP y PCP se retienen por la columna en más de 80%) que podría encontrar 
aplicación como una IAC-SPE selectiva de clase de clorofenoles de muestras de orina 
previa de su cuantificación por técnicas inmunoquímicas o por cromatografía de gases. 
Una extracción más selectiva se consigue mediante un lavado con 20%EtOH/PBS. En 
este caso los principales co-eluyentes son 2,3,4,6-TtCP, 2,4,6.TBP y 2,4-DBP, que son 
precisamente los crossreactantes principlaes del ELISA para la detección de 2,4,6-TCP. 
La selectividad parecida de los anticuerpos usados en la IAC (As45) y el del ELISA 
(As43) se debe al hecho de que fueron generados contra un mismo inmunógeno. La 
especificidad de la columna ha sido considerada al evaluar el efecto matriz de la orinas 
purificada por IAC-SPE. El efecto matriz de orinas (muestras A y B, hidrolizadas y no 
hidorlizadas) están presentadas en la Figura 11.6 donde se observa que la utilización del 
inmunosorbente consigue eliminar en una gran medida el efecto matriz de la orina 
hidrolizada y no hidrolizada.  
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Figura 11.6. Efecto matriz de la orina A hidrolizada con ácido purificada por IAC-SPE sobre el 
ELISA de 2,4,6-TCP. A. lavado con PBS; B. 20%EtOH. La elución es con 70% EtOH. La 
fracción recogida de 3 mL ha sido diluída con PBS 10 veces. Las diluciones consecutivas se 
han hecho en 7% EtOH/PBS. 
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Un análisis del extracto por GC-ECD y la posterior confirmación de los compuestos 
fenólicos por GC-MS ha revelado que la ligera inhibición de la Amax , todavía visible al 
introducir una etapa de lavado con un 20% de EtOH, se debe a interferencias específicas, 
i.e. al hecho de que las muestras de orina usadas no presentan una "muestra blanca". Por 
lo tanto, puede considerarse que la eliminación del efecto matriz procedente de 
interferencias no específicas, es prácticamente total al usar inmunosorbentes. 
 
La recuperación de la IAC del 2,4,6-TCP de muestras de orina depende del volumen de la 
muestra a purificar y del nivel del dopaje. Como se puede ver en Figura 11.7 para orina 
no hidrolizada el volumen de ruptura es más de 50 ml para una carga de 5 ng 2,4,6-TCP 
(4% nivel de carga de la columna) y unos 2 ml para niveles más altos (500 ng TCP, 40%). 
En general la recuperación del TCP de muestras de orina hidrolizada ha sido más baja que 
la de no hidrolizada para un volumen y nivel de carga constantes. Para niveles de carga 
bajos (4%) la recuperación en la orina hidrolizada por ácido está alrededor del 50% al 
introducir 30 mL como volumen de muestra, y para niveles de carga superiores (40%) el 
volumen de ruptura es sólo 5 mL.  
En base de estos resultados se ha seleccionado 10 mL como un volumen adecuado de 
muestra que permita asegurar la extracción del TCP con una recuperación superior al 
80%. El efecto de la carga sobre la recuperación de orinas no hidrolizada e hidrolizada 
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Figura 11.7. Efecto del volumen y la carga de la muestra sobre la recuperación del IAC-SPE
(lavado con PBS y elución con 70% EtOH. La máxima capacidad de la columna corresponde a
1.2 µg 2,4,6-TCP. 
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por ácido (H2SO4) y base (KOH) está presentado en Figura 11.8. Excelentes 
recuperaciones se han obtenido para los tres tipos de orina hasta un nivel de carga de 4%. 
La columna de inmunoafinidad puede extraer eficazmente 200 ng 2,4,6-TCP (16% de 
carga) de orinas no hidrolizada y hidrolizada en medio básico cuando el volumen de 
muestra es de 10 mL. A pesar de esto la capacidad de la columna para orina hidrolizada 
en medio ácido es inferior: 50 ng 2,4,6-TCP (4% de carga). Una comparación de las 
posibles pérdidas de 2,4,6-TCP durante el proceso de hidrólisis (alcalina y ácida) ha 
demostrado que ambos métodos producen una recuperación del TCP similar (alrededor de 
75-80%), por lo tanto la hidrólisi de la orina en medio básico sería el método de elección 
para el caso de un programa de control biológico.  
 
La validación del método IAC-ELISA por GC-ECD ha demostrado una correlación 
excelente para orina hidrolizada y no hidrolizada en el intervalo 2 - 20 µg/L. El protocolo 
fue aplicado a muestras de orina procedentes de diferentes individuos obteniéndose 
recuperaciones entre 80% y 115%, lo que demostró la versatilidad del método 
desarrollado. Finalmente se ha de mencionar que una misma columna de inmunoafinidad 
ha sido estable después de 60 ciclos de análisis. 
 
Concluyendo, el protocolo optimizado de IAC-ELISA consiste de los siguientes etapas: 1. 
hidrolizar la orina; 2. introducir 10 mL de muestra en el inmunosorbente; 3. lavar con 
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Figura 11.8. Efecto del nivel de carga sobre la recuperación de IAC-SPE de orinas 
hidrolizadas y no hidrolizadas (volumen de la muestra 10 mL, lavado con 20% EtOH y 
elución con 70% EtOH).  
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5mL de 20% EtOH (para el caso de un análisis total de clorofenoles, un lavado con PBS 
es suficiente); 4. eluir con 3 mL de 70% EtOH y 5. diluir las fracciones en PBS 10 veces 
(7% EtOH, final) y analizarlas por el ELISA. El LOD del método IAC-ELISA está 
determinado por el LOD del ELISA en 7% EtOH/PBS (0.2 µg/L), los factores de la 
recuperación de la inmunoextracción y de la etapa de hidrólisis y finalmente del hecho de 
que bajo las condiciones del procedimiento establecido la muestra inicial se diluye 3 
veces. Para casos en los que se necesite disminuir aún más el LOD, se ha comprobado 
que una dilución de tan solo 5 veces de las fraciones de elusión (14% EtOH final), 
también permitirián el análisis por ELISA. En Tabla 11.8 se reúnen los LOD y los 
niveles máximos que se pueden detectar cuantitativamente (recuperación superior a 70%) 
para cada tipo de orina. 
 
Tabla 11.8. Rango de concentraciones para una determinación cuantitava de 2,4,6-TCP en 
diferentes orinas por el método de IAC-SPE-ELISA. 
Orina LOD a, µg/L MCM b, µg/L 
No hidrolizada 0.66 50 
Hidrólisis ácida 0.83 5 
Hidrólisis básica 0.99 20<MDC<50 
a LOD7%EtOH/PBS=0.2 µg/L está corregido con las correspondientes recuperaciones de la extracción 
IAC y hidrólisis. b MCM (máxima concentración medida con recuperación >70%) 
 
2,4,6-TCP libre se puede determinar con un LOD de 0.66 µg/L 2,4,6-TCP-IR equiv.en 10 
mL de orina no hidrolizada. La orina no hidrolizada puede ser extraida eficazmente hasta 
unos 50 µg/L de 2,4,6-TCP. Para orina hidrolizada el LOD es alrededor de 0.83 µg/L 
2,4,6-TCP-IR equiv. para hidrólisis ácida y 1 µg/L 2,4,6-TCP-IR equiv.para hidrólisis 
básica. 2,4,6-TCP puede ser extraído cuantitativamente en muestras de orina con un 
contenido en TCP entre 0.83 y 5 µg/L en orina hidrolizada por ácido y entre 1 y 20 µg/L 
en orina hidrolizada por KOH. Para concentraciones mayores de 20 µg/L el análisis 
debería ser repetido después de una dilución de la orina. 
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11.5. Desarrollo de un método HTS-IAC-SPE para la 
detección de clorofenoles en orina 
 
El procedimiento de IAC-SPE-ELISA está limitado principalmente por el tiempo 
necesario para la purificación de una muestra de orina. Ya que el análisis clínico y el 
control biológico exigen un análisis rápido y eficaz de un gran número de muestras se ha 
propuesto de adaptar el protocolo de IAC-SPE a un formato de 96 pocillos (high 
throughput screening, HTS), lo que permitiría la cuantificación simultánea de los 
extractos de orina por ELISA en el mismo formato. Para ello se ha usado el sistema 
comercial Versaplate 96-Well SPE (Varian, Palo Alto). Como soporte se ha usado 
Sepharosa NHS-activada, a la cual se ha acoplado covalentenmente el anticuerpo Ab45 
en batch. Se han empaquetado las 96 columnas con 200 µL (suspensión) del 
inmunosorbente preparado y han sido caracterizadas de una manera similar al descrito 
anteriormente respecto der su capacidad, las condiciones de elución y de lavado, el efecto 
del EtOH, la estabilidad, etc., utilizando el sistema Versaplate conectado al vacío 
mediante un regulador como sistema de elusión. La capacidad máxima de cada columna 
(lecho 0.2 ml) es de 0.5 µg (0.25 nmol) 2,4,6-TCP (CV% = 4.7, N=10). Las columnas 
fueron estables hasta después de 40 ciclos de uso. Un lavado con 20% EtOH se puede 
realizar sin pérdidas del analito retenido a un nivel de carga de 10% de la máxima 
capacidad de la columna (50 ng 2,4,6-TCP, 6 mL, 8 µg/L). A niveles de carga más 
elevados (40%) correspondientes a 200 ng 2,4,6-TCP (32 µg/L) se ha observado que 
6.8% del analito puede eluir en las fracciones de lavado con el 20% de EtOH. Estos 
niveles de TCP son bastante elevados y, en principiio, solo se habrían de encontrar en 
grupos con un alto riesgo de exposición. En base a este comportamiento se ha decidido 
usar 20% EtOH.  
 
El protocolo establecido para el IAC-SPE-ELISA del apartado anterior fue adaptado a 
volúmenes menores: 6 mL carga de muestra de orina; 1.2 mL de lavado con 20% EtOH; 
0.6 mL elución 70% EtOH/PBS, regeneración de la columna con 1.2 mL de PBS. Las 
fracciones recogidas se diluyen 10 veces con PBS y se pueden analizar por ELISA o por 
GC-ECD (GC-MS). Siguiendo el protocolo HTS-IAC-ELISA se ha evaluado la precisión 
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y la exactitud de la extracción por 96 columnas con controles de tampón PBS y orina 
hidrolizada (KOH) a tres niveles de concentración (0.7, 2, 8 µg/L 2,4,6-TCP). La 
recuperación del analito (superior a 80%) y los CV% (inter-ensayo 17-23% (N=24); intra-
ensayo 6-11% (N=72)) demuestran que el método HTS-IAC-ELISA permite una correcta 
cuantificación de 2,4,6-TCP en muestras de orina y que es consistente y fiable.  
 
En Tabla 11.9 están resumidas las características de los dos métodos (IAC-SPE-ELISA y 
HTS-IAC-ELISA). El método HTS-IAC-ELISA ofrece la ventaja de un tratamiento de 
muestras por día mucho mayor que en el caso del uso de una columna. Se pueden 
procesar 100 muestras/día con un LOD alrededor de 0.3 µg/L 2,4,6-TCP-IR equivalentes. 
La otra ventaja del HTS-IAC-ELISA es el LOD más bajos debido al hecho de que no es 
necesario diluir la muestra de orina después de la purificación. 
 
Tabla 11.9. Características del análisis de 2,4,6-TCP en orina mediante IAC-ELISA y HTS-IAC-
ELISA 
Parámetros IAC-ELISA HTS-IAC-ELISA 
volumen de muestra 10 mL 6 mL 
clean-up dilución 1/3 no se diluye 
velocidad del IAC 96 muestras/ 8 días 96 muestras/ 1 hora 
velocidad del análisis total 96 muestras/ 9 días 96 muestras/ 1 día 
LOD a, µg/L 0.99 0.3 
LOQ b, µg/L 1.4 0.55 
MCM c, µg/L 20<MDC<50 30 
% CV d 5.1-18.4% para 5-30 µg/L 17.4 – 22.9% para 0.7 – 8 µg/L 
Número de falsos positivos 0 0 
Número de falsos negativos 0 0 
a El límite de detección esta evaluado según el LOD del ELISA (LOD7%EtOH/PBS=0.2 µg/L, 
correspondiente a 90% de la señal de cero concentración) y las correspondientes recuperaciones de 
la extracción IAC y la hidrólisis. b El límite de cuantificación está evaluado según el LOD del 
ELISA (LOQ7%EtOH/PBS=0.37 µg/L, correspondiente a 80% de la señal de cero concentración) y las 
correspondientes recuperaciones de la extracción IAC y la hidrólisis. c MCM (máxima 
concentración medida con recuperación >70%). d El coeficiente de variación (% CV) corresponde 
a interday análisis. 
 
El método HTS-IAC-SPE-ELISA ha sido validado por GC-MS analizando 117 muestras 
de orina hidrolizada de diferentes individuos. Se han determinado los niveles de 2,4,6-
TCP, 2,4,5-TCP, 2,4-DBP, 2,3,4,6-TtCP y 2,4,6-TBP por análisis de GC-MS y se han 
calculado los correspondientes equivalentes de inmunoreactividad de 2,4,6-TCP según la 
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reactividad cruzada del inmunoensayo. Considerando los 2,4,6-TCP-IR equiv. se ha 
obtenido una correlación muy buena entre los resultados obtenidos por GC-MS y por 
ELISA (y=1.14x-0.21, r2=0.912). 
 
Finalmente el método se ha aplicado al control biológico de tres grupos de población: 
trabajadores en oficinas de servicio, trabajadores en una industria petroquímica y 
población vecina a una incineradora de residuos municipales. Los resultados del análisis 
por el método HTS-IAC-SPE-ELISA están presentados en Tabla 11.10.  
 
Tabla 11.10. Niveles de 2,4,6-TCP-IR equivalentes en orina de tres grupos de población.  
Población N Mean±SD Min 5% 25% 50% 75% 95% Max 
Trabajadores 
en oficinas 
41 1.33±0.78 0.42 0.61 0.85 1.13 1.44 2.67 4.69 
Trabajadores 
en petroquímica 
43 1.90±1.68 0.18 0.65 0.92 1.33 2.02 5.68 8.06 
Vecinos a una 
incineradora 
33 3.86±4.36 0.59 0.78 1.54 2.19 3.93 14.47 22.69 
Las concentraciones están determinadas por HTS-IAC-ELISA y expresadas en µg/g creatinina. El 
LOD es 0.17 µg/g creatinina. 
 
Se puede observar que los valores característicos de la distribución estadística (la media, 
50%, 95% y el valor máximo) son más bajos para los trabajadores de oficinas seguidos 
por los de la industria petroquímica y finalmente con niveles más elevados son los 
vecinos a la incineradora de residuos. Es difícil explicar estos resultados ya que no 
disponemos de información sobre el riesgo real de exposición a compuestos 
organoclorados de los tres grupos, tampoco de sus hábitos particulares y su estado de 
salud. Hay que destacar que las incineradoras se consideran como fuentes de emisión de 
clorofenoles, hexaclorobenceno, hidrocarburos poliaromáticos y dioxinas [374,436], a 
pesar de que la exposición interna real y los efectos sobre la salud de la población son 
todavía cuestión de controversias [35,102,123,375,376,378,437].  
 
Los niveles de cloro- y bromophenoles determinados por GC-MS están presentados en 
Figura 11.9. La excreción de 2,4,6-TCP se observa en el grupo de trabajadores 
petroquímicos, a pesar de que los niveles determinados por nosotros son similares con los 
valores encontrados para la población general de la misma cuidad [118]. La excreción de 
Resumen 
 294
2,3,4,6-TtCP es similar para los tres grupos estudiados. Es sorprendente el mayor nivel de 
fenoles bromados (2,4-DBP, 2,4,6-TBP) en el grupo de vecinos a la incineradora, a pesar 
de que la fuente de compuestos oragonobromados puede ser relacionada con la 
contaminación del agua potable, de la comida y/o el medio ambiente en general debido al 
uso de agentes ignífugos [315,316]. Finalmente, cabe destacar que los niveles de 
triclorofenoles en las orinas de los grupos estudiados son menores de los valores de 
referencia establecidos en Alemania [81] y Estados Unidos [75].  
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Figure 11.9. Descripción de las concentraciones cloro- y bromo- fenoles en la orina de
trabajadores de la petroquímica, de oficinas y de vecinos de una incineradora. Las marcas
superiores corresposnden al 95% de la distribución, las del medio al valor medio y las
inferiores al 5%. Las concentraciones están determinadas por HTS-IAC-GC/MS y
expresadas en µg/g creatinina. Los límites de detección son 0.08 µg/g creatinina para
TCPs y 0.16 µg/g creatinina para DBP, TtCP y TBP. 
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11.6. Desarrollo de un inmunoensayo de quenching con 
fluorescencia inducida por láser con detección en 
microgotas (LIF-QFIA en microgotas) 
 
La fluorescencia inducida por láser en microgotas (volumen alrededor de pL) permite la 
detección de compuestos fluorescentes a nivel molecular [382,383]. Una de las ventajas 
más importantes relacionadas con la detección en microgotas es la reducción del ruido de 
fondo que conduce a límites de detección mucho más bajos que las técnicas de análisis en 
muestras de volumen grande. Con estos antecedentes se ha propuesto demostrar que es 
posible realizar un fluoroinmunoensayo de quenching con detección de la fluorescencia 
inducida por láser en microgotas. Este trabajo se ha realizado en colaboración con los 
grupos de Dr. I. Kennedy y Dr. B. Hammock de University of California - Davis. 
 
En primer lugar se ha sintetizado un conjugado entre el marcador fluorescente 
fluoresceinamina y el hapteno 5 (TCP-F). El producto fue purificado por capa fina y 
caracterizado por RMN. Las propiedades ópticas del conjugado fluorescente han sido 
caracterizados inicialmente en un espectrofotómetro estándar, donde se determinaron la 
longitud de onda de máxima excitación (490 nm) y emisión (520 nm). 
 
La detección de la fluorescencia inducida por laser (Ar, 488 nm) en microgotas se realizó 
mediante un dispositivo formado por un generador de microgotas, un láser y un 
espectrómetro acoplado a una CCD cámara . Las microgotas generadas tenían un 
diámetro de 58 µm (volumen 104 pL). Se ha construido una recta estándar de la 
intensidad de la fluorescencia en función de la concentración del trazador TCP-F. Se ha 
estimado un límite de detección absoluto correspondiente a 5x10-10M (0.5 nM o 5.2 x 10-
20 mol TCP-F) por microgota.  
 
Se ha estudiado la cinética del quenching de la fluorescencia del trazador TCP-F debido a 
su unión con el anticuerpo específico (As43) para varias concentraciones de anticuerpo. 
Se ha determinado también que el tiempo de equilibrio de la reacción inmune es 45 min. 
Mediante una titulación del As43, se ha determinado la concentración de 2.5 µg/mL 
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necesaria para observar unos 80% de quenching de la señal máxima de fluorescencia del 
trazador (véase Figura 11.10). Bajo las condiciones seleccionadas se ha realizado la 
detección de 2,4,6-TCP en las microgotas mediante un fluoroinmunoensayo homogeneo 
competitivo: a concentraciones bajas de analito, el competidor TCP-F está unido al 
anticuerpo y por lo tanto se observa quenching de su fluorescencia; una concentración 
más alta de 2,4,6-TCP provoca el aumento de la intensidad de la fluorescencia debido a la 
presencia de competidor libre (véase Figura 11.11).  
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Figura 11.10. B. Espectro de emisión de la fluorescencia del trazador TCP-F (10 nM) (1) y
su quenching por varias concentraciones de Ab43 en 10 mM PBS: 0.6 µg/mL (2), 2.5
µg/mL (3), 15 µg/mL (4); 15 µg/mL Ab43 en ausencia de TCP-F (5). C. Curva de titulación
del trazador TCP-F y Ab43. Los reactantes han sido incubados por 45 min. La reducción en
la intensidad de la fluorescencia está presentada como la relación entre la fluorescencia de
TCP-F en presencia de Ab43 (IAb) y la fluorescencia de TCP-F sin Ab (ITCP-F). 
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Figura 11.11. Curva de calibarción del ensayo LIF-QFIA para 2,4,6-TCP en microgotas de
tampón PBS y orina diluida 50 veces en tampón. 
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Los parámetros de la curva de calibración del fluroinmunoensayo en microgotas de 
tampón PBS están comparados con el correspondiente ensayo realizado en placa de 96 
pocillos y también con el ensayo ELISA basado en los mismos inmunoreactivos (As43, 
hapetno 5 como competidor) (veáse Tabla 11.11). 
 
Tabla 11.11. Parámetros de los dos inmunoensayos (ELISA y LIF-QFIA) para 2,4,6-TCP. 
ELISA a QFIA 
  microplaca LIF-microgotas 
IC50 (µg/L) 2.74  4.2 0.45 
LOD (µg/L) 0.2 (1 nM) 0.36 (1.8 nM) 0.04 (0.2 nM) 
LOD (ng) 4 x 10-2  
(2x10-13 mol) 
7.2x10-2  
(3,7x10-13 mol) 
1.68x10-4  
(9,7x10-16 mol) 
Trazador 5-HRP 5-Fluoresceina 5-Fluoresceina 
Procedimiento lavados e 
incubaciones 
ensayo heterogéneo ensayo homogéneo 
Excitación - 485 nm (20nm band) láser, 488 nm 
Volumen, µL 200  200 4.2 
a – los datos son de [259] 
 
La significante mejora en la detectabilidad del QFIA en microgotas se debe sobre todo a 
una relación señal-ruido mayor, ya que el fluoroinmunoensayo en microplaca sufre mayor 
ruido de la señal fluorescente. También se debería considerar la posible adsorción 
inespecífica de algunos inmunoreactantes o analitos no polares a los pocillos. Los 
pequeños volumenes de las microgotas minimizan las interferencias en la señal de la 
fluorescencia debido a la dispersión de Raman y Rayleigh. Además, el uso del láser como 
fuente de excitación y la cámara CCD para la detección de la señal emitida permiten 
alcanzar niveles de detección tan bajos. 
 
El fluoroinmunoensayo fue realizado también en microgotas de muestras de orina. El 
efecto matriz debido al ruido de fondo procedente de la fluorescencia de los componentes 
de la orina y debido a la inhibición de la interacción Ag-Ab ha sido eliminado mediante 
una dilución de 50 veces, lo que determina un LOD del método analítico de 1.6 µg/L 
2,4,6-TCP en orina. Este nivel de detectabilidad permite la utilización de este método en 
estudios de la evaluación de la exposición laboral a productos halogenados. 
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La técnica de LIF-QFIA-microgotas podría ser la base para el desarrollo de nuevos 
sensores ópticos miniaturizados. Este trabajo es la primera aplicación de un ensayo QFIA 
con detección en microgotas a muestras de orina demostrando el potencial de esta 
técnicas para el desarrollo de nuevos sistemas de detección bioanalíticos. 
 
11.7. Producción de fragmentos de anticuerpo anti-
digoxina (scFv) por el método de phage display como 
elementos de bioreconocimiento en inmunosensores 
 
La exposición de fragmentos de anticuerpos en la superficie de bacteriófagos 
filamentosos y la posterior selección del fago con el antígeno deseado ha proporcionado 
una manera eficaz de producir fragmentos de anticuerpos de bibliotecas genómicas  y 
también ha impulsado el diseño de novedosos fragmentos recombinantes [160,161]. Estas 
técnicas permiten crear fragmentos de Abs con propiedades que aseguren su 
inmovilización ordenada sobre la superficie de los inmunosnesores. La fusión genética de 
marcajes (tag) con fragmentos de cadena simple (scFv) de anticuerpos ha sido expresada 
con un buen rendimiento a través de la secreción de bacterias [425]. En este contexto se 
ha propuesto producir una proteína de fusión entre el tag calmodulina y un fragmento 
scFv de anticuerpo anti-digoxina con el objetivo de ser aplicada como elemento de 
bioreconocimineto de un inmunosensor de configuración modular. La naturaleza ácida de 
la calmodulina (carga neta –24 a pH=8) aseguraría la inmovilización orientada del 
fragmento scFv por fuerzas electrostáticas sobre la superficie del inmunosensor. Se ha 
elegido como analito la digoxina dado su elevado interés clínico y farmacológico. La 
digoxina es un fármaco cardíaco cuyo estrecho rango terapéutico (5x10-4 – 2x10-3 mg/L) 
exige su monitorización exacta y rápida en suero con el fin de establecer una posología 
adecuada. Este trabajo d eha realizado en el grupo de Dr. G. Winter de Medical Research 
Council, Centre for Protein Engineering (Cambridge, UK) y en colaboración con el grupo 
de Dra. E.Domínguez de la Facultad de Farmacia, Universidad de Alcalá de Henares y 
Dr. I. Katakis de Universidad Rovira y Virgili. 
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Para la selección de scFv con especificidad anti-digoxina se han usado dos bibliotecas 
"sintéticas" de formato phagemid/scFv (~108 clones) basadas en single human framework 
para los dominios VH y Vk con diversidad de las cadenas laterales DVT y NNK en 
ciertas posiciones de las regiones determinantes de complementaridad (CDR2, CDR3). 
Las bibliotecas fueron objeto de tres ciclos de selección en inmunotubos derivatizados 
con digoxina-BSA. Cada ciclo de selección consiste en la unión del fago al antígeno 
inmovilizado, la elución del fago unido y la propagación del fago seleccionado para un 
siguiente ciclo [431]. Se han inducido fragmentos scFv solubles de colonias aisladas de 
bacterias infectadas por los fagos seleccionados. Los sobrenadantes bacterianos que 
contienen scFv monoclonales se han ensayado para su especificidad de unión al antígeno 
por ELISA usando placas tapizadas de digoxina-BSA y digoxina-HRP y por resonancia 
de plasmones de superficie (Surface Plasmon Resonance, SPR). Unión positiva se ha 
observado sólo para los fragmentos scFv producidos de fagos seleccionados de las 
bibliotecas con diversidad DVT. Los V-genes de los clones positivos se han amplificado 
mediante la reacción en cadena de la polimerasa (PCR) y su secuencia de nucleótidos se 
ha determinado por el método del terminador de la cadena (Sanger). El análisis secuencial 
ha mostrado que todos los clones positivos tienen la misma secuencia de DNA para los 
dominios Vk y VH. 
 
Para añadir el gen de calmodulina se ha clonado el gen que codifica el fragmento scFv 
anti-digoxina en el vector pDN152 [425]. La fusión se ha verificado a través de PCR 
screening. La proteína de fusión (CAL-scFv) se ha expresado mediante la secreción de la 
bacteria y su especificidad de unión a la digoxina se ha comprobado por ELISA. La 
fusión también se ha confirmado con electroforesis en gel de poliacrilamida (la fusión 
CAL-scFv (45 kD); el fragmento scFv (28 kD). La proteína CAL-scFv se ha purificado 
del caldo de cultivo mediante cromatografía DEAE de intercambio iónico. Para conseguir 
una purificación mejor la proteína eluída fue purificada adicionalmente con cromatografía 
de proteína A Sepharose. 
 
Con la proteína obtenida CAL-scFv se ha desarrollado un ELISA competitivo para la 
detección de digoxina (veáse Tabla 11.12). El rango lineal del ensayo cubre el rango 
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terapéutico de la digoxina (5 x 10-4 – 2 x 10-3 mg/L) lo que permitiría su aplicación para 
un control toxicológico. 
 
Tabla 11.12. Parámetros del ELISA (scFv-CAL/digoxina-HRP) para la detección de digoxina 
Condiciones Valores Parámetro Valores 
Tiempo de competencia 2 h Amax 0.75 
pH 7.2 Amin 0.03 
Conductividad 15 mS/cm IC50, mg/L 0.016 
Tween 20  0.05% Rango lineal, mg/L 1,2.10-4 – 0.8 
  pendiente 0.6 
  r2 0.996 
 
Finalmente, se ha estudiado la incorporación de los fragmentos producidos en una 
configuración de multicapas [424]. La deposición layer-by-layer de un polímero redox y 
del fragmento CAL-scFv ordenadamente adsorbidos sobre chips de oro ha sido 
monitorizada por SPR. Se ha detectado la formación de monocapas estables de cada uno 
de los componentes de la configuración modular propuesta (Au derivatizado con carga 
negativa/polímero redox con carga positiva/scFv-CAL/digoxina-HRP). Estos resultados 
preliminares demostraron la viabilidad de la configuración propuesta para la 
inmovilización ordenada de fragmentos de anticuerpo que presentan la mínima unidad 
necesaria para el reconocimiento analítico. La optimización de la deposición de las 
monocapas y la construcción de un inmunosensor electroquímico serían los próximos 
objetivos a conseguir. 
 
 
11. 8. Conclusiones 
 
1. Durante el trabajo de investigación de la presente tesis doctoral se ha desarrollado un 
inmunoensayo enzimático ELISA para la detección de 2,4,5-TCP. Basándose a estudios 
semiempíricos de modelización molecular se han elegido dos haptenos como 
inmunogenos para la producción de anticuerpos específicos contra 2,4,5-TCP. Los 
resultados experimentales en los inmunoensayos confirmaron los estudios teóricos.  
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2. En formato no competitivo (directo e indirecto) de los inmunoensayos estudiados se ha 
observado un mejor reconocimiento para las combinaciones homólogas y 
quasihomólogas. El mejor inmunoensayo ha sido As53/7-OVA(1:2.5) con densidad de 
hapteno igual a 10 mol hapteno/mol de proteína. Su LOD es de 0.053 µg/L y su IC50 es de 
0.231 µg/L.. Se ha puesto en evidencia que la detectabilidad está afectada por varios 
factores, tales como la estructura de la molécula (geometría y carga), el método de 
conjugación empleado en la preparación de los antígenos de tapizado, la densidad de 
haptenos en los antígenos de tapizado, el tipo de proteína empleada. Se ha demostrado 
que los mejores ensayos competitivos se han conseguido con los competidores con mayor 
grado de homología respecto al analito. Se ha demostrado también que la detectabilidad 
de los ensayos mejora con la disminución del grado de conjugación (densidad de hapteno) 
alcanzando mejores valores en el caso de 3 ó 5 moléculas de hapteno por molécula de 
proteína.  
 
3. El inmunoensayo As53/7-OVA es estable entre pH de 6.6. y 10.5. La detectabilidad del 
inmunoensayo mejora con el aumento de la conductividad del medio. Se han establecido 
como condiciones óptimas las siguientes condiciones: tiempo de competencia 30 min; 
pH=7.5; salinidad 20 mS/cm; concentración del Tween 20 de 0.025%. El inmunoensayo 
es muy específico y su selectividad es relacionada directamente con la presencia del 
grupo fenólico, dos átomos de cloro (en posiciones orhto y para del anillo aromático) y 
un átomo de hidrógeno en posición meta. Los compuestos con mayor reactividad cruzada 
son 2,4,6-TCP, 2,3,4,6-TtCP 2,4-DBP y 2,4,6-TBP. 
 
4. Como muestras ambientales se ha estudiado agua potable. Es necesario tamponar la 
muestra antes de analizarla por ELISA. Se han conseguido LOD de 2,4,5-TCP de 0.07 
µg/L y para 2,4,6-TCP de 0.18 µg/L lo que permite la evaluación d ela contaminación de 
agua de bebida según las exigencias de la UE. El análisis de TCP en muestras de agua 
tiene una precisión y exactitud muy buena. 
 
5. La determinación de 2,4,5- y 2,4,6-TCP en muestras de leche por los ELISAs 
respectivos sin ningún tratamiento de la muestra no es posible debido a una fuerte 
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inhibición. Precipitación de las proteínas y los iones de calcio presentes en la leche no ha 
mejorado el funcionamiento de los ensayos. Para el análisis de clorofenoles en leche sería 
necesario desarrollar un método de previa purificación de la muestra para eliminar el 
efecto matriz observado. 
 
6. La evaluación de los dos inmunoensayos en suero humano ha demostrado que el mejor 
tratamiento de la muestra es la precipitación de las proteínas del suero con etanol 
absoluto. Una simple centrifugación para eliminar las proteína precipitadas y la posterior 
dilución del sobrenadante con PBS son el único tratamiento necesario antes del análisis 
de los clorofenoles por ELISA. Los LOD conseguidos son 0.8 µg/L 2,4,5-TCP y 4.6 µg/L 
2,4,6-TCP. Los inmunoensayos podrían ser aplicados en estudios toxicológicos y control 
biológico de la población general. 
 
7. Los dos inmunoensayos se han evaluado en muestras de orina caracterizadas por su 
presencia de cloro- y bromofenoles que podrían presentar una interferencia específica. Se 
ha observado una inhibición de la señal máxima en las muestras de orina no hidrolizada e 
hidrolizada que se puede eliminar con una dilución apropiada de la muestra. Este 
procedimiento permite analizar con buena exactitud muestras de orina no hidrolizada con 
LOD de 0.26 µg/L 2,4,5-TCP y 17.5 µg/L 2,4,6-TCP. Por lo tanto, el inmunoensayo para 
2,4,5-TCP podría ser aplicado en la monitorización biológica de la población general, 
pero el de 2,4,6-TCP se podría usar sólo en el caso de la evaluación de población con alto 
riesgo de exposición . El efecto matriz en muestras de orina hidrolizada es mayor y es 
debido a interferencias específicas y no específicas. Se ha observado que muestras de 
diferentes individuos han ejercido un efecto matriz diferente sobre los dos 
inmunoensayos. Debido a la limitada detectabilidad de los inmunoensayos y la 
variabilidad del efecto matriz para los diferentes individuos ha sido necesario desarrollar 
un método de purificación de la orina para poder analizarla por ELISA. 
 
8. La introducción de una extracción en fase sólida por C18 previa al análisis de 2,4,6-TCP 
en muestras de orina ha eliminado una gran parte de las interferencias inespecíficas. Una 
dilución de 25 veces es necesaria para la correcta determinación de 2,4,6-TCP. Esto ha 
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resultado en una mejora del LOD del método que en este caso sería alrededor de 4 µg/L 
2,4,6-TCP.  
 
9. El observado efecto matriz de la orina fue eliminado combinando ELISA con una 
previa purificación mediante extracción de inmunoafinidad (IAC). El procedimiento de 
IAC-ELISA fue evaluado y optimizado respecto a varios parámetros como tipo de la 
hidrólisis, volumen de la muestra, condiciones de elución, etc. Las columnas son estables 
hasta 55 ciclos. 2,4,6-TCP en orina no hidrolizada se puede determinar con un LOD de 
0.66 µg/L y un MCD de 50 µg/L. Orina hidrolizada (ácido) se puede cuantificar 
correctamente en el rango 0.83 – 5 µg/L y orina hidrolizada por KOH – en el rango 1-20 
µg/L. El clean-up de iAC puede ser usado también con una técnica de análisis GC-MS 
(GC-ECD). La técnica inmunoquímica desarrollada se podrá aplicar en la monitorización 
de bajo coste de la exposición ocupacional a clorofenoles y otros contaminantes 
halogenados. 
 
10. Se ha desarrollado un IAC en formato de 96 columnas (HTS-IAC-ELISA). Las 
ventajas principales del método son el aumento de la velocidad del análisis (100 
muestras/día) y la mejor detectabilidad (LOD 0.3 µg/L 2,4,6-TCP; LOQ es de 0.55 µg/L). 
No se observan falsos positivos y negativos. 
 
11. El método HTS-IAC-ELISA ha sido validado por GC-MS y aplicado en un estudio 
previo de monitorización de tres grupos de poblaciones. Los niveles de triclorofenoles 
determinados en la población de Ctaluña no exceden los niveles establecidos como 
valores de referencia en otros países (Alemania, USA). 
 
12. Se ha desarrollado un novedoso sistema de inmunodetección basado en la 
fluorescencia inducida por láser en microgotas. El método tiene una detectabilidad mejor 
que el fluoroinmunoensayo realizado en micropaca y del ELISA correspondiente. Una 
dilución d ela orina permite el análisis de muestras de orina con LOD de 1.6 µg/L. El 
método desarrollado es la base para el desarrollo de un biosensores ópticos 
miniaturizados. 
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13. Se ha realizado el diseño dirigido de una proteína de fusión entre la calmodulina y un 
fragmento scFv anti-digoxina, seleccionado de bibliotecas sintéticas de V genes humanos. 
La nueva proteína producida podría aplicarse como elemento de bioreconocimiento en un 
novedoso inmunosensor de digoxina permitiendo la inmovilización ordenada del 
fragmento del anticuerpo. Con relación a eso será necesario un estudio de las propiedades 
de la proteína CAL-scFv como afinidad, especificidad, estabilidad, etc.  
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